Effects of dual-task functional power training on cognitive function, well-being and inflammatory and neurological markers in older adults by Tait, Jamie L.
  
 
 
 
Effects of Dual-Task Functional Power Training on 
Cognitive Function, Well-Being and Inflammatory and 
Neurological Markers in Older Adults 
 
by 
Jamie L. Tait 
Bachelor of Exercise and Sport Science (BEx&SpS Hons)  
Bachelor of Science (BSc) 
 
Submitted in fulfilment of the requirements for the degree of 
Doctor of Philosophy 
 
 
 
Deakin University 
December 8th, 2017 
 
 


  
iv 
 
1. Acknowledgements 
To paraphrase one of my favourite artists; at times completing this thesis has been akin 
to crawling onto the end of a tree branch and begging for it to be cut off. But for some 
reason I just kept climbing the tree!  
 
Initial thanks and heapings of praise must be bestowed upon my sublime supervisory 
team; Prof. Robin Daly, Dr. Rachel Duckham, Dr. Catherine Milte and Dr. Luana 
Main. Your direction, guidance and support has been amazing, has been invaluable for 
my future endeavours and career, and has taught me many life lessons that I will not 
soon forget. 
 
I also have to thank the participants who generously donated 18 months of their life to 
this study. Without you my PhD would not have been possible, I would not have 
experienced all the wonderful bakeries in metropolitan and regional areas of 
Melbourne, and without you the wider community would not receive any benefits that 
may arise from scientific research. However, I apologise for all the questionnaires you 
had to complete!  
 
I would also like to thank my friends, most of whom I will have to re-introduce myself 
to, for all the laughter and distraction, and my fellow PhD’ers and team members along 
the way who have also been a continual source of inspiration and merriment. In 
addition, I also thank Dr. Timo Rantalainen for re-introducing me to the magic of 
science and inquisitive thought, and for the laughs along the way. Along with the 
inimitable Sarah Brownell, you both made the testing sessions more exciting and 
enjoyable than they should have been. 
 
Finally, to my Mum, Dad, super Tiger brothers and their partners and my unbelievable 
pillar of support Sarah, just like Richmond, we did it! Although my thesis didn’t take 
37 years to complete. Your unbelievable faith, confidence and backing of my dreams 
and aspirations has always been unwavering, and for that I am truly appreciative and 
thankful. Don’t know how anyone could possibly slay this beast alone. They say love 
is the answer, which I think is true, but I think self-belief should be right up there as 
well, as nothing meaningful gets achieved without it...same goes for coffee.   
 
  
v 
 
2. Presentations/publications/conferences 
 
Publications 
Tait, JL, Duckham, RL, Milte, CM, Main, LC, & Daly, RM 2017, ‘Influence of 
Sequential versus Simultaneous Dual-Task Training on Cognitive Function in Older 
Adults’, Frontiers in Aging Neuroscience, vol 9, no. 368. 
doi:10.3389/fnagi.2017.00368. 
Daly, RM, Duckham, RL, Tait, JL, Rantalainen, T, Nowson, CA, Taaffe, DR, 
Sanders, K, Hill, KD, Kidgell, DJ and Busija, L, 2015. Effectiveness of dual-task 
functional power training for preventing falls in older people: study protocol for a 
cluster randomised controlled trial. Trials, vol. 16, no.120. doi: 10.1186/s13063-015-
0652-y.  
Peer-Reviewed Conference Abstracts/Presentations 
Tait, JL, Duckham, RL, Brownell, SM, Rantalainen, T, Nowson, CA, Taaffe, DR, 
Sanders, K, Hill, KD & Daly, RM 2016, 'Strategies and Challenges Associated with 
Recruiting Retirement Communities and Residents into an Exercise Intervention 
Trial', Journal of Aging and Physical Activity, vol. 24, pp. S106-S7. Presented at 
World Congress on Active Ageing, Melbourne Australia, July 1st 2016. 
Rantalainen, T, Duckham, RL, Tait, JL, Brownell, SM & Daly, RM 2016, 
'Sarcopenic Characteristics of a Faller: Can We Capture Fallers with a Few Simple 
Questions?', Journal of Aging and Physical Activity, vol. 24, pp. S28. Presented at 
World Congress on Active Ageing, Melbourne Australia, June 29th 2016. 
Internal Conference Abstracts/Presentations 
Tait, JL, Duckham, RL, Brownell, SM, Rantalainen, T, Nowson, C, Taaffe, DR, 
Sanders, K, Hill, K & Daly, RM 2016, 'Recruiting retirement villages into an exercise 
trial: setbacks and successes’. Presented at Deakin University School of Exercise and 
Nutrition Sciences HDR symposium, Melbourne Australia, September 18th 2015. 
Tait, JL, Duckham, RL, Brownell, SM, Rantalainen, T, Nowson, C, Taaffe, DR, 
Sanders, K, Hill, K & Daly, RM 2016, Can dual-task high-velocity exercise training 
improve cognitive function in older adults at risk for falls?’. Presented at Deakin 
University School of Exercise and Nutrition Sciences HDR symposium, Melbourne 
Australia, October 13th 2017. 
 
 
  
vi 
 
3. Table of Contents 
Acknowledgements ..................................................................................................... iv 
Presentations/publications/conferences ....................................................................... v 
Abbreviations .............................................................................................................. xi 
List of Tables ............................................................................................................ xiv 
List of Figures ......................................................................................................... xviii 
List of Appendices ..................................................................................................... xx 
Abstract ................................................................................................................... xxiii 
Chapter 1 .................................................................................................................... 1 
1.1  Background .................................................................................................. 2 
1.2  Thesis aims and hypotheses ........................................................................ 6 
1.3  Significance of the research ........................................................................ 7 
Chapter 2 .................................................................................................................... 9 
2.1  Age-related cognitive decline .................................................................... 10 
2.1.1  Effects of ageing on cognitive function ............................................... 11 
2.1.2  Neuroanatomical alterations with ageing ............................................. 18 
2.1.3  Functional changes in neurophysiology that occur with ageing .......... 21 
2.1.4  Theories of cognitive ageing ................................................................ 22 
2.2  Consequences of age-related cognitive decline ....................................... 24 
2.2.1  Population and economic burden of cognitive decline and dementia .. 24 
2.2.2  Risk factors for dementia and related disorders ................................... 27 
2.3  Interventions to mitigate cognitive decline in older adults .................... 30 
2.3.1  Cognitive training interventions to improve cognitive function .......... 30 
2.3.2  Effect of physical activity and exercise on cognitive function ............ 31 
2.3.3  Effect of aerobic exercise training on cognitive function .................... 34 
2.3.4  Effect of progressive resistance training on cognitive function ........... 36 
2.3.5  Effect of multimodal training on cognitive function ........................... 40 
2.4  Effect of combined exercise and cognitive training interventions ........ 42 
2.4.1  Effect of sequential cognitive-exercise training on cognitive function 43 
2.4.2  Effect of simultaneous dual-task exercise-cognitive interventions on 
cognition ............................................................................................................. 49 
  
vii 
 
2.5  Age-related challenges to HR-QoL and well-being ................................ 57 
2.5.1  Conceptual overview of QoL, HR-QoL and well-being ...................... 58 
2.6  Interventions to improve QoL in older adults ........................................ 62 
2.6.1  Epidemiological studies on physical activity and HR-QoL in adults .. 64 
2.6.2  Effect of physical activity and exercise interventions on HR-QoL in 
older adults .......................................................................................................... 66 
2.6.3  Effect of aerobic training on HR-QoL in older adults .......................... 68 
2.6.4  Effect of resistance training on HR-QoL in older adults ...................... 69 
2.6.5  Effect of multimodal training on HR-QoL in older adults ................... 71 
2.6.6  Effect of cognitively challenging exercise training on HR-QoL in older 
adults……………………………………………………………………………72 
2.6.7  Summary of the effects of exercise on HR-QoL in older adults .......... 75 
2.7  Satisfaction with Life in older adults ....................................................... 75 
2.7.1  Effect of physical activity and exercise on SWL in older adults ......... 76 
2.7.2  Summary of the effects of exercise on SWL in older adults ................ 79 
2.8  Mechanisms underlying changes in cognitive function following 
exercise ................................................................................................................... 79 
2.8.1  BDNF and its links to cognitive function ............................................. 82 
2.8.2  Effect of exercise on BDNF and its links to cognitive function .......... 84 
2.8.3  Insulin-like growth factor and its link to cognitive function ................ 88 
2.8.4  Effect of physical activity and exercise on IGF-1 and its links to 
cognitive function ............................................................................................... 89 
2.8.5  VEGF and its links to cognitive function ............................................. 92 
2.8.6  Effect of age-related increases in inflammation on health outcomes ... 95 
2.8.7  Inflammation and its links to cognitive function .................................. 97 
2.8.8  Effect of exercise on inflammation in older adults .............................. 99 
2.9  Neurological and inflammatory markers and their links to well-being
 ……………………………………………………………………………104 
2.9.1  BDNF and its links to well-being and HR-QoL ................................. 104 
2.9.2  IGF-1 and its links to well-being and HR-QoL .................................. 105 
2.9.3  VEGF and its links to well-being and HR-QoL ................................. 106 
2.9.4  Inflammation, well-being and HR-QoL ............................................. 107 
2.10  Summary .................................................................................................. 108 
Chapter 3: ............................................................................................................... 112 
  
viii 
 
3.1  Methods .................................................................................................... 113 
3.2  Study design ............................................................................................. 113 
3.3  Participants .............................................................................................. 113 
3.3.1  Recruitment ........................................................................................ 113 
3.3.2  Screening and eligibility criteria ........................................................ 115 
3.4  Randomisation ......................................................................................... 121 
3.5  Allocation, concealment and blinding ................................................... 121 
3.6  Intervention .............................................................................................. 122 
3.6.1  Structure of the exercise sessions....................................................... 124 
3.6.2  Structure of the dual-task functional power training program ........... 135 
3.7  Outcome measures .................................................................................. 137 
3.7.1  Cognitive measures ............................................................................ 138 
3.7.2  Health-related quality of life and well-being measures ..................... 147 
3.7.3  Inflammatory, neurological and hormonal markers ........................... 150 
3.7.4  Anthropometry and body composition .............................................. 151 
3.7.5  Functional measures ........................................................................... 152 
3.7.6  Health and medical history, medication use and smoking status ....... 156 
3.7.7  Habitual physical activity................................................................... 156 
3.7.8  Exercise adherence ............................................................................. 156 
3.7.9  Adverse events ................................................................................... 157 
3.8  Statistical analyses ................................................................................... 157 
3.8.1  Sample size calculations .................................................................... 157 
3.8.2  Statistical methods ............................................................................. 159 
3.9  Ethics and Funding ................................................................................. 160 
Chapter 4 ................................................................................................................ 161 
4.1  Introduction ............................................................................................. 162 
4.2  Methods .................................................................................................... 164 
4.2.1  Study design ....................................................................................... 165 
4.2.2  Participants ......................................................................................... 165 
4.2.3  Measurements .................................................................................... 165 
4.2.4  Statistical analyses ............................................................................. 169 
4.3  Results....................................................................................................... 170 
4.3.1  Relationships between age, BMI and physical activity with cognition 
HR-QoL, well-being, and inflammatory and neurological markers ................. 173 
  
ix 
 
4.3.2  Cognitive function and inflammatory markers .................................. 175 
4.3.3  Cognitive function and neurological markers (BDNF, IGF-1, and 
VEGF)    ……………………………………………………………………...175 
4.3.4  Cognitive function and amyloid-β (Aβ) peptides ............................... 180 
4.3.5  HR-QoL, well-being and inflammatory and neurological markers ... 180 
4.3.6  Interactions ......................................................................................... 184 
4.4  Discussion ................................................................................................. 185 
Chapter 5 ................................................................................................................. 196 
5.1  Introduction .............................................................................................. 197 
5.2  Methods .................................................................................................... 200 
5.2.1  Participants ......................................................................................... 200 
5.2.2  Study design ....................................................................................... 200 
5.2.3  Intervention ........................................................................................ 200 
5.2.4  Measurements ..................................................................................... 201 
5.2.5  Statistical analyses .............................................................................. 205 
5.3  Results ....................................................................................................... 206 
5.4  Discussion ................................................................................................. 228 
Chapter 6 ................................................................................................................. 247 
6.1  Introduction .............................................................................................. 248 
6.2  Methods .................................................................................................... 251 
6.2.1  Participants ......................................................................................... 251 
6.2.2  Study design ....................................................................................... 251 
6.2.3  Intervention ........................................................................................ 251 
6.2.4  Measurements ..................................................................................... 252 
6.2.5  Statistical analyses .............................................................................. 253 
6.3  Results ....................................................................................................... 254 
6.4  Discussion ................................................................................................. 262 
Chapter 7 ................................................................................................................. 278 
7.1  Introduction .............................................................................................. 279 
7.2  Methods .................................................................................................... 282 
7.2.1  Participants ......................................................................................... 282 
7.2.2  Study design ....................................................................................... 282 
7.2.3  Intervention ........................................................................................ 282 
  
x 
 
7.2.4  Measurements .................................................................................... 283 
7.2.5  Statistical analyses ............................................................................. 284 
7.3  Results....................................................................................................... 286 
7.4  Discussion ................................................................................................. 296 
Chapter 8 ................................................................................................................ 312 
8.1  Summary .................................................................................................. 313 
8.2  Key research findings, limitations and directions for future 
research ............................................................................................................... 314 
8.2.1  Inflammatory and neurological markers show limited relationships with      
cognition, HR-QoL and well-being .................................................................. 316 
8.2.2  Dual-task functional power training can improve various cognitive 
abilities in older adults ...................................................................................... 318 
8.2.3  It is unclear as to whether dual-task functional power training can 
improve HR-QoL and well-being in older adults ............................................. 321 
8.2.4  The most effective exercise modality for the attenuation of 
inflammation and release of growth factors in older adults remains unclear ... 324 
8.3  Conclusions and Public Health implications ........................................ 327 
References ............................................................................................................... 331 
Appendices .............................................................................................................. 410 
 
 
 
  
 
 
 
 
 
 
 
 
  
xi 
 
4.  Abbreviations 
oC: Degrees Celsius 
Aβ: Amyloid beta 
AD: Alzheimer’s disease 
ADLs: Activities of daily living 
APOE: Apolipoprotein 
BMD: Bone mineral density 
BMI: Body mass index 
BDNF: Brain derived neurotrophic factor 
BIA: Bioelectric impedance analysis 
CBB: CogState Brief Battery 
CI: Confidence interval 
CHAMPS: Community Healthy Activities Model Program for Seniors 
cm: Centimetre(s) 
CON: Usual care control group 
CRP: C-reactive protein 
CSRT: Choice stepping reaction time test 
CVD: Cardiovascular disease  
DASS: Depression, Anxiety and Stress Scale 
DET: Detection task 
DT: Dual-task 
DT-FPT: Dual-task functional power training 
EDTA: Ethylenediaminetetraacetic acid 
EOI: Expression of interest 
ES: Effect size 
ESSA: Exercise and Sports Science Australia 
FSST: Four square step test 
g.kg-1.day-1: grams per kilogram per day 
GCF: Global cognitive function 
GH: Growth hormone 
GMT: Groton Maze Learning Test 
GP: General practitioner  
HR-QoL: health-related quality of life 
HRmax: Maximum heart rate 
HRR: Heart rate reserve 
hsCRP: High-sensitivity C-reactive protein 
  
xii 
 
HV-PRT: High-velocity progressive resistance training  
IDE: Insulin-degrading enzyme 
IDN: Identification task 
IGF-1: Insulin-like growth factor-1 
IL-1β: Interleukin 1-beta 
IL-4: Interleukin 4 
IL-6: Interleukin 6 
IL-8: Interleukin 8 
IL-10: Interleukin 10 
Kcal: Kilocalories 
kg: Kilogram(s) 
kJ: Kilojoule(s) 
L-WM: Learning-Working memory composite 
m: Metre(s) 
m/s: Metres per second 
MCI: Mild cognitive impairment 
MCS: Mental component summary 
Met: Methionine  
MET: Metabolic equivalent 
mg/L: Milligrams per litre 
min: Minutes 
ml: Millilitre(s) 
MMSE: Mini Mental State Examination  
MVPA: Moderate-vigorous physical activity 
ng/mL: Nanograms per millilitre 
nmol/L: Nanomoles per litre 
NHMRC: National Health and Medical Research Council 
NSAID: Nonsteroidal anti-inflammatory drug 
OCL: One Card Learning task 
ONB: One Back task 
OR: Odds ratio 
PA: Physical activity  
PACE-IT: Physical and Cognitive Exercise Intervention Trial 
PCR: Polymerase chain reaction  
PCS: Physical component summary 
PFC: Prefrontal cortex 
pg/ml: Picograms per millilitre 
  
xiii 
 
PLS: Plain language statement 
PRT: Progressive resistance training 
Psy-Att: Psychomotor function-Attention composite 
PWI: Personal Wellbeing Index 
QoL: Quality of life 
RCT: Randomised controlled trial 
RM: Repetition maximum 
RPE: Rating of perceived exertion 
RR: Relative risk 
s, sec: Seconds 
SF-36® v2™: The Short form 36® version 2™ 
SD: Standard deviation  
SEM: Standard error of the mean 
SMD: Standardised mean difference 
SNP: Single nucleotide polymorphism 
SPMSQ: Short Portable Mental Screening Questionnaire 
STS: Sit-to-stand  
SWB: Subjective well-being 
SWL: Satisfaction with Life 
SWLS: Satisfaction with Life Scale 
TGFβ1: Transforming growth factor beta-1 
TNF-α: Tumor necrosis factor-alpha 
TUG: Timed up and go 
Val: Valine 
VEGF: Vascular endothelial growth factor  
VO2max: Maximal oxygen consumption 
W/kg: power (Watts) relative to body weight 
WHO: World Health Organisation 
 
 
 
 
 
 
 
 
  
xiv 
 
5. List of Tables 
Table 2.1: Strength of evidence on risk factors for cognitive decline and dementia. Adapted 
from Prince et al. (2014). ........................................................................................................ 29 
 
Table 2.2: Moderator analysis of the effect of various exercise modalities on cognition, 
including number of effect sizes and estimates. Taken from Northey et al. (2017). .............. 38 
 
Table 2.3: Randomised controlled trials examining the effects of sequential exercise-
cognitive training on cognitive function in older adults. ........................................................ 46 
 
Table 2.4: Randomised controlled trials examining the effects of simultaneous (dual-task) 
exercise-cognitive training on cognitive function in healthy older adults. ............................. 53 
 
Table 3.1: Overview of village recruitment for each of the three cohorts. .......................... 114 
 
Table 3.2: Overview of the number of expressions of interest (EOI) sent and received from 
each village within each cohort that were included in the trial, and the number (and 
proportion) of participants randomized within each village. ................................................ 115 
 
Table 3.3: PACE-IT trial inclusion and exclusion criteria. ................................................. 117 
 
Table 3.4: Falls questionnaire used to determine eligibility for study. ................................ 118 
 
Table 3.5: Examples of some of the balance and mobility exercises and progressions used 
throughout the study. ............................................................................................................ 125 
 
Table 3.6: Examples of some of the lower leg resistance exercises and progressions used 
throughout the study. ............................................................................................................ 129 
 
Table 3.7: Examples of some of the core stability and postural exercises and progressions 
used throughout the study. .................................................................................................... 130 
 
Table 3.8: Examples of some of the supplementary resistance training exercises and 
progressions used throughout the study. ............................................................................... 131 
 
Table 3.9: Examples of secondary task activities that were performed with the resistance and 
balance exercises throughout the study. ............................................................................... 132 
 
Table 3.10: Structure of the 26-week PACE-IT training program including example 
functional exercises with secondary tasks. ........................................................................... 136 
 
  
xv 
 
Table 3.11: PACE-IT trial outcome measures. ....................................................................139 
 
Table 3.12: Description of the cognitive tasks used in the CogState computerized test 
battery. ..................................................................................................................................146 
 
Table 4.1: Participant characteristics. ..................................................................................171 
 
Table 4.2: Mean values for cognitive function, HR-QoL and well-being. ..........................172 
 
Table 4.3: Associations between age (years), BMI (kg/m2) and physical activity (kJ/week), 
with cognition Z-scores, HR-QoL, well-being, and concentrations of inflammatory and 
neurological markers. ............................................................................................................174 
 
Table 4.4: Associations between cognitive function and inflammatory markers. ...............176 
 
Table 4.5: Association between single-inflammatory composite Z-score, cognitive function 
Z-scores, and HR-QoL and well-being scores. .....................................................................177 
 
Table 4.6: Association between cognitive function composite scores and the various 
circulating growth and neurological markers. ......................................................................181 
 
Table 4.7: Association between HR-QoL and well-being composite scores with individual 
circulating inflammatory markers. ........................................................................................182 
 
Table 4.8: Summary of significant associations between inflammatory and neurological 
markers, cognitive function and HR-QoL. ...........................................................................183 
 
Table 5.1: Baseline characteristics of participants randomised to the dual task functional 
power training group (DT-FPT) and the usual care control (CON) group. ..........................207 
 
Table 5.2: Cluster size per village, retention of participants at 26 weeks follow-up testing, 
number of participants from each village who did not attend 26 weeks testing in the dual task 
functional power training (DT-FPT) or usual care control (CON), and average exercise 
compliance of villages in the intervention group. .................................................................209 
 
Table 5.3: Baseline medications taken by participants randomised to the dual task functional 
power training group (DT-FPT) and the usual care control (CON) group. ..........................210 
 
Table 5.4: Change in medications taken by participants randomised to the dual task 
functional power training group (DT-FPT) and the usual care control (CON) group over the 
26-week intervention. ...........................................................................................................211 
  
xvi 
 
Table 5.5: Number and percentage of musculoskeletal and health complaints reported by 
participants in the dual task functional power training group. ............................................. 214 
 
Table 5.6: Mean baseline cognitive performance Z-Scores, the within-group changes 
relative to baseline and net between-group differences for the change after 26 weeks in the 
dual-task functional power training (DT-FPT) and control (CON) groups. ......................... 216 
 
Table 5.7: Interactions between intervention effects on cognitive function, group allocation, 
time, APOE and BDNF genotype status, and sex. ................................................................ 219 
 
Table 5.8: Mean baseline body composition variables, within-group changes relative to 
baseline and net between-group differences for the change after 26 weeks in the dual-task 
functional power training (DT-FPT) and control (CON) groups. ........................................ 220 
 
Table 5.9: Mean baseline muscle function variables, within-group changes relative to 
baseline and net between-group differences for the change after 26 weeks in the dual-task 
functional power training (DT-FPT) and control (CON) groups. ........................................ 222 
 
Table 5.10: Mean baseline muscle function/strength and functional gait performance within-
group changes relative to baseline and net between-group differences for the change after 26 
weeks in the dual-task functional power training (DT-FPT) and control (CON) groups. .... 223 
 
Table 5.11: Number and proportion of participants with counting errors during timed up and 
go (TUG) and functional gait testing at baseline and 26 weeks in the dual-task functional 
power training (DT-FPT) and control (CON) groups. ......................................................... 224 
 
Table 5.12: Mean baseline choice stepping reaction time (CSRT) test variables, within-
group absolute changes relative to baseline and net between-group differences for the change 
after 26 weeks in the dual-task functional power training (DT-FPT) and control (CON) 
groups. .................................................................................................................................. 226 
 
Table 6.1: Mean baseline HR-QoL norm-based and PWI scores, the within-group changes 
relative to baseline and net between-group differences for the change after 26 weeks in the 
dual-task functional power training (DT-FPT) and control (CON) groups. ......................... 258 
 
Table 7.1: Baseline characteristics of the subset of participants randomised to the dual task 
functional power training group (DT-FPT) and the usual care control (CON) group that 
provided blood samples and a complete data set at baseline. ............................................... 287 
 
  
xvii 
 
Table 7.2: Mean baseline inflammatory profile, the within-group changes relative to 
baseline and net between-group differences for the change after 26 weeks in the dual-task 
functional power training (DT-FPT) and control (CON) groups. .........................................291 
 
Table 7.3: Mean baseline neurological marker concentrations, the within-group changes 
relative to baseline and net between-group differences for the change after 26 weeks in the 
dual-task functional power training (DT-FPT) and control (CON) groups. .........................295 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
xviii 
 
6. List of Figures 
Figure 2.1: Cognitive changes between the ages of 20-60 in multiple cognitive domains 
using cross-sectional data showing differential decline across the lifespan. Taken from 
Salthouse (2009). .................................................................................................................... 11 
 
Figure 2.2: Cross-sectional data adapted from Park et al. (2002) showing changes in 
performance on measures of processing speed, working memory, long-term memory and 
knowledge across the lifespan. Taken from Park & Reuter-Lorenz (2009). .......................... 14 
 
Figure 2.3: Regions coordinating semantic procedural and working memory. Image taken 
from Budson & Price (2005). ................................................................................................. 17 
 
Figure 2.4: Model of the continuum and clinical trajectory of Alzheimer’s disease, 
compared to normal ageing. Taken from Sperling et al. (2011). ............................................ 25 
 
Figure 2.5: Estimated number of people with dementia, by age and sex, in Australia in 2011, 
highlighting the deviations that occur after age 80 between sexes (Australian Institute of 
Health and Welfare 2012). ..................................................................................................... 26 
 
Figure 2.6: Model of the mechanisms that link exercise and cognitive training with 
cognitive and functional improvements. Adapted from Gates et al. (2011). .......................... 45 
 
Figure 2.7: A proposed model of QoL incorporating HR-QoL, well-being and satisfaction 
with life. Adapted from Guerin (2012). .................................................................................. 60 
 
Figure 2.8: Outline of the SF-36 version 2 Questionnaire. All health domains contribute to 
both the physical (PCS) and mental (MCS) health component summary scores. Scales 
contributing most to the summary measure are indicated by a solid line (—), scales 
contributing to a lesser degree are indicated by a dotted line (---). Taken from Ware Jr et al. 
(2008). .................................................................................................................................... 63 
 
Figure 2.9: Factors influencing brain health and inflammation. AD: Alzheimer’s disease. 
Taken from Cotman at al. (2007). .......................................................................................... 81 
 
Figure 2.10: Factors related to pro-and anti-inflammatory cytokines. Adapted from Sartori et 
al. (2012). ............................................................................................................................... 96 
 
Figure 3.1: Study flow diagram of villages and participants over the 26-week intervention.
 .............................................................................................................................................. 119 
 
  
xix 
 
Figure 3.2: Groton Maze Learning Test. .............................................................................141 
 
Figure 3.3: Detection Task. .................................................................................................142 
 
Figure 3.4: Identification Task. ...........................................................................................144 
 
Figure 3.5: One Back task. ..................................................................................................145 
 
Figure 4.1: Associations between serum levels of brain derived neurotrophic factor (BDNF), 
insulin-like growth factor-1 (IGF-1), and cognitive performance for Detection task (DET); 
processing speed,  Identification task (IDN);  visual attention, and One Card Learning task 
(OCL); attention and visual memory, with trend line fitted where significant. ....................178 
 
Figure 4.2: Associations between serum levels of brain derived neurotrophic factor (BDNF), 
insulin-like growth factor-1 (IGF-1), and cognitive performance for the Learning/working 
memory composite (L-WM), Psychomotor function-Attention composite (Psy-Att), CogState 
Brief Battery (CBB), combination of Learning-Working memory and Psychomotor function-
Attention composites, and global cognitive function (GCF), with trend line fitted where 
significant. ............................................................................................................................179 
 
Figure 5.1: Exercise adherence histogram for all participants randomised to the dual-task 
functional power training group. ..........................................................................................214 
 
Figure 5.2: Mean (±SEM) absolute changes in Psychomotor function (Detection Task), 
Attention/choice reaction time (Identification task), Psychomotor function-Attention 
Composite, Learning-Working Memory Composite, CogState Brief Battery and Global 
Cognitive Function Z-scores in the dual-task functional power training (DT-FPT) and control 
(CON) group after 26 weeks. ................................................................................................218 
 
Figure 6.1: Mean (±SEM) change in norm-based scores of the SF-36 domains; physical 
functioning, social functioning, role emotional, role physical, physical component summary 
(PCS), mental component summary (MCS), global health-related quality of life (HR-QoL), 
and Personal Well-being Index, in the dual-task functional power training (DT-FPT) and 
control (CON) group after 26 weeks. ...................................................................................260 
 
Figure 7.1: Mean (±SEM) percentage changes in Interleukin-4 (IL-4), Interleukin-10 (IL-
10), Interleukin-8 (IL-8), C-reactive protein (CRP), Interleuklin-6 (IL-6), and tumor necrosis 
factor alpha (TNF-α) log-transformed serum concentrations, and amyloid beta (Aβ) (1-42) 
and Aβ (1-40) log-transformed plasma concentrations, in the dual-task functional power 
training (DT-FPT) and control (CON) group after 26 weeks.. .............................................293 
  
xx 
 
7. List of Appendices 
Appendix A: Short Portable Mental Screening Questionnaire. ........................................... 411 
 
Appendix B: Pre-Exercise Screening Tool based on ESSA guidelines. ............................. 412 
 
Appendix C: PACE-IT modified plain language statement, original plain language 
statement used in recruiting cohort 1, and consent form. ..................................................... 413 
 
Appendix D:  Example PACE-IT Exercise Card. ............................................................... 424 
 
Appendix E: Frequency of health conditions reported by participants. .............................. 425 
 
Appendix F: Adverse Events questionnaire administered after the commencement of the 
intervention. .......................................................................................................................... 426 
 
Appendix G: Frequency of missing data from the original cohort of 300 participants 
enrolled in the intervention trial, and from the 268 participants included in Study 1 (Chapter 
4). .......................................................................................................................................... 427 
 
Appendix H: Mean unweighted scores for domains of the SF-36 for the 268 participants 
included in the analyses for Chapter 4. ................................................................................. 429 
 
Appendix I: Mean baseline inflammatory and neurological marker values for the 268 
participants included in the analysis for Chapter 4. .............................................................. 429 
 
Appendix J: Associations between cognitive function and neurological markers. ............. 430 
 
Appendix K: Associations between HR-QoL subdomains and inflammatory markers. ..... 431 
 
Appendix L: Associations between HR-QoL and neurological markers. ........................... 432 
 
Appendix M: Associations between HR-QoL and well-being and neurological markers. . 433 
 
Appendix N: Mean baseline outcome values (raw and standardised) for participants that 
provided data at both time points, and those not providing data at 26-week follow-up testing.
 .............................................................................................................................................. 434 
 
Appendix O: Frequency of missing baseline data for participants randomised to the dual 
task functional power training group (DT-FPT) and the usual care control (CON) group. . 436 
 
  
xxi 
 
Appendix P: Mean baseline cognitive function Z-scores by group, the within-group changes 
relative to baseline and net between-group differences for the change after 26 weeks in the 
dual-task functional power training (DT-FPT) and control (CON) groups according to per 
protocol analyses (≥50% compliance). .................................................................................437 
 
Appendix Q: Mean baseline body composition variables, the within-group changes relative 
to baseline and net between-group differences for the change after 26 weeks in the dual-task 
functional power training (DT-FPT) and control (CON) groups according to per protocol 
analyses (≥50% compliance). ...............................................................................................439 
 
Appendix R: Mean baseline muscle function variables, within-group changes relative to 
baseline and net between-group differences for the change after 26 weeks in the dual-task 
functional power training (DT-FPT) and control (CON) groups. .........................................440 
 
Appendix S: Mean baseline muscle power/strength variables, within-group changes relative 
to baseline and net between-group differences for the change after 26 weeks in the dual-task 
functional power training (DT-FPT) and control (CON) groups. .........................................441 
 
Appendix T: Mean baseline functional gait performance while under single and dual-task 
conditions, within-group changes relative to baseline and net between-group differences for 
the change after 26 weeks in the dual-task functional power training (DT-FPT) and control 
(CON) groups. ......................................................................................................................442 
 
Appendix U: Mean baseline choice stepping reaction time (CSRT) test variables, within-
group changes relative to baseline and net between-group differences for the change after 26 
weeks in the dual-task functional power training (DT-FPT) and control (CON) groups. ....443 
 
Appendix V: Mean baseline HR-QoL and well-being norm-based values for participants 
that provided HR-QoL and well-being data at both time points, and those not providing data 
at 26-week follow-up testing. ...............................................................................................445 
 
Appendix W: Mean baseline raw HR-QoL values for participants randomised to the dual-
task functional power training group (DT-FPT) and control (CON) group..........................445 
 
Appendix X: Mean baseline HR-QoL norm-based and well-being scores, the within-group 
changes relative to baseline and net between-group differences for the change after 26 weeks 
in dual-task functional power training (DT-FPT) and control (CON) groups in per protocol 
analyses (≥50% compliance). ...............................................................................................446 
 
  
xxii 
 
Appendix Y: Mean baseline inflammatory and neurological biomarker untransformed 
concentrations in the subset of participants who provided blood samples at both time points 
and those not attending 26-week follow-up testing. ............................................................. 448 
 
Appendix Z: Reasons why total sample of participants randomised to the dual task 
functional power training group (DT-FPT) and the usual care control (CON) group (n=300), 
did not provide blood samples at baseline and 26-week time points. .................................. 448 
 
Appendix AA: Mean baseline inflammatory profile by group, within-group changes relative 
to baseline and net between-group differences for the change after 26 weeks in the dual-task 
functional power training (DT-FPT) and control (CON) groups according to per protocol 
analyses (≥50% compliance). ............................................................................................... 449 
 
Appendix BB: Mean baseline neurological marker concentrations by group, within-group 
changes relative to baseline and net between-group differences for the change after 26 weeks 
in the dual-task functional power training (DT-FPT) and control (CON) groups according to 
per protocol analyses (≥50% compliance). ........................................................................... 451 
 
Appendix CC: Review article of dual-task training published in Frontiers in Aging 
Neuroscience November 2017 (Tait et al. 2017). ................................................................. 452 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
xxiii 
 
8. Abstract 
Age-associated cognitive decline and its associated illnesses are growing public health 
concerns with no known cure, and represent a substantial threat to the health, 
functional independence and well-being of older Australians. These declines, in 
conjunction with other age-related health conditions can subsequently impair 
functional performance, which can collectively reduce quality of life (QoL). The 
underlying mechanism(s) which contribute to cognitive decline are multifaceted but 
may include low-grade systemic inflammation, which is associated with poorer 
cognitive performance, age-associated cognitive decline, and neurodegenerative 
disease. Similarly, an increased concentration of neurotrophic factors, centrally or in 
circulation, may provide resistance to functional and structural neurodegeneration of 
the brain. At present there is mixed data regarding whether higher levels of 
neurological markers and lower concentrations of inflammatory markers are 
associated with better cognitive function in healthy older adults, while data regarding 
the associations of these markers with HR-QoL or well-being is lacking.  
 
There is some evidence to suggest that exercise has neuroprotective effects, while 
emerging research has shown that the simultaneous performance of exercise and 
cognitive and/or motor training (dual-task exercise) can provide cognitive benefits for 
both healthy and cognitively impaired older adults. Furthermore, functional exercise 
and power training can both produce functional advantages for older adults. Many falls 
in older adults result from insufficient lower limb muscle power to step quickly when 
balance is lost, while age-related cognitive deficits, particularly in the ability to 
concentrate and multi-task, also increase falls risk. Given these factors, a dual-task 
functional power training program may be effective for improving cognitive function 
and functionality, yet the effects of such a program are currently untested. Similarly, 
the potential benefits of this type of training on HR-QoL or well-being are unknown. 
The mechanism(s) underpinning the improvements in cognition following dual-task 
exercise training that have been previously observed are currently unclear, but may 
relate to the induction of neurological growth factors and/or the attenuation of low-
grade systemic inflammation. Despite this, the response of these markers to long-term 
exercise training in older adults has been inconsistently reported. Furthermore, limited 
evidence suggests that the response of neurological markers to exercise may be 
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regulated by genetic factors, such as the possession of the Met allele of the BDNF 
gene, and the ε4 variant of the APOE gene, which may impair elderly cognition.  
 
Therefore, an initial aim of this thesis was to identify the associations between various 
inflammatory and neurological markers and their composite scores with cognitive 
function, well-being and HR-QoL in older adults residing independently in retirement 
villages. Given the clinical relevance of muscle power and dual tasking to ‘real life’ 
situations, the main aims of this 26-week cluster randomised controlled trial were to 
evaluate the efficacy of dual-task functional power training (DT-FPT) on cognition, 
health-related quality of life (HR-QoL) and well-being in independently living older 
adults at risk of falls (Chapters 5-6). In addition, this thesis aimed to determine whether 
DT-FPT induced improvements in neurological and inflammatory concentrations 
(Chapter 7). Secondary aims were to determine if the response of any of these variables 
to DT-FPT differed by sex or genotype.  
 
Twenty-two independent living retirement villages with 300 residents aged >65 years 
at risk of falling, were randomised to DT-FPT involving high-velocity functional 
exercises (45-60 minutes, twice per week) performed simultaneously with cognitive 
and/or motor tasks, or a usual care control (CON) group. Overall 233 (78%) 
participants completed the study; with exercise compliance averaging 50%. At 
baseline and 26 weeks, cognitive function was assessed via a computerised test battery, 
while questionnaires were used to assess HR-QoL, well-being, habitual physical 
activity, health and medical history. Blood samples were collected, and body 
composition, muscle strength, power and function were also measured. 
 
 An assessment of blood data at baseline found that higher levels of circulating BDNF 
were associated with greater performance in psychomotor function, attention, 
working-memory and global cognitive function while an inverse relationship between 
IGF-1 and visual memory and attention was detected. Higher levels of CRP and the 
pro-inflammatory composite score were associated with lower perceptions of the HR-
QoL domain of vitality. Polymorphisms of the APOE gene showed differential 
relationships in the associations between Aβ (1-42) and executive function, and 
inflammation and working memory. However, the majority of circulating 
inflammatory and neurological markers were not associated with cognitive function, 
HR-QoL or well-being.  
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After 26 weeks, DT-FPT resulted in greater improvements in lower limb muscle power 
(P<0.001), mobility (P<0.05) and stepping reaction time (P<0.05) than CON, with no 
differences in dual-task functional performance. For cognition, there was a significant 
net 0.18-0.20 SD benefit in reaction time/attention (P<0.05) and a composite of 
psychomotor ability/attention (P<0.05) in DT-FPT versus CON, but no effects on 
executive function, memory or global cognition. In terms of HR-QoL, DT-FPT only 
improved the role physical domain, however per protocol analyses detected a 
significant net benefit in social functioning, the physical component summary score 
and global HR-QoL. DT-FPT had no effect on circulating levels of pro- or anti-
inflammatory markers, or neurological markers. The response of cognition, HR-QoL, 
well-being or blood markers to the intervention was no different between older men 
and women, with the exception that older men in the training program reported greater 
net decreases in the domain of general health, and well-being, compared to the control 
group. Similarly, the response of these variables to DT-FPT was not influenced by 
genotype.  
 
In conclusion, these findings indicate that DT-FPT provides some cognitive benefits 
to healthy older adults which may delay an onset of cognitive decline, while also 
improving functional capacity. Collectively these improvements may maintain an 
older adult’s ability to perform everyday activities which can prolong functional 
independence. However, 26 weeks of DT-FPT only provided limited benefits to HR-
QoL, and did not improve circulating levels of biomarkers. Further research is required 
to determine the underlying mechanisms of cognitive improvement following dual-
task exercise.   
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1. Chapter 1   
                                            
                                          Introduction 
This chapter provides a background that leads to the aims and 
hypotheses of this thesis, and outlines the significance of the research                            
presented in the thesis. 
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1.1 Background 
Over the past 50 years a decline in late-life mortality and improvements in medicine 
and health care have led to steady increases in human life expectancy (Suzman et al. 
2015). For example, in 2016 there were an estimated 3.7 million Australians aged 65 
and over (15% of the population) (Australian Institute of Health and Welfare 2016b), 
and this statistic is projected to grow to nearly 9 million (22% of the population) by 
2056 (Australian Bureau of Statistics 2013). In other terms, it is estimated that 19% of 
adults will be aged over 65 by 2046, compared to 13% in 2016 (Australian Bureau of 
Statistics 2015c). Furthermore, the number of older Australians aged 85 and over is 
expected to double between 2014 and 2034 (Australian Bureau of Statistics 2013). An 
ageing population may be problematic as the public health burden of age-related 
disability and the associated costs of medical care will rise accordingly, to account for 
the increasing numbers of older adults needing care for age-related, long-term health 
problems and disability. For instance, in 2012-2013 adults aged over 65 admitted to 
hospital cost the government over $16 billion which was almost the equivalent 
expenditure for adults aged 20-64 combined (Australian Institute of Health and 
Welfare 2016a). These costs will be compounded by the younger cohort entering the 
‘over 65’ category who may possess a larger burden of lifestyle-related diseases (e.g., 
type 2 diabetes) than previous cohorts. 
 
It is widely recognised that ageing is associated with declines in the ability to complete 
everyday tasks such as cooking, organising finances, and driving, and can eventually 
compromise mobility and basic personal care needs (e.g., dressing, feeding and 
bathing). Cognitive skills are vital for the daily functioning of older adults, and in 
addition to other age-associated disease and disability, a decline in cognitive function 
that often occurs with ageing (Christensen et al. 1999; Yaffe et al. 2010) may also 
impair functional performance in these activities of daily living (Cahn-Weiner et al. 
2000; Mehta, Yaffe & Covinsky 2002; Owsley et al. 2002), which can collectively 
reduce quality of life (QoL). Together, these declines can create a dependence on 
family and friends to act as carers, and along with a loss of independence, place 
financial pressures on the nation such as aged-care services including residential and 
community-based support, which was estimated to cost the Australian government 
$14.8 billion in 2014 (Steering Committee for the Review of Government Service 
Provision 2015).  
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Ageing is also an important risk factor for mild cognitive impairment (MCI), which is 
characterised by memory and learning complaints (de Mendonça et al. 2004; Gauthier 
et al. 2006), and dementia, which represents a deterioration in cognitive function which 
is more marked than the decline associated with normal ageing (Sperling et al. 2011). 
Currently, dementia affects 1 in 10 Australian adults aged ≥ 65 years (Australian 
Institute of Health and Welfare 2016a), and the number of these adults living with 
dementia is projected to increase to almost 900,000 by 2050, due to the ageing 
population (Australian Institute of Health and Welfare 2012; Brown, Hansnata & La 
2017). This will also place an added burden on health and aged care service costs, with 
expenditure related to the high level of care needed for sufferers of dementia totalling 
$8.8 billion in Australia in 2016 (Brown, Hansnata & La 2017). This data suggests 
that the majority of older adults will not develop dementia or Alzheimer’s disease 
(AD) in their lifetime, but may suffer from milder impairments which can reduce the 
quality of cognitive functioning. More importantly, given the current proportion of 
older adults in Australia (and globally), and the projected increases in their 
representation of the population in the near future, age-associated cognitive decline 
has the potential to diminish the functional capacity of a significant proportion of the 
population, which, in addition to personal loss, will place added burden on national 
resources. As there is currently no cure for age-associated cognitive decline or 
dementia, intervention approaches that can mitigate these personal and financial 
burdens, prevent or delay the onset of cognitive decline or dementia, and optimise 
physical and cognitive health and well-being in older adults, especially strategies that 
modify lifestyle factors, are required.  
 
Age-associated cognitive decline can have widespread effects on the health of older 
adults. In combination with functional limitations that result from cognitive  
impairment or health conditions (e.g., stroke, hearing loss) (Lin et al. 2013), a 
deterioration in cognitive function may affect social skills and behaviour which can 
leave an afflicted older adult socially disconnected from friends and family, and render 
them unable to engage in activities that once provided purpose or pleasure (Logsdon 
et al. 1999; Mega et al. 1996). Collectively, these factors can impair the QoL of older 
adults with cognitive decline (Bárrios et al. 2013; Teng, Tassniyom & Lu 2012), along 
with their family, and caregivers (Prince et al. 2016). These elements may be 
compounded by the transition from middle age to older age, which is typically 
accompanied by lifestyle changes such as moving to a new residence, illness, 
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retirement, or death of a spouse that can induce changes in the physical, social and 
mental fabric of an older individual. These cognitive, social and physical fluctuations 
have the capacity to compromise functionality, emotional and psychological health, 
and hamper an older individual’s ability to adapt to these changes, which can also 
affect QoL (Lavretsky & Irwin 2007).  
 
Interactions between subjective perceptions of QoL and an individual’s state of health 
can be captured by an assessment of health-related quality of life (HR-QoL). HR-QoL 
is widely recognized as a multilayered concept whereby a subjective rating of QoL is 
primarily influenced by the health status of an individual (Guyatt, Feeny & Patrick 
1993), but also incorporates psychosocial (including emotional components), physical 
and mental influences (Revicki 1989). Further, HR-QoL assessments can evaluate the 
impact of illness, chronic conditions, disability, socioeconomic status, and exercise 
interventions on aspects of physical and mental health in healthy and clinical 
populations (Brown et al. 2004; Halvorsrud & Kalfoss 2007). Evidence from 
observational studies suggests that regular participation in physical activity is 
positively associated with HR-QoL in older adults (Pucci et al. 2012; Rejeski & 
Mihalko 2001), however meta-analytic data has been inconclusive as to whether 
structured exercise can modify HR-QoL in older adults (Kelley et al. 2009; Netz et al. 
2005). Therefore the optimal exercise modality and dose for HR-QoL benefits remains 
uncertain.  
 
A number of interventions have been investigated for their ability to reduce the risk of 
cognitive decline and improve cognitive function in older adults. Cognitive training 
and regular participation in mentally stimulating activities have been demonstrated to 
exert positive effects on cognitive function in older adults with and without cognitive 
impairment  (Martin et al. 2011; Reijnders, van Heugten & van Boxtel 2013; 
Valenzuela & Sachdev 2009), however there is only limited evidence that 
computerised cognitive training can also significantly improve functional performance 
in terms of gait speed, or gait speed while talking (an example of dual-tasking) 
(Verghese et al. 2010). Given this limited data, there is uncertainty as to whether such 
training alone can confer cognitive benefits that enhance performance in common 
functional tasks of everyday living such as talking whilst walking. Regular 
participation in physical activity has also been associated with a reduced risk of 
cognitive impairment and dementia in older adults (Blondell, Hammersley-Mather & 
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Veerman 2014; Etgen et al. 2010), while structured interventions involving aerobic 
training, progressive resistance training or the combination have also produced 
cognitive benefits in both healthy and cognitively impaired older adults (Colcombe & 
Kramer 2003; Gates et al. 2013; Heyn, Abreu & Ottenbacher 2004; Northey et al. 
2017). Despite this, the most beneficial types and dosage of exercise required to 
provide cognitive benefits for older adults is unknown.  
 
Many older adults often experience a decline in the ability to simultaneously divide 
attention between a primary and secondary task, such as having a conversation or 
carrying an object (e.g., coffee) while walking, which is referred to as dual-tasking. A 
reduced ability to perform dual-tasking is clinically important as it has been associated 
with reduced reaction time and walking speed, more frequent contact with obstacles 
whilst walking, and an increased risk of falls (Melzer et al. 2010; Pichierri et al. 2011). 
Furthermore, declines in divided attention have been associated with age-related 
cognitive deficits, particularly in executive function (Al-Yahya et al. 2011; Chu et al. 
2013; Hsu et al. 2012). There has been recent interest into whether dual-task cognitive-
motor exercise training, whereby cognitive or motor tasks are performed sequentially 
(exercise and cognitive training are undertaken separately), or simultaneously with 
exercise training, result in greater improvements in selected cognitive domains than 
either exercise or cognitive training alone (Lauenroth, Ioannidis & Teichmann 2016; 
Zhu et al. 2016). The available evidence does not consistently support improvements 
in cognitive function following sequential training, with minimal additive benefits 
compared to either cognitive or exercise training alone (Lauenroth, Ioannidis & 
Teichmann 2016; Zhu et al. 2016). However, simultaneous training interventions, 
particularly multimodal exercise in combination with secondary tasks regulated by 
sensory cues, have shown some ability to significantly improve cognition and 
functionality in healthy and clinical populations of older adults (Lauenroth, Ioannidis 
& Teichmann 2016; Zhu et al. 2016). Given the emerging nature of this data, and the 
inconsistencies in existing dual-task studies, in terms of different training modalities 
and intensities, the unsystematic selection of cognitive assessments, and the 
characteristics of the control group, questions remain as to the optimal type and dose 
(frequency, intensity, duration) of dual-task exercise needed to optimise cognitive 
benefits in older adults.  
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The mechanisms underpinning the cognitive and functional improvements observed 
in dual-task training are currently unclear, but may relate to improvements in body 
composition and muscle function, along with the induction of neurological growth 
factors such as brain derived neurotrophic factor (BDNF) and insulin-like growth 
factor (IGF-1)(Cotman, Berchtold & Christie 2007), and/or the attenuation of low-
grade systemic inflammation (Beavers, Brinkley & Nicklas 2010) following exercise. 
Furthermore, the response of these neurological markers to exercise may be regulated 
by genetic factors, as evidence suggests that possession of the Met allele of the BDNF 
gene (Miyajima et al. 2008; Raz et al. 2009), and the ε4 variant of the APOE gene 
(Etnier et al. 2007; Kuller et al. 1998), may impair cognition. Therefore, it is currently 
unknown whether improvements in levels of inflammation and growth factors may 
contribute to any ameliorations in cognition, and also HR-QoL and well-being, 
following a dual-task exercise intervention, and whether the response of these 
variables differs by genotype or sex. The investigation of these aspects would 
determine whether a specific type of dual-task exercise training represents an effective 
strategy to preserve functional independence in older adults.  
 
1.2 Thesis aims and hypotheses 
The primary aim of this thesis is to examine the effects of a 26-week dual-task 
functional power training (DT-FPT) program on cognitive function, and health-related 
quality of life as well as circulating levels of inflammatory and neurological markers, 
in older adults residing independently in retirement villages  
 
The specific aims to be addressed are:  
 
1. To evaluate the relationships between individual inflammatory and neurological 
markers with domains of cognitive function, health-related quality of life and well-
being, in older adults living independently in retirement villages. A secondary aim 
is to assess whether genetic polymorphisms of the APOE and BDNF genes, and sex 
differences, can influence these associations. 
 
2. To assess if the DT-FPT program improves cognitive function compared to usual 
care in older adults living independently in retirement villages. Secondary aims are 
to determine whether the response to the intervention varies by genetic factors and 
sex, and the efficacy of the intervention in improving muscle function and dual-task 
performance. 
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3. To determine if the DT-FPT program improves health-related quality of life and 
well-being in older adults independently living in retirement villages. A secondary 
aim is to determine whether the response to the intervention varies by sex.   
 
4. To determine the effect of the DT-FPT program on circulating levels of 
neurological and inflammatory markers in independently living older adults. A 
secondary aim is to assess whether the response of these markers to the intervention 
is influenced by genetic polymorphisms of the APOE and BDNF genes. 
 
It is hypothesized that:  
1. Pro-inflammatory cytokines, amyloid beta biomarkers and an inflammatory 
composite will be inversely associated with cognitive function, health-related 
quality of life and well-being. Higher levels of anti-inflammatory cytokines and 
growth factors will associate with greater scores in these outcomes. These 
associations will be influenced by genetic polymorphisms. 
 
2. The 26-week DT-FPT intervention will improve cognitive function, compared to 
a usual care group, and carriers of Met (BDNF gene) and ε4 (APOE gene) alleles 
will exhibit poorer cognitive function. DT-FPT will improve muscle function and 
dual-task performance.  
 
3. The 26-week DT-FPT intervention will improve domains of health-related quality 
of life and well-being, however there will be no differences between the sexes. 
 
4. The 26-week DT-FPT intervention will reduce pro-inflammatory cytokines and 
amyloid beta peptides, and increase levels of anti-inflammatory cytokines and 
growth factors. These modifications will be more apparent in older adults who do 
not carry Met (BDNF) or ε4 (APOE) alleles. 
 
1.3 Significance of the research 
Cognitive decline and its associated illnesses represent a substantial threat to the 
health, functional independence and well-being of older Australians. Further, poor 
cognition and well-being may personally deprive an older adult of their quality of life, 
and years of life, however the social burden and exorbitant health care costs shouldered 
by a nation as a result of these health issues are also of concern. Latest figures estimate 
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that ~6% of Australians aged 65 years or over currently live in independent living 
retirement villages, which equates to over 184,000 older adults (Property Council of 
Australia 2014; Zuo et al. 2014). This number is expected to increase to 8% in the next 
decade due to the projected increase in life expectancy and a growing acceptance of 
retirement villages (Zuo et al. 2014). Residents of these villages experience a high 
level of functional impairment and increased risk of falling (Menz, Morris & Lord 
2006). Therefore identifying and implementing cost-efficient and effective strategies 
to maintain their independent lifestyle is vital, and can reduce health-care costs 
associated with disease and disability.  
 
Various exercise modalities have been shown to improve cognitive function and HR-
QoL, in healthy and cognitively impaired older adults, representing a potential 
therapeutic strategy for the attenuation of cognitive decline and the enhancement of 
HR-QoL. Similarly, cognitive training alone has been shown to have some positive 
effects on cognitive function. Therefore the implementation of this particular dual-task 
intervention represents an untested, multi-pronged approach for improving factors 
associated with cognitive decline and well-being; circulating inflammatory and 
neurological markers, and also directly targets cognitive function, well-being and 
functional independence.  
 
This study will add to emerging research investigating the effects of dual-task training 
on cognitive function, and to our knowledge is one of the few studies to assess the 
relationship between HR-QoL and inflammatory and neurological markers. 
Furthermore, it will be the first study to collectively investigate the response of 
biomarkers, HR-QoL and well-being following dual-task exercise training. This will 
provide a greater understanding of the determinants of cognitive health and well-being 
in older adults, extend the evidence for dual-task training studies, and reveal whether 
this intervention can preserve the health of older adults to be implemented in the wider 
community.   
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2. Chapter 2  
     Literature Review 
This chapter outlines the trajectory of cognitive function with ageing, and critically 
evaluates past literature regarding the effects of exercise on cognitive function, HR-
QoL, well-being, and inflammatory and neurological markers, while identifying gaps 
in the research. The section from this chapter relating to the effects of dual-task 
exercise on cognitive function, has been published as a review in Frontiers in Aging 
Neuroscience (Tait et al. 2017). 
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2.1 Age-related cognitive decline 
Increased variability in cognitive function occurs during the normal ageing process, 
and while some older adults perform at the level of younger adults, others exhibit 
substantial declines (Christensen et al. 1999; Wilson et al. 2002). Maintained cognitive 
function during ageing is associated with many health advantages, including 
prolonged survival and a lower incidence of disability when compared to individuals 
with minor degrees of cognitive decline (Yaffe et al. 2010). This may reflect an 
interplay between genetic, cellular, environmental and behavioural factors (Broe et al. 
1998).  
 
Age-related cognitive decline represents a dynamic longitudinal process affecting 
multiple cognitive domains (Royall et al. 2005), however the age at which cognitive 
decline becomes evident in healthy adults remains uncertain (Nilsson 2003; Nilsson et 
al. 2009; Salthouse 2009). A number of cross-sectional studies have reported linear 
declines in multiple areas of cognitive function across the lifespan in healthy adults, 
with some reporting a reduction from as early as 20 years of age (Nilsson 2003; Park 
et al. 2002; Salthouse 2009) (Figure 2.1). In contrast, several longitudinal studies have 
reported that the onset of cognitive decline occurs a short time before the age of 60 
(Schaie 1994; Zelinski & Burnight 1997), or after 60 (Christensen 2001; Hedden & 
Gabrieli 2004), with other data even suggesting that a decline may begin in middle-
age (45-50 years) (Singh-Manoux et al. 2012). It is speculated that the magnitude of 
cognitive changes derived from cross-sectional studies may not accurately reflect 
longitudinal changes due to the presence of “cohort effects”, which can confound 
results and overestimate age-related differences (Hedden & Gabrieli 2004; Salthouse 
2009; Singh-Manoux et al. 2012). Cohort effects create differences between younger 
and older cohorts which stem from socio-historical influences such as educational 
opportunities, the quality and accessibility of health care and cultural factors. 
However, a limitation of several longitudinal studies it that they do not include a wide 
age range or adequate sample sizes, and may be subject to practice effects and selective 
attrition (Hedden & Gabrieli 2004; Salthouse 2009). These limitations may 
underestimate the magnitude of changes in multiple cognitive domains, and thus 
questions remain with regard to the age of onset (and rate of decline) in cognitive 
function, which may be clinically relevant to determine the optimum time to 
implement protective interventions.  
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Figure 2.1: Cognitive changes between the ages of 20-60 in multiple cognitive 
domains using cross-sectional data showing differential decline across the lifespan. 
Taken from Salthouse (2009).  
 
2.1.1  Effects of ageing on cognitive function   
Cognitive ageing is not a uniform process, and it is apparent that some cognitive 
abilities are more susceptible to age-related decline than others. There is significant 
inter-individual heterogeneity in the rate and appearance of age-related cognitive 
changes (Christensen et al. 1994), which may reflect the combined effects of age, 
sensory deficits, comorbid conditions and underlying neuropathology (Royall et al. 
2005), as well as genetic differences (Harada, Natelson Love & Triebel 2013; 
McClearn et al. 1997). Two concepts are used to describe cognitive change over the 
lifespan; crystallised and fluid intelligence (Anstey & Low 2004). Crystallized 
intelligence refers to accumulated knowledge, wisdom and expertise which are gained 
from socio-cultural influences and experiences, and can be evaluated through 
assessments of vocabulary, verbal ability and general knowledge. Crystallized abilities 
display resilience to cognitive ageing, and gradually improve at a rate of 0.02 to 0.003 
standard deviations (SD) per year through the sixth and seventh decades of life 
(Salthouse 2012), and decline thereafter at a slower rate and to a lesser degree than 
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fluid intelligence (Christensen 2001; Christensen et al. 1994). For instance, aspects of 
language subserved by crystallized cognitive abilities (e.g., vocabulary) remain stable 
and may even improve over time (Park & Reuter-Lorenz 2009; Salthouse 2009), 
however verbal fluency which describes the ability to search and generate words 
within a particular category (animal names, letters) shows age-related decline 
(Salthouse 2010; Singh-Manoux et al. 2012).  
 
Fluid intelligence represents the ability to use knowledge flexibly and adaptively, and 
encompasses a variety of abilities used for novel problem solving, spatial 
manipulation, mental speed, memory, and reasoning (Anstey & Low 2004; Craik & 
Bialystok 2006). Executive function, psychomotor ability, processing speed and 
memory are considered fluid cognitive domains, and are typically measured with tests 
that involve identifying patterns in numbers or shapes, or abstract thinking (Anstey & 
Low 2004). These abilities are essential for the completion of everyday activities, yet 
they appear to be the most vulnerable to decline as a part of normal ageing (Wilson et 
al. 2002), which can have detrimental and widespread effects on an older adult’s 
functional independence. As such, they are often targeted by various interventions 
which have attempted to maintain or improve these abilities in older adults, and are 
also a focus of this thesis.  Before these strategies are examined, the functional losses 
that are possible with age-related cognitive decline in aspects of fluid intelligence will 
be discussed in the next sections, in terms of the rate of change and the age of onset of 
any decline in these vital cognitive domains in healthy adults.  
 
Processing speed  
Processing speed refers to the speed with which cognitive activities are performed as 
well as the speed of motor responses, and are typically measured through reaction 
times (Salthouse 2000). A slower processing speed can negatively impact performance 
on many neuropsychological tests (e.g., working memory), and accounts for a 
substantial proportion of age-related decline in other cognitive domains including 
memory and executive function (up to 74%) (Salthouse & Coon 1993; Zimprich & 
Martin 2002). Longitudinal and cross-sectional studies have both indicated that the 
speed of processing and psychomotor ability improves during the first three decades 
of life, before linearly declining at an estimated rate of 0.02 SD per year (Nilsson 2003; 
Salthouse 2012; Salthouse 2009) (Figure 2.2). This manifests as a slowing of response 
times across a range of cognitive tasks (Deary & Der 2005; Sliwinski & Buschke 
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1999). A reduction in psychomotor speed may be explained by a deterioration in the 
speed of nerve conduction (Rivner, Swift & Malik 2001), white matter modifications 
(Ylikoski et al. 1993) and a loss of myelin integrity (Salat 2011), resulting in a greater 
time taken to produce a motor response. Diverse patterns of decline have been reported 
between different measures of reaction time; simple reaction time (responding to one 
set of stimuli) versus choice reaction time (responding to multiple sets of stimuli). 
While choice reaction time appears to slow throughout adulthood, simple reaction time 
only starts to decline around the age of 50 years (Der & Deary 2006), and may be 
affected by a trade-off between speed and accuracy during task performance, whereby 
accuracy is favoured over speed (Brébion 2003).  
 
Attention 
Attention refers to the ability to concentrate and focus on stimuli with conscious 
cognitive effort, and its subdivisions are necessary for effective cognitive function 
(Glisky 2007). Selective attention involves focusing on specific information in the 
environment while disregarding irrelevant stimuli, while divided attention involves the 
ability to simultaneously focus on and process two or more sources of information 
(Glisky 2007). Attentional processes are facilitated by structures such as the prefrontal 
cortex (PFC), parietal cortex, and anterior cingulate cortex (Milham et al. 2002). Both 
divided and selective attention are susceptible to age-related changes (Carlson et al. 
1995; Verhaeghen & Cerella 2002), whereas sustained attention (ability to concentrate 
over an extended period of time), and simple auditory attention span (involving 
immediate memory), are less affected by ageing (Glisky 2007). However the largest 
attentional deficits may be seen during dual-task performance (using divided 
attention), whereby an individual must not only attend to two or more tasks 
simultaneously, but must also switch their attention between tasks or stimuli 
(Verhaeghen & Cerella 2002). Deficits in selective and divided attention have been 
explained in terms of age-associated reductions to inhibitory control (Bugg et al. 
2007), processing resources (Verhaeghen & Cerella 2002), and processing speed 
(Salthouse 1996). Importantly, age-related deficits in divided attention, or dual-task 
performance, have the potential to compromise functionality (Pichierri et al. 2011; 
Rosano et al. 2005).  
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Figure 2.2: Cross-sectional data adapted from Park et al. (2002) showing changes in 
performance on measures of processing speed, working memory, long-term memory 
and knowledge across the lifespan. Taken from Park & Reuter-Lorenz (2009). 
 
Memory  
Abilities within the cognitive domain of ‘memory’ display variability across the 
lifespan, but are subjectively and empirically conspicuous in their decline (Rönnlund 
et al. 2015), as older adults do not perform to the same standard as young adults on a 
range of learning and memory assessments. Working memory and long-term memory 
are commonly observed to decline in older adults (Bopp & Verhaeghen 2005; Buckner 
2004), while other facets such as nondeclarative and semantic memory, remain intact 
and comparable to younger individuals (Bopp & Verhaeghen 2005; Nyberg et al. 
1996). Memory can be categorised into three main aspects; declarative, nondeclarative 
and working memory (Harada, Natelson Love & Triebel 2013). Declarative (explicit) 
memory involves the conscious recollection of facts and events from long-term 
memory and is divided into branches of semantic memory (e.g., language usage, 
practical knowledge and facts) and episodic memory (e.g., memories of personally 
experienced events, contextually encoded with location and time) (Budson & Price 
2005; Tulving 1987). Episodic memory is particularly sensitive to age-related effects, 
with cross-sectional data suggesting that the onset of decline may occur in the 20s or 
30s, with a decline of 2 SD-units present at age 80 (Nilsson et al. 1997; Rönnlund et 
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al. 2005). In contrast, longitudinal data is equivocal, but a linear decline beginning at 
around 60 years of age has been reported (Christensen 2001; Schaie 1994). 
Conversely, semantic memory exhibits a different pattern with ageing, instead 
displaying stability and sometimes improvement with age, before minor decrements 
appear at around age 55 (Bäckman & Nilsson 1996; Rönnlund et al. 2005). The medial 
temporal lobes, including the hippocampi and prefrontal cortex facilitate episodic 
memory processes, while semantic memory is mediated by the inferolateral temporal 
lobes, as shown in Figure 2.3 (Budson & Price 2005). Nondeclarative (implicit or 
explicit) memory operates outside of an individual’s awareness (e.g., the effortless 
ability to remember a familiar song) and shows stability across the lifespan (Churchill 
et al. 2003; Lezak 2004). Procedural memory involves the memory of cognitive and 
motor patterns required for familiar tasks (e.g., riding a bike), and depends on many 
regions including the basal ganglia and cerebellum (Verhaeghen & Cerella 2002). 
Collectively, age-related changes to memory may be partially attributed to slower 
processing speed (Luszcz, Bryan & Kent 1997), and a poorer ability to ignore 
irrelevant information (Darowski et al. 2008).  
 
Working memory is regarded as an integration of attention, concentration and short-
term memory, and is divided into components that process phonologic or visuospatial 
information (Budson & Price 2005). These processes are coordinated by a central 
executive that allocates attentional resources and facilitates purposive behaviour 
(Baddeley 1992), and an episodic buffer which acts as a conduit to long-term memory 
(Baddeley 2000). Working memory can therefore be viewed as a limited capacity  
system that is used for the transient storage and manipulation of visual, verbal and 
auditory information, to be used in the planning and execution of behaviour to achieve 
a particular goal (Cowan 2008). Working memory is facilitated by a distributed 
network encompassing the lateral PFC, parietal and temporal lobes (Budson & Price 
2005; Wager & Smith 2003), which overlaps other neuroanatomical areas implicated 
in related fluid abilities. Older adults tend to perform worse than younger adults in 
tasks assessing working memory (Borella, Carretti & De Beni 2008; Salthouse et al. 
1989), with this ability declining throughout life, especially in the seventh decade 
(Park et al. 2002; Park et al. 1996). As working memory theoretically exists as part of 
a multicomponent system controlled by a central executive (Baddeley 1992), its 
decline is thought to contribute to a range of age-related deficits in problem solving, 
decision making and long-term memory (Salthouse, Atkinson & Berish 2003). 
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Collectively, working memory and episodic memory are sensitive to age-related 
decline (Harada, Natelson Love & Triebel 2013; Rönnlund et al. 2005) while semantic 
and nondeclarative memory forms show less change from ageing (Nilsson 2003). It is 
thought that declines in memory may be due to deficits in encoding (Haaland, Price & 
Larue 2003) and memory retrieval, which limit the accessibility of new and older 
information (Craik & Bialystok 2006). Further, age-related variance indicating a 
decline in working memory and other memory forms, can be partly explained by 
decrements in processing speed (Brown et al. 2012b; Salthouse 1992).  
 
Executive Function  
Executive function is an umbrella term for the executive control processes which 
regulate fluid cognitive processes such as planning, inhibition, attention, working 
memory, problem-solving and multi-tasking. This capacity enables an individual to 
selectively direct attention, to concentrate on a particular task, and make purposeful 
choices in line with current goals, for the facilitation and adjustment of appropriate 
behaviours and responses (Craik & Bialystok 2006). These executive processes 
undergo disproportionate and extensive age-related deterioration along with the neural 
structures and connecting circuitry that sustain these processes, such as the 
hippocampus and frontal regions; the dorsolateral prefrontal cortex, anterior cingulate 
cortex, and orbitofrontal cortex (Alvarez & Emory 2006; Hillman, Erickson & Kramer 
2008; Kramer et al. 1999).  
 
The central importance of executive function is underscored by data which suggests 
that deteriorations in executive abilities significantly contribute to overall deficits in 
other domains of fluid intelligence, and mediate age-associated declines in global 
cognitive performance (Salthouse, Atkinson & Berish 2003; Schretlen et al. 2000). 
These findings align with the frontal lobe hypothesis of ageing, which postulates that 
age-related cognitive declines are associated with a deterioration of the frontal lobes 
(West 1996). Supporting this hypothesis, a preferential decline in prefrontal brain 
volume and function has been witnessed through neuroimaging and lesion studies (Raz 
2000; Salat 2011), however dysfunction in other brain regions and networks may also 
mediate this decline (Greenwood 2000).  
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Figure 2.3: Regions coordinating semantic procedural and working memory. Image 
taken from Budson & Price (2005). 
 
The onset of decline for executive abilities such as reasoning, abstract thinking, and 
mental flexibility is heterogeneously reported in the literature, as declines have been 
reported in the seventh decade (Boone 1999; Lezak 2004) and middle age (Robbins et 
al. 1998; Singh-Manoux et al. 2012), while other cross-sectional data proposes that 
detrimental processes begin to affect executive function in the twenties (Salthouse 
2009; Salthouse 2010). Analogous to the trajectory of other cognitive domains, 
declines in reasoning have been reported between 20 and 75 years of age, displaying 
an inverse correlation with age that ranges from -0.3 to -0.5 (Salthouse 2012; 
Verhaeghen & Salthouse 1997). Similarly, the performance of older adults (60 years) 
in reasoning tests has been found to be 0.65 to 0.7 SD lower than that of 18 year olds 
(Salthouse 2009). However, some abilities within executive function remain 
unchanged with ageing, such as the identification of similarities and proverbial 
meanings (Harada, Natelson Love & Triebel 2013).  
 
A decline in executive function has been previously attributed to a lower rate of 
processing speed, which can compromise executive abilities involving a psychomotor 
component (Fisk & Warr 1996; Salthouse 2000). Controlling for the variance in 
reasoning and memory in certain tasks has also substantially reduced the age-related 
declines witnessed in executive function (Schretlen et al. 2000). Deficits in executive 
function may also result in a reduced efficiency for dual-tasking (the ability to 
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simultaneously divide attention between a primary and secondary task) and the shifting 
of attention between one task and another (Verhaeghen & Cerella 2002). Collectively, 
deteriorations in aspects of executive function may impair functionality (Melzer et al. 
2010; Pichierri et al. 2011), and the performance of activities of daily living (ADLs) 
in older adults (Grigsby et al. 1998). These impairments may result from age-
associated deficits in response inhibition, which involves the inhibition of automatic 
responses in producing novel responses (Wecker et al. 2000).  
 
Summary of cognitive changes that occur with ageing 
There are inconsistencies in the cognitive ageing literature regarding the rate, timing 
and impact of cognitive decline across the various domains during the lifespan, which 
largely stem from issues related to differences in study design. The cognitive abilities 
most commonly considered to succumb to age-related deterioration include working 
memory, episodic memory, processing speed, executive function and attention, but the 
age of onset for the decline in these measures varies. Conversely, crystallised abilities 
and faculties acquired over a lifetime such as vocabulary, visuospatial ability and 
procedural memory, tend to display greater stability with ageing (Glisky 2007; 
Rönnlund et al. 2005).  
 
2.1.2 Neuroanatomical alterations with ageing 
Age-related cognitive decline is complex and variable, and may represent the 
culmination of a range of structural and physiological changes which are typically seen 
in the ageing brain. A variety of mechanisms are likely to interact in the age-associated 
decline in brain structure, including hypertension, oxidative stress, vascular and 
microvascular changes, recurrent inflammation and alterations to neurotransmitter and 
hormonal levels (Hedden & Gabrieli 2004; Raz & Rodrigue 2006; Whalley et al. 
2004). However, the biology of cognitive ageing is not well understood. Cross-
sectional data reveals that several neural substrates exhibit continuous age-related 
deterioration which may begin in the twenties, including measures of regional brain 
volume (Raz et al. 2005; Raz & Rodrigue 2006), myelin integrity (Andrews-Hanna et 
al. 2007), cortical thickness (Raz & Rodrigue 2006), accumulation of neurofibrillary 
tangles (Braak & Del Tredici 2011), and concentrations of various brain metabolites 
(Kadota, Horinouchi & Kuroda 2001). The following sections will briefly discuss the 
functional and structural changes that may lead to, and accompany, cognitive decline.   
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The efficiency of cognitive function is determined by several structural and functional 
factors which may diminish in older age. Evidence indicates that both grey and white 
matter loss contribute to cognitive decline in healthy ageing, along with modifications 
to neurotransmitter levels (e.g., dopamine), degraded myelination of fibres between 
neurons in different cortical areas, and alterations to synaptic physiology (Craik & 
Bialystok 2006; Salat 2011; Volkow et al. 2000). Structural brain changes are regional 
and differential; deterioration of the brain begins in the frontal regions of older adults, 
and the greatest volume loss is observed in brain regions such as the PFC, 
hippocampus and caudate nucleus (Raz 2000; West 1996). The onset and rate of this 
deterioration is dependent on the brain regions involved, with some gray matter 
structures declining after adolescence (Giedd et al. 1999). In addition, particular 
regions may experience significant shrinkage in a time period as short as 30 months 
(Raz et al. 2010). These losses correlate with deficits in executive function (Gunning-
Dixon & Raz 2003; Park & Reuter-Lorenz 2009), while a reduction in gross brain 
volume predicts poorer cognitive performance (Rabbitt et al. 2006). Neuroimaging and 
electrophysiological studies have also revealed that alterations to the structure and 
neural networks within the PFC, temporal and parietal lobes are associated with 
cognitive deterioration (Cabeza 2001; Raz et al. 1998; Reuter-Lorenz & Lustig 2005). 
These structural changes will be briefly discussed below.  
 
Grey and white matter loss in ageing  
Grey matter consists of neuronal cell bodies, dendrites and axons (myelinated and 
unmyelinated), glial cells, synapses and capillaries within the brain (Zhang & 
Sejnowski 2000), and declines over the lifespan from as early as 20 years of age (Craik 
& Bialystok 2006; Raz et al. 2005; Terry & Katzman 2001). In older adults grey matter 
shrinkage is more prominent in the prefrontal cortex and parietal regions (Resnick et 
al. 2003; Reuter-Lorenz & Lustig 2005), however the degradation of hippocampal 
volume may create losses in the temporal lobes (Raz et al. 2005). Specifically, atrophy 
to the grey matter in the lateral PFC may occur at a rate of over 5% per decade between 
the ages of 20 and 80 years (Raz et al. 2004). High concentrations of the protein 
amyloid beta (A), and neurofibrillary tangles which are aggregates of tau proteins, 
may also contribute to neuronal death and cortical shrinkage, with AD a downstream 
outcome (Becker et al. 2011; Storandt et al. 2009). The role of A in cognitive decline 
will be discussed in more depth in later sections.  
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White matter consists largely of myelinated axon tracts which are essential for an 
effective flow of information in functional networks, and very few cell bodies (Zhang 
& Sejnowski 2000). White matter is also susceptible to age-related changes, and global 
and regional reductions in volume and a degradation of structural integrity have been 
observed with ageing, especially in the prefrontal regions and corpus callosum (Head 
et al. 2004; Raz et al. 2005). The loss of white matter integrity may be especially 
deleterious to mental abilities such as fluid intelligence (e.g., executive function), as it 
can lead to impairments in information transfer between different cortical areas, which 
is crucial for higher-order cognitive function (Madden et al. 2012; Zhang & Sejnowski 
2000). White matter deterioration has been shown to begin in the fifth decade of life, 
and follow a non-linear course compared to grey matter deteriorations (Raz et al. 1997; 
Raz & Rodrigue 2006), with a volume reduction of 16-20% in older adults compared 
to younger subjects (Meier-Ruge et al. 1992). Ageing is also associated with a greater 
appearance of lesions deep in the white matter known as hyperintensities (Debette & 
Markus 2010; Ylikoski et al. 1995), and a higher prevalence of white matter lesions is 
associated with poorer performances in assessments of processing speed, executive 
function and attention (Rabbitt et al. 2007; Ylikoski et al. 1993). Whereas grey matter 
changes are induced by the environment, white matter changes are shaped by genetic 
influences, and may be created by vascular insufficiency (Craik & Bialystok 2006). 
Collectively, these results infer that age-related damage to grey and white matter may 
negatively affect many domains of cognitive function.  
 
Structural losses of the brain may be amplified in individuals with Alzheimer’s disease 
(AD) and dementia, and characterised by neuronal loss in the temporal lobes which 
interferes with memory processes (Sabuncu et al. 2011; West et al. 1994).  Individuals 
with AD also experience substantial losses of white matter (Bartzokis et al. 2003; Head 
et al. 2004), and a loss of medium and large pyramidal neurons (Mann et al. 1988) 
which contributes to an atrophy of cortical gray matter (Thompson et al. 2003). These 
deteriorations coincide with synaptic loss (Terry et al. 1991), and the presence of 
intraneuronal neurofibrillary tangles (Brion 1998; Goedert et al. 1989). Other 
hallmarks of AD include an elevation of Aβ in circulation and the deposition of Aβ in 
senile plaques (extracellular deposits in the brain), along with a disturbance of 
cholinergic function in the brain (Albert et al. 2011; Graff-Radford et al. 2007; 
Sperling et al. 2011). Notably, Aβ also accumulates in the brains of cognitively normal 
adults (Bennett et al. 2006; Davis et al. 1999; Price & Morris 1999). These individuals 
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may possess the same risk factors for AD that enhance amyloid deposition, however 
it has also been speculated that a greater cognitive reserve (e.g., higher level of 
education, genetic predisposition) may enable these adults to tolerate a significant 
amount of AD pathology without a manifestation of dementia (Stern 2002). 
 
2.1.3 Functional changes in neurophysiology that occur with ageing 
In normal ageing, changes in neuroarchitecture may be accompanied by alterations in 
neural connectivity, which can compromise cognitive function, even in the absence of 
disease. Brain activation is less coordinated in older age, leading to reduced integration 
of separate brain regions and poor performance in several cognitive domains (Mattay 
et al. 2002; Park & Reuter-Lorenz 2009; Persson & Nyberg 2006; Reuter-Lorenz & 
Lustig 2005). Cortical activation displays bilateral patterning in children, with 
progressive expertise allowing this activation to become more focal and lateralised 
with age (Stiles et al. 2003). This functional organisation gradually reverses in older 
age, with a more bilateral pattern of activation observed compared to younger adults 
(Cabeza 2002). Higher functioning older adults may exhibit an overactivation in 
frontal brain areas during the performance of cognitive tasks, interpreted as a 
recruitment of additional brain areas to compensate for age-related changes (Cabeza 
et al. 2002; Park & Reuter-Lorenz 2009; Reuter-Lorenz & Lustig 2005). The PFC has 
demonstrated this flexibility, with increased bilateral PFC activity observed in older 
adults during tasks incorporating memory and other fluid abilities (Cabeza 2002; 
Grady et al. 1998; Reuter-Lorenz & Lustig 2005). Despite these changes, exercise and 
cognitive training studies have both demonstrated that executive control processes and 
underlying brain regions are plastic and adaptive, with the brain retaining the capacity 
for functional reorganisation (Erickson et al. 2007; Voelcker-Rehage & Niemann 
2013). 
 
The trajectory of ageing in the human brain may also be influenced by neurological 
biomarkers which are critical for neurogenesis, angiogenesis and synaptic plasticity 
(Cotman, Berchtold & Christie 2007). Emerging research has shown that growth 
factors such as brain derived neurotrophic factor (BDNF) insulin-like growth factor 
(IGF-1) and vascular endothelial growth factor (VEGF) have neuroprotective roles for 
brain function and structure (Voss et al. 2013). Accumulating evidence has also linked 
inflammatory mechanisms to age-associated cognitive decline (Godbout & Johnson 
2009), including AD and vascular dementia (Engelhart et al. 2004; Hofman et al. 
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1997), with the capacity to impair neurotrophic signalling (Cotman, Berchtold & 
Christie 2007; Packer, Pervaiz & Hoffman-Goetz 2010; Petersen & Pedersen 2005). 
The relationship between growth factors, inflammation and physical activity (PA) on 
cognitive function will be outlined in later sections. 
 
2.1.4 Theories of cognitive ageing  
Several theories of cognitive ageing have been suggested which implicate changes at 
the level of mental processing as potential agents of age-associated cognitive decline 
across multiple domains. Age-related deficits in cognitive function most likely result 
from a combined integration of these events, rather than a specific mechanism.  
 
Processing speed theory  
The ‘processing speed theory of ageing’ of Salthouse proposes that age is associated 
with decrements in the speed of mental processing, and that this decline in speed can 
account for impairments experienced in multiple areas of fluid intelligence (Salthouse 
1996). Conflicting data has indicated that a reduction in processing speed may not be 
the sole-contributor to age-related cognitive decline, and instead may interact with 
age-related deficits in working memory and inhibitory control (Head et al. 2008; Park 
et al. 1996).  
 
Inhibitory control theory 
The inhibitory control theory of Hasher and Zacks (Hasher & Zacks 1988) proposes 
that inhibitory control processes lose efficiency with age, diminishing an older 
individual’s ability to disregard irrelevant information from entering working memory. 
Working memory functions become more susceptible to irrelevant cues and stimuli 
with age, and this irrelevant content has the potential to compromise performance in 
tasks which rely on working memory and selective attention, by taxing storage 
capacity (Milham et al. 2002). A related theory posits that attentional and processing 
resources are depleted and are harder to access with ageing (Craik & Byrd 1982). An 
increased cognitive demand for these resources by competing attentional and cognitive 
processes (as seen in a dual-task context) further taxes these limited stores (Craik & 
Byrd 1982). Consequently, this affects task performance requiring higher memory 
loads or the division of attention (Verhaeghen et al. 2003), and the encoding of 
information and events into memory (Craik & Byrd 1982).   
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Frontal lobe hypothesis of cognitive decline 
The frontal lobe theory of ageing attempts to associate age-related declines in 
cognitive function to changes in the structure and function of the ageing brain (West 
1996). Specifically, these declines are attributed to deteriorations in the anterior 
portions of the brain, which are particularly vulnerable to the effects of ageing 
(Resnick et al. 2003; Reuter-Lorenz & Lustig 2005). In support of this claim, the PFC 
is the first cortical region to exhibit atrophy with normal ageing (Dempster 1992), and 
cognitive functions coordinated by the frontal lobes show earlier and more pronounced 
signs of malfunction than other fluid and crystallised abilities controlled by other 
regions (Grady et al. 1998). These deficits may explain age-related declines witnessed 
in reasoning, executive function and working memory (Grady et al. 1998; West 1996).   
 
Cognitive Reserve 
Age-associated decline may be prevented by certain activities, according to a theory 
of cognitive reserve. This hypothesis proposes that pathological changes to the brain 
may be resisted or curtailed in some individuals due to biological and environmental 
influences which create a greater “brain reserve” (Stern 2002; Whalley et al. 2004). 
For example, higher levels of education, baseline intelligence and participation in 
activities such as exercise may be protective elements, and individuals who are more 
cognitively active may accrue a greater ‘reserve capacity’ which can delay or reduce 
the impact of cognitive decline (Whalley et al. 2004). Forms of “passive reserve” 
include genetically determined factors such as brain volume and synaptic and neuronal 
density, while “active reserve” describes the potential for plasticity and the 
reorganisation of neural circuitry to occur in a compensatory manner to pathological 
changes (Harada, Natelson Love & Triebel 2013). This reorganisation is speculated to 
occur via the ‘scaffolding theory of ageing and cognition’ (STAC), which describes 
the compensatory recruitment and forging of additional neural pathways (scaffolds) 
and regions for successful cognitive task achievement in older adults (Park & Reuter-
Lorenz 2009). In addition, the compensation-related utilization of neural circuits 
hypothesis (CRUNCH) model posits that a decline in neural efficiency with ageing 
leads to a greater engagement of neural pathways, leading to bilateral recruitment in 
tasks with a low cognitive load (Reuter-Lorenz & Cappell 2008).  
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Summary of functional changes that occur with ageing 
Electrophysiological and neuroimaging data propose that age-related deteriorations in 
cognitive function are associated with structural losses to localised areas such as the 
PFC, parietal and temporal lobes, which are important for memory and higher order 
cognitive functions, leading to inefficient communication between brain networks 
(Fjell & Walhovd 2010; Raz et al. 2005). However, modest associations between 
structural brain differences and cognitive ability suggest that this decline is not 
inevitable with ageing (Hedden & Gabrieli 2004; Raz & Rodrigue 2006). Inter-
individual differences in cognitive reserve, shaped by cognitive abilities gained from 
earlier life experiences, education and occupation can buffer cognitive insults 
(Salthouse 2009; Whalley et al. 2004), while a compensatory recruitment of unrelated 
brain regions may counteract structural losses (Hedden & Gabrieli 2004; Park & 
Reuter-Lorenz 2009).  
 
2.2 Consequences of age-related cognitive decline 
2.2.1 Population and economic burden of cognitive decline and dementia 
In older adults, cognitive function exists along a continuum ranging from normal 
cognitive functioning to dementia, and is associated with individual variability and the 
normal ageing processes (Kalaria et al. 2008) (Figure 2.4). Cognitive deterioration 
may be a precursor to a clinical disorder that can progress under the influence of certain 
biological (e.g., genetics) and environmental factors (e.g., poor dietary habits, low 
education levels). Dementia represents a decline in cognitive function which is more 
marked than the cognitive decline associated with normal ageing (Sperling et al. 2011). 
Described by the World Health Organisation (WHO) as a syndrome associated with 
more than 100 different diseases, dementia is typified by a progressive decline in 
cognitive, social and physical functioning due to a variety of brain illnesses or damage, 
and is not regarded as a normal consequence of ageing (World Health Organization 
2012). The most common form of dementia is AD, accounting for 60-70% of cases, 
while other types include vascular dementia and dementia with Lewy bodies (World 
Health Organization 2012).  
 
Currently in Australia, dementia affects 1 in 10 adults aged ≥ 65 years, and 3 in 10 
adults over the age of 85 (Australian Institute of Health and Welfare 2016a). Estimates 
from 2017 indicate that over 314,000 Australian adults aged ≥ 65 years were living 
with dementia (Figure 2.5), and this number is projected to increase to almost 900,000 
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by 2050 due to an ageing population (Australian Institute of Health and Welfare 2012; 
Brown, Hansnata & La 2017). Worldwide, dementia is expected to afflict over 131 
million people by 2050 (Prince et al. 2016), however data suggests that the prevalence 
of dementia in older populations may be decreasing, which may result from a reduction 
in risk factors such as improvements in education and prevention and treatment 
strategies for various common chronic conditions (Matthews et al. 2013). The various 
forms of dementias cumulatively represent the leading cause of ‘years lost due to 
disability’ for Australians aged 65 years and over (Australian Institute of Health and 
Welfare 2012), the sixth leading cause of disease burden but leading cause for adults 
over 85, and the leading cause of disability burden (Australian Institute of Health and 
Welfare 2012; Brown, Hansnata & La 2017). Further, in the most recent estimates, 
dementia was the second leading cause of death in Australia, with over 25 people dying 
from this disease every day (Australian Bureau of Statistics 2015a), while older adults 
with dementia have a mortality rate 33 times higher than people without dementia 
(Australian Institute of Health and Welfare 2012). Collectively, these statistics 
highlight that cognitive deterioration may have widespread and fatal effects on 
multiple physiological systems, or may be a by-product of systemic illness and disease. 
Moreover, sufferers of dementia requiring a high level of care, place an added burden 
on health and aged care service costs (McClure et al. 2005) with expenditure related 
to dementia totalling $8.8 billion in Australia in 2016 (Brown, Hansnata & La 2017). 
 
 
 
Figure 2.4: Model of the continuum and clinical trajectory of Alzheimer’s disease, 
compared to normal ageing. Taken from Sperling et al. (2011). 
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.  
Figure 2.5: Estimated number of people with dementia, by age and sex, in Australia 
in 2011, highlighting the deviations that occur after age 80 between sexes (Australian 
Institute of Health and Welfare 2012). 
 
Alzheimer’s disease 
Alzheimer’s disease (AD) is the most common form of dementia, increasing in 
prevalence from less than 1% below the age of 60 years to more than 40% above 85 
years of age (Beydoun et al. 2014). Currently, there is no cure for AD, and the initial 
phase of AD is characterised by a progressive deterioration of episodic memory, while 
disturbances in executive function may also be present (Baudic et al. 2006; Perry, 
Watson & Hodges 2000). As the process advances, impairment then spreads to other 
aspects of memory and other cognitive abilities such as language, planning, and global 
cognitive function (Petersen et al. 1999; Small et al. 1997). There is accumulating 
evidence that AD pathology starts decades before the symptoms are recognised, 
implying that adults may be in the preclinical phase of AD for 20-30 years before its 
clinical onset, which may explain cognitive decline otherwise attributed to normal 
ageing (Goedert & Spillantini 2006; Sperling et al. 2011). The identification of 
neuroprotective strategies which may prevent AD and dementia is therefore required 
and should be applied in individuals prior to the appearance of cognitive decline. 
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Mild Cognitive Impairment  
Mild Cognitive impairment (MCI) is defined as cognitive decline that does not meet 
the criteria for dementia, but which is greater than would be expected for an 
individual’s age and educational background (de Mendonça et al. 2004; Gauthier et al. 
2006). This can be diagnosed if an individual satisfies the following criteria; concern 
regarding a decline in cognitive function, modest impairment in cognitive performance 
as documented by a standardised cognitive assessment, preserved independence in 
functional abilities, and not meeting the criteria for dementia (American Psychiatric 
Association 2013; Petersen et al. 1999). Its prevalence ranges from 3-19% in adults 
over 65 and these adults retain the ability to perform ADLs (Gauthier et al. 2006). MCI 
may also represent a transitional stage between normal ageing and the onset of 
dementia (Petersen 2007). While some individuals with MCI demonstrate stability or 
return to normal cognitive function, approximately half of affected adults progress to 
dementia within 5 years (Gauthier et al. 2006; Mitchell & Shiri‐Feshki 2009). Further, 
adults with MCI have been observed to develop dementia and AD at a rate of 5-15% 
per year (Mitchell & Shiri‐Feshki 2009; Petersen et al. 2001). By comparison, healthy 
adults convert to AD at a rate of 1-2% per year (Australian Institute of Health and 
Welfare 2012; Petersen et al. 2001). This data suggests that the majority of older adults 
will not develop AD in their lifetime, but may suffer from milder impairments which 
can reduce the quality of cognitive functioning.  
 
2.2.2 Risk factors for dementia and related disorders 
The changes to cognitive function that occur with age are not consistent across older 
populations, and may be shaped by modifiable and non-modifiable factors. Advancing 
age is one of the major risk factors for cognitive decline and age related dementias 
such as AD and vascular dementia (Alzheimer’s Association 2015), while genetic 
traits (e.g., family history, carrier of the ApoE-ε4 variant coding for apolipoprotein E 
which binds and transport lipids through the lymphatic and circulatory system) have 
also been strongly implicated as contributing factors (Alzheimer’s Association 2015; 
Poirier et al. 1993; Sperling et al. 2011). For example, possession of an APoE-ε4 allele 
may exert a small adverse effect on cognitive performance even in healthy older adults, 
which can manifest as poorer performance in general cognitive ability, perceptual 
speed, episodic memory and executive functioning assessments (Small et al. 2004; 
Wisdom, Callahan & Hawkins 2011). Plasma levels of Aβ (Aβ (1-42) and Aβ (1-40)) 
and the ratio between these isoforms have also shown to be an effective biomarker for 
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identifying individuals at risk for developing MCI or AD (Albert et al. 2011; Gauthier 
et al. 2006; Koyama et al. 2012). This neuropathology is thought to be triggered by 
mechanisms such as oxidative stress, inflammatory processes and neurovascular and 
mitochondrial dysfunction (Akiyama et al. 2000; Lin & Beal 2006; Zlokovic 2011). 
Emerging evidence has also demonstrated that a range of potentially modifiable 
environmental (e.g., low socio-economic conditions, less education) (Kalaria et al. 
2008) and lifestyle factors (e.g., poor diet, mental health, diabetes and physical 
inactivity), may also contribute to dementia and age-associated cognitive decline 
(Barnard et al. 2014; Baumgart et al. 2015). The presence of cardiovascular disease 
risk factors such as hyperlipidemia, obesity and hypertension have also been shown to 
increase the risk for cognitive disorder (Baumgart et al. 2015; Prince et al. 2014). A 
summary of the strength of the evidence for these lifestyle-oriented risk factors for 
dementia is presented in Table. 2.1. Furthermore, chronic low grade systemic 
inflammation, which is often seen with ageing and the presence of chronic disease, has 
also been implicated in age-related cognitive decline, dementia, and depression 
(Graham, Christian & Kiecolt-Glaser 2006; Kiecolt-Glaser, Gouin & Hantsoo 2010; 
Sartori et al. 2012). There is strong evidence linking inflammatory biomarkers with 
atherosclerosis and cardiovascular disease (CVD) processes (Hansson 2005; Hansson 
& Hermansson 2011; Ridker et al. 2000), including changes in vascular function and 
structure, and these processes may contribute to cerebrovascular disease or lesions 
which can compromise white matter integrity (Wersching et al. 2010; Zhang et al. 
2009), resulting in cognitive deterioration. Associations between inflammation and 
brain health will be extensively discussed in later sections. Normative age-associated 
cognitive decline and the progressions into MCI and dementia therefore represent 
stages along a continuum which are influenced and neutralised by a confluence of 
environmental and biological risk-factors. 
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Table 2.1: Strength of evidence on risk factors for cognitive decline and dementia. Adapted from Prince et al. (2014). 
 
                                              Cognitive decline risk                            Dementia Risk  
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 Increased Decreased Increased Decreased 
High 
Traumatic brain injury 
Mid-life obesity 
Mid-life hypertension 
Current Smoking 
Diabetes 
 
Physical Activity 
Years of formal education 
 
 
Traumatic brain injury 
Diabetes 
 
Late life hypertension  
Years of formal education  
Moderate  
Mediterranean Diet 
Cognitive Training 
Mid-Life Obesity 
Mid-Life hypertension 
Current Smoking  
Depression 
 
Physical Activity 
Occupational Status 
 
      Low 
History of depression 
Sleep Disturbances 
Moderate alcohol 
consumption 
 
Mediterranean Diet 
Cognitive Training 
Insufficient Hyperlipidemia Social Engagement 
History of Depression 
Sleep Disturbances 
Hyperlipidemia 
Early life events 
Psychological distress 
Moderate Alcohol Consumption 
Social Engagement 
Nutrition (growth and development) 
Cognitive Stimulation 
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2.3 Interventions to mitigate cognitive decline in older adults 
A continuum of finely-graded cognitive changes occur with normal ageing (Royall et 
al. 2005), ranging from normal cognitive functioning to substantial disability or 
mortality (Christensen et al. 1999; Wilson et al. 2002; Yaffe et al. 2010). There is 
currently no cure for age-associated cognitive decline or dementia, and available 
pharmacologic treatment strategies mainly offer symptomatic benefits (Naqvi et al. 
2013). Therefore, interventions that can delay the onset of cognitive decline or 
dementia, especially strategies that modify lifestyle factors (e.g., exercise, dietary 
factors or the combination), are required. The following section will first provide a 
brief overview of the evidence from cognitive training programs designed to improve 
cognitive function, before the efficacy of other strategies such as physical activity and 
exercise are discussed.  
 
2.3.1 Cognitive training interventions to improve cognitive function 
While it is beyond the scope of this thesis to thoroughly review all of the available 
evidence with regard to the effects of cognitive training on cognitive function, there is 
evidence that regular participation in mentally stimulating activities (e.g., reading, 
memory training, word games) and specific cognitive training (e.g., memory training, 
strategy learning), can both produce robust and persistent protective effects on various 
cognitive domains in older adults (Martin et al. 2011; Stern & Munn 2010; Valenzuela 
& Sachdev 2009). Computerised or traditional paper-and-pencil training interventions 
involving the repetition of mental exercises (e.g., remembering word lists, locating 
visual information in a divided attention format) have been investigated for their 
capacity to improve cognitive function and offset age-related cognitive decline and 
dementia in older adults with varying cognitive ability (Ball, Edwards & Ross 2007; 
Kueider et al. 2012; Reijnders, van Heugten & van Boxtel 2013; Valenzuela & 
Sachdev 2009)). 
 
As reviewed by Ball and colleagues (2007), speed of processing training produces 
immediate improvements in older adults, which can lead to greater performance of 
ADLs, such as finding a phone number in a directory, finding an item on a crowded 
shelf, and reading medication labels (Owsley et al. 2002). This is also important as a 
reduction in information processing speed may account for considerable proportions 
of the cognitive decline experienced with ageing (Ball, Edwards & Ross 2007; Lemke 
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& Zimprich 2005). Further, a 2012 systematic review reported that specialised 
computerised cognitive training programs incorporating neuropsychological software 
designed to test and enhance domains of cognition in older adults, can produce 
improvements across a range of cognitive domains (e.g., reaction time, processing 
speed, working memory), which are comparable to more traditional cognitive training 
interventions which may also use computers, but rely on guided practice on 
standardised tasks (e,g., training of processing speed, target identification, audio-based 
memory training), with effect sizes ranging from 0.06 to 7.14 (Kueider et al. 2012). 
Despite these findings, cognitive training interventions in general can be costly and 
time-consuming in their coordination, training is usually of a solitary nature, and the 
optimal mode of training delivery is still unclear. In addition, controversy surrounds 
whether this form of training can confer benefits that carry across to functional tasks 
in older adults and prevent dementia (Ratner & Atkinson 2015; Simons et al. 2016), 
as most cognitive training programs target specific domains with little or no carry over 
to other abilities. It is also contended that an exposure to 5-100 hours of concerted 
brain training, as found in most training programs, is insignificant compared to a 
lifetime of mental challenge and cognitive exertion. Given these concerns, the 
identification of alternative therapies that can provide far-reaching health benefits is 
necessary to maintain cognitive function in older adulthood.  
 
2.3.2 Effect of physical activity and exercise on cognitive function  
Regular physical activity (PA) and exercise training are also considered to be 
neuroprotective against age-related cognitive decline (Packer, Pervaiz & Hoffman-
Goetz 2010). Both forms of activity can reduce peripheral risk factors such as 
hyperlipidemia, obesity, inflammation and high blood pressure, which have been 
strongly linked to cognitive decline and dementia (Beydoun et al. 2014; Solomon et 
al. 2009). Physical activity is described as any bodily movement produced by the 
contraction of skeletal muscle that substantially increases energy expenditure, and 
includes leisure-time, transport and other domains (United States Department of 
Health and Human Services 1996). By comparison, exercise is a sub-type of PA which 
is planned, structured, repetitive, and purposeful, in improving one or more 
components of physical fitness (Caspersen, Powell & Christenson 1985), and 
conceptually distinct from PA. However, many studies in the literature that have 
investigated associations between cognition and physical activity commonly 
interchange the terms ‘physical activity’ and ‘exercise’, and even combine the time 
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spent in both types of activities in their analyses. Therefore for the purposes of the next 
sections, prospective studies will mostly assess habitual physical activity, with 
intervention studies typically prescribing exercise training. The following sections will 
outline the cognitive benefits observed in association with regular PA, and other 
training formats such as aerobic training, progressive resistance training (PRT), and 
multimodal training, whilst also discussing the shortcomings of each modality in 
preserving cognitive function in older adults.  
 
2.3.2.1 Epidemiological studies investigating the effect of PA on cognitive function  
Several longitudinal studies have investigated the effects of regular or habitual PA on 
cognitive function, and have attempted to establish a dose-response relationship 
between levels of PA and the risk of cognitive impairment and dementia (Barnes et al. 
2003; Blondell, Hammersley-Mather & Veerman 2014; Etgen et al. 2010; Laurin et 
al. 2001). Due to the extensive nature of the available data, meta-analytic data will be 
presented, evaluated and critiqued in this section of the literature review, along with 
findings derived from several systematic reviews.  
 
The influence of habitual PA on cognitive function was explored in a 2011 meta-
analysis of 15 prospective studies in cognitively intact older adults (all but one study 
included adults ≥65 years) (Sofi et al. 2011). Both low-to-moderate PA level [hazard 
ratio (HR): 0.65 (95% CI 0.57- 0.75); P<0.001] and high PA levels [HR: 0.62 (95% 
CI 0.54-0.70); P<0.001] were shown to be protective of cognitive decline for up to 15 
years, compared to sedentary older adults. Unfortunately, these findings provide no 
clear evidence of a dose-response relationship between PA and cognitive decline, 
which may result from the variable methods of classifying PA levels within the studies 
included in this meta-analysis. In a further meta-analysis of 16 prospective studies 
incorporating over 160,000 participants, the relationship between different levels of 
PA (e.g., highest levels vs lowest levels in terms of frequency/time) and a diagnosis of 
dementia or cognitive impairment at follow-up was measured in healthy older adults 
(Hamer & Chida 2009). The highest levels of PA defined by each study in this review 
were found to significantly reduce the risk of dementia by 28% (P<0.001) and the risk 
of AD by 45% (P<0.006), when compared to the lowest levels (Hamer & Chida 2009). 
Despite these reductions, a consistent linear dose-response relationship was not 
demonstrated even in the most effective studies with well-defined PA quintiles. 
Furthermore, variation in the highest PA classification reported across the studies and 
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inaccurate definitions of PA levels in terms of frequency, intensity and duration, 
precludes any establishment of a dose-response relationship. Partially supporting these 
conclusions, a meta-analysis containing data from more recently conducted 
prospective studies (until 2014) reported similar protective effects for PA levels on 
developing cognitive decline and dementia in older adults [relative risk (RR): 0.65 
(95% CI 0.55-0.76) and RR: 0.86 (95% CI 0.76-0.97) respectively], over follow up 
periods lasting from one to 21 years (Blondell, Hammersley-Mather & Veerman 
2014). However, as moderate to high levels of heterogeneity were detected in the 
methodologies between the cognitive decline and dementia studies included for 
analysis, this may have affected the conclusions drawn. For example, the variability 
of follow-up periods between the studies in this analysis was shown to have an impact 
on the findings, with sensitivity analyses demonstrating weaker protective effects of 
PA in studies with a follow-up period greater than 10 years (Blondell, Hammersley-
Mather & Veerman 2014). In addition, the outcome measure predominantly used to 
assess cognitive decline by most studies in this review was the Mini Mental State 
Exam (MMSE), whose use has been challenged as it is considered to have insufficient 
scope and sensitivity to identify mild forms of cognitive decline (Jacova et al. 2007).  
 
Collectively, the available longitudinal findings from observational studies suggest 
that older adults that participate in regular PA, especially higher levels of PA 
categorized as moderate-strenuous [>64% of maximum heart rate (HRmax) or ≥ 3 
METS (metabolic equivalent)] and performed ≥3 times a week, display less cognitive 
decline and a reduced risk of progression to neurological disease, over one- to 21- year 
follow-up periods, compared to more sedentary counterparts (Blondell, Hammersley-
Mather & Veerman 2014; Etgen et al. 2010; Hamer & Chida 2009; Laurin et al. 2001). 
Further evidence has also indicated that intensity rather than quantity of PA may be 
more important in the association between PA and cognitive function after adjusting 
for confounders, with higher intensities of objectively measured PA shown to 
significantly improve working memory, attention and processing speed (all P<0.05) 
(Brown et al. 2012a).  However, there is considerable heterogeneity in the definition 
of PA between the studies included in the various meta-analyses, stemming from 
insufficient amounts of detail on the type, frequency, duration and intensity of PA 
involved. Furthermore, discrepancies between studies may result from inconsistent 
lengths of follow-up periods, self-reporting of PA rather than objective data collection, 
and an insensitivity of the selected cognitive outcome measures to detect subtle 
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changes in cognitive function at baseline, which can lead to mischaracterization of an 
older adult’s cognitive status and possibly affect status at follow-up (Hamer & Chida 
2009). 
 
A limitation of these observational studies is that they do not provide a causal link 
between higher PA levels and improved cognitive function. For example, a diminished 
cognitive function with ageing may in fact reduce the opportunity and desire for PA, 
and increase cardiometabolic risk factors which are associated with cognitive 
impairment and disease. While physical inactivity is a separate construct to sedentary 
behaviour, this modifiable factor has been previously linked with an increased risk of 
dementia (Voss et al. 2014). Therefore, intervention studies involving various modes 
of exercise may provide more evidence as to the directionality of the relationship 
between cognitive function and PA, and will be discussed in detail in the next section.  
 
2.3.3 Effect of aerobic exercise training on cognitive function 
Aerobic exercise training refers to exercises in which the large muscles of the body 
move in a rhythmic manner for sustained periods (Chodzko-Zajko et al. 2009). Many 
randomised controlled trials (RCT) have examined the effects of aerobic exercise 
training on cognitive function in healthy adults, with somewhat mixed findings. 
Several narrative reviews have asserted that aerobic exercise has multifaceted benefits 
for cognitive function in older adults (Hillman, Erickson & Kramer 2008; Kramer, 
Erickson & Colcombe 2006; Nagamatsu et al. 2014), and meta-analyses have reported 
aerobic training-induced improvement in cognitively impaired older adults over the 
age of 55 years (Gates et al. 2013; Heyn, Abreu & Ottenbacher 2004). However, meta-
analytic data derived from aerobic training RCTs in healthy older adults has not been 
able to consistently demonstrate these effects, and will be discussed in the following 
sections.  
 
Despite extensive research into the efficacy of aerobic training on cognitive function, 
collective findings have been mixed. In a 2010 meta-analytic review of 29 RCTs 
involving aerobic training in over 2000 adults with and without MCI (>18 years), it 
was reported that aerobic exercise was positively related to modest improvements in 
attention and processing speed (effect size (ES): 0.16), executive function (ES: 0.12), 
and memory (ES: 0.13) (all P<0.026), with less consistent effects on working memory, 
compared to control groups (Smith et al. 2010). The majority of included studies 
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utilised at least moderate-intensity aerobic training (~40-59% heart rate reserve, or 64-
76% HRmax) performed three times a week, however inconsistent intervention lengths 
(6 weeks to 18 months) and heterogeneity between the neurocognitive measures may 
have prevented robust effects from emerging. Furthermore, these effects are not 
specific to older adults. In support of these findings, an earlier meta-analysis using 
data from older participants (over 55 years), reported that aerobic training had a 
moderate effect on multiple cognitive domains (ES=0.41, P<0.05), including 
executive function, processing speed and  visuospatial ability (Colcombe & Kramer 
2003). However, in addition to the inclusion of non-RCT studies in this analysis, 
cognitively impaired and depressed adults were also included, limiting its 
generalisability to healthy older adults. A recent meta-analysis has also supported the 
benefits of aerobic training in older adults (>50 years), reporting that moderate-high 
intensity aerobic training can provide a small benefit (ES: 0.24) across cognitive 
domains including executive function, attention and working memory (Northey et al. 
2017). However, this study included trials involving healthy and cognitively impaired 
older adults, which were not separated in the analyses.  
 
There is some evidence that aerobic training can produce cognitive benefits in older 
adults (Colcombe & Kramer 2003; Smith et al. 2010), however it is unclear as to 
whether concomitant improvements in fitness are needed to drive these benefits.  
Aerobic training interventions that improve cardiorespiratory fitness (measured 
through direct indexing or estimation of VO2max) have showed minimal cognitive 
benefits (Angevaren et al. 2008), in line with the ‘cardiovascular fitness hypothesis’ 
(McAuley, Kramer & Colcombe 2004). However numerous meta-analyses and 
reviews have not found sufficient evidence to suggest that regular PA or aerobic 
exercise that improves cardiovascular fitness can improve cognitive function in older 
adults (Etnier et al. 2006; Kelly et al. 2014; Snowden et al. 2011; Young et al. 2015). 
Kelly and colleagues (2014) demonstrated some benefit of aerobic exercise on 
executive function across individual trials in their meta-analysis, but a lack of 
consistent significant findings was reported. These inconsistencies were ascribed to 
variations in methodologies (e.g., insufficient training intensities), and cognitive 
outcome measures across the studies. Instead, the authors recommended that 
interventions combining resistance and aerobic training in 31-45 minute sessions, for 
6 months or longer in duration, may optimise benefits for cognitive function in older 
adults, aligning with previous recommendations (Colcombe & Kramer 2003; Kelly et 
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al. 2014). Aerobic training was also reported to have no benefit across multiple study 
designs and cognitive domains in a recent meta-analysis of 12 RCTs in older adults 
with no cognitive impairment (Young et al. 2015), with this Cochrane review unable 
to provide any recommendations as to the optimal dose required for cognitive 
improvement. Variations in training dose and protocol, study design (i.e. insufficient 
training frequencies and intensities), and inconsistent neurocognitive outcome 
measures between RCTs are typically cited as contributing factors to the null findings 
reported within these analyses. However, limitations within these meta-analyses 
themselves may also influence the reported efficacy of aerobic training. These include 
the inclusion of unpublished data (Etnier et al. 2006), a rigorous screening criteria that 
may diminish the scope of data collection (Snowden et al. 2011; Young et al. 2015), 
and a broad age range (>50 years old) which may allow ceiling effects to be factored 
into neurocognitive performance outcomes (Kelly et al. 2014). Longer (>6 months), 
well-controlled studies with standardised neurocognitive tests and age-groups, may 
assist in establishing a direct relationship between aerobic training and cognitive 
improvement in older adults.   
 
In summary, while many studies prescribe moderate-intensity aerobic training for 
cognitive benefits, the optimal dose (frequency, intensity, duration) required to elicit 
cognitive changes in older adults is far from established. Individual RCTs report small 
to modest cognitive benefits in healthy older adults following aerobic training, 
however several meta-analyses have not supported these conclusions. Inconsistencies 
in study design, exercise programming, and the populations included may contribute 
to these uncertainties (Angevaren et al. 2008; van Uffelen et al. 2008).  
  
2.3.4 Effect of progressive resistance training on cognitive function  
Mixed evidence suggests that Progressive Resistance Training (PRT) has the capacity 
to elicit improvements in cognitive function in older adults, with several studies 
attempting to further establish if there is an optimal dose and type of training required 
for cognitive benefit (Chang et al. 2012; Kelly et al. 2014). Resistance exercise training 
includes exercise that causes muscles to work or hold against an applied force or 
weight (Chodzko-Zajko et al. 2009), and is typically classified as low (50-70% 1RM), 
moderate (67-84 % of 1RM) or high intensity (>85% of 1RM) (Haff & Triplett 2015). 
The next sections will outline the evidence that PRT, alone and in combination with 
other training modalities, may be a viable strategy for cognitive improvement. In these 
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sections, the terms PRT, strength training, and resistance training, will be 
interchangeable. Due to a lack of available meta-analytic data in this area, evidence 
from reviews and RCTs will be presented to demonstrate the efficacy of this training 
modality, in cognitively intact older adults.   
 
Narrative reviews have provided some evidence which outlines the potential for PRT 
to elicit improvements in cognitive functioning (Liu-Ambrose & Donaldson 2009; 
Nagamatsu et al. 2014), however inconsistent cognitive benefits have been reported in 
other formal reviews (Chang et al. 2012; Kelly et al. 2014). A 2012 review of RCTs 
reported that PRT, either alone or in combination with other exercise regimens, using 
loads of 60-80% 1RM and performed at least twice a week for 2-12 months, can 
improve processing speed, attention, memory types and executive function, however 
it found no consistent evidence across all reviewed studies (Chang et al. 2012). The 
inconsistent findings may have been influenced by variation in the quality of studies 
reviewed, with positive results from low-quality RCTs potentially overestimating the 
effect of PRT on cognition. In addition, this review failed to determine whether 
cognitive improvements might result from confounding elements such as practice 
effects, which have the potential to artificially elevate post-intervention cognitive 
results. Nevertheless, these findings were supported by a meta-analysis including six 
RCTs which compared the effects of PRT to either an active control group or non-
exercising control groups, across multiple cognitive domains (Kelly et al. 2014). Only 
a significant improvement on the cognitive measure of ‘reasoning’; an ability 
coordinated by executive function, was observed when PRT was compared to an active 
control group. Furthermore, a recent meta-analysis demonstrated that PRT and other 
modes of exercise, have beneficial effects on cognitive function in adults over 50 
(Northey et al. 2017) (Table 2.2). Specifically, PRT of either a moderate or high-
intensity was shown to significantly improve executive function and working memory, 
however this review included healthy and cognitively impaired older adults, which 
may limit the implications of these findings for healthy older adults. These 
inconsistencies may stem from a lack of standardised reporting of intervention 
characteristics within the studies reviewed, heterogeneity in the neurocognitive 
measures used, and that only two out of the six studies reviewed involved PRT in 
isolation. Together, this may reflect the low quality of available studies in the 
literature, but also suggests that PRT alone is not commonly prescribed as an approach 
to optimise cognitive function.  
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Table 2.2: Moderator analysis of the effect of various exercise modalities on 
cognition, including number of effect sizes and estimates. Taken from Northey et al. 
(2017). 
. 
 
 
It is unclear whether a dose-response relationship between PRT and cognitive benefits 
exists in older adults due to the conflicting evidence present in the literature. Several 
intervention studies have attempted to manipulate the frequency and intensity of 
training to establish the key components of PRT that may produce cognitive benefits 
(Cassilhas et al. 2007; Liu-Ambrose et al. 2010; Tsutsumi et al. 1998). To investigate 
the relationship between PRT frequency and executive functions, Liu-Ambrose and 
colleagues (2010) randomised 155 community-dwelling women (aged 55-75 years) 
into two PRT groups of different training frequencies (once and twice a week) for 12 
months, along with a control group who undertook balance training and toning. Both 
training groups significantly improved their performance in conflict resolution and 
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selective attention, by 12.6% and 10.9% respectively, performing better than those in 
the control group who demonstrated a 0.5 % deterioration. Training frequency may 
therefore not be as important as the training mode in community dwelling older 
women.  
 
The dose-response relationship between PRT and cognition was also examined in a 
26-week study including older men who performed either moderate (50% 1RM) or 
high intensity (80% 1RM) PRT three times a week (Cassilhas et al. 2007). Significant 
improvements in working memory, executive function, attention and visuospatial 
abilities were observed in both training groups when compared to a non-exercising 
control group (all P<0.03), however no differences were observed between intensities 
(Cassilhas et al. 2007). This infers that moderate intensity exercise may produce 
similar benefits to high intensity exercise, which may be important for adherence to a 
training program. In contrast to this finding, 12 weeks of either low-moderate or high 
intensity strength training (55-65% 1RM or 75-85% 1RM) in 42 community-dwelling 
older adults (aged 61-86 years) had no effect on performance in a mental arithmetic 
and mirror drawing task, compared to a non-exercising control group (Tsutsumi et al. 
1998). As this study used similar intensities to the previous research, the contrasting 
findings may result from a reduced intervention length or ceiling effects present in a 
highly functioning sample (Tsutsumi et al. 1998). Collectively, limited data suggests 
that moderate intensity PRT may be as effective as more strenuous levels of PRT in 
providing cognitive benefits in older adults.  
 
High velocity-PRT, or power training, has gained considerable interest in recent years 
for its greater capacity to improve movement speed and muscle power (ability to 
produce force quickly) and other measures of functional performance in older adults 
compared to traditional slow speed PRT (Steib, Schoene & Pfeifer 2010; Tschopp, 
Sattelmayer & Hilfiker 2011). This training format may also be easier to perform than 
high-intensity PRT, due to the lighter loads used and the similarities between the 
functional nature of the exercises and ADLs, creating a lower perception of effort 
commonly experienced by participants (Sayers 2007). However, based on the limited 
evidence available, power training shows mixed effects for improving cognitive 
function in older adults (Sayers et al. 2003; Yoon et al. 2017). One HV-PRT study 
with older women only measured global cognitive function as a descriptive measure 
at baseline, without reporting any intervention effects on this variable (Sayers et al. 
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2003). However, in a recent 12-week study, both moderate-intensity elastic band-
based HV-PRT and PRT produced clinically significant improvements in the cognitive 
status of 58 older women aged >65 years (21% and 14% improvement respectively in 
MMSE), compared to a non-exercising control group (P<0.05) (Yoon et al. 2017), 
however no cognitive abilities were assessed. Further research with this training 
format is therefore required. 
 
2.3.5 Effect of multimodal training on cognitive function  
Multimodal protocols frequently compare a combination of training modes (such as 
aerobic plus PRT) to either single modes of exercise, or non-exercising control groups, 
to determine whether an additive approach can modulate cognitive function. The 
following section will highlight the cognitive improvements observed following 
multimodal training incorporating PRT, using RCT data from healthy older adults.  
 
The superiority of multimodal training to other forms of exercise has been recently 
investigated, and meta-analytic research from older adults (over 55 years) has 
suggested that combining aerobic and resistance training interventions may improve 
cognitive function to a greater degree than aerobic training alone, across a range of 
cognitive tasks (ES=0.59 vs 0.41) (Colcombe & Kramer 2003). Attempts to replicate 
these findings in individual studies have been mixed (Cancela Carral & Ayán Pérez 
2007; Forte et al. 2013; Taguchi et al. 2010), which may be supported by findings from 
a recent meta-analysis in adults aged >50 years, whereby multimodal training 
produced similar cognitive benefits to PRT or aerobic training alone (Table 2.2) 
(Northey et al. 2017). More consistent benefits of multimodal training have been 
demonstrated when this form of training is compared to a non-exercising control group 
(Langlois et al. 2013; Vaughan et al. 2014; Williams & Lord 1997). For example, 
Vaughan and colleagues (2014) found that 16 weeks of a multimodal exercise program 
(low-moderate intensity aerobic training, PRT and balance training performed for 60 
minutes twice a week) exerted moderate improvements in executive function, 
inhibition and verbal fluency in 49 older women, compared to a wait-list control group. 
However, as PRT only contributed 10 minutes to the overall 60-minute training 
session, it is difficult to determine the effectiveness of PRT within this multimodal 
training protocol. Cognitive improvements in executive function, processing speed 
and working memory (all P<0.035) were also demonstrated with a similar contribution 
of moderate-high PRT to 12 weeks of multimodal training (10 minutes within a 60-
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minute program, three times a week) in frail older adults (Langlois et al. 2013). A 
longer RCT (42 weeks) incorporating low-intensity resistance training combined with 
aerobic conditioning and balance group exercises produced significant improvements 
in working memory in 197 older women, compared to a usual care group (P=0.004) 
through a per protocol analysis, although an intention-to treat analysis may have shown 
weaker exercise-induced effects (Williams & Lord 1997). These findings collectively 
suggest that multimodal training may produce cognitive benefits in older adults, 
however this approach may be no more effective than PRT or aerobic training alone 
(Northey et al. 2017). Further, given the modest proportions of PRT contained in the 
studies above, factors such as training duration or intensity may be more influential in 
improving cognition in multimodal programs.  
 
Limited evidence suggests that interventions which focus on a combination of PRT 
and balance training may also be effective for improving cognitive function in older 
adults. Six months of home-based moderate-intensity PRT and balance-focused 
exercise performed three times a week by older adults (70 years) at risk of falling, 
significantly improved the executive process of response inhibition by 12.8% (Liu‐
Ambrose et al. 2008), compared to a control group. Further, in a group-based 6-month 
cluster RCT involving 154 older adults from retirement facilities (mean age: 79.6 
years), Brown and colleagues (2009) demonstrated that a combination of low-intensity 
resistance and balance training performed twice a week for 60 minutes was effective 
in increasing an index of fluid intelligence (P<0.001), compared to sham exercise and 
no-exercise control groups. However, as participants were drawn from two different 
types of retirement village (independent living and intermediate care), it is unclear as 
to whether there were inherent functional differences between these groups which 
affected the findings. Conflicting with these findings, 12 weeks of balance and 
moderate-intensity PRT (>60% 1RM, 90 minutes twice a week) in 171 community-
dwelling older adults, had no effect on an indirect measure of executive function 
(Kimura et al. 2010). In conclusion, limited evidence suggests that a combination of 
PRT and balance training may be an effective strategy for improving cognitive 
function in more frail populations (Brown et al. 2009; Liu-Ambrose et al. 2008), but 
this requires confirmation from further trials.  
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Summary of the effects of PRT on cognitive function 
In summary, there is insufficient evidence for the effectiveness of PRT alone on 
cognitive function in older adults, and therefore the optimal type and dose (frequency, 
intensity, duration) of PRT necessary for cognitive improvement in older adults is 
unclear. Some studies have shown PRT to be effective for small-moderate 
improvements in cognitive domains such as attention and processing speed, with the 
most consistent effects being observed for increases in executive function (Cassilhas 
et al. 2007; Colcombe & Kramer 2003; Liu-Ambrose et al. 2010). However, most 
reviews have typically reported no collective benefits for this form of training (Chang 
et al. 2012; Kelly et al. 2014; van Uffelen et al. 2008). This conflicting data may be 
due to inconsistencies in study design, exercise programming and modality and the 
sample characteristics, along with a variety of cognitive measures used across studies 
(Chang et al. 2012; Kelly et al. 2014; Snowden et al. 2011; van Uffelen et al. 2008). 
The role of HV-PRT in improving cognitive function has been inadequately 
investigated, and protocols that have incorporated PRT in a multimodal setting have 
reported mixed findings, with this training format mainly effective when compared to 
a non-exercising control group, and when including functional training components 
such as balance or aerobic training (Forte et al. 2013; Komulainen et al. 2010; Langlois 
et al. 2013; Vaughan et al. 2014). These improvements have been mainly observed in 
older women and frail older adults and may not be generalizable to healthy older 
adults.  
 
2.4 Effect of combined exercise and cognitive training interventions 
Cognitive benefits have been produced from aerobic, PRT, and multimodal exercise 
in older adults, while cognitive training interventions have also produced some 
improvements in cognitive function in older adults. (Lampit, Hallock & Valenzuela 
2014; Valenzuela & Sachdev 2009). The physiological and psychological mechanisms 
that may underpin any cognitive improvements following exercise or cognitive 
training are varied and will be discussed in detail in later sections. However, cognitive 
and exercise training may activate similar neurobiological and psychological pathways 
that can produce a synergistic response, as shown in Figure 2.6. Given this potential 
overlap in training effects, several studies have investigated whether a combination of 
exercise and cognitive and/or motor training (e.g., throwing a ball, dexterity training, 
citing words/numbers) may be effective for improving cognitive function in older 
adults (Barnes et al. 2013; Fabre et al. 2002; Oswald et al. 2006). Within these 
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combined cognitive-exercise protocols, exercise is typically followed sequentially by 
cognitive/motor training on the same day, or both forms of training are scheduled on 
separate days. This is distinct from simultaneous cognitive-motor training, where 
physical exercise is performed simultaneously with a secondary attention-demanding 
task (e.g., cognitive or motor) in a dual-task context. This next section will therefore 
review RCTs involving sequential cognitive-exercise training in older adults, before 
an evaluation of the evidence from simultaneous dual-task studies is presented. Due to 
the aims of the current thesis, only brief attention will be given to studies with 
cognitively impaired older adults.   
 
2.4.1 Effect of sequential cognitive-exercise training on cognitive function  
Over the past two decades several intervention trials have investigated whether 
combined cognitive and exercise training can benefit cognitive function in older adults 
to a greater extent than either cognitive or exercise training alone (Table 2.3). A 
number of systematic reviews have reported that combined programs including 
exercise training followed sequentially by cognitive/motor training on the same day 
(prior to or after exercise training), or separate days were effective for enhancing 
cognitive abilities, including memory and executive function in healthy older adults 
(Bamidis et al. 2014; Lauenroth, Ioannidis & Teichmann 2016; Law et al. 2014a; 
Schaefer & Schumacher 2011). However, as shown in Table 2.3 there is considerable 
heterogeneity between the different interventions. Factorial (2x2) design RCTs 
provide the highest level of evidence to address whether combined training is more 
effective that either intervention alone. In one of the first factorial design RCTs to 
address whether sequential exercise-cognitive training can improve cognitive 
function, Fabre et al. (Fabre et al. 2002) randomised 32 healthy older adults aged 60-
76 years to moderate-intensity aerobic training performed twice per week combined 
with memory training once per week or either intervention alone. After 8 weeks, they 
found that the combined intervention was more effective than either aerobic and 
memory training alone at improving a composite memory score. However, a limitation 
of this study is that the total dose of training was greater in the combined training 
group. Despite this discrepancy in the dose between groups, the findings from a 16-
week factorial design RCT in 180 adults living independently in retirement villages 
aged 65-93 years found that a combination of exercise (walking and resistance training 
three times per week) and cognitive training (three times per week) or cognitive 
training alone, led to greater improvements in hand-and-eye coordination, global 
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visual memory, and speed of information processing, than those who did not engage 
in cognitive training (exercise alone and control groups) (Shatil 2013). Nonetheless, 
as shown in Table 2.3, additional evidence from other factorial design and intervention 
trials has demonstrated that sequential training involving interventions ranging from 
7-30 weeks incorporating a range of intensities of aerobic and/or PRT in combination 
with cognitive training, does not appear to confer any superior transfer effects to 
cognitive performance (executive function, processing speed and memory) compared 
to cognitive training alone (Desjardins-Crépeau et al. 2016; Linde & Alfermann 2014; 
Oswald et al. 2006; Rahe et al. 2015a; Shah et al. 2014). Furthermore, only a few 
studies have demonstrated greater cognitive benefits following sequential training 
compared to exercise alone (Fabre et al. 2002; Shatil 2013; van het Reve & de Bruin 
2014) in older adults aged >50 years.  
 
There are a number of factors that could explain the mixed findings with regard to the 
effects of sequential exercise-cognitive training on cognitive function. These include 
variations in the dosage of physical and cognitive training components including 
differences in the exercise training intensity, intervention lengths, differences in the 
outcomes measures and populations studied, the specificity of cognitive training (e.g., 
multidomain versus specific memory training), and/or whether the cognitive training 
was conducted prior to or after exercise training. For instance, the findings from a 16-
week RCT in the elderly observed no cognitive benefits when exercise training was 
delivered after the cognitive training (Legault et al. 2011), whereas a 30-week trial in 
older adults aged 75-93 years reported positive effects on cognitive performance when 
the exercise training was performed before the cognitive training (Oswald et al. 2006). 
Indeed, there is evidence from animal studies whereby exercise promotes neurogenesis 
in the brain (Van Praag et al. 2005), while cognitive training regulates synaptic 
formation (Trachtenberg et al. 2002) and enhances the survival of these exercise-
induced neurons (Fabel et al. 2009). Therefore, physical exercise may facilitate 
synaptic plasticity and neurogenesis within a fertile neuro-environment, created 
through the release of growth factors such as BDNF (Cotman, Berchtold & Christie 
2007). The potential cognitive advantages from sequential training may therefore 
require an additional exposure to cognitive or motor training elements following 
exercise training, in order to exploit this environment to a greater extent than either 
cognitive or physical training alone (Curlik & Shors 2013; Kraft 2012).   
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Figure 2.6: Model of the mechanisms that link exercise and cognitive training with cognitive and functional improvements. Adapted from Gates et al. 
(2011).
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Table 2.3: Randomised controlled trials examining the effects of sequential exercise-cognitive training on cognitive function in older adults. 
Author Participants N Study Design 
Duration 
(weeks) 
Cognitive Intervention Exercise Intervention Control 
Group 
Cognitive Outcomes 
ExCT  vs 
Type Dose Type Dose Measure >Ex >CT >CON 
Legault et 
al. (2011) 
 
Community 
dwelling, 
risk of CI 
70-85 years 
80 Factorial 
ExCT, Ex, 
CT and 
Con 
16 Memory training 
(before Ex) 
50 min 
1-2/week 
Aerobic and 
flexibility 
60 min  
2/week   
(150 min 
total) 
Health 
education 
EF 
Mem 
N 
N 
N 
N 
N 
N 
Fabre et 
al. (2002) 
 
Community 
dwelling, 
60-76 years 
32 Factorial 
ExCT, Ex, 
CT and 
Con 
8 Memory training 
(after Ex) 
90 min 
1/week 
Aerobic 60 min  
2/week 
Health 
education 
Mem Y 
 
Y 
 
Y 
 
van het 
Reve & de 
Bruin 
(2014) 
Community/ 
residentially 
dwelling 
>65 years 
182 
 
RCT 
ExCT and 
Ex 
12 Attention and 
alertness training 
(unclear) 
10 min 
3/week 
PRT and 
balance 
30 min 
3/week 
- EF 
RT/PS 
Y 
N 
- 
- 
- 
- 
Oswald et 
al. (2006) 
 
Community 
dwelling 
75-93 years 
with 5-year 
follow-up 
375 Quasi RCT 
Factorial 
ExCT, Ex, 
CT, PET, 
ExPET and 
Con 
30 Processing speed, 
memory and 
attention training 
(before & after Ex) 
90 min 
1/week 
Coordination 
flexibility 
and balance 
45 min 
1/week 
No treatment RT/PS 
Att 
Mem 
EF 
 
NA 
NA 
NA 
NA 
NA 
NA 
NA 
NA 
Y 
Y 
Y 
Y 
Barnes et 
al. (2013) 
 
Community 
dwelling, 
subjective CI 
≥ 65 years 
126 2x2 
Factorial 
ExCT, 
CTCon, 
ExCon, 
ConCon 
12 Visual and auditory 
processing training 
(unclear) 
60 min 
3/week 
Aerobic and 
PRT 
60 min 
3/week 
Educational 
DVDS, 
stretching 
and toning 
EF 
VS 
Mem 
Global 
N 
N 
N 
N 
N 
N 
N 
N 
N 
N 
N 
N 
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Att: Attention; Con: Control group; CI: Cognitive impairment; CT: Cognitive training group; DT: Dual-task training; EF: Executive Function; Ex: Exercise 
group; ExCT: Exercise and Cognitive training combined group; Mem: Memory; Global: Global Cognitive Function; min: minutes; N: no; NA: not assessed; 
PET: Psychoeducational training; PRT: Progressive Resistance Training; PS: Processing speed; RCT: Randomised Controlled Trial; RT: Reaction time; VF: 
Verbal fluency; VS: Visuospatial ability; Y: yes.  † Only in DT training groups; # CT also greater than Con.
Shatil 
(2013) 
Independent 
living- 
retirement 
village 
65-93 years 
180 Factorial 
ExCT, Ex, 
CT, and 
Con 
16 Multidomain 
cognitive training 
(unclear) 
40 min 
3/week 
Aerobic and 
PRT 
45 min 
3/week 
Book club Att 
Mem 
EF 
PS 
N 
Y 
N 
Y 
N 
N# 
N 
N# 
N 
Y 
N 
Y 
Rahe et al. 
(2015a) 
Community 
dwelling 
50-85 years 
 
68 Factorial 
ExCT* CT, 
7 Memory, attention, 
EF training 
(after Ex) 
90 min 
2/week 
Aerobic, 
PRT, 
coordination, 
flexibility 
90 min 
2/week 
- Mem 
Att 
EF 
Global 
VF 
- 
- 
- 
- 
- 
N 
N 
N 
N 
N 
- 
- 
- 
- 
- 
Desjardins
-Crepeau 
et al. 
(2016) 
Community 
dwelling 
≥ 60 years 
 
76 2x2 
Factorial 
ExCT, 
CTCon, 
ExCon, 
Con 
12 DT cognitive 
training 
(after Ex) 
60 min 
1/week 
Aerobic and 
PRT 
60 min 
2/week 
Mental 
activity, 
stretching 
and toning 
Mem 
EF 
Att 
N 
N 
N 
 
N 
N 
N 
N 
Y† 
N 
Shah et al. 
(2014) 
Community 
dwelling 
60-85 years 
 
224 Non-RCT 
ExCT, CT, 
Ex, Con 
16 Multidomain 
cognitive training 
(unclear) 
60 min 
5/week 
Walking and 
PRT 
60 min 
3/week, 
40 min 
 2/week 
No treatment Mem 
PS 
Att 
EF 
Global 
N 
N 
N 
N 
N 
N 
N 
N 
N 
N 
Y 
N 
N 
N 
N 
Linde and 
Alfermann 
(2014) 
Community 
dwelling 
60-75 years 
 
70 Factorial 
ExCT, CT, 
Ex, Con 
16 Multidomain 
cognitive training 
(before Ex) 
30 min 
1/week 
Aerobic and 
PRT 
60-90 min 
2/week 
No treatment Att 
EF 
PS 
Mem 
N 
N 
N 
N 
N 
N 
N 
N 
N 
N 
Y 
N 
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Sequential cognitive-exercise training interventions in cognitively impaired older 
adults have largely produced negative findings in terms of any additive benefits of 
combined training on cognitive function. In a 4-month factorial design RCT in 80 older 
adults aged 70-85 years at risk of cognitive impairment, combined exercise and 
cognitive training (target 150 minutes per week of aerobic exercise plus 50 minutes, 
twice a week cognitive training) led to similar benefits in composite scores of cognitive 
function compared to exercise and cognitive training alone, or a health education 
control group (Legault et al. 2011). Similarly, another 12-week factorial design RCT 
in which 126 community-dwelling older adults with subjective cognitive complaints 
all engaged in home-based mental activity (60 minutes per day, 3 days per week) plus 
class-based physical activity (60 minutes per day, 3 days per week) and were 
randomized to either a mental activity intervention (intensive computer) or mental 
activity control (educational DVDs) plus exercise intervention (aerobic) or exercise 
control (stretching and toning), reported similar improvements in composite measures 
of executive function, processing speed and visuospatial ability (Barnes et al. 2013). 
An important strength of this study is that all groups were exposed to the same volume 
of training, and although these findings may reflect practice effects, it is possible that 
training dose is a more important factor for maintaining cognitive health in this 
population than the type of activity performed.  
 
In light of the increasing number of interventions which have examined the effects of 
sequential exercise-cognitive training on cognitive function in older adults, Zhu et al. 
(Zhu et al. 2016) conducted a meta-analysis of 20 intervention studies comprising 2667 
cognitively healthy older adults aged 65 to 82 years which included both sequential 
and simultaneous training studies. Overall, they observed a small effect of these 
combined interventions on cognitive function, particularly memory, executive 
function, attention, visuospatial ability and global cognition, when compared to a 
control group [ES: 0.29 (95% confidence interval (CI): 0.12-0.46), P<0.001] or 
exercise training alone [ES: 0.22 (95% CI: 0.06-0.38), P<0.01). However, there were 
no differences between the combined intervention and cognitive intervention (Zhu et 
al. 2016), which is supported by findings from sequential training studies (Desjardins-
Crépeau et al. 2016; Linde & Alfermann 2014; Oswald et al. 2006; Rahe et al. 2015a; 
Shatil 2013). This tentatively suggests that cognitive training may be a key driver in 
any improvements following a sequential training format, or alternatively that any 
cognitive benefits available from exercise training may take longer than 16 weeks to 
Chapter 2 
49 
 
emerge. Furthermore, secondary analysis revealed that the effect size for sequential 
(separate) interventions was less than those for simultaneous interventions [sequential 
ES 0.27 (95% CI: 0.08-0.46); simultaneous ES 0.43 (95% CI: 0l.01-0.86)] (Zhu et al. 
2016). However a key limitation of this meta-analysis and other studies (Lauenroth, 
Ioannidis & Teichmann 2016; Law et al. 2014a; Zhu et al. 2016), is that they did not 
separate and outline the distinct cognitive benefits available from either simultaneous 
or sequential cognitive-exercise training. Given this lack of separation of data from 
simultaneous and sequential training studies, the following sections will provide an 
overview of the evidence related to the effects of simultaneous dual-task exercise-
cognitive interventions on cognitive function in healthy older adults.  
 
2.4.2 Effect of simultaneous dual-task exercise-cognitive interventions on cognition  
Previous research has shown that older adults may experience an age-related decline 
in the ability to simultaneously divide attention between a primary and secondary task, 
such as carrying on a conversation while walking, which may impair functionality 
(e.g., increase risk of falls) (Melzer et al. 2010; Pichierri et al. 2011). Simultaneous 
dual-task cognitive-motor exercise training is thought to stimulate brain activity in 
areas responsible for performing both cognitive and motor tasks at once, which leads 
to training-induced improvements in the learned dual-task, but may also transfer to 
untrained cognitive and physical tasks (Schaefer & Schumacher 2011). Dual-task 
exercise training may therefore provide cognitive benefits that carry across to 
maintaining function in older adults, however the effectiveness of this form of training 
on cognitive performance in healthy older adults is yet to be confirmed. Before a 
critique of dual-task training research is presented, an understanding of the theories of 
dual-task interference is warranted.   
 
Several dual-task paradigms have been used to examine age-related changes in motor-
cognitive performance and cognitive capacities (Wollesen & Voelcker-Rehage 2013). 
Motor and cognitive performance declines in dual-task situations are considered in 
regards to several theoretical positions: the central bottleneck theory states that due to 
an information processing bottleneck only one task can be processed at a time; 
processing of a second task cannot commence until the first is complete. This 
bottleneck usually results in a longer response time for one of the two tasks within a 
dual-task paradigm (Pashler 1994). The four-dimensional multiple resource or cross-
talk model (Wickens 2002) proposes that interference may be dependent on the content 
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of the information being processed, in that there will be greater interference between 
two tasks to the extent that they share stages, sensory modalities, processing codes, 
and channels of visual information. For example, two tasks that both demand one level 
of a given dimension (e.g. two tasks demanding visual perception) will interfere with 
each other more than two tasks that demand separate  levels on the dimension (e.g. one 
visual, one auditory task). Finally, according to the attentional resource theory 
individuals share processing or attentional capacity (or mental resources) among tasks 
(Kahneman 1973). This model therefore suggests that declines in motor–cognitive 
functioning under dual-task conditions result from interference caused by competing 
demands for attentional resources, which results in less attention available to each task. 
Motor-cognitive functioning is expected to deteriorate in complex situations if there 
are fewer resources available for performance than are required. 
 
A number of formal reviews have amalgamated studies employing sequential and 
simultaneous dual-task formats, without directly evaluating the effectiveness of either 
approach for improving cognitive function in older adults (Lauenroth, Ioannidis & 
Teichmann 2016; Law et al. 2014a; Schaefer & Schumacher 2011; Wollesen & 
Voelcker-Rehage 2013; Zhu et al. 2016). However a recent review provided evidence 
that simultaneous dual-task training, particularly multimodal exercise in combination 
with secondary tasks regulated by sensory cues, may provide greater benefits than 
sequential training (Tait et al. 2017). Sequential and simultaneous cognitive-exercise 
training interventions display considerable heterogeneity in terms of training 
modalities, study designs, and sample characteristics, and therefore the most beneficial 
training components specific to simultaneous dual-task training, require separate 
evaluation. In consideration of these shortcomings, and the aims of the current thesis, 
the following sections will evaluate the available evidence related to the efficacy of 
simultaneous dual-task exercise interventions (>7 weeks) for improving untrained 
cognitive performance in healthy older adults (≥60 years where possible), including if 
there is an optimal modality, and training parameters which may confer the greatest 
cognitive gains. Limited evidence from studies with cognitively impaired older adults 
has also suggested that cognitive benefits are available following simultaneous 
training protocols involving multimodal (Coelho et al. 2013a; Gill et al. 2016; Suzuki 
et al. 2012), and walking and movement-based exercise training (Kounti et al. 2011). 
However, due to the aims of the current thesis, only evidence from dual-task exercise 
studies using healthy older adults will be evaluated. Further, exergaming is a relatively 
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new and unique form of dual-task training that may be an attractive alternative to 
traditional simultaneous training protocols, as it includes cognitive challenges 
embedded within realistic physical activities, whilst providing virtual feedback 
(Ogawa, You & Leveille 2016). It is currently unclear if exergaming has additional 
benefits compared to traditional physical exercise alone (Ogawa, You & Leveille 
2016), and while an in-depth review of exergaming is beyond the scope of this thesis, 
a critique of the evidence from some of these studies will be presented below. 
 
2.4.2.1 Effect of single format dual-task cognitive-motor and exercise interventions  
Simultaneous dual-task exercise protocols incorporating aerobic training components 
have largely attempted to discriminate the beneficial effects of dual-task elements by 
including an active control group (Anderson-Hanley et al. 2012; Barcelos et al. 2015; 
Theill et al. 2013) (Table 2.4). A multi-site cluster RCT investigated the impact of 3 
months of exergaming (stationary cycling with a virtual reality tour) on cognitive 
function in 102 older adults over 55 years old (Anderson-Hanley et al. 2012), who 
trained 5 days per week for up to 45 minutes per session (~60% heart rate reserve). 
The intervention group reported a higher composite score of executive function 
(P=0.002), compared to a traditional cycling group, despite both groups exerting the 
same level of effort, however only 63 participants completed follow-up testing. A 
more recent 3-month pilot study extending on these findings found that older adults 
from independent living facilities who were given additional cognitive tasks to 
complete whilst cycling in an exergame, demonstrated significantly greater 
improvements in executive function compared to an exergaming group with a lower 
cognitive load, despite both groups undertaking the same dose of moderate-intensity 
training (20-45 minutes per session, 3-5 times per week) (Barcelos et al. 2015). 
However, due to a low compliance (42%) and high attrition rate (only 20 of the 48 
participants completed the intervention), the findings may be limited. In one of the few 
simultaneous studies to compare dual-task exercise to cognitive training, 10 weeks of 
treadmill walking (60-80% of HRmax) performed simultaneously with memory training 
(40 minutes), and verbal memory training alone (30 minutes), both improved 
performance in an executive control task compared to a non-exercising control group 
in 63 community-dwelling older adults (aged 65-84 years) (Theill et al. 2013). 
However, dual-task treadmill walking produced a significantly larger training gain 
than cognitive training in a computerised memory task, which suggests that the use of 
memory-training as a secondary task may produce cognitive benefits specific to the 
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domain it activates (Theill et al. 2013). Collectively, these findings provide some 
evidence that simultaneous protocols including moderate intensity aerobic training 
(above 60% of maximum heart rate) may benefit cognitive domains such as executive 
function in healthy older adults, echoing previous findings from aerobic exercise 
interventions (Dustman et al. 1984; Smith et al. 2010). 
 
Functional training has been shown to improve physical function and ADLs in older 
adults (Hazell, Kenno & Jakobi 2007), but limited data suggests this format may also 
provide cognitive benefits when included within a dual-task exercise intervention. A 
6-month RCT compared 6 months of functional stepping and dancing exercises 
performed synchronously with verbal and motor tasks, in accordance to musical cues 
(60 minutes, once a week) to a usual lifestyle group, in 134 community dwelling older 
adults 65 years and over at increased risk of falling (Hars et al. 2014). Following 
training, significant improvements in a measure of executive function were observed 
(Hars et al. 2014), along with reductions in the number of individuals with global 
cognitive impairment (i.e. MMSE score ≤23). Despite these changes, this study was 
not adequately powered to detect changes in its secondary outcome measures of 
cognition. Twelve weeks of dual-task training involving walking at different rhythms 
in response to auditory and visual cues, in 32 older adults aged between 60-82 years 
(60 minutes, three times per week), also improved the speed of visual processing 
(P=0.032) and simple reaction time (P<0.035), compared to a usual care control group 
(Marmeleira, Godinho & Fernandes 2009). As these cognitive outcomes were 
measured in a driving simulator, it is unclear as to whether they can be generalised to 
everyday activities, or are pertinent for older adults who may have lost the capacity to 
operate an automobile.  
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Table 2.4: Randomised controlled trials examining the effects of simultaneous (dual-task) exercise-cognitive training on cognitive function in healthy 
older adults. 
Author Participants N Study Design 
Duration 
(weeks) 
Simultaneous Intervention Control 
Group 
Cognitive Outcomes 
Cognitive  Exercise  Dose Measure ExCT > Con 
Theill et al. 
(2013) 
 
Community-
dwelling  65-84 
years 
63 RCT 
ExCT vs CT 
vs Con 
10 Memory training Aerobic training ExCT, 40 min, 2/week 
(Total 800 min) 
CT, 30 min, 2/week 
No treatment EF 
Att 
Mem 
PS 
Y* 
N 
Y 
N 
Anderson- 
Hanley et al. 
(2012) 
Independent 
living- 
retirement 
village 
≥55 years 
102 RCT 
ExCT vs Ex 
12 VR enhanced Stationary cycling 45 min, 3-5/week 
(Total 2700 min) 
 
- EF 
Att 
VS 
Mem 
Y 
N 
N 
N 
Barcelos et al. 
(2015) 
 
Independent 
living- 
retirement 
village  
Mean: 82 years 
64 RCT 
ExCT (high) 
vs ExCT 
(low) 
12 VR enhanced 
(high or low 
cognitive demand) 
Stationary cycling 
 
45 min, 3-5/week 
(Total 2700 min) 
 
- EF Y 
Hars et al. 
(2014) 
Community 
dwelling at risk 
of falling 
≥65 years 
134 RCT 
ExCT vs Con 
26 Auditory cues Walking, motor 
activity 
60 min, 1/week 
(Total 1560 min) 
 
No treatment EF 
VS 
Global 
Y 
N 
N 
Marmeleira et 
al. (2009) 
Community 
dwelling 
 ≥60 years 
 
32 RCT 
ExCT vs Con 
12 Auditory and visual 
cues 
Walking, motor 
activity 
60 min, 3/week 
(Total 2160 min) 
 
No treatment EF 
RT 
CRT 
Att 
VS 
N 
Y 
N 
N 
Y 
Leon et al. 
(2015) 
Community 
dwelling 
 ≥60 years 
151 RCT 
ExCT vs Ex 
vs Con 
12 Auditory and visual 
cues, motor activity  
Aerobic (walking) 
and PRT 
60 min, 2/week 
(Total 1440 min) 
No treatment RT 
CRT 
Y 
Y* 
Schoene et al. 
(2013) 
 
Independent 
living- 
retirement 
village 
≥65 years 
37 RCT 
ExCT vs Con 
8 Computerised and 
interactive 
Step training 20 min, 2-3/week 
(Total 480 min) 
 
No treatment PS 
EF 
 
Y 
N 
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Schoene et al. 
(2015) 
Independent 
living- 
retirement 
village 
≥60 years 
 
90 RCT 
ExCT vs Con 
16 Computerised and 
interactive 
Step training 20 min, 3/week 
(Total 960 min) 
 
No treatment EF 
PS 
CRT 
RT 
Att 
VS 
N 
Y 
Y 
Y 
Y 
Y 
Yokoyama et 
al. (2015) 
Community 
dwelling  
≥65 years 
 
27 RCT 
ExCT vs Ex 
12 Auditory cues, 
arithmetic and 
word games 
Aerobic and PRT 60 min, 3/week 
(Total 2160 min) 
- Global 
VF 
Att 
EF 
PS 
N 
Y 
Y 
Y 
N 
Nishiguchi et 
al. (2015) 
Community 
dwelling  
≥60 years 
48 RCT 
ExCT vs Con 
12 Verbal and motor 
tasks 
PRT, step training, 
walking 
90 min, 1/week 
(Total 1080 min) 
No treatment Global 
Mem 
EF 
N 
Y 
Y 
Eggenberger et 
al. (2015) 
Community 
dwelling  
≥70 years 
89 RCT 
ExCT (VR) 
vs ExCT vs 
Ex 
26 Verbal memory 
training or VR 
enhanced 
Aerobic (treadmill or 
dancing) + PRT and 
balance 
60 min, 2/week 
(Total 3120 min) 
- EF 
Mem 
Att 
PS 
N 
N 
N 
N 
Hiyamizu et al. 
(2012) 
Community 
dwelling 
 ≥70 years 
43 RCT 
ExCT vs Ex 
12 Arithmetic, visual, 
verbal training 
PRT and balance 60 min, 2/week 
(Total 1440 min) 
- EF Y 
Gill et al.     
(2016) 
Community 
dwelling  
55-90 years, 
subjective CI 
44 RCT 
ExCT vs Ex 
26 Verbal and 
arithmetic tasks 
Aerobic, PRT, 
balance, flexibility, 
step training 
90 min, 3/week 
(Total 1440 min) 
- Global 
EF 
PS 
Mem 
VF 
Y 
N 
N 
Y 
Y 
Maillot et al. 
(2012) 
 
Community 
dwelling older 
adults  
(Mean age 73.5 
years) 
32 RCT 
ExCT vs Con 
12  Aerobic within 
Exergaming 
60 min, 2/week 
(Total 1440 min) 
No treatment EF 
VS 
PS 
 
Y 
Y 
Y 
 
Kayama et al. 
(2014) 
Community 
dwelling  
≥65 years 
48 Unclear 
ExCT vs Ex 
12 Suduko within VR 
enhanced Tai-Chi 
Aerobic, PRT, 
balance, flexibility, 
step training 
80 min, 1/week 
(Total 960 min) 
- EF 
VF 
Y 
N 
Att: Attention; Con: Control group; CI: Cognitive impairment; CRT: Choice Reaction Time; CT: Cognitive training group; DT: Dual-task training; EF: Executive Function; Ex: Exercise group; ExCT: 
Exercise and Cognitive training combined group; Global: Global Cognitive Function; Mem: Memory; min: minutes;  N: no; PRT: Progressive Resistance Training; PS: Processing speed; RCT: Randomised 
Controlled Trial; RT: Reaction time; VF: Verbal fluency; VR: Virtual Reality, VS: Visuospatial ability; Y: yes. * Compared to Ex and Con. 
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As an alternative to more traditional protocols, the effectiveness of step training has 
also been evaluated in an exergaming context. Indirect benefits to processing speed 
were witnessed following an 8-week study using computerised home-based step-pad 
training (15-20 minutes performed 2-3 times per week) in 37 independently living 
older adults (Schoene et al. 2013). In addition to the modest sample size that may have 
been unable to detect changes in cognitive function, an insufficient training exposure 
(both training dose and length of intervention) may have influenced results. However, 
a longer 16-week intervention which included more cognitively challenging home-
based stepping games (20 minutes, three times per week), with 90 independently living 
older adults, signficantly improved central processing, visuospatial abilities, and 
efficiency of executive networks compared to healthy ageing (Schoene et al. 2015). 
Despite the positive findings observed with this study, the implementation of this 
computerised system might pose problems for older adults with functional and 
technological limitations (Gerling & Masuch 2011), as evident by 77% of participants 
being classified as ‘low-adherers’ in this study (< 3 stepping games played, at least 
twice per week). In light of this mixed data, other forms of dual-task training 
interventions require evaluation regarding the benefits they might provide to older 
adults.  
 
2.4.2.2 Effect of multimodal dual-task cognitive-motor exercise training on cognitive 
function  
A number of interventions have evaluated the cognitive benefits available for healthy 
older adults following multimodal exercise incorporating PRT, and performed 
concurrently with a secondary attention-demanding task (Eggenberger et al. 2015; 
Hiyamizu et al. 2012; Leon et al. 2015; Yokoyama et al. 2015) (Table 2.4). In 27 
community-dwelling older adults, improvements in executive function and attention 
were observed following 12 weeks of low-intensity aerobic and PRT performed 
simultaneously with arithmetic and word games, compared to a group performing 
exercise only (both 60 minutes, three times a week) (Yokoyama et al. 2015). In partial 
support of these findings, a 12-week intervention including low-intensity PRT and 
balance training combined with simultaneous arithmetic and verbal fluency training in 
adults over 70 years, had a small effect on an aspect of executive function compared 
to physical training alone (Hiyamizu et al. 2012). This evidence suggests that 
multimodal dual-task exercise training that includes aerobic training and/or PRT may 
provide cognitive benefits for older adults. This aligns with findings from a systematic 
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review of 20 RCTs implementing simultaneous dual-task training which showed that 
the most successful interventions involved aerobic training with PRT, combined with 
cognitive training of attention, working memory or executive function (Lauenroth, 
Ioannidis & Teichmann 2016). Furthermore, a recent meta-analysis has also suggested 
that multimodal exercise alone may provide greater cognitive benefits than aerobic 
training or PRT alone (Northey et al. 2017).  
 
From limited evidence, the inclusion of functional stepping exercises in multimodal 
training within simultaneous training may provide cognitive benefits in several 
domains (Gill et al. 2016; Kayama et al. 2014; Nishiguchi et al. 2015). For instance, 
Nishiguchi and colleagues (2015) investigated the impact of a 90 minute multimodal 
exercise program combining minimal PRT (15 minutes), stepping exercises performed 
synchronously with verbal and motor tasks (60 minutes) performed once a week for 
12 weeks, plus the prescription of daily pedometer based walking exercise in 48 
community dwelling older adults. Compared to a usual lifestyle, significant 
improvements in several forms of memory and executive function were witnessed 
following training. In contrast to this finding, 26 weeks of PRT and balance training 
(40 minutes twice a week) combined with either virtual reality dancing, or moderate-
intensity treadmill walking performed with simultaneous arithmetic and memory 
training (all 20 minutes, twice a week), had no effect on cognitive function compared 
to exercise alone in older adults (≥70 years) (Eggenberger et al. 2015). From this data 
it could be speculated that the inclusion of a passive control group in simultaneous 
multimodal training studies may discriminate between training effects and learning 
effects from repeated testing, and accentuate potential training effects. However, prior 
research has demonstrated that simultaneous interventions can produce cognitive 
benefits compared to physical exercise alone (Kayama et al. 2014; Yokoyama et al. 
2015).  
 
An important question is whether there is an optimal training type and dose (frequency, 
intensity, duration) of simultaneous exercise and cognitive-motor training that 
promotes cognitive improvement in older adults. Based on the available data, 
simultaneous training interventions incorporating stepping exercises (Hars et al. 2014; 
Nishiguchi et al. 2015; Schoene et al. 2015), and moderate-intensity aerobic or 
multimodal exercise training (Anderson-Hanley et al. 2012; Barcelos et al. 2015; 
Yokoyama et al. 2015) appear to be effective in healthy older adults. In partial support 
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of this notion, a systematic review of 20 RCTs found that five out of six studies that 
adopted a sequential approach and 12 out of 13 studies that implemented simultaneous 
training reported significant cognitive improvement, with the most successful 
interventions involving aerobic training (65-80% maximum heart rate) and PRT, 
combined with cognitive training of attention, working memory or executive function 
(Lauenroth, Ioannidis & Teichmann 2016). However, this review did not separate the 
different types of combined training studies. In terms of the optimal training dose, 
evidence from simultaneous training studies suggests that significant cognitive 
benefits for older adults typically appear after a minimum of 12 weeks or a total of 
1000 minutes (~16.5 hours) of exposure, with a training frequency between 1-3 times 
per week (Table 2.4). However, significant improvements in cognitive function have 
been produced with less than 1000 minutes of training (Schoene et al. 2015; Theill et 
al. 2013), but not with 3000 minutes (50 hours) (Eggenberger et al. 2015).  
 
In summary, 17 of the 19 simultaneous studies featured in Table 2.4 produced benefits 
in at least one cognitive domain, compared to six out of the ten sequential studies in 
Table 2.3. However the optimal type of simultaneous dual-task exercise for cognitive 
benefits in healthy older adults is still unclear due to heterogeneity between studies in 
terms of intervention length (7 weeks to 12 months), differences in training modalities 
and intensity, the unsystematic selection of cognitive assessments, and the 
characteristics of the control groups included. 
 
2.5 Age-related challenges to HR-QoL and well-being 
The concept of successful ageing is associated with a positive psychological outlook, 
happiness, and general well-being, which support and enhance quality of life (QoL) 
(Depp & Jeste 2006; Lavretsky & Irwin 2007). With life expectancy increasing and 
Australia’s population ageing, these attributes gain importance, as longevity does not 
guarantee QoL (Lavretsky 2012). The transition from middle age to older age may 
bring about numerous changes in health and lifestyle, including moving to a new 
residence, illness, retirement, or death of a spouse (Lavretsky & Irwin 2007). These 
situations have the potential to be unsettling, and may therefore evoke stressful, 
depressive or anxious emotional states that have damaging consequences in terms of 
QoL (Chachamovich et al. 2008).  
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Factors such as age-associated cognitive decline can also lead to a loss of 
independence and reduced QoL for older adults. It is unclear as to whether older adults 
may acquire an increased susceptibility for experiencing mood disturbances with these 
declines in cognitive abilities (Arent, Landers & Etnier 2000), however the associated 
stigma and potential for social exclusion with even minor cognitive decline can leave 
an older adult vulnerable to a host of emotional and physiological co-morbidities. 
Furthermore, poorer cognitive function has been associated with an increased 
susceptibility to depression (Ganguli et al. 2006; Geerlings 2000; Paterniti 2002) and 
social withdrawal (Bassuk, Glass & Berkman 1999), all of which can reduce 
perceptions of QoL.  Conversely, depressive symptomology is associated with an 
increased risk of cognitive decline among older adults (Jorm 2000), and an increased 
risk of falls (Deandrea et al. 2010), whilst stress can adversely affect cognitive function 
by interfering with memory, executive function and the speed of processing (Li et al. 
2006; Sheline et al. 2006). The associations between QoL and cognitive function will 
not be a feature of this thesis, however this data suggests that a relationship exists 
between QoL and cognitive function in older adults, which can compromise multiple 
aspects of health. In addition, many older adults may experience sub-threshold mood 
and anxiety symptoms (Heun, Papassotiropoulos & Ptok 2000), which can create co-
morbidities with physical conditions and medical illness (Butterworth et al. 2006; 
Wolitzky-Taylor et al. 2010). Moreover, negative psychological experiences 
constitute a risk factor for higher levels of inflammation (Kiecolt-Glaser et al. 2002), 
which are associated with functional limitations and disabilities in older adults 
(Ferrucci et al. 1999; Visser et al. 2002). Collectively, a diminished QoL may therefore 
compromise the health of older adults. A brief overview of the factors contributing to 
QoL and well-being will be discussed in the next sections, with an emphasis placed on 
the relation of these concepts to older adults.  
 
2.5.1 Conceptual overview of QoL, HR-QoL and well-being 
The multidimensional construct of QoL encompasses physical, psychological and 
social domains of well-being, and its subjective and objective measurement attempts 
to provide a comprehensive profile of an individual (Felce 1997; Halvorsrud & Kalfoss 
2007). Conceptualisations of QoL in the literature vary considerably and its 
descriptions are commonly entangled with those of well-being, satisfaction with life 
(SWL) and health-related quality of life (HR-QoL). Despite definitional discrepancies, 
the domains incorporated within QoL typically share similar content, and may include 
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areas such as objective circumstances and personal values, in addition to subjective 
appraisals of physical, mental and psychosocial well-being. The World Health 
Organization’s Quality of Life Project (WHOQOL) broadly defines QoL as an 
individual’s “perception of their position in life in the context of the culture and value 
systems in which they live and in relation to their goals, expectations, standards and 
concerns” (WHOQOL Group 1993). Six QoL domains have been identified as 
universally important to both healthy and unwell people in influencing their QoL: 
physical health, psychological state, level of independence, social relationships, 
environment, and spirituality, religiousness and personal beliefs (WHOQOL Group 
1995). These domains may hold different levels of value among individuals, and 
within individuals depending on their stage of life (Carr, Gibson & Robinson 2001; 
Spirduso & Cronin 2001). In community-dwelling older adults, the prevention of 
obesity, the maintenance of functionality, and regular PA are primary predictors of 
QoL, while concomitant disease and musculoskeletal complaints are dominant 
predictors for QoL in institutionalized older adults (Borowiak & Kostka 2004). 
Furthermore, depression is the most powerful predictor of QoL in both cohorts 
(Borowiak & Kostka 2004). Theoreticians propose that integrative models that can be 
applied and interpreted across a range of life domains and influences, with QoL as an 
overarching endpoint, are satisfactory constructs for use with a wide number of 
populations and contexts (Felce 1997; Guérin 2012). For the purposes of this thesis, 
QoL will be regarded as a framework which incorporates the elements subjective well-
being and HR-QoL within its structure, according to the proposed model as shown in 
Figure 2.7. (Guérin 2012).  
 
Measures of QoL can inform health practitioners and policy makers as to the 
effectiveness of interventions and policies for older populations (Guérin 2012), and 
also allow exercise researchers to detect whether an exercise intervention can shape 
perceived health and QoL outcomes, in participants of varying health and ability. For 
the purposes of the next sections, exercise is a sub-type of PA which is planned, 
structured, repetitive, and purposeful (Caspersen, Powell & Christenson 1985), and 
conceptually distinct from PA.  
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Figure 2.7: A proposed model of QoL incorporating HR-QoL, well-being and 
satisfaction with life. Adapted from Guerin (2012). 
 
2.5.1.1 Conceptual overview of HR-QoL 
Exercise can reverse age-related changes in physical function, prevent muscle loss, 
and reduce the risk of developing cardiometabolic and other diseases which may 
contribute to a loss of independence and QoL in older adults (Taylor et al. 2004). The 
interactions between changes in physical and mental functionality following 
prescribed exercise, and subjective perceptions of QoL and health status, are captured 
by an assessment of HR-QoL. HR-QoL is widely recognized as a multilayered concept 
whereby a subjective rating of QoL is primarily influenced by the health status of an 
individual (Guyatt, Feeny & Patrick 1993), but also incorporates psychosocial 
(including emotional components), physical and mental influences (Revicki 1989). 
HR-QoL is therefore a more specific measure than QoL, as it considers how an 
individual’s health and psychosocial attributes can influence their QoL at a given 
moment in time. Further, HR-QoL can evaluate the impact of illness, chronic 
conditions, disability, socioeconomic status, and exercise interventions on parameters 
of physical and mental health in healthy and clinical populations (Brown et al. 2004; 
Halvorsrud & Kalfoss 2007). Underscoring the importance of HR-QoL measures, 
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perceived psychosocial benefits may occur in the absence of identifiable changes in 
physiological parameters, and similarly, an intervention may establish physiological 
changes without improving perceptions of health (Rejeski & Mihalko 2001). Further, 
this construct is positively associated with objective health outcomes (e.g., body mass 
index and the number of chronic conditions) and mortality (Kroenke et al. 2008), while 
it may also be influenced by the ability to maintain good physical, emotional, and 
intellectual functions, and to satisfactorily take part in social activities. 
 
Given the scope of its measurement, HR-QoL is frequently used as a proxy measure 
of overall QoL, an individual’s overall well-being, and other self-reported 
psychosocial perceptions within the literature. Adding to this confusion, different HR-
QoL instruments are constructed with diverse conceptual emphases, such as the 
psychological domain (e.g., Psychological General Well-Being Schedule) (Dupuy 
1984), and QoL (WHOQOL-BREF) (Harper 1998). Further to these questionnaires, 
the Short Form Health Survey (SF-36) (Ware Jr & Sherbourne 1992), assesses physical 
functioning and independence, and represents the most commonly used measure of 
HR-QoL (Pucci et al. 2012). The SF-36 has been validated, with high reliability in 
older adults (≥65 years) (Benjamin‐Coleman & Alexy 1999; Walters, Munro & 
Brazier 2001), and used across a range of health conditions worldwide (Gillison et al. 
2009; Pucci et al. 2012). This survey measures eight components of HR-QoL; physical 
functioning, role limitations because of physical health (role physical) and emotional 
problems (role emotional), bodily pain, general health, vitality, social functioning, and 
mental health, along with two component summary scores for physical (PCS) and 
mental health (MCS) based on these eight subcomponents (Ware Jr & Sherbourne 
1992) (Figure 2.8 and further detail provided in Chapter 3). 
 
2.5.1.2  Conceptual overview of subjective well-being and satisfaction with life 
Subjective well-being (SWB) is comparable to HR-QoL as it takes into account 
physical, social, environmental and psychological influences of an individual’s life 
(Diener 2000). However, it is distinct in that an assessment of SWB considers an 
individual’s mood and emotion as well as a cognitive judgement of life satisfaction, in 
broad and specific life domains (Diener 2000; Pavot & Diener 1993). Notably, a 
number of reviews and meta-analyses have reported the predictive power of high SWB 
for better health and longevity (Chida & Steptoe 2008; Diener & Chan 2011; 
Hemingway & Marmot 1999). It is proposed that positive and negative affect 
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(personality traits that describe how individuals experience, process and transmit 
positive and negative emotions), happiness, and life satisfaction, are all conceptually 
linked to a holistic assessment of SWB. The concept of SWB is in turn associated with 
psychological well-being which together inform an evaluation of well-being, a 
construct often interchangeable with QoL, as indicated in Figure 2.7. Further, while 
global QoL is defined as a psychological construct, life satisfaction is regarded as the 
best representation of this variable (Rejeski & Mihalko 2001), and is therefore 
commonly used as a proxy measure of QoL. In ageing research, one of the barriers to 
assessing SWL and QoL following exercise stems from the vague operational 
definitions given to these concepts. Therefore, for the purposes of this thesis, although 
they are both used as proxy measures of QoL in several studies, SWL and HR-QoL 
will be regarded as distinct contributing factors to overall QoL, in line with Figure 2.7. 
 
2.6 Interventions to improve QoL in older adults 
Regular exercise and PA have proven to be effective behavioural strategies for the 
treatment of clinical depression, anxiety, mood disorders and stress in healthy and 
clinical populations of older adults (Arent, Landers & Etnier 2000; Barbour & 
Blumenthal 2005; Wipfli, Rethorst & Landers 2008), and have proved to be as 
effective as pharmacological treatments in younger cohorts (Blumenthal 2011; 
Hoffman et al. 2011). While the mechanisms surrounding these exercise-induced 
improvements in mood and well-being have yet to be fully discovered, improvements 
in physical function may either coincide or contribute to psychosocial improvements 
(e.g., enhanced self-esteem or mental health) (Arent, Landers & Etnier 2000; Elavsky 
et al. 2005; McAuley et al. 2006). The therapeutic effects of exercise on depression 
and mood disorders are not the focus of this thesis, however these brief findings 
demonstrate that regular PA and exercise can modify psychological health, which may 
carryover to psychological (mental) components of HR-QoL in older adults. Due to a 
lack of available data from studies exclusively including adults over 65 years, the next 
sections will review research that includes both middle-aged and older adults, with 
distinctions made where appropriate. Of further note, there is a degree of overlap in 
some studies which include middle aged and older adults. For example, although older 
adulthood is generally considered to include individuals over 65 years, some research 
includes adults over 55 years old into this category. For these reasons, the relationship 
between PA and HR-QoL in adults will be discussed to provide a brief overview, 
before evidence specific to older adults is introduced.  
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Figure 2.8: Outline of the SF-36 version 2 Questionnaire. All health domains 
contribute to both the physical (PCS) and mental (MCS) health component summary 
scores. Scales contributing most to the summary measure are indicated by a solid line 
(—), scales contributing to a lesser degree are indicated by a dotted line (---). Taken 
from Ware Jr et al. (2008). 
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2.6.1 Epidemiological studies on physical activity and HR-QoL in adults 
A number of reviews have included evidence from observational and prospective 
studies which indicates that regular PA and exercise are associated with greater 
perceptions of QoL and HR-QoL in both middle-aged and older adults (>55 years), 
typically measured through instruments such as the SF-36 (Bize, Johnson & Plotnikoff 
2007; Pucci et al. 2012). For example, a 2007 systematic review discovered moderate-
strong positive associations between HR-QoL scores and PA levels in healthy adults 
(<65 years) from a range of observational studies (Bize, Johnson & Plotnikoff 2007), 
but limited positive relationships from longitudinal data. Higher levels of PA were 
typically associated with higher scores in SF-36 domains with a physical basis (i.e. 
physical functioning, general health, vitality, PCS) (Bize, Johnson & Plotnikoff 2007). 
However, a high degree of heterogeneity in the classification of PA levels (e.g., energy 
expenditure vs hours of PA) was detected between the cross-sectional studies, which 
may limit an estimation of the collective findings. In adults aged >55 years, cross-
sectional data has also revealed positive associations between PA and HR-QoL (Pucci 
et al. 2012; Spirduso & Cronin 2001), and these relationships persist in chronically 
diseased populations (Rejeski, Brawley & Shumaker 1996). For example, a systematic 
review including 12 observational studies with older adults (>55 years), with or 
without clinical conditions, consistently reported a positive association between PA 
and HR-QoL (mainly measured through the SF-36) (Pucci et al. 2012). Specifically, 
improvements in overall QoL (global score) and the SF-36 domains; physical 
functioning, vitality and mental health, demonstrated the most consistent correlations 
with higher classifications of PA levels. 
 
A potential relationship between long-term changes in PA and HR-QoL has also been 
investigated in a number of reviews in adults, with maintained or increased PA tending 
to result in greater scores in HR-QoL over time (Bize, Johnson & Plotnikoff 2007; 
Pucci et al. 2012). For example, a 3-year follow-up of a middle-aged cohort aged 35-
60 years observed that an increased duration of leisure-time PA from baseline was 
associated with higher scores in health-related quality of life domains of physical 
functioning, mental health, and vitality for both men and women, as well as social 
functioning for women only (Tessier et al. 2007). In a similarly aged cohort, an 
increase in leisure time PA of 60 minutes per week over 5 years was significantly 
associated with an improvement in social functioning in both males and females, 
irrespective of PA intensity, however no other associations were shown with other 
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domains (Wendel-Vos et al. 2004). Furthermore an increase in total PA was associated 
with improvements in vitality, mental health and MCS in men alone. This limited data 
suggests that sex differences may influence the long term relationship between HR-
QoL and PA. Longitudinal studies in community-dwelling older adults have also 
reported inconsistent, yet positive findings which suggest that maintained or increased 
levels PA over time are associated with higher scores of HR-QoL compared to those 
that remain sedentary (Balboa-Castillo et al. 2011; Choi et al. 2013; Lee & Russell 
2003). In a 3-year study of 6472 women aged over 70, those who maintained (same 
PA levels at both time points) or adopted PA (higher PA levels at follow-up) 
demonstrated greater changes in the social functioning and mental health domains, and 
less decline in vitality and role emotional, compared to those who remained sedentary 
or ceased PA (measured through a weighting of PA frequency or duration with 
intensity) (Lee & Russell 2003). However a limitation of these findings was they did 
not take into account the presence of adverse health conditions at follow-up, which 
may have affected both the capacity to perform PA and HR-QoL. Additional findings 
in older adults suggest that greater amounts of PA (measured through energy 
expenditure and duration of PA) can mitigate age-associated declines in HR-QoL and 
provide benefits in multiple SF-36 domains up to six years later, compared to those 
who performed no PA (Balboa-Castillo et al. 2011). Given these limited findings, the 
optimal type and dose of PA required for long-term HR-QoL benefits remains unclear.  
 
Research that has investigated the optimal type and dose of PA that benefits HR-QoL 
has provided mixed findings. A 2001 systematic review of observational and 
prospective studies indicated minimal, yet beneficial effects of a variety of PA 
modalities (e.g., walking, exercise) on HR-QoL and well-being in older adults over 65 
with different functional abilities, but did not find any evidence for a dose-response 
relationship (Spirduso & Cronin 2001). Again, a determination of the optimal dose, 
type and intensity of PA required to elicit benefits in HR-QoL in older adults may have 
been limited by differences in PA cut-offs and measurement, and selection criteria for 
these studies. Despite this review, an observational study including 5654 middle-aged 
adults aged 35-60 years reported that 30 minutes per day of moderate PA on a regular 
basis was associated with greater HR-QoL across all subdomains (measured through 
the SF-36) (Vuillemin et al. 2005). Furthermore, vigorous PA (≥60 minutes per week 
>6 METs) was associated with greater scores in physical functioning, bodily pain, 
vitality, general health and physical component summary, than those performing 
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moderate-intensity PA (Vuillemin et al. 2005). A 3-year follow-up of this cohort found 
that an increase of 60 minutes per week of leisure time PA was associated with a 0.17- 
and 0.39-point increase in the vitality dimension in men and women, respectively 
(Tessier et al. 2007), however the authors did not indicate whether a particular intensity 
of PA was more beneficial. These findings emphasize the importance of promoting at 
least moderate PA for community-dwelling adults. However, conflicting evidence has 
been reported that daily participation in moderate-vigorous PA (MVPA), participation 
in very short periods of PA (<20 minutes a day) and extended periods of PA (≥90 
minutes a day), are all associated with poorer HR-QoL in adults over 18 years (Brown 
et al. 2004), however the authors attributed at least some of this inconsistency to self-
report bias, and it is not clear how this data reflects any relationships between HR-
QoL and PA dose in older adults.   
 
Collectively, it is unclear as to whether greater perceptions of HR-QoL lead to higher 
levels of PA, or vice versa, or if there is a mutual influence, or whether internal or 
external factors (e.g., peer support) may mediate higher PA levels and HR-QoL scores. 
For example, internal factors such as self-efficacy can also influence health 
perceptions and the vitality of individuals (Elavsky et al. 2005; Pucci et al. 2012), 
while personality factors and exercise motivation levels can positively predict 
participation levels in PA, along with the resulting physical and psychological 
improvements from PA participation (Huang, Lee & Chang 2007). Given the 
limitations of cross-sectional designs, further evidence from intervention studies may 
determine whether there is an optimal dose and type of PA that improves HR-QoL.   
 
2.6.2 Effect of physical activity and exercise interventions on HR-QoL in older adults  
Compared to cross-sectional evaluations of PA in naturalistic settings, the 
measurement of HR-QoL before and after an exercise intervention can provide a 
higher level of evidence for a causal pathway between regular exercise and changes in 
HR-QoL (Gillison et al. 2009). For efficiency, previous studies have measured HR-
QoL, QoL, and well-being outcomes with the same questionnaire (e.g., SF-36), which 
leads to the terms HR-QoL, well-being and QoL being interchangeable in reflecting 
the same construct (HR-QoL). Due to their reporting in the literature, these terms will 
be used interchangeably for the next section of this thesis. Similarly, as the SF-36 is 
used to address the current study aims, and is the most commonly used self-report 
measure, its use in previous research will be emphasized.  
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There is accumulating evidence that exercise behaviour plays a role in improving an 
adult’s perception of their HR-QoL (Pucci et al. 2012; Rejeski & Mihalko 2001; Wolin 
et al. 2007). However, the optimal dose and type of PA and exercise required to elicit 
improvements in HR-QoL in healthy older adults are currently unclear, and may not 
follow the same patterns witnessed in middle-aged and younger adults (Bize, Johnson 
& Plotnikoff 2007; Gillison et al. 2009). Moreover, intervention studies investigating 
the effect of exercise on HR-QoL in older adults have not shown the consistency of 
large observational and prospective studies, and contradict the robust positive 
associations between PA and HR-QoL reported in these analyses. A 2009 meta-
analysis including 11 RCTs which incorporated the SF-36 and a usual care control 
group with community-dwelling older adults aged over 50 years (Kelley et al. 2009), 
found that exercise interventions involving aerobic training, PRT or multimodal 
training only produced small to moderate improvements in the physical functioning 
domain of SF-36 (Hedges’ g=0.41, (95% CI 0.19-0.64); P<0.001). A trend for 
improvement in the overall physical component summary (PCS) was also observed 
following exercise, while the odds of improving physical functioning when enrolled 
in an exercise group was 2.14 times as large as those of the control group (Kelley et 
al. 2009). However, the detection of positive findings in other domains may have been 
limited by the inconsistent reporting of SF-36 data between studies, as some studies 
only collect and/or analyze data from certain subdomains.  
 
Diverse effects on domains of HR-QoL have been demonstrated following exercise 
interventions in healthy middle-aged and older adults, and these inconsistencies may 
result from the different instruments used to measure this construct. For instance, a 
2009 meta-analysis of 56 RCT studies, provided an overview of the effect of exercise 
interventions on subjective QoL in adults from healthy or clinical populations aged 
<50 to >50 years (Gillison et al. 2009). These authors found a small but meaningful 
improvement in the physical and psychological domains of QoL in healthy populations 
(ES=0.22, P<0.01 and ES=0.21, P<0.01 respectively), following exercise 
interventions lasting between 3-6 months. Although these findings are promising, they 
may not be generalizable to older populations, and QoL domains were categorised 
according to broader WHOQOL definitions (WHOQOL Group 1995). Significant 
exercise-induced improvements in ratings of psychological well-being have also been 
reported by other meta-analytic work in healthy and clinical populations of older adults 
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(Lawlor & Hopker 2001; Netz et al. 2005), while a systematic review reported an 
overall significant improvement in a composite of mental health (ES=0.27) with 
exercise (Windle et al. 2010). Collectively, these limited findings suggest that exercise 
may have a positive effect on several aspects of HR-QoL, but do not provide any 
information as to the optimal type or dose of exercise that may benefit older adults. 
The following sections will therefore critique the evidence as to whether there are any 
HR-QoL benefits observed in older adults following aerobic training, PRT, 
multimodal training and cognitively challenging programs, with an emphasis on 
studies using the SF-36 questionnaire.  
 
2.6.3 Effect of aerobic training on HR-QoL in older adults 
Aerobic exercise is a powerful modifier of perceived psychological health and well-
being (DiLorenzo et al. 1999; Netz et al. 2005), however the mechanisms responsible 
for such improvements remain unclear. Aerobic training may have distinct benefits for 
HR-QoL in older adults which do not overlap those of PRT or other forms of training. 
A 2005 meta-analysis found that aerobic training exerted moderate effects in 
improving a range of psychosocial well-being outcomes in adults aged over 54 years 
(d=0.29, P<0.05) (Netz et al. 2005), however it is unclear as to how improvements in 
this broad categorisation are relatable to HR-QoL. The relationship between aerobic 
fitness and HR-QoL was explored in an 8-month RCT with a parallel three arm design, 
whereby the effects of aerobic training were compared to PRT (both three times a week 
for 50 minutes, at 80% heart rate reserve and 80% 1RM respectively) and a wait-list 
control group (Canuto Wanderley et al. 2015). Compared to the control group, both 
the PRT and aerobic training groups significantly improved in the PCS (P≤0.04), while 
those in the aerobic training group showed greater improvements in mental health 
compared to PRT (P≤0.01). These findings provide support for previous research 
demonstrating the psychological benefits of aerobic training, and collectively advocate 
the ability of aerobic training and PRT to improve domains of physical functioning 
(Kelley et al. 2009). In contrast to these findings, no superior effects of aerobic training 
(moderate-intensity, up to 90 minutes a session, twice a week) were detected after 21 
weeks in adults aged 39-77 years, when compared to PRT (60-80% 1RM, 60-90 
minutes, twice a week), a combination of training methods (four PRT and aerobic 
training sessions), or a control group (Sillanpaa et al. 2012). These contrasting findings 
between studies may be due to differences in intervention lengths, while the training 
response on HR-QoL may vary depending on participants’ age, with the inclusion of 
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middle-age and older adults obscuring an intervention’s true effect on a specific age 
group (i.e. older adults) (Sillanpaa et al. 2012). While this limited evidence suggests a 
role for aerobic training in improving HR-QoL, further research is needed to establish 
the effectiveness of aerobic training in older adults.  
 
2.6.4 Effect of resistance training on HR-QoL in older adults 
Limited evidence from meta-analytic studies suggests that PRT can significantly 
improve certain aspects of well-being and HR-QoL in older adults (Kelley et al. 2009; 
Liu & Latham 2011; Netz et al. 2005). For example, a 2011 meta-analysis including 
33 studies investigated the effects of PRT in healthy and frail adults aged over 60 
years, and found that PRT exerted a small effect in improving self-reported physical 
disability, which was measured through several instruments (SMD=0.14, P<0.05) (Liu 
& Latham 2011). However, the effect was not significant when 14 trials that assessed 
physical functioning from the SF-36 were analyzed separately. This may have been 
due to the inclusion of frail older adults, for whom the SF-36 questionnaire may lack 
responsiveness (Stadnyk, Calder & Rockwood 1998). Furthermore, this meta-analysis 
could not provide any dose-response relationship between PRT and HR-QoL. 
Interventions that have attempted to evaluate the efficacy of PRT or the optimal dose 
required to improve HR-QoL have returned mixed results (Cassilhas et al. 2007; de 
Vreede et al. 2007; Liu-Ambrose et al. 2005; Paw et al. 2004; Sillanpaa et al. 2012). 
For example, in a 12-week RCT, 90 community-dwelling women aged over 70 were 
randomised to one of two training groups; the training of functional tasks and 
movements, or PRT (moderate intensity), with both groups attending 60-minute 
sessions, three times a week, or a usual lifestyle control group (de Vreede et al. 2007). 
Following the intervention, PRT produced significantly greater improvements in the 
SF-36 physical functioning score (7.7 ± 12.4 points in absolute score) than in the 
control and functional groups (de Vreede et al. 2007). Attempts to establish an optimal 
dose of PRT for HR-QoL benefits were made in a 24-week RCT including 62 older 
men (aged 65-75 years), whereby moderate-intensity PRT (50% 1RM) significantly 
increased both general health and vitality domains of the SF-36 (P=0.005 and P=0.006 
respectively), while high-intensity PRT (80% 1RM) only increased general health 
(P=0.04), compared to a non-exercising control group (Cassilhas et al. 2007). No 
significant differences were detected between training groups despite training at the 
same frequency (three sessions a week). This suggests that both moderate intensity 
and high-intensity PRT may improve selected domains of HR-QoL in older men. In 
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contrast to the study above, 21 weeks of high-intensity PRT (70-80% 1RM) did not 
produce any improvements in SF-36 domains in healthy adults aged 39-77 years, 
compared to moderate-intensity aerobic training, a combination of aerobic and PRT, 
or a control group (Sillanpaa et al. 2012). However, participants undertaking PRT 
reported a significantly greater perception of bodily pain post-intervention, which was 
attributed to muscle soreness from the commencement of PRT (Sillanpaa et al. 2012). 
As no attempts were made to categorise HR-QoL effects by groupings of age, it is 
unclear as to whether these findings are specific to older adults.   
 
Currently, research into the effectiveness of PRT for enhancing HR-QoL in older 
adults has produced equivocal findings, which has led to investigators exploring new 
training formats. Functional resistance exercise training has only been investigated in 
one study to date, and demonstrated similar effects to PRT on multiple domains of 
HR-QoL (de Vreede et al. 2007). High-velocity PRT or ‘power training’ has also 
received little interest as an alternative training mode to PRT in the past 15 years, but 
may improve aspects of HR-QoL due to the light loads and functional movements 
within its programming, which mimic ADLs. However, the limited data currently 
available has only provided mixed evidence. A 16-week pilot study enrolling 30 
women aged 65 years and over with self-reported disability compared the effectiveness 
of HV-PRT, or PRT (70% 1RM) performed three times a week. Following the 
intervention, no differences in HR-QoL were observed between the training groups. 
Instead, significant within-group improvements in disability domains of the SF-36 
(physical functioning, role physical and mental health) were observed after pooling 
data from all participants (Sayers et al. 2003). It is unclear whether both forms of PRT 
were effective in modifying other HR-QoL outcomes, while a larger sample size and 
passive control group may have provided further evidence. Improvements in 
perceptions of physical and psychosocial well-being in 24 older women (measured 
through menopause-specific QoL questionnaire) have also been demonstrated 
following 12 weeks of HV-PRT performed either twice or three times a week, 
compared to a control group (Ramirez-Campillo et al. 2016). Contrasting findings 
have been reported in 69 pre-frail adults (aged 65-94 years), whereby self-reported 
disability did not change following 12 weeks of either moderate-high intensity PRT or 
HV-PRT performed for 45 minutes twice-weekly, in comparison to a control group 
(Zech et al. 2012). However, during this intervention the drop-out rate was twice as 
high in the HV-PRT group than the PRT group, which suggests that power training 
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may be perceived as more difficult in a frail cohort, and may consequently impact HR-
QoL (Zech et al. 2012). Nonetheless, as this form of training is generally well-tolerated 
by older adults (Hazell, Kenno & Jakobi 2007; Henwood & Taaffe 2005), further 
research is needed to advocate the use of HV-PRT for HR-QoL benefits in healthy 
older adults.  
 
In summary, the available evidence surrounding the effects of PRT on HR-QoL is 
inconsistent, with variable intervention lengths, sample characteristics and 
instrumentation, limiting any inferences about the effectiveness of this modality. 
Although meta-analyses have indicated minimal positive effects of PRT on HR-QoL, 
individual studies incorporating PRT find limited agreement with these overall 
findings, but may require longer than 12 weeks for HR-QoL benefits to emerge 
(Cassilhas et al. 2007; de Vreede et al. 2007).  
 
2.6.5 Effect of multimodal training on HR-QoL in older adults 
Multimodal studies that expose a training group to several forms of exercise (including 
PRT) in an efficient and multifaceted approach have been investigated for their 
capacity to improve HR-QoL. A combination of high-intensity PRT (70-80% 1RM) 
and moderate-intensity aerobic training (at or below aerobic threshold) improved 
scores of vitality by 7% (P<0.001) in a sample of middle-aged and older adults (39-77 
years), compared to both aerobic training and PRT, as well as a control group, 
following 21 weeks of training (Sillanpaa et al. 2012). Despite this finding, the 
combined training group participated in twice as many sessions per week as the single 
aerobic and PRT groups (four vs. two times a week), which limits the reliability of the 
findings. In contrast, no changes to HR-QoL were detected in a 6-month study of 56 
independently living older adults (>70 years old), which combined supervised 
moderate-intensity aerobic training and PRT (75-80% intensity, 60 minutes each 
session, three times a week) and compared this to a non-exercising control group 
(Cress et al. 1999). As only the physical functioning domain of the SF-36 was 
measured in this study, the conclusions that can be drawn from this intervention are 
limited. Null findings have also been observed following multimodal exercise 
interventions using HR-QoL instruments that target specific domains such as vitality 
(Paw et al. 2004), and changes in functionality (Taguchi et al. 2010).  
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The prescription of balance training plus PRT in a multimodal context has also led to 
significant improvements in HR-QoL in some studies, demonstrating that a range of 
perceived health advantages can be produced from the same training modality (Inaba 
et al. 2008; Kimura et al. 2010). For example, a 3-month RCT involving 171 
community-dwelling older adults found that a combination of moderate-intensity PRT 
and balance training (90 minutes, twice a week) significantly improved scores in the 
mental health domain of the SF-36, compared to a health education control group 
(Kimura et al. 2010). In contrast, studies incorporating a multimodal program of PRT 
and balance training in a home-based manner have proven to be ineffective in 
improving HR-QoL elements (Barnett et al. 2003; Nelson et al. 2004), echoing 
findings from home-based PRT (Kanemaru et al. 2010). However it is possible that 
these findings may be related to a lower-training intensity and compliance. Moreover, 
following a 6-month intervention involving 72 community dwelling adults aged >70 
years with functional limitations, Nelson and colleagues (2004) reported no effect of 
unsupervised home-based PRT and balance training (performed three times a week) 
on HR-QoL in comparison to a group which received nutrition education, however 
this cohort may not be comparable with healthy older adults. Collectively, this infers 
that the effects of balance training within a multimodal program are unclear, and that 
supervised exercise in a group-based setting may provide structure and factors (e.g., 
social interaction) which can facilitate training-induced HR-QoL benefits for older 
adults.  
 
2.6.6 Effect of cognitively challenging exercise training on HR-QoL in older adults 
In addition to more traditional exercise formats, exercise regimes that possess a 
cognitively challenging component, such as exergaming and dancing, have also been 
evaluated for their effects on HR-QoL in older adults. In an 8-week study involving 
virtual-reality based tai-chi exercise (60 minutes, three times a week), in 54 older 
women (aged 65 years and over), significantly greater increases in the SF-36 domain 
of mental health were produced compared to balance and lower body strength training 
(Lee et al. 2015). Despite this solitary difference between groups, both training groups 
significantly improved across multiple domains of the SF-36 (virtual reality training: 
role-physical, bodily pain, general health, vitality, role-emotional and mental health; 
balance training: role-physical, general health, social functioning). This suggests that 
both forms of training may be effective for improving HR-QoL in older women. 
Improvements in psychological QoL (WHOQOL-BREF) were also reported in 
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residentially-dwelling older adults, following 8 weeks of engaging in virtually-led 
sports games compared to a control group (P=0.012, d=0.74) (Keogh et al. 2014), 
however no significant changes were seen in a global composite of the SF-36 
following exergaming (10-15 minutes, twice a week for 3 weeks), balance training 
(30-45 minutes, twice a week for 3 weeks), or no exercise, in  32 older adults (63-90 
years) (Franco et al. 2012). In addition to an insufficient exposure to exergaming, and 
the discrepancy in dose between intervention groups, as the findings from individual 
domains of the SF-36 were not reported, it is not known if either intervention produced 
more discrete changes in HR-QoL.  
 
To date, no simultaneous dual-task cognitive-motor exercise studies have included 
measures of HR-QoL or well-being, however physically demanding interventions that 
also contain a cognitively challenging aspect, such as dancing, have been shown to be 
effective for enhancing HR-QoL in older adults. Eight weeks of dance-based exercise 
(60 minutes, three times a week) significantly improved absolute scores in general 
health, mental health and physical functioning domains of the SF-36 in 40 community 
dwelling older adults (>65 years), compared to a non-exercising control group (Eyigor 
et al. 2009). Further, a 10-week multimodal intervention compared aspects of dance 
exercise combined with strength and balance training, in both traditional and aquatic 
settings, in 80 healthy older adults (65 years and over) (Oh et al. 2015). Compared to 
land-based exercise, water-based exercise produced greater improvements in physical 
functioning and bodily pain (ES: d=0.681 and d=0.648 respectively), role emotional, 
role physical, vitality, and mental health (ES: d=0.843) (Oh et al. 2015). Dance-based 
exercise and exergaming may therefore benefit HR-QoL in older adults, however a 
quantification of training load is not available for these studies (i.e. intensity), which 
requires further testing with these formats.  
 
One sequential cognitive-exercise study (training conducted over separate sessions) 
has investigated the effects of combined training on self-rated health (Oswald et al. 
2006). In a 30-week intervention, cognitive training in conjunction with PA 
(coordination and balance training) (135 minutes, once a week), was compared to 
single cognitive (90 minutes) and PA (45 minutes) training groups, a 
psychoeducational group (90 minutes), a combined psychoeducational and PA group 
(135 minutes), and a control group (no training) in 375 community-dwelling older 
adults (75–93 years), who were followed longitudinally for five years (Oswald et al. 
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2006). At 5-years post-intervention, both the combined cognitive and PA group and 
the combined psychoeducational and PA group, reported significantly higher ratings 
of perceived health than a control group. Rather than advocating the use of a combined 
cognitive-exercise program, these findings infer that physical exercise may have a role 
in augmenting perceptions of health, however more specific HR-QOL instruments 
(such as the SF-36) and a more traditional exercise regime (e.g., PRT) may have 
produced different outcomes. 
 
Collectively, studies involving cognitively challenging exercise provide limited 
evidence for an improvement in multiple aspects of HR-QoL, especially psychological 
domains, in older adults. These forms of exercise (exergaming, dance-based exercise) 
are typically performed at a lower intensity, where joint load and effort are reduced, 
leading to lower sensations of pain and disability during exercise, and the potential for 
a sense of accomplishment from successful participation, which collectively improve 
ratings of HR-QoL. The evaluation of a dual-task training program would provide 
further evidence, as it may improve cognitive and physical domains which both 
contribute to HR-QoL outcomes. 
 
Dose-response relationship in shaping HR-QoL 
The evaluation of HR-QoL outcomes in response to variations in exercise intensity is 
complex and unresolved, and several studies have attempted to establish the optimal 
training intensity that can enhance HR-QoL in middle-aged and older adults. Both less 
intense forms (e.g., yoga and Pilates) (Cassilhas et al. 2007; Netz & Lidor 2003; Oken 
et al. 2006) and more intense modalities such as aerobic or step training have elicited 
improvements in psychological domains of QoL in middle-aged and older adults (Bize 
& Plotnikoff 2009; Kim & Kim 2007). A 2005 meta-analysis reported improvements 
in psychological well-being following moderate intensity exercise compared to light 
or strenuous intensity in older adults (d=0.34) (Netz et al. 2005). Greater 
improvements in overall and psychological HR-QoL were reported for light, rather 
than moderate-intensity exercise training in middle-aged adults (Gillison et al. 2009), 
but a moderate- intensity elicited larger effects on physical domains of HR-QoL. Other 
evidence has indicated that HR-QoL may improve following two sessions per week of 
light-moderate intensity, with each session a minimum of 45 minutes (Windle et al. 
2010). Moderate-intensity exercise may therefore be suitable to elicit HR-QoL benefits 
in older adults, however the equivocal conclusions reported in reviews may stem from 
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inadequacies in research design, such as ineffective aerobic or strength training 
treatments, and variable levels of participation and effort from participants within 
studies (Kelley et al. 2009).  
 
2.6.7 Summary of the effects of exercise on HR-QoL in older adults 
Lines of evidence suggests that exercise can improve HR-QoL in an older population, 
yet the most effective training format and the domains of HR-QoL that can benefit 
from exercise are not clear. There is some evidence which suggests that multimodal 
training can improve HR-QoL, while only minimal evidence can be found to promote 
PRT and HV-PRT as effective for HR-QoL enhancement. Cognitively challenging 
exercise programs have shown favourable effects for improving health perceptions, 
but no dual-task studies have quantified changes in HR-QoL. The mixed findings 
between exercise studies may result from variations in self-report measures, unequal 
intervention lengths between studies and training exposures between groups in a study 
(Sillanpaa et al. 2012), the comparative control group (Kimura et al. 2010; Nelson et 
al. 2004), and the possibility that healthy older adults may have a reduced capacity for 
improvement in HR-QoL. Further, as HR-QoL is a secondary outcome for several 
studies, their analyses may be underpowered to detect significant changes in this 
measure.  
 
2.7 Satisfaction with Life in older adults 
Satisfaction with life (SWL) is a cognitive judgement about one’s own QoL which 
takes into account personal and external factors (Diener 1994). Life satisfaction is 
generally regarded to exist within a narrow positive range, and is highly personalized, 
with this latter point contributing to difficulties in measuring, interpreting and 
improving this construct. For the purposes of the next sections of this chapter, as SWL 
is believed to contribute to subjective well-being (Diener 2000; Guérin 2012), these  
terms will be used interchangeably.  
 
Several characteristics have been found to positively correlate with SWL, including 
high self-esteem, optimism, a sense of control, and adaptability (Diener 2000; Diener 
& Chan 2011). It can be assessed with the Satisfaction With Life Scale (SWLS) 
(Diener et al. 1985), a five-item unidimensional measure with excellent psychometric 
properties (Pavot & Diener 1993), or the more recently developed Personal Wellbeing 
Index (PWI) (International Wellbeing Group 2006). In older adults, SWL may also 
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relate to the ability to set and complete goals which may change with age (Maher et 
al. 2015). Life satisfaction was once regarded as a trait that displayed stability across 
the life span (Diener 1996), however a growing body of evidence has revealed that 
SWL may change according to an individual’s phase of life. Several models of the 
trajectory of SWL have been proposed, including a U-shaped trajectory with a nadir 
between an adult’s mid 30’s to early 50’s (Blanchflower & Oswald 2008; Ulloa, 
Møller & Sousa-Poza 2013), and a cubic trajectory whereby SWL is lower during 
emerging adulthood, higher during midlife, before again declining during older 
adulthood (Baird, Lucas & Donnellan 2010).  
 
The observed differences in life satisfaction between age groups are speculated to stem 
from age-related changes in motives and goals (Carstensen 2006), which are impacted 
by changes in social and family roles, physical functioning and behaviour 
(Heckhausen, Wrosch & Schulz 2010). For example, age-related declines in physical 
and mental capabilities may diminish the capacity to pursue and achieve desired goals 
(Gerstorf et al. 2010), such as the maintenance of health and functional independence 
(Baltes & Carstensen 1996; Baltes 1997), and contribute to a decline in SWL. 
Conversely, participating in regular PA and the subsequent maintenance of health and 
fitness can allow middle-aged and older adults to pursue relevant goals and feel 
competent, which contributes to an increased experience of life satisfaction (Maher et 
al. 2015; McAuley et al. 2006; Rejeski & Mihalko 2001). Another hypothesis posits 
that age-related cognitive and functional declines directly detract from SWL and 
minimise well-being in old age (Gerstorf et al. 2010). Given the potential for age-
related changes in health to reduce SWL in older adults, interventions that can target 
areas of function, which are valued and relevant to older adults, may benefit SWL and 
overall QoL. Exercise prescription has been evaluated in older adults for its ability to 
improve SWL, and a brief overview of its effectiveness will be provided below.  
 
2.7.1 Effect of physical activity and exercise on SWL in older adults 
Cross-sectional and prospective studies have reported a positive association between 
PA levels and SWL in middle-aged and older adults, both in healthy (Elavsky & 
McAuley 2005; Rejeski & Mihalko 2001) and clinical populations (Courneya & 
Friedenreich 1997, 1998). This association between PA and SWL in older adults may 
not be a direct relationship, but instead mediated by physical and mental health status 
(McAuley et al. 2006; Stewart & King 1991), and positive affect and self-esteem 
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(Elavsky et al. 2005). In contrast to the consistent benefits witnessed in cross-sectional 
studies (McAuley & Rudolph 1995), the role of structured exercise in improving SWL 
and well-being in older adults has been inadequately covered in the literature, with 
mixed findings reported from a limited number of RCTs. For example, a 2001 review 
including the findings from 12 studies (six RCTs, five cross-sectional, one quasi 
experimental) investigating the relationship between PA and SWL in older adults, 
reported mixed results (Rejeski & Mihalko 2001). Cross-sectional studies 
demonstrated a positive relationship between PA and SWL, however only half of the 
RCTs reported improved life satisfaction following PA and exercise interventions 
(Rejeski & Mihalko 2001). These inconsistencies may result from variations in the 
assessment of SWL, and differences in exercise prescription. Mihalko and McAuley 
(1996) found that 8 weeks of high-intensity strength training conducted three times 
per week (30 minutes per session) in 58 older adults in residential care (71-101 years 
old) resulted in a significantly higher level of SWL than a stretching control group 
(measured through SWLS; ES: 0.52). Conversely, 7 months of low-intensity PRT 
produced no significant differences in SWL (twice a week, 45 minutes a session, 
measured through life satisfaction index) in 49 residentially-dwelling older adults 
(mean age: 81 years), compared to a social interaction control group (McMurdo & 
Rennie 1993). These limited findings suggest that a higher training intensity may be 
needed for greater SWL in residentially-dwelling older adults, however control groups 
may dictate any observed differences.  
 
Preliminary data suggests that HV-PRT may offer older adults unique benefits for 
SWL, possibly to a greater extent than PRT. A 12-week RCT in 45 older adults (mean 
age: 74.8 years) detected significantly greater changes in satisfaction with physical 
function, self-efficacy and SWL following HV-PRT, compared to a non-exercising 
control group, whereas participants undertaking PRT only reported a greater 
improvement in self-efficacy compared to controls (Katula, Rejeski & Marsh 2008). 
Although a larger sample size may have provided greater statistical power to detect 
changes, this limited data suggests that HV-PRT may improve several aspects of QoL 
in older adults, which may be due to the benefits in physical functioning available from 
this format of training (Byrne et al. 2016), which can subsequently enhance 
perceptions of self-efficacy and well-being. Aerobic training has also been evaluated 
for its ability to improve satisfaction with life in older adults, returning mixed findings 
(Awick et al. 2015; McMurdo & Burnett 1992). In a 32-week multimodal program, a 
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combination of aerobic and light strengthening exercise (three times a week, 45 
minutes) led to significantly greater improvements in SWL (measured through the life 
satisfaction index) in 87 adults aged over 65 years, compared to a health education 
control group (McMurdo & Burnett 1992). Twelve months of moderate-intensity 
aerobic walking training (65-75% heart rate reserve) was also shown to be an effective 
strategy in 179 community-dwelling and sedentary older adults (aged 60-80 years), 
and produced significantly greater improvements in SWL (measured by the SWLS), 
compared to a toning and flexibility training group (Awick et al. 2015). Collectively, 
these limited findings partially support the conclusions from a review which found that 
aerobic exercise can provide some modest positive effects on SWL (Rejeski & 
Mihalko 2001), and further suggest that moderate-intensity aerobic training may be an 
effective format, however further data is required to confirm these conclusions.   
 
Multimodal studies combining aerobic training and PRT, or comparing the separate 
effects of these training modes, have been reported to enhance broader determinants 
of mood and well-being (Brown et al. 2009; Kohut et al. 2006), however a more 
specific rating of SWL appears to be a harder construct to modify through this 
multimodal format (Fox et al. 2007; Solberg et al. 2013). In a 13-week RCT, 118 
community-dwelling older adults (mean age 74.3 years) were randomized to either 
PRT (80-90% 1RM), functional training (circuit-based functional exercises) or aerobic 
training (moderate-intensity hiking and aerobics), performed three times a week for 60 
minutes each session, or a control group (Solberg et al. 2013). Improvements in SWL 
were detected in the functional training group compared to the control group at the 5-
week point of the intervention (P<0.05), but these differences were not present after 
the intervention. A longer trial may have demonstrated a rebound in life satisfaction 
by the training groups, however this was not observed in a multi-site non-RCT 
including 176 older adults (aged 70 and over), whereby 12 months of aerobic training 
plus PRT (3 times a week for 90 minutes each session, intensity unreported), did not 
change SWL compared to a control group (Fox et al. 2007). Limited data therefore 
suggests that SWL is not directly modified by multimodal training, but this requires 
further testing. The effects of simultaneous dual task functional power training on 
SWL are yet to be evaluated in older adults, but the inclusion of HV-PRT within a 
functional training context may be more effective for improving functional 
performance and ADLs compared to other previously tested formats (e.g., PRT, 
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aerobic training or the combination) (Byrne et al. 2016), which may in turn contribute 
to an enhancement in life satisfaction. 
  
2.7.2 Summary of the effects of exercise on SWL in older adults 
Due to limited and inconsistent data it is not possible to draw any firm conclusions 
regarding the optimal dose and type of exercise for improvements in SWL or well-
being. Mixed evidence does not support a role for PRT in the modification of SWL, 
with the only study involving HV-PRT demonstrating positive effects. The 
mechanisms underpinning this evidence are unclear, however SWL may operate 
within a narrow range in an individual, regardless of external factors such as increased 
exercise. Based on the available evidence, long-term research in older adults (≥6 
months) should incorporate moderate-intensity protocols that train a range of 
functional abilities, to foster perceptions of autonomy and achievement which 
contribute to individual perceptions of life satisfaction and well-being.  
 
2.8 Mechanisms underlying changes in cognitive function following exercise 
Evidence suggests that physical exercise can benefit cognitive function in older adults 
(Colcombe & Kramer 2003; Liu-Ambrose & Donaldson 2009), however the 
mechanisms underlying exercise-induced improvements are yet to be identified. 
Complex vascular, immune, and epigenetic mechanisms are thought to facilitate these 
improvements (Cotman, Berchtold & Christie 2007), by enhancing neural structures, 
the metabolic processes serving these structures, or functional brain processes. Dual-
task training is unique as cognitive and physical exercise training have overlapping 
benefits that may work synergistically to produce cognitive improvement (Figure 2.6). 
While most of the benefits available from cognitive and exercise training are beyond 
the scope of this thesis, a brief overview of the functional adaptations typically 
associated with exercise and dual-task training will be provided, along with the key 
physiological drivers of improved cognitive function. Following this, the 
neuroprotective pathways facilitated by neurological and inflammatory markers will 
be discussed in detail, and evidence detailing the response of these biomarkers to 
exercise will be critiqued. 
 
Ageing deteriorates the integrity of neural tissue, especially within the frontal and 
medial temporal cortices which are important for memory and higher order cognitive 
functions, leading to inefficient communication between brain networks (Fjell & 
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Walhovd 2010; Raz et al. 2005). However, exercise and cognitive training have both 
demonstrated that executive control processes and underlying brain regions are plastic 
and adaptive (Erickson et al. 2007; Voelcker-Rehage & Niemann 2013), with 
preliminary findings indicating increases in brain volume in the prefrontal and 
temporal cortices and hippocampus following exercise (Colcombe et al. 2006; 
Erickson et al. 2011). Improvements in functional connectivity in the frontal executive 
and fronto-parietal networks have also been demonstrated (Voelcker-Rehage & 
Niemann 2013), with these improvements positively associated with cognitive 
performance (Erickson et al. 2011; Voss et al. 2010). Research posits that dual-task 
training may redirect neural transmission in older adults, leading to more efficient 
performance in dual-task activities. Specifically, it is theorised that when a movement 
pattern (e.g., walking) becomes automatically regulated by the basal ganglia, which 
play a major role in the control of learned and repetitive movement sequences (Iansek 
et al. 1995), attention can be directed to secondary attention-demanding tasks through 
the frontal cortical regions (O'Shea, Morris & Iansek 2002).  
 
The neuroprotective effects of regular PA and physical exercise training may also 
result from metabolic processes that are stimulated through physical exertion. Exercise 
has been shown to reduce risk factors such as hyperlipidemia, obesity, inflammation 
and high blood pressure, which have been strongly linked to cognitive decline and 
dementia (Beydoun et al. 2014; Solomon et al. 2009). Aerobic exercise has been 
reported to increase cerebral blood flow in animal models and human studies (Guiney 
et al. 2015), and induce angiogenesis in the cortex and cerebellum (Black et al. 1990; 
Ding et al. 2006b). Cognitive training has also been associated with improved cerebral 
blood flow (Mozolic, Hayaska & Laurienti 2010), suggesting that cognitive training 
and physical exercise have overlapping benefits that may work synergistically within 
dual-task training. These modifications are proposed to facilitate the transportation of 
nutrients and oxygen to vital neural structures downstream, which may promote 
neurogenesis and other modulations in neuronal circuitry. 
  
Neural growth factors are thought to have a central role in the exercise-dependent 
benefits to cognitive health and function (Carro et al. 2001; Cotman, Berchtold & 
Christie 2007; Ding et al. 2006a), and are critical for neurogenesis, angiogenesis 
(formation of new capillaries from existing capillaries), and synaptic plasticity (Voss 
et al. 2014). At present, brain derived neurotrophic factor (BDNF), insulin-like growth 
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factor-1 (IGF-1) and vascular endothelial growth factor (VEGF), are the principal 
growth factors released through physical exercise, and may mediate the beneficial 
effects of exercise on the brain through independent and interconnected 
neurophysiological pathways (Cotman, Berchtold & Christie 2007; Voss et al. 2013). 
An increased concentration of these factors, centrally or in circulation, is considered 
to make the brain more resistant to functional and structural neurodegeneration (Voss 
et al. 2013). Accumulating evidence has also linked inflammatory mechanisms to age-
associated cognitive decline (Godbout & Johnson 2009), including AD and vascular 
dementia (Engelhart et al. 2004; Hofman et al. 1997). Naturally occurring age-related 
rises in inflammation may be countered by exercise, through an initiation of anti-
inflammatory responses which protect vasculature and neural tissue, and restore 
neurotrophic signalling (Cotman, Berchtold & Christie 2007; Packer, Pervaiz & 
Hoffman-Goetz 2010; Petersen & Pedersen 2005). Exercise is thus uniquely 
positioned to improve brain health and function by reducing peripheral risk factors for 
cognitive decline, as depicted in Figure 2.9. Evidence outlining the role of neurological 
and inflammatory markers in facilitating cognitive improvement and resisting brain 
deterioration will be a focus of the following sections, with an emphasis on how 
various exercise modalities can shape circulating levels of these biomarkers. 
 
 
Figure 2.9: Factors influencing brain health and inflammation. AD: Alzheimer’s 
disease. Taken from Cotman at al. (2007).
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2.8.1 BDNF and its links to cognitive function  
Brain-derived neurotrophic factor (BDNF) has critical neuroprotective roles in 
mitigating cognitive decline and disease, as it plays an important role in the survival, 
maturation and maintenance of developing neurons (Christie et al. 2008), protecting 
against neuronal death and encouraging neurogenesis (Park & Poo 2013). This growth 
factor also modulates synaptic plasticity in the adult brain, and facilitates learning and 
memory in the hippocampus (Bekinschtein et al. 2008; Cotman, Berchtold & Christie 
2007). As such, BDNF is highly concentrated in the hippocampus and brain (Murer et 
al. 1999), but also produced by numerous organs and endothelial and immune cells 
(Kerschensteiner et al. 1999). Circulating BDNF is therefore thought to partially 
reflect BDNF released from the brain and periphery (Pan et al. 1998), and represents 
a viable biomarker for brain dysfunction (Croll et al. 1998). 
 
Concentrations of BDNF can be influenced by nutritional factors such as reduced 
caloric intake (Weinstein et al. 2014) as well as body weight, and display sex specific 
differences (Komulainen et al. 2008; Krabbe et al. 2009). Circulating levels of BDNF 
may also decline with age (Golden et al. 2010; Gunstad et al. 2008), and emerging 
evidence from animal and human studies has associated these reductions with age-
related deteriorations in cognitive function, especially in memory and executive 
function (Croll et al. 1998; Gunstad et al. 2008; Laske et al. 2006; Shimada et al. 2014). 
In a sample of 1389 older adults aged 57-79 years old, a 1 SD decrease in plasma 
BDNF concentration was observed to increase the risk for impaired verbal fluency by 
53% (P<0.001), global cognitive function by 63% (P=0.001), and working memory by 
up to 64% (P=0.002) only in older women (Komulainen et al. 2008). Further, low 
serum levels of BDNF are associated with lower performance in processing speed and 
memory (P<0.05), and a marginally increased risk for MCI in older adults (OR: 1.41; 
95% CI 1.00-1.99) (Shimada et al. 2014). Conversely, higher serum levels of BDNF 
were weakly associated with better cognitive performance in healthy older adults 
(Gunstad et al. 2008), protective against future occurrence of dementia and AD 
(Weinstein et al. 2014), and associated with a slower rate of cognitive decline in 
Alzheimer’s patients (Laske et al. 2011). 
 
A reduction in BDNF expression is thought to contribute to the pathology of 
neurodegenerative diseases including MCI, dementia, AD and Parkinson’s disease in 
older adults (Coelho et al. 2013b; Laske et al. 2011; Westwood et al. 2014). 
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Furthermore, mixed evidence suggests that older women have higher basal levels of 
circulating BDNF (Golden et al. 2010; Trajkovska et al. 2007), which may provide 
differential gender specific effects on cognitive function. For example, older women 
with lower BDNF levels exhibited steeper rates of brain deterioration with ageing 
(Driscoll et al. 2012). This suggests that BDNF levels may undergo age-related 
decline, and these reductions may shape cognitive performances and disease risk, 
however causality cannot be inferred from these studies. The identification of 
interventions that can improve levels of this neurotrophin are therefore necessary. 
 
BDNF polymorphisms  
An in-depth investigation into the genetic factors that underlie cognitive function is 
beyond the scope of this thesis, however the next section will briefly outline the genetic 
factors regulating BDNF expression, which is hypothesized to shape cognitive 
performance. This is important when considering the significance of BDNF secretion 
following PA or exercise training, and the potential biological limitations to peripheral 
modification. 
 
Expression of the BDNF peptide is under genetic control, and a specific polymorphism 
of the BDNF gene has been identified as a candidate which may contribute to AD and 
poorer cognitive function in older adults (Egan et al. 2003; Kunugi et al. 2001). In 
humans, a functional single nucleotide polymorphism (SNP) on the BDNF gene causes 
a substitution of the amino acid methionine (Met) for valine (Val) at codon 66, to 
produce the Val66Met gene polymorphism or rs6265 SNP, which is thought to reduce 
the activity-dependent secretion and distribution of BDNF in the brain, and also impact 
intracellular trafficking (Egan et al. 2003). There is some evidence that possessing the 
Met allele variation of the BDNF gene has been associated with impaired neurogenesis 
and functional connectivity, neuroanatomical reductions (Mandelman & Grigorenko 
2012; Miyajima et al. 2008), and weaker cognitive performances in episodic memory 
and processing speed in older adults (Miyajima et al. 2008; Raz et al. 2009). However 
other data has not supported these findings, suggesting that the effects of this 
polymorphism may be age and domain-specific (Erickson et al. 2008; Gajewski et al. 
2011; Mandelman & Grigorenko 2012). Therefore, it is unclear as to whether Val/Val 
homozygosity may confer greater cognitive abilities in older adults, and if BDNF 
signaling may interact with multiple neurophysiological pathways to influence 
cognitive outcomes in older adults. Further studies are needed to explore the 
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associations between the genetic dependency of circulating BDNF and release of 
BDNF following exercise, and whether these polymorphisms differentially affect 
cognitive function in older men and women.  
 
2.8.2 Effect of exercise on BDNF and its links to cognitive function  
Accumulating evidence has demonstrated that physical exercise has neuroprotective 
effects, and it has been hypothesised that circulating levels of growth factors (e.g., 
BDNF) may play a mediating role in the relationship between exercise and cognition 
(Figure 2.6). In addition to other mechanisms of BDNF release, the muscular 
contractions produced through exercise can upregulate BDNF in muscle (Yarrow et 
al. 2010), which is then released into the circulation and eventually the brain (Cotman, 
Berchtold & Christie 2007). Along with other exercise-induced neurophysiological 
and metabolic changes, this may enhance synaptogenesis and plasticity in the brain 
(Christie et al. 2008), representing a biomarker that links a healthier lifestyle with 
successful ageing.  
 
Despite these potential links, the relationship between habitual PA and circulating 
BDNF levels is currently unclear in older adults (Flöel et al. 2010; Winker et al. 2010). 
A review including studies with adults >18 years outlined a potential inverse 
relationship between BDNF levels and habitual PA levels, however lifestyle factors 
such as diet and cardiovascular risk factors were typically unaccounted for in their 
influence on BDNF levels (Huang et al. 2014). Chronic exercise training has been 
shown to have mixed effects on peripheral BDNF release in adults. A systematic 
review reported greater effects for aerobic exercise than PRT (Huang et al. 2014), 
while a small effect for regular exercise training (>3 weeks) on resting BDNF levels 
has been observed across a wide variety of age groups and exercise modalities  
(Hedges' g=0.27, P=0.005) (Szuhany, Bugatti & Otto 2015). These findings may be 
limited by heterogeneity in age groups, intervention lengths and the inclusion of 
uncontrolled studies within these reviews (Huang et al. 2014). In healthy and clinical 
populations of older adults, elevations in BDNF have been reported following 
moderate-intensity exercise (Coelho et al. 2013b), however no information is available 
regarding the most effective training modes. The next sections will therefore critique 
the evidence for the effects of exercise on peripheral levels of BDNF in older adults, 
and detail the associations between exercise-induced BDNF and its effects on 
cognitive performance. 
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2.8.2.1 Effect of aerobic training on BDNF in older adults 
Evidence from meta-analytic data suggests that aerobic exercise can produce selective 
benefits to neurocognitive functions in both healthy (Colcombe & Kramer 2003; Smith 
et al. 2010) and cognitively impaired older adults over the age of 55 years (Gates et al. 
2013; Heyn, Abreu & Ottenbacher 2004). It is currently unknown as to whether BDNF 
may facilitate these increases following aerobic training in older adults, as aerobic 
training has shown mixed benefits for BDNF and cognitive function (Erickson et al. 
2011; Leckie et al. 2014; Ruscheweyh et al. 2011; Voss et al. 2013). In a 12-month 
study of 120 older adults (>65 years), BDNF levels significantly increased following 
both aerobic training (walking at 60-75% HRR, 40 minutes 3 times per week), and 
stretching and toning (Erickson et al. 2011), and were weakly associated with 
increased hippocampal volume following aerobic training (P<0.01). In contrast to 
these findings, 12 months of moderate-intensity walking exercise in older adults aged 
55-80 years (40 minutes, three times a week), whereby no differences were detected 
in serum BDNF levels, compared to an active control group (Leckie et al. 2014). 
Instead, exercise-induced changes in BDNF mediated the effect of the intervention on 
an improvement in executive function, but only in individuals aged over 70 years, 
indicating that aerobic exercise may confer greater cognitive and neurotrophic gains 
to this cohort of older adults. Despite these findings, the majority of this sample 
consisted of women (66%), who displayed a higher level of serum BDNF at baseline 
compared to older males, and therefore ceiling effects may have precluded the 
observation of improvements. Collectively, this limited data suggests that aerobic 
exercise may not directly increase peripheral BDNF levels in older adults, but may 
have a role in mediating cognitive changes.  
 
2.8.2.2 Effect of PRT on BDNF  
Resistance exercise is a potent stimulus for the release of a variety of neuroendocrine 
and growth factors from skeletal muscle and other tissues (Cotman, Berchtold & 
Christie 2007). At present the response of BDNF to long-term PRT is yet to be 
established in older adults (>65 years), while the interaction between cognitive 
function and BDNF release following PRT is also unclear. To date, the evidence 
detailing the response of BDNF to PRT has been equivocal, and may be influenced by 
sex-specific exercise-induced differences (Coelho et al. 2012; Forti et al. 2014; Forti 
et al. 2015; Pereira et al. 2013). In a convenience sample of 40 older adults aged 62-
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72 years, 12 weeks of intensive PRT (70-80%) did not influence circulating BDNF 
levels in comparison to a matched group of non-exercising controls (Forti et al. 2014). 
In addition to the lack of randomisation, given the narrow age range of participants, 
these results may not be generalizable to all older adults. Variations in PRT intensity 
have also been investigated for their capacity to elicit different responses in BDNF. 
Research from the same laboratory found that 12 weeks of a mixture of low and 
moderate intensity resistance exercise performed to volitional exhaustion (60 
repetitions at 20% + 20 repetitions at 40% 1RM), significantly increased BDNF by 
23% in older males only, compared to low intensity (20% 1RM) and high intensity 
PRT (80% 1RM) (p=0.013) (Forti et al. 2015). Exercise was performed at the same 
volume and with a similar adherence rate in each training group. No differences were 
observed in older women, which suggests that either this mixed form of PRT has no 
effect in older women, or that BDNF responses in women may be influenced by higher 
levels of BDNF at baseline. In summary, it is possible that PRT may modulate BDNF 
circulating concentrations in older adults, but the heterogeneous use of training 
intensities between studies, uncontrolled studies, and variable sample characteristics 
disallows an accurate interpretation of the effects of this training format on circulating 
BDNF concentrations in older adults.  
 
2.8.2.3 Effect of multimodal and dual-task training on BDNF  
Multimodal training, involving the combination of multiple modes of exercise, has 
also been evaluated as a potential strategy for improving circulating BDNF levels in 
older adults. In a number of studies, significant elevations in resting serum BDNF were 
reported following training in older adults with MCI (Nascimento et al. 2015), and 
cognitively intact older adults (Ruiz et al. 2015; Vaughan et al. 2014). Neurocognitive 
functioning and BDNF levels were also assessed in 49 older women aged 65-75 years, 
who undertook a 60-minute multimodal exercise program twice a week for 16 weeks 
(low-moderate intensity aerobic training, PRT, and balance training), or were in a wait-
list control group. Multimodal training significantly increased log-transformed BDNF 
levels, and several measures of executive function and memory (Vaughan et al. 2014), 
however no efforts were made to link BDNF with the cognitive function gains. In 
contrast to these findings, an 8-week multimodal intervention focusing on light-
moderate intensity aerobic training and PRT (45 minutes, three times a week) had no 
benefit on cognitive function (measured through the MMSE), or BDNF in 
nonagenarians residing in aged care (Ruiz et al. 2015). An interpretation of these 
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findings is limited by a small sample size (n=20), and may not relate to older adults 
under 90 years.  
 
The addition of cognitive training to exercise, either sequentially (i.e. cognitive 
training prior to exercise training), or simultaneously (i.e. in a dual-task setting), has 
produced variable findings (Anderson-Hanley et al. 2012; Rahe et al. 2015a). Seven 
weeks of a combination of cognitive and physical training (mode and intensity 
unreported), and cognitive training alone, were both successful in enhancing various 
aspects of cognition and BDNF in 68 older adults, however no differences were 
reported between the groups (Rahe et al. 2015a). A diminished dose of physical 
exercise within the combined sessions (20 minutes from the 90-minute total) may have 
been insufficient to elicit any neurotrophic benefits, and the lack of a passive control 
group may have limited findings. Dual-task exercise training has produced different 
findings, as 3-months of moderate-intensity stationary cycling (HRR 60%) with a 
virtual reality tour produced a significantly higher composite score of executive 
function (P<0.002), and significantly increased BDNF compared to traditional cycling 
(Anderson-Hanley et al. 2012). Despite the inferences of these findings, no data was 
presented that associated the two factors, and plasma samples were only drawn from a 
third of participants, which limits the validity and extent of these findings. Further 
research using a dual-task cognitive and exercise training program may support these 
findings.  
 
Summary of effects of exercise training on circulating BDNF levels 
Collectively, the available data provides limited evidence that the implementation of a 
multimodal exercise intervention (Anderson-Hanley et al. 2012; Nascimento et al. 
2015; Vaughan et al. 2014) and PRT (Forti et al. 2015; Pereira et al. 2013) can 
significantly increase BDNF levels in older adults, while there is minimal data 
demonstrating the effectiveness of aerobic training (Erickson et al. 2011). The 
responses of BDNF to exercise may be sex-specific (Forti et al. 2015; Pereira et al. 
2013; Vaughan et al. 2014), but also shaped by genetic factors (Nascimento et al. 
2015). A dose-response relationship has not been established between BDNF and 
exercise, with BDNF secretion shown to be dependent on either the volume of exercise 
performed (Ruscheweyh et al. 2011), or exercise intensity (Forti et al. 2015). To date 
only one dual-task training study has included BDNF in its battery (Anderson-Hanley 
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et al. 2012), and therefore further evaluation is required to determine if this training 
format has any benefits for circulating BDNF levels. 
 
2.8.3 Insulin-like growth factor and its link to cognitive function  
Insulin-like growth factor (IGF-1) is a key growth factor that has significant roles in 
muscle growth and repair (Foldvari et al. 2000; Marcell 2003). IGF-1 also plays a role 
in higher brain functions underlying cognitive function (Fernandez et al. 2007), as it 
promotes neuronal growth and differentiation, and neurotransmitter synthesis and 
release (Anlar, Sullivan & Feldman 1999). IGF-1 may also support cognitive function 
in the face of age-related brain dysfunction (Sonntag et al. 2000), through the 
regulation and elimination of amyloid-β in the brain (Landi et al. 2007), which can 
protect hippocampal neurons (Carro et al. 2001). Along with other by-products of the 
GH/IGF-1 (growth hormone/ insulin-like growth factor) axis that experience a decline 
with ageing, research has indicated that serum IGF-1 and the density of IGF-1 
receptors in neural structures decrease with age (Sonntag, Ramsey & Carter 2005). 
Given these roles of IGF-1, the following sections will evaluate data from 
observational studies linking this factor to elderly cognition.   
 
Consistent positive associations between IGF-1 and cognitive abilities, especially 
processing speed, memory and tasks coordinated by executive function, have been 
observed in older adults, inferring that circulating levels may have predictive value in 
cognitive performance in later life (as reviewed in (Aleman & Torres-Aleman 2009). 
Meta-analytic data has supported these observations, reporting that levels of IGF-1 
show a significant positive relationship with cognitive functioning in healthy older 
adults, mainly measured with the MMSE (ES=0.6) (Arwert, Deijen & Drent 2005). 
Higher levels of IGF-1 have also been prospectively associated with less cognitive 
decline over a 2-year period in older adults (55-80 years) (OR per SD increase=0.65) 
(Kalmijn et al. 2000). Conversely, low levels of circulating IGF-1 have been shown to 
place older individuals at risk for cognitive impairment (Aleman & Torres-Aleman 
2009; Landi et al. 2007), and neurodegenerative disease (Westwood et al. 2014), and 
may interact with depressive symptoms to produce poorer cognitive performances (Lin 
et al. 2014). Sex specific differences have also been reported, with higher levels of 
IGF-1 shown to relate to better cognitive test performance in areas of verbal fluency 
and the MMSE in older men, but not older women (Al-Delaimy, von Muhlen & 
Barrett-Connor 2009). Collectively, these findings suggests that higher levels of IGF-
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1 may protect against subclinical neurodegeneration in older adults, however RCTs 
are needed to confirm the directionality of this relationship (Westwood et al. 2014).  
 
2.8.4 Effect of physical activity and exercise on IGF-1 and its links to cognitive 
function  
While there is evidence that IGF-1 levels are positively associated with cognitive 
function in older adults (Landi et al. 2007), the response of this hormone to habitual 
or prescribed PA and exercise is less clear. The following sections will outline the 
hypothesised mechanistic actions of IGF-1 in modifying cognition, before presenting 
the limited data from observational and long-term exercise intervention studies 
investigating the effect of various training formats on IGF- 1 release in older adults.  
Limited evidence suggests that IGF-1 is up-regulated in hippocampal neurons in 
response to exercise (Carro et al. 2000), with further animal models demonstrating  
that IGF-1 is an important candidate for exercise-induced angiogenesis and 
neurogenesis (Trejo, Carro & Torres-Alemán 2001), through the stimulation of 
vascular endothelial growth factor (VEGF) and BDNF (Cotman & Berchtold 2002; 
Cotman, Berchtold & Christie 2007; Ding et al. 2006a). Research suggests that IGF-1 
and BDNF work in concert (Cotman, Berchtold & Christie 2007; Ding et al. 2006a), 
and IGF-1 entrains similar pathways to that of BDNF, suggesting a convergence on 
BDNF signalling as the final common downstream mechanism (Cotman, Berchtold & 
Christie 2007). This pathway results in exercise-induced synaptic and cognitive 
plasticity (Ding et al. 2006a), and hippocampal plasticity and learning (Cotman & 
Berchtold 2002).  
 
The potential for exercise to modulate IGF-1 levels has been comprehensively 
investigated in animal models, however this strategy has been incompletely examined 
in older adults. In one of the only epidemiological studies to link regular PA and IGF-
1 in 26 older adults, a history of long-term regular participation in PA (> 60 minutes, 
three times a week for 40 years) was associated with levels of IGF-1 that were 88% 
higher than those measured in sedentary individuals (de Gonzalo-Calvo et al. 2012). 
The external validity of these findings is limited by a small sample size, the potential 
for recall-bias and the lack of specificity of the training modes undertaken. IGF-1 is 
recognized as a potential factor that could specifically connect PRT with improved 
cognition (Chang et al. 2012), and muscular strength (Dennis et al. 2009), however the 
optimal exercise modality, duration and intensity which may produce the greatest 
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improvements in IGF-1, and any attendant cognitive or health benefits for older adults, 
is still unknown. 
 
2.8.4.1 Effect of aerobic training on IGF-1  
The beneficial effects of exercise on cognition in older adults may involve the 
exercise-induced release of neurotrophic growth factors, however a number of studies 
have reported that regular long-term aerobic exercise training has largely no effect on 
IGF-1 release in older adults (Baker et al. 2010a; Chen et al. 2017; Maass et al. 2016; 
Vitiello et al. 1997; Voss et al. 2013). In a 3-month aerobic exercise trial, 40 older 
adults (aged 60-77 years old) were pseudo-randomly assigned to either moderate-
intensity treadmill exercise (30 minutes, three times a week at 65% HRmax), or a muscle 
relaxation/ stretching control group (Maass et al. 2016). No significant differences in 
serum VEGF, IGF-1 or BDNF levels were detected compared to the control group, 
however pooled changes in IGF-1 levels across both the exercise and control groups 
were positively correlated with changes in memory recall performance (r=0.42, 
P=0.005). This preliminary data may infer that growth factors can modulate cognitive 
function, independently of exercise and changes over time. Similar findings were 
observed following a 1-year RCT involving 40 minutes of walking, three times a week 
in 65 older adults (aged 55-80 years), where there was no effect of exercise on 
circulating levels of IGF-1, BDNF, or VEGF, compared to an active control group 
(Voss et al. 2013). A more intense 6-month aerobic training protocol than the previous 
studies (80-85% heart rate reserve five times a week), which significantly increased 
maximal aerobic capacity, failed to observe any marked increase in basal levels of 
IGF-1 in older men (Vitiello et al. 1997), compared to a group performing at a lower 
frequency (three days a week), and a stretching/flexibility group (Vitiello et al. 1997). 
The exact mechanisms accounting for this lack of response are unclear, but these 
findings tentatively suggest that long-term aerobic training does not require increased 
levels of IGF-1 to exert any beneficial effects on cardiovascular or cognitive function.  
 
2.8.4.2 Effect of PRT on IGF-1  
It is thought that the muscular contractions produced in PRT can elicit increases in 
IGF-1, with some evidence demonstrating that GH and IGF-1 are released in response 
to PRT in adults aged 30-50 years old (Borst et al. 2001; Kraemer et al. 1999; Kraemer 
& Ratamess 2005). Chronic adaptations of circulating IGF-1 to resistance exercise 
show greater variability in older adults, who display a different hormonal profile to 
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younger adults following PRT, with significant increases in testosterone but not IGF-
1 (Kraemer et al. 1999). These alterations may be attributable to a reduced output in 
the GH/IGF-1 endocrine axis that is speculated to occur with ageing (Sherlock & 
Toogood 2007). Indeed, intervention studies utilising PRT in older adults have 
produced conflicting findings. A 24-week program of intensive PRT (80% 1RM) was 
effective in improving mood and serum IGF-1 concentration (35% increase, P<0.05) 
in 43 older men (aged 65-75 years old) compared to a stretching group (Cassilhas et 
al. 2010). In another study, sedentary older women (aged 60-80) with low bone mineral 
density performing high-intensity PRT (75-80% 1RM) three times a week for 8 
months, displayed a significant increase in basal IGF-1 levels (70% increase), 
compared to an inactive control group (Parkhouse et al. 2000). However, the training 
group displayed lower levels of IGF-1 at baseline than matched healthy controls, 
which may have allowed greater increases in IGF-1 to emerge following PRT. In 
contrast, several studies have also failed to detect any effect of PRT on circulating 
levels of IGF-1 in older adults (Arnarson et al. 2015; Bermon et al. 1999; Nicklas et 
al. 1995; Walsh et al. 2015). A lower quality of study design may have compromised 
some of these findings, such as a lack of control group (Arnarson et al. 2015; Nicklas 
et al. 1995; Walsh et al. 2015), and a small sample of older adults (Nicklas et al. 1995; 
Walsh et al. 2015). Bermon and colleagues (1999) have also demonstrated that 8 weeks 
of high-intensity PRT, performed three times a week, did not induce any changes in 
IGF-1 in 32 healthy older adults. From animal models it is speculated that IGF-1 levels 
may transiently decrease within a short-term training program, before returning to, or 
extending beyond baseline levels with a continuation of training (Eliakim et al. 1997). 
Therefore, a training duration of 12 weeks may be insufficient to detect any rebound 
of IGF-1 to elevated levels (Arnarson et al. 2015; Bermon et al. 1999; Walsh et al. 
2015). Furthermore, the capacity of moderate-high intensity PRT to stimulate the 
release of IGF-1 in older adults may be influenced by additional factors such as total 
energy and dietary protein intake, as the addition of protein (1.3.g.kg-1.day-1) to 
moderate-intensity PRT produced a 10% greater increase in IGF-1 compared to PRT 
alone, in a 4-month trial in older women living independently (Daly et al. 2014). 
Therefore, although not a focus of this thesis an older adult’s nutritional status during 
an exercise intervention may also influence outcomes. 
 
Attempts to establish a dose-response relationship between IGF-1 and PRT in older 
adults have produced conflicting findings. In a study of 62 males aged between 65-75 
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years, 24 weeks of both moderate (50% 1RM) and high intensity (80% 1RM) PRT 
performed 3 times a week for 60 minutes, induced significant increases in IGF-1 
compared to a non-exercising control group, which were accompanied by 
improvements in memory and executive function (Cassilhas et al. 2007). In contrast, 
a smaller sample of older adults (n=30) undertook PRT at similar variations of 
intensity (either 40% 1RM or 80% 1RM) for 12 weeks, in a mixture of three gym and 
home-based sessions per week, with neither intensity altering serum IGF-1 
concentrations (Onambélé-Pearson, Breen & Stewart 2010). However, in addition to 
a shorter training duration and smaller sample, this study did not contain a passive 
control group, which precludes any comparisons to normal ageing, as seen in the 
previous study (Cassilhas et al. 2007). Serum IGF-1 release was also unaltered 
following different intensities of PRT in a 6-month study (50% 1RM or 80% 1RM) 
compared to a non-exercising control group of older adults, despite increases in 
strength being recorded (Borst et al. 2002). These findings suggest that other training 
components may be more influential determinants of IGF-1 release, or alternatively, 
exercise-induced IGF-1 secretion is independent of PRT intensity.  
 
Summary of effects of exercise training on circulating IGF-1 levels 
Circulating levels of IGF-1 appear to be unaffected by aerobic exercise training, 
however short to long-term PRT can elicit improvements in the circulating profile of 
this hormone, and these adaptations may require a duration of at least 12 weeks 
(Cassilhas et al. 2007; Parkhouse et al. 2000). Despite relative consistency between 
training studies, a dose-response relationship has not been established, and it is 
currently unknown how IGF-1 responds to a combination of cognitive training and 
physical exercise, as seen in a dual-task format.  
 
2.8.5 VEGF and its links to cognitive function  
An increased uptake of peripheral IGF-1 by the brain during exercise is thought to 
stimulate the secretion of VEGF (Carro et al. 2001; Carro et al. 2003), which is 
primarily expressed in platelets and in smooth and skeletal muscles (Kraus et al. 2004; 
Prior et al. 2003). VEGF is involved in a range of physiological processes, most 
notably angiogenesis, and the remodelling and creation of blood vessels within cortical 
structures and other tissues (Lopez-Lopez, LeRoith & Torres-Aleman 2004; Neufeld 
et al. 1999). Besides its role in vessel modulation, there is an abundance of evidence 
that VEGF possesses neurotrophic and neuroprotective roles for neuronal cells in 
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culture and in vivo, and can stimulate the proliferation and survival of neural stem cells 
(Zachary 2005). It is currently unclear as to the directionality of health benefits offered 
by either elevated, or lower levels, of circulating VEGF, which may relate to its 
emerging relevance for clinical populations who display an altered circulating profile 
compared to healthy older adults. Cognitive functioning may be influenced by both 
brain and circulating levels of VEGF, and both lower, and elevated levels of peripheral 
VEGF have been observed in AD patients, although it is thought that an increase in 
VEGF levels may be a secondary response to brain insults produced by AD (de 
Almodovar et al. 2009).  
 
Animal studies have shown that VEGF is increased in the peripheral circulation 
following chronic exercise (Ding et al. 2006b), which may provide cognitive benefits. 
Angiogenic stimuli within contracting muscle activate the functional remodelling of 
vasculature through VEGF upregulation (Prior et al. 2003), and these exercise-induced 
elevations can cross the blood– brain barrier to orchestrate neurogenesis and 
angiogenesis, and promote synaptic plasticity (Carro et al. 2003; de Almodovar et al. 
2009; Fabel et al. 2003; Landi et al. 2007). The response of VEGF to exercise in 
humans, especially healthy older adults, has been inadequately investigated, and the 
following section will therefore evaluate the available research regarding the effects 
of various exercise modalities on the secretion of VEGF in healthy older adults.  
 
2.8.5.1 Response of VEGF to exercise  
Acute bouts of aerobic exercise have been shown to increase circulating levels of 
VEGF protein in older adults with type 2 diabetes (Brinkmann et al. 2017), and arterial 
disease (Sandri et al. 2011), while acute PRT can also elevate VEGF gene expression 
to a similar level in both older and younger adults (Jozsi et al. 2000). However, a 
review including seven studies investigating the response of VEGF to chronic exercise 
training reported largely negative findings, with only two of these studies showing an 
increase in VEGF following exercise (Vital et al. 2014). A key feature of these studies 
that demonstrated increases in VEGF was their inclusion of adults with comorbidities 
such as arterial pathology, (Sandri et al. 2005), or obesity (Park et al. 2010). For 
example, VEGF concentrations increased in 20 obese older women (mean age: 66.9 
years) following a 12-week combined exercise program, including 70 minutes of 
moderate-intensity aerobic exercise, 15 minutes of elastic-based PRT and yoga (15 
minutes), 3 times a week, compared to a control group (P<0.001) (Park et al. 2010). 
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Despite these increases, it is unclear if the same findings could be derived in older 
adults of a healthy weight. 
 
Trials including healthy older adults have largely reported no effect of various exercise 
formats on circulating concentrations of VEGF, following an uncontrolled 12-week 
elastic-cable based resistance training program (40 minutes, once a week) (Ogawa et 
al. 2010), 3 months of moderate-intensity treadmill exercise (30 minutes, three times 
a week) (Maass et al. 2016), or a 1-year RCT involving walking (40 minutes, three 
times a week) (Voss et al. 2013). Further, no changes in serum VEGF levels were 
detected in 68 older adults following either 7 weeks of both sequential cognitive-
exercise training (20 minutes moderate-intensity aerobic and PRT then 70 minutes 
cognitive training; twice per week), or cognitive training (90 minutes; twice per week) 
in healthy older adults (Rahe et al. 2015a). Confounding the integrity of assay analysis, 
blood sampling was not performed at the same time of day for all participants, which 
may have left the samples vulnerable to intra-individual differences due to diurnal 
variation. Collectively, this limited data suggests that clinical populations may benefit 
more from exercise, however uncertainties in comparing relative exercise intensities 
from clinical to healthy populations, and the differences in the physiological 
characteristics of the populations, limit the generalisability of these findings to healthy 
populations. The effects of a dual-task cognitive-exercise program on circulating 
VEGF concentrations have not been tested, but may provide further evidence of the 
functional significance of VEGF expression.  
 
2.8.5.2 Amyloid beta and its links to cognitive function  
Amyloid-β (Aβ) is a peptide secreted by neurons (Selkoe 1994) and platelets (Chen et 
al. 1995) and derived from the cleavage of amyloid precursor protein (APP) (Selkoe 
2001). Higher levels of Aβ present in the cerebrospinal fluid and circulating plasma 
may also contribute to inflammatory processes, and their deposition into senile plaques 
in the brain is a key aspect of AD pathology (Akiyama et al. 2000; Rowe et al. 2007). 
The most common isoforms of this peptide; Aβ (1-42) and Aβ (1-40), have been 
identified as potential blood-based biomarkers for identifying individuals at risk for 
developing MCI or AD (Koyama et al. 2012; Song et al. 2011). While lower levels of 
Aβ (1-42) in cerebrospinal fluid have been shown in AD patients (Sunderland et al. 
2003), the published data outlining the associations between plasma Aβ levels and 
cognitive deterioration has been inconclusive. For example, mixed evidence from a 
Chapter 2 
95 
 
meta-analysis indicated that plasma levels of Aβ were not strong predictors of 
dementia or AD risk, however a significant elevated risk for cognitive decline or AD 
was found in older individuals with lower Aβ (1-42): Aβ (1-40) ratios (Koyama et al. 
2012). The reduction of circulating Aβ levels in response to PA is speculated to be a 
mediator in the relationship between PA and brain health, with lower plasma Aβ 1-
42/1-40 ratios observed in older adults reporting higher levels of PA (Brown et al. 
2013). However, the response of these peptides to exercise is poorly understood, with 
aerobically trained clinical cohorts showing a trend towards lower Aβ (1-42) levels 
(Baker et al. 2010a; Baker et al. 2010b). Further, significant increases in Aβ (1-40) and 
decreases in plasma Aβ 1-42/1-40 ratios have been reported in groups performing both 
a dual-task program involving multimodal exercise performed with arithmetic and 
word games, and physical exercise alone (Yokoyama et al. 2015). Given these mixed 
findings, the significance of this biomarker necessitates further research.  
 
2.8.6 Effect of age-related increases in inflammation on health outcomes 
Pro-inflammatory and anti-inflammatory cytokines are soluble protein messengers 
secreted by immune cells, adipose tissue and a host of other organs (Krabbe, Pedersen 
& Bruunsgaard 2004; Maier & Watkins 1998) which regulate the proliferation and 
differentiation of immune cells (Goshen & Yirmiya 2009; Motivala 2011). In the 
absence of infection, injury, or trauma, these inflammatory biomarkers are tightly 
regulated (Cohen et al. 1997; Harris et al. 1999), however ageing is typically associated 
with two to four-fold elevations in circulating levels of inflammatory mediators such 
as Interleukin 6 (IL-6), tumor necrosis factor (TNF)-α and the acute-phase protein C-
reactive protein (CRP) (Brüünsgaard & Pedersen 2003; Krabbe, Pedersen & 
Bruunsgaard 2004). The processes underlying these small elevations remains unclear, 
however sub-clinical inflammation is associated with a constellation of functional 
limitations and disabilities in older adults (Ferrucci et al. 1999; Visser et al. 2002), and 
represents a risk factor for a host of diseases, including  atherosclerosis (Libby, Ridker 
& Maseri 2002), type 2 diabetes (Duncan & Schmidt 2006), cancer (Ershler & Keller 
2000), cognitive decline (Yaffe et al. 2004) and neurodegenerative disease (Dziedzic 
2006), as well as mortality (Harris et al. 1999).  
 
In addition to their role as surrogate indicators of disease, low grade systemic 
inflammation may also represent a link between modifiable lifestyle factors, infectious 
diseases, and physiological changes during the ageing process (Krabbe, Pedersen & 
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Bruunsgaard 2004). For example, obesity increases adipose tissue which produces 
TNF- α and IL-6, and along with determinants such as poor nutrition, physical 
inactivity, and smoking, can interact with illness, chronic health conditions, and age-
related hormonal decreases, to contribute to a state of chronic low-grade systemic 
inflammation (Ferrucci et al. 1999; Straub et al. 2001), as summarised in Figure 2.10. 
It is unclear as to whether these age-related elevations result from an impairment to 
regulatory mechanisms with age (De Martinis et al. 2006), are a necessary 
consequence of ageing, or are the accumulated by-products of disease (e.g., CVD) and 
risk factors that lie parallel with ageing (Ferrucci et al. 2005). Regardless, the 
inflammatory pathway represents an important biological contributor to ageing-related 
disability (Ferrucci et al. 2002; Nicklas & Brinkley 2009).  
 
 
  
 
Figure 2.10: Factors related to pro-and anti-inflammatory cytokines. Adapted from 
Sartori et al. (2012). 
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2.8.7 Inflammation and its links to cognitive function 
Accumulating evidence has linked inflammatory mechanisms to age-associated 
cognitive decline (Godbout & Johnson 2009), and neurodegenerative diseases 
including AD and vascular dementia (Engelhart et al. 2004; Hofman et al. 1997), 
however the causality and directionality of these associations is unresolved. It has been 
proposed that inflammation may affect cognitive functioning in older adults through 
several processes: 1) either through local pro-inflammatory responses in the brain, or 
2) heightened levels of inflammation in the peripheral circulation as a by-product of 
normal ageing (Packer, Pervaiz & Hoffman-Goetz 2010; Sartori et al. 2012). An 
accumulation of pro-inflammatory cytokines in neural tissue (Zipp & Aktas 2006) is 
thought to create a neurotoxic environment (Perry 2004; Russo, Barlati & Bosetti 
2011), which can impair hippocampal neurogenesis and function (Malberg et al. 2000; 
Spulber et al. 2008), and induce changes in vascular function and structure which 
compromises white matter integrity (Wersching et al. 2010; Zhang et al. 2009). 
Furthermore, IL-1β up-regulates expression and processing of the amyloid-β precursor 
protein (APP) gene, and increased concentrations of this cytokine are found in regions 
of the brain involved in AD progression (Cacabelos et al. 1994; Grimaldi et al. 2000). 
Data suggesting that the administration of anti-inflammatory medication may slow 
cognitive decline and related disorders has therefore provided a rationale for an 
inflammatory hypothesis of cognitive impairment (Gorelick 2010). Thus, 
inflammatory processes appear to have an important role in neuropathological ageing, 
however it remains unresolved as to whether pro-inflammatory processes directly 
influence disease progression and cognitive trajectory, are simply by- products of 
evolving pathophysiology (Wyss-Coray 2006; Yaffe et al. 2004), or facilitate 
beneficial repair processes in the brain (Krabbe, Pedersen & Bruunsgaard 2004). 
Observational data describing the associations between inflammation and cognitive 
function in older adults will be evaluated in the next section. 
 
Epidemiological studies associating inflammation and cognitive function  
Large-scale observational and longitudinal studies investigating inflammation and 
cognitive decline in older adults suggest that inflammatory dysregulation is negatively 
related to cognitive function, with a 2010 review noting consistent relationships 
between systemic inflammation and cognitive impairment, and the risk of 
neurodegenerative disease (Gorelick 2010). Similarly, a large prospective cohort study 
of 3031 older adults (mean age 74 years) reported significant associations between 
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higher plasma concentrations of IL-6 and CRP at baseline with worse global cognitive 
performance at baseline and at a 2-year follow up, compared to individuals in the 
lowest tertile, after adjusting for multiple physiological and lifestyle factors (Yaffe et 
al. 2003). However, blood samples were only taken at baseline and due to the natural 
variations of inflammatory markers over time, repeated measurements may have 
provided more reliable data. Higher systemic levels of IL-6 have also been linked to a 
steeper annual decline in memory over 2 years (P<0.03) in adults over the age of 85, 
with ApoE-ε4 carriers more vulnerable to these effects (Schram et al. 2007). In 
contrast, a number of other studies have demonstrated no links between inflammation 
and cognitive function. (Alley et al. 2008; Dik et al. 2005; Weuve et al. 2006). A 
population based study of 1284 older adults (62-85 years) found no associations 
between either serum CRP or IL-6 and cognitive decline, or changes in cognitive 
performance (memory, executive function, processing speed), after 3 years (Dik et al. 
2005). However, a sensitivity analysis indicated that high levels of CRP and IL-6 were 
strongly associated with decline in the MMSE in cognitively impaired participants 
who were lost to follow-up. Further, in 851 high functioning older adults those in the 
top IL-6 tertile demonstrated a decline in global cognitive function over the course of 
7 years (Alley et al. 2008). This relationship could not be shown after accounting for 
confounders (e.g., age, health status, socioeconomic status), however significant 
inverse associations between IL-6 and working memory and orientation persisted after 
adjustment (Alley et al. 2008).  
 
The descrepancies between studies are likely related to methodological differences, as 
the use of cognitive assessments that are more suited for the screening of dementias in 
those with latent cognitive impairment (i.e. MMSE) may provide different results than 
tests tailored for the detection of subclinical cognitive change in healthy older adults. 
Further, while some studies have adjusted for basic demographics, others have 
additionally adjusted for genetic, psychological and lifestyle factors (Alley et al. 2008; 
Baune et al. 2008; Weuve et al. 2006). Moreover, few studies have used a large array 
of inflammatory or neurological markers with a battery of neuropsychological tests 
(Chi et al. 2017; Trollor et al. 2012). A recent study aggregating multiple inflammatory 
markers into a single composite found that higher Z-scores (indicating increased 
inflammation) were significantly associated with deficits in psychomotor speed and 
memory in the elderly (aged >75 years) over 7 years, however this composite was not 
associated with cognitive performance at baseline (Chi et al. 2017). An earlier cross-
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sectional study reported that larger scores in an inflammatory factor largely comprised 
of pro-inflammatory cytokines was associated with poorer memory performance, 
however only one of these cytokines (IL-12) showed a significant association with 
cognitive function in individual analysis (Trollor et al. 2012). It is therefore unclear as 
to whether specific inflammatory markers are related to cognition or whether 
composite scores might provide greater insight into this relationship in older adults 
living in retirement villages.  
 
2.8.8 Effect of exercise on inflammation in older adults 
Strategies such as pharmacological intervention may reduce inflammation, however 
they may only offer symptomatic benefits and their clinical application is limited by 
the potential for unwanted side effects (Canvin & El-Gabalawy 1999). Another 
challenge involves selecting therapies which may benefit individuals with sub-clinical 
levels of low grade systemic inflammation. Evidence suggests that exercise may be an 
effective option in combating the rise in circulating inflammatory cytokines through a 
range of pathways, including an initiation of local and systemic anti-inflammatory 
responses following muscular contraction (Flynn, McFarlin & Markofski 2007; 
Pedersen & Febbraio 2012), a decrease in adiposity which contributes to systemic 
inflammation (Petersen & Pedersen 2005), the regular release of glucocorticoids and 
catecholamines which can decrease inflammatory activity (Christensen & Galbo 1983; 
Elenkov & Chrousos 2006; van der Poll et al. 1996), and protection against 
inflammatory-related damage cause by oxidative stress (Bruunsgaard & Pedersen 
2000; Chung et al. 2009). A detailed discussion of the mechanisms by which exercise 
may reduce systemic inflammation is beyond the scope of this thesis, however regular 
exercise may also represent an effective strategy for reducing central and peripheral 
risk factors which promote inflammation in older adults, such as obesity and 
cardiovascular disease (Lavie et al. 2011). The effects of exercise may also extend to 
improvements in cognitive function, through the induction of anti-inflammatory 
cytokines and modifications to pro-inflammatory cytokine levels in circulation and 
neural tissue, which can restore neurotrophic signalling (Cotman, Berchtold & Christie 
2007; Packer, Pervaiz & Hoffman-Goetz 2010), as outlined below.  
 
2.8.8.1 The effect of regular physical activity on inflammatory markers 
Large cohort studies conducted in older individuals (average age >60 years) have 
demonstrated an inverse relationship between levels of self-reported PA and peripheral 
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markers of inflammation (Colbert et al. 2004; Taaffe et al. 2000; Woods et al. 2012). 
However, these associations may be limited by the biases introduced by the use of self-
report measures to assess PA status, instead of a direct and objective measurement of 
PA, and the variable classification of PA levels between studies (Colbert et al. 2004; 
Taaffe et al. 2000). Long-term exercise interventions in older adults may be more 
useful for determining any cause and effect relationship between exercise and a range 
of inflammatory markers, however considerable evidence from intervention studies 
indicates a variable inflammatory response to long-term structured physical exercise, 
which may depend on the training mode (Beavers, Brinkley & Nicklas 2010; Woods 
et al. 2012). In addition, it is currently unclear as to whether exercise-induced 
improvements in the inflammatory milieu can have far-reaching consequences in 
terms of enhanced cognition in older adults. The following sections will critique the 
evidence outlining the inflammatory response following long-term aerobic training, 
PRT, and multimodal training studies in older adults.  
 
2.8.8.2 Effect of aerobic training on inflammation in older adults 
Studies investigating the effects of aerobic exercise on inflammatory markers in older 
adults have returned equivocal findings, however successful exercise interventions 
typically result in low to moderate decreases in body weight or fat, which can in turn 
lower inflammation. Moreover, as regular exercise can decrease fat mass; a strong 
correlate of circulating inflammatory levels (Nicklas, You & Pahor 2005), adjusting 
for body mass index (BMI) typically attenuates the relationship between inflammatory 
biomarkers and exercise in intervention studies (Woods et al. 2012). A 2006 meta-
analysis pooling the results of five interventions from adults (>18 years) found no 
effects of aerobic training on circulating CRP, however these findings may not 
generalize to older adults (Kelley & Kelley 2006). Another review reported mixed 
effects from regular aerobic training on inflammatory markers in healthy older adults, 
suggesting this may be a more important strategy in conditions associated with 
elevated inflammation such as obesity and cardiovascular disease (Beavers, Brinkley 
& Nicklas 2010). Adequately-powered aerobic interventions in healthy older adults 
have also reported mixed benefits. A 10-month intervention comparing aerobic 
training (three times a week, 45-60 min at 60-70% VO2max) to balance and flexibility 
training (twice a week for 75 minutes) in sedentary older adults (~70 years) found that 
aerobic training significantly reduced serum CRP levels by 13%, and this effect was 
partially associated with reduced trunk fat (Vieira et al. 2009). This suggests that a 
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reduction in visceral fat may underpin a reduction in inflammatory levels. However, 
10 months of similar intensity aerobic training (65-80% HRmax) significantly reduced 
serum CRP, IL-6 and IL-18, compared to balance, PRT and flexibility training (both 
three times a week, 45 minutes each session) in 83 older adults aged over 64 years old 
(Kohut et al. 2006), independent of changes in overall adiposity, as BMI was 
unchanged. In contrast to the studies above, 6-months of high-intensity aerobic 
training (mode unreported, 80% HRmax) had no effect on CRP levels in 61 community-
dwelling older adults (60-85 years), compared to a usual care group (Hammett et al. 
2004). Although fitness increased in the training group, no changes in body fat were 
detected. Collectively, these findings tentatively suggest that reductions in body fat 
following aerobic intervention may influence inflammatory biomarker levels in 
healthy older adults (Hammett et al. 2004; Vieira et al. 2009), however the optimal 
dose and length of aerobic training required to attenuate inflammation is unclear.  
 
2.8.8.3 Effect of resistance training on inflammation in older adults 
Currently, the effects of PRT on systemic inflammation are unclear. Bruunsgaard and 
colleagues (2004) found that 12 weeks of lower-limb PRT (50-80% 1RM; 45 minutes, 
three times a week) produced no significant effects on plasma levels of IL-6 or TNF-
α in a small sample of frail nursing home residents (86-95 years old, n=21), when 
compared to a control group who engaged in social outings. It is possible that a more 
global training program, and a longer intervention, may have elicited changes in pro-
inflammatory cytokines. In a component of a larger 12-month RCT, a sequence of 6 
months moderate-high intensity PRT (60-85% of 1-RM) and 6 months HV-PRT in 90 
men aged 50–79 years (60-75 minutes, three times a week), reduced IL-6 by 29%, 
compared to a control group (P=0.06), however these differences were not present 
after adjusting for changes in fat mass (Peake et al. 2011). Limited data from two 12-
week interventions also suggests that alternate forms of PRT incorporating elastic 
bands and power training, does not influence inflammatory cytokine levels in older 
adults (So et al. 2013; Valls et al. 2014), however these findings may result from both 
insufficient (So et al. 2013) and excessive training loads (Valls et al. 2014). For 
example, although no increases in oxidative stress or muscle damage were observed 
following training, the performance of high-velocity contractions at 70% of 1RM (3-
4 sets of 10-12 repetitions) may have been too physiologically demanding to allow 
adaptive inflammatory changes to occur in older adults, and lower loads may be more 
effective (Valls et al. 2014). Variable training benefits from PRT have also been 
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reported in sedentary women aged over 65 (Cordova et al. 2011; Ogawa et al. 2010; 
Phillips et al. 2010), which are hard to interpret due to study limitations such as the 
lack of a control group (Ogawa et al. 2010), samples only collected post-intervention 
(Cordova et al. 2011), and unequal intervention group sizes (Phillips et al. 2010). 
 
The optimal dose of PRT required for inflammatory benefits in older adults is currently 
unknown, with only one study attempting to establish a dose-response relationship 
(Onambélé-Pearson, Breen & Stewart 2010). Older adults undertaking 12 weeks of 
low-intensity mostly home-based PRT (40% 1RM; mean age: 76 years) displayed a 
15% decrease in levels of serum TNF-α compared to gym-based high-intensity PRT 
(80% 1RM; mean age: 69 years) (P=0.030) (Onambélé-Pearson, Breen & Stewart 
2010). However, the inconsistent distribution of home-based and gym-based sessions, 
and disparity in the mean ages of the training groups, limits any comparison. In another 
study, neither low-intensity PRT or aerobic training had any effect on CRP levels in 
45 older adults (~76 years), compared to a control group following 16 weeks of 
training (45 min, 3 times a week) (Martins et al. 2010), however other inflammatory 
markers may have responded to this intensity of PRT. Currently, there is a lack of 
evidence to advocate the use of PRT in attenuating systemic inflammation in healthy 
older adults, and PRT may instead elicit reductions in local levels of inflammatory 
cytokines (myokines) within skeletal muscle, postulating an anti-inflammatory role for 
exercise (Lambert et al. 2008). While the methodological heterogeneity between the 
studies in the literature may obscure the benefits to be obtained from PRT, this training 
format may be ineffective for reducing fat mass, which may be a key determinant for 
the attenuation of circulating markers.  
 
2.8.8.4 Effect of multimodal training on inflammation in older adults 
Given the inconsistent evidence from aerobic and PRT studies, multimodal protocols 
have assessed a combination of these elements for their ability to reduce inflammation 
in healthy older adults (Beavers, Brinkley & Nicklas 2010; Martins et al. 2010; Nicklas 
et al. 2004; Nicklas et al. 2008; Stewart et al. 2007). In a 12-month RCT, moderate-
intensity walking based training (150 minutes per week) coupled with home-based 
low-intensity lower extremity strength and balance exercises (3-4 times a week for 40-
60 minutes) was assessed in 424 community-dwelling, overweight/ obese (BMI >28) 
adults aged 70-89 years (Nicklas et al. 2008). Compared to a health education control 
group, the training group exhibited a significant 16% reduction in IL-6, with this 
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benefit most pronounced in those individuals with higher levels of IL-6 at baseline, 
and a trend for decreased levels of CRP (32%). No changes in body weight or 
percentage body fat were reported in either group, which suggests a reduction in 
systemic inflammation independent of weight loss. In contrast to these findings, 
significant reductions in CRP, IL-6 and TNF-α were detected following an 18-month 
dietary weight loss program, whereas a multimodal exercise program similar to that 
used in the previous study, had no effect on inflammatory levels (Nicklas et al. 2004). 
Importantly, the observed reductions in the weight-loss group were not mediated by 
decreases in body weight or BMI, which implies that other cellular factors may have 
contributed to the ability of the treatment to lower CRP and IL-6. Collectively, 
multimodal interventions have also provided inconsistent evidence for their ability to 
modify inflammatory markers in healthy older adults.  
 
2.8.8.5 Summary of the effects of exercise on inflammatory levels in older adults 
Given the inconsistencies of structured physical exercise to improve the inflammatory 
profile of older adults across a number of reviews (Beavers, Brinkley & Nicklas 2010; 
Woods et al. 2012), there is a lack of available data to make any firm conclusions 
regarding the optimal training type and dose. Improvements in inflammatory levels 
following exercise formats such as aerobic training and/or PRT have been reported in 
some trials independent of changes in body composition, suggesting that several 
exercise-induced mechanisms may underlie any improvements in inflammation. 
However, the few studies that have evaluated the effect of power training (Hvid et al. 
2017; Valls et al. 2014) or functional exercise training (Nishida et al. 2015) have 
reported mixed effects on inflammatory markers. Furthermore, to date, studies 
investigating the effects of cognitive-exercise training on neurological markers have 
not included inflammatory markers (Anderson-Hanley et al. 2012; Rahe et al. 2015a), 
and therefore the effects of this mode of training are unknown. Nonetheless, more data 
is needed to understand the significance of lower levels of IL-6, as it has also been 
credited with anti-inflammatory roles following acute exercise (as muscle-derived IL-
6) (Petersen & Pedersen 2005), and in local and systemic acute inflammatory 
responses (Xing et al. 1998). The inclusion of an inactive control group is necessary 
to detect any effects of an exercise intervention, due to the natural transience and large 
variability of inflammatory biomarkers within and between individuals that may 
otherwise indicate treatment-induced changes (Nicklas & Brinkley 2009). Further 
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research with these methodological considerations may provide an insight into any 
roles that exercise has in modulating these biomarkers.  
 
2.9 Neurological and inflammatory markers and their links to well-being 
Improvements in HR-QoL and well-being have been reported following exercise or 
PA in older adults (Kohut et al. 2006; McGrath, O'Malley & Hendrix 2011; Sayers et 
al. 2003), however the factors underpinning these psychosocial enhancements are 
unclear, and may entail several overlapping mechanisms. Apart from a decrease in 
symptoms and risk factors for chronic disease, exercise may create a higher QoL and 
HR-QoL when an individual can readily accomplish ADLs with fewer limitations, 
which provides a new found experience of accomplishment and independence, 
contributing to more positive emotions (Elavsky et al. 2005; McAuley et al. 2006). A 
complex interconnection of physiological and psychological improvements may also 
be contributing factors to enhanced mood and well-being following exercise (Arent, 
Landers & Etnier 2000; Elavsky et al. 2005; McAuley et al. 2006). For example, 
exercise is thought to correct the dysregulation of neurotransmitters which is linked to 
the pathogenesis of depression, anxiety and other negative mood paradigms (Barbour 
& Blumenthal 2005). Similarly, there is now an emerging body of evidence which 
suggests that circulating levels of neurological and inflammatory markers may shape 
well-being in adults (Duman & Monteggia 2006; Kiecolt-Glaser et al. 2002), with 
exercise capable of modifying these markers (Cassilhas et al. 2010; Kohut et al. 2006). 
This positions exercise as a strategy that can potentially improve several aspects of 
function and independence. The next sections will critique the limited evidence 
reporting the associations between the neurotrophic growth factors BDNF, IGF-1 and 
VEGF with overall well-being in older adults, owing to the lack of data pertaining to 
HR-QoL. Where possible, data from studies including measures of HR-QoL will be 
included, however as most studies report QoL as a surrogate marker for well-being 
and HR-QoL, these terms will be interchangeable.  
 
2.9.1 BDNF and its links to well-being and HR-QoL 
Relationships between BDNF and HR-QoL have not been investigated in older adults, 
however there is some evidence that higher levels of BDNF may be crucial for a greater 
sense of well-being in adults (Duman & Monteggia 2006). Depression and mood 
disorders are not a focus of this thesis, however they can have a significant impact on 
well-being. Therefore, studies recruiting depressed populations and middle-aged 
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adults will be briefly discussed in the following sections, as their findings may be 
pertinent to healthy older adults. Emerging evidence suggests that BDNF contributes 
to the development of depression, and other chronic stress-induced mental disorders 
in adults (Duman & Monteggia 2006; Sen, Duman & Sanacora 2008). A number of 
studies and meta-analyses have reported that serum levels of BDNF are significantly 
decreased in depressed patients compared to healthy controls (Karege et al. 2002; Sen, 
Duman & Sanacora 2008; Shimizu et al. 2003), and older adults with mood-disorders 
(Hashizume et al. 2015). The exact pathophysiological mechanisms underlying these 
associative links are yet to be clarified, however the ‘neurotrophic hypothesis of 
depression’ posits that decreased levels of BDNF and other neurotrophic factors (e.g., 
IGF-1) are principal contributors to mood disorders, and are associated with 
dysfunction of neuronal networks (Pittenger & Duman 2008). The directionality of the 
relationship between BDNF and well-being is not distinct, however stress decreases 
the expression of BDNF in limbic structures that control mood such as the amygdala, 
hippocampus and prefrontal cortex (Duman & Monteggia 2006; Smith et al. 1995). 
Together with depressive symptoms these reductions in BDNF levels may collectively 
contribute to the pathophysiology of cerebral atrophy and eventual cognitive decline 
in older adults (Duman & Monteggia 2006; Lee et al. 2009; Sambataro et al. 2010). 
Antidepressant treatment and exercise can provide similar therapeutic benefits (Carro 
et al. 2000; Duman et al. 2008; Strohle 2009), and upregulate neurotrophic expression 
in limbic brain regions involved in the regulation of mood and cognition, which 
reverses depression-induced neuronal atrophy and cell loss (Duman 2004; Gonul et al. 
2005). This suggests a link between clinical improvements in well-being and 
neuroplasticity, however these associations require evaluation in older adults before 
any firm conclusions can be reached.  
 
2.9.2 IGF-1 and its links to well-being and HR-QoL 
Evidence has positively associated IGF-1 levels with cognitive function (Aleman & 
Torres-Aleman 2009), however receptors for IGF-1 are also prominent in the 
prefrontal cortex and limbic areas (e.g., hippocampus, amygdala) (van Dam & Aleman 
2004), regions that regulate learning and memory, as well as depressive 
symptomatology (Dere, Pause & Pietrowsky 2010). IGF-1 may also have a role in the 
modulation of well-being and mood (Cassilhas et al. 2010), and mediate the 
relationship between well-being and cognitive performance in older adults (Lin et al. 
2014). However, a direct relationship between IGF-1 and well-being in older adults 
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remains unclear, with the majority of associated research including growth hormone 
(GH) deficient adults, whose basal levels of IGF-1 are altered by disease, and are 
subject to significant impairments in QoL (Malik et al. 2003; Moock et al. 2009).  
The influence of IGF-1 concentrations on a variety of self-reported behavioural and 
psychosocial parameters has been inadequately investigated in older adults. Limited 
data has reported weak, positive correlations between IGF-1 and psychological well-
being in healthy adults aged 20-74 years (all P<0.05), however these associations did 
not persist when focused on middle (45-59 years) or older age adults (60-74 years) 
(Unden et al. 2002). Limited intervention data has so far not been available to confirm 
causality between well-being and levels of IGF-1 in older adults, with inconclusive 
findings seen with middle-aged breast cancer survivors (Sprod et al. 2012). Further 
data from exercise interventions are needed to establish whether there are associations 
between IGF-1 levels and well-being in healthy older adults. 
 
2.9.3 VEGF and its links to well-being and HR-QoL 
It is currently unclear if circulating levels of VEGF play any role in contributing to 
well-being or HR-QoL in humans (Lee & Kim 2012). VEGF is an angiogenic factor 
with high relevance to cancer [see (Gasparini 2000) for review], and as such, 
relationships between VEGF and well-being have been predominantly evaluated in 
clinical contexts (e.g., cancer patients), where evidence suggests that psychological 
factors of well-being, such as stress, depression, and social support share an inverse 
association with this correlate of malignant disease (Lutgendorf et al. 2002; Mills et 
al. 2005; Sharma et al. 2008). Mixed data has also reported both higher (Lee & Kim 
2012) and lower VEGF levels (Ventriglia et al. 2009) in individuals with depression 
and mood disorder, respectively. While clinical populations are not the focus of this 
thesis, their preponderance in the literature may provide some background as to the 
associations between VEGF and well-being in healthy adults, as no studies have 
explored the cross-sectional relationship between VEGF and HR-QoL in older adults. 
The profile of VEGF release in clinical patients therefore appears to contrasts with the 
limited data that has outlined positive associations between IGF-1, BDNF and QoL 
outcomes in healthy adults (Duman & Monteggia 2006; Unden et al. 2002), however 
such associations with healthy adults, or older adults, remain untested.   
 
In summary, neurological markers such as BDNF, VEGF and IGF-1 display 
inconsistent associations with extensions of well-being, and these relationships are 
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typically conceptualized from animal studies and clinical populations, limiting their 
relevance to healthy older adults. The response of these markers to exercise and any 
links to changes in HR-QoL and well-being, may provide valuable information for 
enhancing far-reaching health outcomes in older adults. 
 
2.9.4 Inflammation, well-being and HR-QoL 
Emerging areas of research have revealed significant associations between pro-
inflammatory cytokines and disruptions to well-being in older adults (e.g., poor social 
support, stress, and loneliness) (Kiecolt-Glaser, Gouin & Hantsoo 2010; Kiecolt-
Glaser et al. 2002), while higher levels of IL-6, CRP and TNF-α have been reported in 
depressed older adults (Penninx et al. 2003). The precise mechanisms underlying the 
association of higher pro-inflammatory levels and decreased well-being are not fully 
understood, although there is strong evidence that the brain and peripheral immune 
system form a bidirectional communication network, whereby acute psychological and 
physical stress can produce sequelae similar to an immune response [for review see 
(Maier & Watkins 1998; Turnbull & Rivier 1999)]. As such, psychosocial stress, 
depression and anxiety can upregulate pro-inflammatory cytokine production 
(Kiecolt-Glaser et al. 2002; Lutgendorf et al. 1999; Pitsavos et al. 2006), through 
adrenergic stimulation of the signaling molecule nuclear factor kappa B (NF-κB) 
(Bierhaus et al. 2003). As ageing is associated with low-grade inflammation and 
impaired immune competency (Bruunsgaard & Pedersen 2000), these conditions have 
the potential to negatively impact psychological well-being and expose an older adult 
to further inflammatory-led health risks (Segerstrom & Miller 2004).  
 
Currently, few studies have investigated associations between inflammation and HR-
QoL in older adults. The biological origins of self-rated health perceptions were 
evaluated in healthy older adults aged ≥ 65 years (Unden et al. 2007), whereby higher 
levels of TNF-α and IL-1β were moderately associated with poor self-rated health 
(P<0.01), and a lower QoL (P<0.05) (Unden et al. 2007). Further data has found that 
adults (mean age 52.1 years) reporting high life satisfaction demonstrated a lower CRP 
concentration (P=0.03), compared to dissatisfied adults, while an inverse relationship 
between pooled CRP levels and life satisfaction scores was also observed, even after 
adjusting for BMI and education (Hamer & Chida 2011). Finally, additional cross-
sectional evidence demonstrated  that elevated levels of CRP significantly predicted 
lower odds of reporting high QoL (measured as self-rated general and relationship 
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happiness) in 3005 older adults (aged 75-85 years) (Nowakowski 2014). The direction 
of these relationships are uncertain, however it is likely that inflammation may interact 
with or contribute to chronic disease, which reduces QoL (Nowakowski, Graves & 
Sumerau 2016). These collective findings also support previous research linking 
elevated cytokine concentrations with adverse behavioural adaptations (Dantzer et al. 
2008; Maier & Watkins 1998), and suggest that positive psychological attributes may 
protect against disease risk through a reduction in systemic inflammation.  
 
The potential for exercise to attenuate the progression of inflammation and thereby 
maintain or enhance well-being older adults has been inadequately evaluated (Kohut 
et al. 2006; Starkweather 2007). Kohut and colleagues (2006) observed that 10 months 
of aerobic exercise training (65-80% HRmax) resulted in significant reductions in serum 
CRP, IL-6 and IL-18 in healthy older adults compared to an active control group, 
however these reductions did not mediate improvements in well-being measures of  
depression, optimism and a sense of coherence. Further, 10 weeks of moderate-
intensity walking (30 minutes, five times a week) in 20 older adults living in residential 
care, produced a significant decrease in IL-6 and improvements in five domains of the 
SF-36 compared to a control group (Starkweather 2007), but these changes were not 
significantly associated. This limited data collectively suggests that aerobic training 
may improve peripheral inflammation, but the relationship between the inflammatory 
profile and QoL requires further investigation. 
 
2.10 Summary  
Age-associated cognitive decline and its associated illnesses are growing public health 
concerns with no known cure, and represent a substantial threat to the health, 
functional independence and well-being of older Australians. Therefore identifying 
and implementing cost-efficient and effective strategies to maintain their independent 
lifestyle is vital, and can reduce health-care costs associated with disease and 
disability. Regular exercise (e.g., aerobic training, PRT, power training, or the 
combination) has been shown to provide small-moderate cognitive benefits in healthy 
and cognitively impaired older adults in domains such as executive function, memory, 
processing speed, and attention (Colcombe & Kramer 2003; Heyn, Abreu & 
Ottenbacher 2004; Northey et al. 2017). However the optimal type and dose 
(frequency, intensity, duration) of exercise remains unclear due to inconsistencies in 
study design, exercise programming, the included populations, and the selection of 
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cognitive assessments across studies. Furthermore, the effects of power training and 
functional training on cognition in healthy older adults is unclear, with a few studies 
involving this type of training mostly showing benefits in populations who are 
cognitively impaired or frail (Ponce-Bravo et al. 2015; Yoon et al. 2017). Cognitive 
training and regular participation in mentally stimulating activities have also been 
demonstrated to have positive effects on cognitive function in older adults (Martin et 
al. 2011; Valenzuela & Sachdev 2009), but it is unclear as to whether such training 
alone can enhance functional tasks of everyday living such as talking whilst walking 
(Simons et al. 2016; Verghese et al. 2010), which is an example of dual-tasking. Given 
the decline in cognitive function and dual-task ability that occurs with ageing, dual-
task cognitive-motor exercise training can improve selected cognitive domains and 
reduce the risk of cognitive-related diseases such as dementia and AD in older adults, 
however the optimal type, dose, intensity and duration of dual-task exercise training is 
currently unknown, while the effects of functional power training are untested within 
this context (Lauenroth, Ioannidis & Teichmann 2016; Zhu et al. 2016). This type of 
training may be especially beneficial for older adults independently living in 
retirement villages, who experience a high level of functional impairment and 
increased risk of falling (Menz, Morris & Lord 2006).  
 
There is evidence that age-related losses in muscle mass, strength and function are 
associated with physical disability, increased risk of falls and a loss of functional 
independence, which have been linked to reduced HR-QoL and broader aspects of 
QoL (Fielding et al. 2011; Landi et al. 2012; Rizzoli et al. 2013; Sayer et al. 2006). 
Therefore interventions that can exert a positive effect on cognitive function, and 
improve muscle strength and function may also have benefits for quality of life and 
well-being in older adults (Canuto Wanderley et al. 2015). Structured exercise formats 
involving aerobic training or PRT have been shown to exert some positive effects on 
physical and mental aspects of health-related quality of life and well-being, in healthy 
older adults and those with chronic disease. However, these trials have not provided 
any information regarding the optimal dose or type of exercise required to elicit 
changes in HR-QoL, which may result from variations in self-report measures, unequal 
intervention lengths and the possibility that healthy older adults may have a reduced 
capacity for improvement in HR-QoL. To date, there is limited data available from 
functional and power training studies in regards to their effects on HR-QoL and well-
being, while no studies have investigated the capacity of dual-task cognitive-exercise 
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training to improve ratings of HR-QoL or well-being. Given the ability of functional 
exercise and power training to improve functional outcomes in older adults (Byrne et 
al. 2016), a combination of these training types within a dual-task setting may be an 
effective strategy for the enhancement of HR-QoL, through the fostering of 
perceptions of autonomy and a sense of achievement from such functional 
improvement.  
 
The mechanisms underpinning the improvements in cognition following dual-task 
exercise training are currently unclear, but may relate to the induction of neurological 
growth factors such as brain derived neurotrophic factor (BDNF) and insulin-like 
growth factor (IGF-1) (Cotman, Berchtold & Christie 2007), and/or the attenuation of 
low-grade systemic inflammation (Beavers, Brinkley & Nicklas 2010). The response 
of these inflammatory and neurological markers to long-term exercise training in older 
adults has been inconsistently reported, and there is limited evidence that interventions 
≥12 weeks incorporating aerobic training and/or PRT can significantly increase levels 
of BDNF or IGF-1 (Cassilhas et al. 2007; Nascimento et al. 2015; Vaughan et al. 
2014). Similarly, structured physical exercise has been shown to have some 
effectiveness in improving the inflammatory profile of older adults across a number of 
reviews (Beavers, Brinkley & Nicklas 2010; Woods et al. 2012), however the optimal 
training type and dose remains unclear. By comparison, few studies have evaluated the 
effect of power training (Hvid et al. 2017; Valls et al. 2014), functional exercise 
training (Nishida et al. 2015) or combined cognitive-exercise training (Anderson-
Hanley et al. 2012; Rahe et al. 2015a), on inflammatory and neurological markers, 
reporting mixed effects. Furthermore, limited evidence suggests that the response of 
neurological markers to exercise may be regulated by genetic factors, such as the 
possession of the Met allele of the BDNF gene (Miyajima et al. 2008; Raz et al. 2009), 
and the ε4 variant of the APOE gene (Etnier et al. 2007; Kuller et al. 1998), which may 
impair cognition in older adults.  
 
Therefore, further evaluation is required to determine if a dual-task training program 
can improve circulating levels of neurological and inflammatory markers, and whether 
beneficial changes in these levels may underlie the cognitive improvements observed 
following dual-task training, and also relate to a greater sense of well-being and HR-
QoL in older adults (Duman & Monteggia 2006). This may provide a greater 
understanding of the determinants of cognitive health and well-being in older adults, 
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extend the evidence regarding the cognitive benefits available from dual-task exercise, 
and reveal whether this multi-pronged approach can prolong functional independence 
in independently living adults at risk of falls.
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3. Chapter 3:  
This chapter presents a detailed summary of the general methods used for the 26-
week dual-task functional power training intervention that was part of the larger 
18-month cluster RCT, of which some of the methods have been previously 
reported (Daly et al. 2015), and the justification for the methods and materials 
used. The methods and statistical analyses pertaining to each separate study are 
also presented in the methods section for each study. 
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3.1 Methods  
The following chapter will outline the general research design, recruitment strategies, 
participant inclusion/exclusion criteria and methodology to investigate the effects of 
the intervention on cognitive function, HR-QoL and inflammatory and neurological 
markers in older adults. In each subsequent results chapter, a brief overview related to 
the methodology will be presented. This research was part of a larger 18-month 
NHMRC funded community-based cluster RCT in which the primary aim was to 
investigate the effects of dual-task functional power training (DT-FPT) on fall rates in 
older adults residing in independent living retirement villages. This study was referred 
to as the Physical and Cognitive Exercise Intervention Trial (PACE-IT). Due to the 
larger aims of the project in determining the cost-benefit of implementing a program 
in the general community, a 2 x 2 factorial design including a single cognitive training 
group and a FPT-only group was not considered to address the aims of this thesis. In 
this chapter, detailed procedures and justifications will be given for all outcome 
measurements pertaining to the aims of this thesis.  
  
3.2 Study design 
This was a 26-week clustered RCT whereby independent living retirement villages 
with residents (men and women) aged 65 years and over were randomised to either a 
supervised dual-task functional power training (DT-FPT) program or a usual care 
(control) group. Baseline and 26-week functional assessments were conducted to 
assess measures of cognitive function, inflammation, HR-QoL and well-being. The 
study was managed by the Institute for Physical Activity and Nutrition Research from 
the Burwood campus of Deakin University (Melbourne, Victoria, Australia). 
 
3.3 Participants 
3.3.1 Recruitment 
Village recruitment 
Participants were recruited from independent living retirement villages in the greater 
metropolitan region of Melbourne and regional areas of Victoria. A list of potential 
village operators was sourced via internet based searches of ‘Yellow Pages’, 
‘Retirement Living Online’, ‘Health and Aged Assist’, and ‘Age Care Guide’, and 
included in an Excel database. Retirement communities from this database were 
excluded if they were not independent living. An initial search of villages within a 25 
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km radius of Deakin University (Burwood) revealed that there were 117 potential 
villages. Potential village operators were contacted via phone and email to determine 
their interest, and meetings were held with the operations manager to determine their 
level of interest and assess the feasibility and eligibility of the communities. Following 
operation management meetings, individual letters were sent to all village managers 
within the selected communities inviting them to become a host retirement village for 
the study. For villages who expressed interest and were deemed suitable for the 
intervention, participant recruitment progressed according to the steps outlined below.   
 
To be deemed eligible for inclusion in the study, villages had to fulfil several criteria 
including a suitable venue and availability to host an exercise program twice a week if 
randomised to the exercise intervention group, availability and space for researchers 
to carry out 26-weekly functional testing, independently living residents, and at least 
six residents expressing interest and meeting eligibility criteria. In total, 22 villages 
were recruited to accommodate 300 participants, in three cohorts over a 14-month 
period. This was greater than the number anticipated based on the findings from a 
previous 4-month study conducted at Deakin University, whereby 100 elderly women 
residing in retirement villages were recruited in a rolling recruitment  (Daly et al. 
2014). Based on this research it was estimated that ~7-8 villages (a total of 14 to 16 
villages over two years) would be required to accommodate 140 participants for each 
cohort. For this study, 57 retirement communities were approached, 28 accepted and 
22 were eligible to participate (Table 3.1). The 28 villages recruited were within a one 
to 164 km radius of Deakin University Burwood. Villages recruited into the study had 
resident populations ranging from 60 to 350 (Table 3.2). Six villages were excluded 
due to a low number of eligible participants (<6), lack of a suitable venue to conduct 
the training and/or an ability to host the research twice a week if they were randomised 
as an exercise village. Thus, 22 villages were eligible for randomization.  
 
Table 3.1: Overview of village recruitment for each of the three cohorts.  
 Cohorts (n)  
 #1 #2 #3 Total 
Village Operators Approached 3 1 8 12 
Village Operators Accepted 3 1 4 8 
Villages Invited 26 6 25 57 
Villages Recruited 12 6 10 28 
Villages Eligible 8 6 8 22 
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Table 3.2: Overview of the number of expressions of interest (EOI) sent and received 
from each village within each cohort that were included in the trial, and the number 
(and proportion) of participants randomized within each village. 
  
Retirement 
Village ID 
Number  
EOI sent 
Number EOI 
received (%) 
Randomised,        
n (% EOI received) 
1 70 21 (30) 12 (57) 
2 155 35 (23) 11 (31) 
3 60 15 (25) 12 (80) 
4 65 14 (22) 11 (79) 
5 80 12 (15) 7 (58) 
6 170 16 (9) 8 (50) 
7 126 24 (19) 16 (67) 
8 156 14 (9) 5 (36) 
Subtotal 882 151 (17) 82 (54) 
9 262 25 (10) 17(6) 
10 79 12 (15) 10 (13) 
11 139 25 (18) 14 (10) 
12 198 35 (18) 23 (12) 
13 310 33 (11) 19 (6) 
14 277 50 (18) 21 (8) 
Subtotal 1265 180 (14) 104 (58) 
15 120 22 (18) 15 (13) 
16 169 13 (8) 12 (7) 
17 144 19 (8) 16 (11) 
18 134 14 (10) 8 (6) 
19 196 19 (10) 15 (10) 
20 154 27 (18) 21 (14) 
21 120 16 (13) 12 (10) 
22 350 27 (8) 15 (4) 
Subtotal 1387 157 (11) 114 (73) 
Total 3534 488 (14) 300 (8) 
NB: The number of EOI sent and received does not include data from the six villages that were excluded 
for not meeting the study requirements (EOI sent, n=413; EOI received, n=29). 
 
3.3.2 Screening and eligibility criteria 
Participants who expressed interest were initially screened by a telephone 
questionnaire, and eligibility as highlighted in Table 3.3, was based on the following 
criteria: male or female aged 65 years and over, scoring ≥3 on a defined criteria for an 
increased risk of falls (an algorithm adapted from identified risk factors for falls) 
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(Sanders et al. 2009) (Table 3.4), and scoring no more than two errors on the Short 
Portable Mental Screening Questionnaire (SPMSQ) to exclude cognitive impairment 
(Appendix A). In addition, all eligible participants were further screened with the 
Exercise and Sports Science Australia (ESSA) exercise screening tool (Appendix B) 
to evaluate any contraindicated medical conditions to exercise. Participants answering 
‘Yes’ on this questionnaire were required to obtain medical clearance from their 
physician prior to participating in this intervention. 
 
Participants were ineligible based on the following criteria: 1) current or prior 
participation in physical activity exceeding 150 minutes of moderate to vigorous 
activity per week/ or participation in a structured progressive resistance training (PRT) 
or balance program more than once per week in the past 3 months; 2) musculoskeletal 
or neurological diseases that may limit training, and 3) unstable cardiovascular or 
respiratory disorders, along with others outlined in Table 3.3. All physicians of eligible 
participants received a letter informing them of the study and that their patient was 
taking part. Informed consent was attained prior to commencement of testing. 
 
Participant recruitment from within villages 
Three hundred participants aged between 65 and 96 years (mean age ± SD, 77.4 ± 6.8 
years) at increased risk of falling were recruited following a rolling recruitment 
strategy which occurred over three cohorts over 14 months from February 2014 to 
April 2015 (cohort 1: February 2014 – April 2014; cohort 2 April 2014 –September 
2014; cohort 3: October 2014 – April 2015). A study flow diagram illustrating the 
overall number of villages and participants through the 26-week intervention is 
presented in Figure 3.1. Overall, 3947 expressions of interest (EOI) were sent to 
residents in 28 villages, with 517 returned. However, within the 22 villages that were 
deemed eligible for the study, 3534 EOI were distributed with 488 (13.8%) returned 
(Table 3.2). The methods and number of villages and participants recruited for each 
cohort are discussed in detail in the next section.  
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Table 3.3: PACE-IT trial inclusion and exclusion criteria. 
Eligibility Criteria Ineligibility / Exclusion Criteria 
 Men and women 65 years 
or older living 
independently in a 
retirement village 
 Current or prior participation in progressive 
resistance training or a balance study/ program 
(more than once a week) in the past 3 months 
 Must score ≥ 3 points on 
the defined criteria for 
increased risk of falling 
 Current or prior participation in moderate-
vigorous intensity physical activity ≥150 
minutes/week for longer than three months 
 Must score no more than 2 
errors on the Short 
Portable Mental Screening 
Questionnaire (SPMSQ) 
 Musculoskeletal or neurological diseases 
disrupting voluntary movement or that might 
limit training 
 Must be able to walk at 
least 50 meters unaided or 
with assistive device 
 Upper or lower extremity fracture in the past 3 
months 
 Must speak English 
proficiently 
 Acute or terminal illness likely to compromise 
exercise participation 
 
 Unstable or ongoing cardiovascular or 
respiratory disorders 
 
 Severe orthopaedic, cardiovascular or 
respiratory conditions precluding participation 
in an exercise program or those with absolute 
contraindications to exercise according to the 
ESSA guidelines 
  Travelling for longer than 6 weeks during the proposed course of intervention  
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Table 3.4: Falls questionnaire used to determine eligibility for study.   
Risk Factor Guidelines Score (circle) 
History of Falling 1 Self-reported risk of falling (1 or more falls in 
past year) refer to definition in the footnote 1 
3 
Age  >75 years 
70-75 years  
2 
1 
Low trauma fracture2 or 
osteoporosis 
Since age of 50 years (T-score < -2.5 SD at 
hip/spine) 
2 
Difficulty when rising 
from a chair or toilet 
without using arms 
When getting up from a chair or the toilet do you 
use your arms  
2 
History of slipping or 
tripping 
Have you had a slip or trip in the past year 2 
Medication use How many medications are you currently taking? 
If four or more include as two points 
2 
Use of walking aid  2 
One psychoactive drug Do you take any medications to treat anxiety, 
panic attacks, insomnia seizures 
1 
On feet < 4 hours per 
day 
Are you on your feet < 4 hours a day 1 
Multi-focal glasses Do you wear multi-focal glasses 1 
Poor vision (e.g. 
cataract, glaucoma) 
Self-reported or assessed by primary care 
physician do you have cataract or glaucoma 
1 
When walking  Do you ever have trouble walking or feel 
unsteady on your feet? 
1 
Self-rated health as fair 
or worse compared to 
last year 
(excellent/good/fair/poor/very poor)…… If poor 
or very poor 1 point 
1 
Thinness BMI <20 1 
High risk of low 
vitamin D  
 
In Summer “Do you spend < 10 minutes per day 
outdoors (with part of your body exposed to 
sunlight), without taking vitamin D supplements 
between the hours of 10 to 3pm” 
                           OR 
In Winter  “Do you spend < 30 minutes per day 
outdoors (with part of your body exposed to 
sunlight), without taking vitamin D supplements”   
 
 
 
1 
Total Score (Include if score ≥ 3):  
1A fall is defined as an event that results in unintentionally coming to rest on the ground or a lower 
surface, other than as a consequence of a sudden onset of paralysis, epileptic seizure, or overwhelming 
external force. 2 A low trauma fracture is defined as a fragility fracture of the spine, hip or wrist.  
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Figure 3.1: Study flow diagram of villages and participants over the 26-week 
intervention. 
 
Cohort 1 
Three village operators were recruited during Cohort 1, from which 26 villages were 
invited to participate, with 12 villages expressing interest in being involved in the trial. 
Due to eligibility requirements whereby a village had to contain at least six eligible 
participants, and possess a suitable venue with the ability to host the research twice a 
week if they were randomised as an exercise village, eight villages were deemed 
eligible. Village managers expressing interest were sent information packets to 
distribute to residents, which contained a letter of invitation to become involved in the 
study, EOI forms, a self-addressed envelope, and Plain Language Statement (PLS) 
outlining the objectives of the study (Appendix C). Posters and newsletter 
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advertisements promoting the study were provided to managers and information 
sessions were also conducted on-site throughout all recruitment campaigns. Research 
staff collected EOIs from interested residents in person at information sessions, or via 
post in all cohorts. All participant details were recorded on a password protected 
tracking database using Microsoft Excel. In total, 1150 EOI were sent out to 12 villages 
from which 176 were returned, which represents a response rate of 15.3%. Twenty-
one participants did not provide consent for telephone screening and so 155 
participants were screened for eligibility (via the process detailed in section 3.3.2). 
Overall 137 participants met the inclusion criteria after telephone screening, with 82 
providing consent and completing baseline testing. Of the 55 eligible participants that 
did not join the study, the reasons were health issues (n=9), did not provide consent 
(n=28), GP did not support participation (n=3), and resided at an ineligible village 
(n=15). 
 
Cohort 2 
Only one village operator was engaged in Cohort 2, from which six villages were 
recruited into the study. A previous study found that targeted mail-outs can account 
for up to 70% of recruitment (Sanders et al. 2009), therefore individually addressed 
information packets were couriered to managers at each community, who then hand 
delivered these individually addressed packets to their residents. These packets 
contained the same information as detailed above, along with a consent form, and 
promotional materials for a pre-arranged information session. Information sessions at 
each village were accompanied by a free assessment of muscle function (e.g., muscle 
strength, mobility and body composition) to any resident aged 65 years and over 
(n=123). In total, 1265 EOI were delivered and 180 were returned, a response rate of 
14.2%. From these, 156 older adults were screened for eligibility and 123 met our 
inclusion criteria, with 104 completing baseline testing. Of the 19 eligible participants 
that did not join the study, the main reasons were health issues (n=3), GP did not 
support participation (n=2), no consent given (n=11) and were not able to attend testing 
(n=3). 
 
Cohort 3 
Eight village operators were approached for Cohort 3, and four were recruited. Generic 
information packets containing the information listed above were hand delivered to 
residents’ mailboxes by the research staff. Information sessions were also held at each 
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village, typically during the resident’s meeting to provide a captive audience. From 
these operators, 25 villages were invited to participate, and 10 villages expressed 
interested. Due to eligibility requirements, 8 of these villages were eligible for 
participation in the study. In total, 1532 EOI were sent out to 12 villages, and 161 were 
returned, a response rate of 10.5%. From these, 156 residents were screened with 138 
meeting our inclusion criteria after telephone screening, and 114 participants from the 
eligible villages underwent baseline testing. Of the 24 eligible participants that did not 
join the study, the reasons were health issues (n=4), GP not supporting participation 
(n=1), no consent given (n=16), and resident at an ineligible village (n=3). 
 
3.4 Randomisation 
Randomisation was performed by cluster based on the retirement village to avoid 
potential contamination and facilitate logistical arrangement. Each village was given 
an ID number and group assignment by blocks of two, and randomisation was stratified 
by village size (<75 or ≥75 residents) using computer-generated random numbers 
(Microsoft Excel), by a researcher not involved in the study. In all, there were 22 
clusters, 11 were randomised to the intervention and 11 randomised to the usual care 
group, with each cluster comprised of at least five eligible participants. The goal was 
to have at least six participants in each cluster, however at one village three participants 
dropped out of the study on the day of baseline testing due to illness, leaving a cluster 
size of five.  
 
3.5 Allocation, concealment and blinding 
Allocation of the retirement villages to the intervention or usual care group occurred 
only after the participants had completed baseline testing. The retirement villages, 
residents and the research staff undertaking baseline testing were blinded to the 
allocation until this point.  For pragmatic reasons not all research staff were blinded in 
this study so as to facilitate their necessary involvement in scheduling baseline and 
follow-up testing sessions and their frequent communication with enrolled 
participants. To minimize any potential bias in functional testing, the unblinded 
researcher conducted cognitive testing and administered adverse events 
questionnaires. However, the majority of the research staff undertaking baseline and 
follow-up assessments, and the statistical analysis, were blinded to the treatment 
allocation of the retirement villages.  
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3.6 Intervention 
Dual-task functional power training 
The dual-task functional power training program was an evidence-based 
multicomponent exercise program which primarily targeted the larger muscle groups 
of the lower limb to increase muscle power and mobility to reduce the risk of falls in 
older adults (Byrne et al. 2016; Gianoudis et al. 2014; Trombetti et al. 2011; Yamada 
et al. 2011). The program incorporated a combination of high-velocity progressive 
resistance training (also known as power training) combined with a range of functional 
balance/mobility activities to optimise muscle function, mobility and core stability. 
The unique feature of this program was the addition of a range of secondary attention-
demanding tasks (motor and cognitive dual-task activities), which were incorporated 
into the exercise program to optimise dual-task performance.  
 
Participants residing in the retirement villages allocated to the dual task functional 
power training program (DT-FPT) trained twice a week on non-consecutive days, for 
26 weeks. Each session was supervised and conducted on-site at each retirement 
village in small groups (5-10 per group), and designed to be completed within 45 to 
60 minutes. This approach aimed to provide greater access and opportunities for 
independently living older adults to participate in this program, whilst allowing for 
independent programming and safety considerations. This approach has previously 
been successful, where compliance with a similar PRT program averaged 74% (Torres 
et al. 2017). Similarly, twice a week training has been shown to be as effective as 
training three days per week in terms of the strength gains and neuromuscular 
improvements (Taaffe et al. 1999). Previous research has also shown that an exercise 
intervention length of 26 weeks is adequate to detect gain in muscle mass, strength and 
function and modifications to inflammatory cytokines, neurological markers, 
cognition, and well-being scores (Cassilhas et al. 2007; Chang et al. 2012; Katula, 
Rejeski & Marsh 2008; Liu‐Ambrose et al. 2008; Nascimento et al. 2014).  
 
All training was implemented and supervised by Accredited Exercise Physiologists 
(AEPs) or experienced Certificate III and IV personal trainers, who were sourced 
through advertisements placed on the ESSA website or referrals, and interviewed by 
the project manager for their suitability. Trainers attended one-on-one training 
workshops which explained the rationale behind the PACE-IT study, and provided 
details of how to appropriately implement and progress the exercises and the dual task 
Chapter 3 
123 
 
activity, as well as issues related to safety. Monthly meetings were also conducted with 
the trainers either in-person or via teleconference, to discuss any issues or feedback 
regarding the training program, while emails and telephone conversations occurred on 
a weekly basis. All trainers were provided with a detailed instructor’s manual 
containing all the necessary information to deliver the intervention. This folder 
included documents describing the phases of the intervention, pictorial examples of 
specific exercises for use within the program, and example programs and progressions, 
to aid with their exercise prescription. All programs were designed and modified at the 
trainer’s discretion. Furthermore, all trainers received folders for each of the 
participants within their group, which included an information booklet, exercise cards, 
participants’ personal details including any relevant medical conditions, their doctor’s 
signed consent form and exercise tolerance test results where applicable, and the 
participant’s results from the baseline functional testing sessions, to provide an 
indication of the individual’s functional ability to assist in appropriate exercise 
prescription for their program. Participants individually documented the number of 
sets and repetitions completed, along with their Rating of Perceived Exertion (RPE) 
using the Borg 0-10 point scale, for each exercise on their personal exercise cards, 
which were checked by the trainers after each session (Appendix D). Exercise cards 
were collected by the trainers every four weeks during the intervention, and returned 
to the research staff for review and data entry. Trainers were instructed to document 
any injuries or adverse events on the back of the exercise cards and to complete an 
adverse events questionnaire which was immediately returned to the project co-
ordinator. All trainers were responsible for maintaining a high level of motivation and 
ensuring that the correct movement speeds were achieved. 
 
To ensure consistency amongst exercise program facilitators, and the delivery of the 
intervention between different training sites, a member of the research staff (an AEP) 
acted as a trainer at several of the villages and also had a specific role as a liaison 
between the project manager and PhD candidate coordinating the trial, and the external 
trainers and village managers. This role involved fortnightly site visits to monitor the 
consistency and quality of delivery of the DT-FPT program at all retirement villages. 
The researcher (clinical AEP) was also responsible for monitoring and influencing 
participant attendance levels, which was achieved via telephone and in person. This 
included discussing any issues related to absenteeism, and where appropriate, 
strategies to overcome barriers and reinforce enabling or motivational factors.   
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3.6.1 Structure of the exercise sessions  
Each training session lasted approximately 45-60 minutes and was divided into four 
components; 1) a 5-10 minute warm-up consisting of rhythmic and range of motion 
exercises targeting major muscle groups and joints such as marching and dynamic 
stretching, 2) 2-3 challenging balance and mobility exercises which simulated 
common daily functional tasks such as avoiding and stepping over obstacles, weight-
shifts and leaning to reach objects, 3) high-velocity functional power training 
consisting of 5-6 lower leg exercises, 1 supplementary exercise (for the upper limbs), 
and 1 core stability/postural exercises, and 4) a 5-10 minute cool-down. All programs 
were individually tailored to the functional capabilities of the participant and 
progressed according to the participant’s improvement and their self-rating on the 10- 
point Borg RPE scale (Borg 1982).  
  
Challenging Balance and Mobility Training 
(Prescription: 2-3 exercises; 2 sets of 10-50 repetitions, progressing to 50 repetitions 
or a length of 30 seconds for certain exercises)   
Challenging balance and mobility training exercises included a range of multi-
directional rapid stepping exercises, marching, standing functional balance exercises 
and seated centre of gravity-based exercise (Table 3.5). Particular emphasis was placed 
on training the lower limb muscles (ankle dorsi- and plantar flexors, knee flexors and 
extensors, hip abductors, adductors and extensors) that are associated with balance and 
mobility. Exercises were progressed through a gradual reduction in the base of support, 
dynamic movements that perturbed the centre of gravity, reducing sensory input, 
introducing different environmental hazards to negotiate, and introducing a more 
complex skill and/or a secondary task.  
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Table 3.5: Examples of some of the balance and mobility exercises and progressions used throughout the study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Activity Exercises   Progressions 
 
Seated Centre 
of Gravity 
Exercises 
Seated balance on chairs 
with Dura Disc/Swiss 
Ball 
 • With feet shoulder width apart the participant should 
maintain an upright seated position for 30 seconds with 
eyes open fixed to a spot such as a door.  
• Repeat the position with eyes closed. 
• Repeat the exercise with the arm(s) placed in a more 
difficult position such as positioned away from the body to 
the side/front/diagonal to the body.  
 
Seated balance with 
voluntary trunk lean 
 • Lean the trunk forward/ backwards/ diagonal. Lean from 
the hips until the nose is above the knees, lean back to 
extend the back. 
• Progress by adding an unstable surface under the feet such 
as foam. 
Seated balance with 
voluntary leg movement 
 • Heel/Toe Lifts: perform continuous heel/toe lifts with both 
feet simultaneously/alternating.  
• Perform double and single heel/toe lifts to a verbal cue 
(double, single). 
• Ankle Circles: lift one foot slightly off the floor and circle 
the ankle in a clockwise and anticlockwise direction. 
Change legs. 
• Single Leg Raises: Extend leg out until it is close to 
horizontal to the floor. Hold for the count of three and 
repeat on the other leg.  
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**NB: Many of the balance and stability exercises can progress to a secondary task or already had one built into the activity that was functionally related 
 
 
Standing/ 
Functional 
Balance 
Exercises 
 
 
 
 
 
 
 
 
 
 
 
Standing/ 
Functional 
Balance 
Exercises 
 
Standing balance  • Standing feet apart. 
• Together. 
• Tandem. 
• Single Leg Stance. 
• Change the surface. 
• Progress to walking  
Ball kicking 
 
 
 
 
 
 
 •  Participant kicks a ball against a wall or to a partner. 
•  Alternate the leg used to kick the ball 
•  Reduce the size of the ball 
 
 
 
 
 
 
Gait variation  
obstacle courses 
 • Gait variation relay course can occur in a number of 
different ways such as tandem walking, sideways crossover 
stepping. 
• These can be progressed by changing the surface of the 
walk e.g., tandem walk on a half foam roller.  
• Once the above gait patterns have been mastered an 
obstacle course can be set up. To increase the difficulty of 
the task, change the task or environmental demands by: 
 Increasing the number of obstacles to negotiate 
 Introduce an object to be carried 
 Require the participant to perform a task after stepping 
onto each piece of equipment in the obstacle course 
(i.e. marching in place 10 times on foam pad, perform 
swing through steps on bench, balance for ten seconds 
on half foam roller with eyes closed 
 Require the retrieval of objects 
 Require the course to be completed in a specific time 
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High Velocity Functional Power Training 
(Prescription: 5-6 lower limbs exercise, 1 supplementary and 1 core exercise); 2 sets, 
10-15 repetitions)  
For each high-velocity exercise, participants were instructed to perform all repetitions 
as quickly as possible during the concentric (shortening) phase, with the eccentric 
(lengthening) phase controlled over 3-4 seconds. Exercises were progressed by 
increasing the resistance or changing to a more complex exercise. The core lower 
extremity exercises were functionally relevant and included squats, hip abduction, hip 
extension and ankle plantar- and dorsiflexion exercises. Training loads were 
manipulated through weighted vests, therabands, hand held weights and ankle weights.  
 
Participants were instructed to perform the exercises at a self-reported intensity of 4 to 
6 (moderate to hard) on the 10-point Borg RPE scale, and increase the load as tolerated.  
In addition to the high-velocity lower limb exercises, at least one core stability/postural 
exercise was prescribed per session, along with at least one supplementary resistance 
training exercise targeting the shoulders, chest, upper arms or abdominals. Examples 
of some of the exercises used throughout the study are shown in Table 3.6 to 3.8.  
 
Dual-task training component 
(Prescription: Visual, cognitive, motor task or a combination of these secondary tasks 
with the resistance and balance exercise) 
A fundamental aspect of the exercise program was the incorporation of a dual-task 
training component, which was performed simultaneously with the challenging 
balance/mobility and HV-FPT exercises to mimic activities of daily living which often 
require multitasking. In our study, simultaneous dual-task training involved a 
combination of cognitive, visual, visual memory and motor tasks, which were 
presented on flash cards that could be fixed to each exercise station, or whose 
instructions were delivered verbally by trainers. 
 
 Dual-task activities were performed independently, in training pairs or during group 
exercises. Examples of cognitive activities used in the program are included in Table 
3.9, and included tasks related to verbal fluency (e.g., listing words within a category 
such as animals, vegetables, etc.). Examples of motor tasks included are also presented 
in Table 3.9, such as multi-directional stepping in time with music and catching a ball 
whilst performing exercise. Dual-task exercises (motor or cognitive tasks) were 
Chapter 3 
128 
 
progressed every four weeks, or as needed, by increasing their complexity (changing 
serial subtraction number, adding obstacles, handling objects in specific 
combinations), or by adding more secondary tasks to an exercise.   
 
Usual care control group 
The control group received their usual care from their medical practitioner and 
community services. They also received standardised falls prevention advice in the 
form of two booklets (Department of Health: ‘Don’t fall for it – falls can be prevented’, 
and ‘An active way to better health’).  
 
To minimise attrition and enhance adoption, all participants in both groups received 
tailored 3-monthly newsletters which contained project updates and educational 
content, while rewards were also offered (e.g., monthly prize for the return of falls 
calendars, competitions in newsletters). 
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Table 3.6: Examples of some of the lower leg resistance exercises and progressions 
used throughout the study. 
Muscle 
Groups Exercises Progressions 
Calf Calf raises 
(seated/stand
ing) 
 
• Seated on stability ball 
• Standing 
• Adding resistance with 
weights/vest 
• Change to unstable surface  
• Progress to a step   
Tibialis 
Anterior 
Toe Raises 
 
• Seated – Increase resistance 
band  
• Standing 
• Adding resistance with 
weights/ bands/vest 
• Changing the surface 
Plantar and 
Dorsi Flexors 
Toe Pointing 
& Flexion 
 
• Seating- Increase the 
resistance of the band 
• Progress further by 
changing the exercise to 
standing with ankle weights 
Hamstrings/ 
gluteals 
Leg Curl 
 
 
• Standing with support 
performed with no weight 
• Increase the resistance 
(ankle weight) 
• Change surface of support 
(stability foam or ball) 
Quadriceps Leg 
Extensions  
 
• Seated leg extension on a 
Swisse ball 
• Increase resistance 
Hip 
Abductors/ 
Adductors 
Hip 
Abduction/ 
adduction 
 
• Standing hip abduction/ 
adduction 
• Increase resistance using 
resistance bands. 
• Progress further by using 
ankle weights 
Hamstring, 
Quadriceps, 
gluteals 
Squats 
 
• Wall Squats 
• Wall Squats with a Swisse 
ball 
• Add resistance 
• Change the surface and base 
of support of the squat 
• Remove wall support 
• Progress to single leg squats 
 
Hamstring, 
Quadriceps, 
gluteals 
Lunges 
 
• Standing lunge 
• Add resistance 
• Change the surface of the 
lunge with a stability disc 
• Lunge onto a box 
• Walking lunges 
• Walking lunges on foam 
• Add further resistance 
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Table 3.7: Examples of some of the core stability and postural exercises and 
progressions used throughout the study. 
Muscle 
Groups 
Exercises  Progressions 
Abdominal/
core 
muscles 
Standing 
side bends 
 
 
 
 
 
Body 
Rotation/ 
Ball Lifts/ 
wood 
chopper 
 
 
• Standing side 
   bends 
• Increase resistance     
with weights or 
resistance bands 
 
• Seated on a Swisse ball, 
or standing holding a 
weighted ball; lifting the 
ball up and over the head 
• Vary the direction, 
lifting the ball side to 
side, etc. 
• Progress to standing  
• Increase resistance 
 Sit-ups / 
crunches 
• Swisse ball sit ups 
• Swisse ball rotation sit 
ups 
• Medicine ball sit ups 
• Add resistance 
Erector 
Spinae/ 
Multifidus 
Back 
Extensions 
 
• Prone back extensions 
• Increase resistance 
• Add a Swisse ball to 
change stability 
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Table 3.8: Examples of some of the supplementary resistance training exercises and 
progressions used throughout the study. 
Groups Exercises  Progressions 
Biceps 
brachii 
Biceps curl 
(single/ 
alternate) 
 
• Increase Reps 
• Increase Resistance  
• Change to a less stable 
surface 
• Progress to single leg 
Triceps Triceps 
Extensions 
 
• Increase Reps/    
resistance 
• Progress to overhead 
extensions with weights/ 
resistance bands 
• Progress further to 
triceps dips on a bench 
• Progress to unstable 
surface  
Deltoids Lateral 
Raises 
(single/ 
alternate) 
 
• Increase Reps 
• Increase Resistance 
• Progress to an unstable 
surface 
• Progress to single leg 
 Front 
Raises 
(single/ 
alternate) 
 
• Increase Reps 
• Increase Resistance 
• Progress to an unstable 
surface 
• Progress to single leg 
Rhomboids/ 
Latissimus 
Dorsi 
 
Rows 
 
• Commence standing  
• Increase Reps/ resistance 
• Progress to an unstable 
surface such as foam or 
stability ball 
• Complete with a partner 
Pectorals Wall Press/ 
Chest press 
 
• Increase Reps 
• Increase feet distance 
from the wall 
• Progress to push ups on 
knees 
• Progress to traditional 
push ups 
•  Add an unstable surface  
 such as foam or stability 
 ball 
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  Table 3.9: Examples of secondary task activities that were performed with the resistance and balance exercises throughout the study. 
 Secondary Cognitive Tasks  Secondary Cognitive Tasks 
V
i
s
u
a
l
 
T
a
s
k
s
 
  Dot Identification: 
Among a number of 
circles, identify and 
concentrate on the black 
dot while performing the 
exercise. 
 
 
 
 
 Number of Dots:  
As you perform the 
exercise, concentrate on 
the green dots. Progress 
this dual-task to 
concentrating on and 
counting the number of 
green dots. 
 
V
i
s
u
a
l
 
M
e
m
o
r
y
 
T
a
s
k
s
 
 
 Shopping List:  
As you perform the 
exercise, try to 
remember and recite 
as many of the 
objects as possible.  
 
 Maze task:            
As you perform your 
exercise, try to find 
your way through 
the maze from start 
to finish. 
 
 Memory recall:     
As you perform the 
exercise, try to 
remember all the 
items beginning with 
‘C’. Progress to 
remembering two 
syllable items 
beginning with ‘C’.  
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 Secondary Cognitive Tasks  Secondary Cognitive Tasks 
C
o
g
n
i
t
i
v
e
 
T
a
s
k
s
 
  Triangles:                     
As you perform your 
exercise, how many 
triangles can you 
identify? 
 
 The name game:  
As you perform your 
exercise how many 
names can you think of 
starting with the 
identified letters? 
 
 Anagrams:                   
As you perform your 
exercise try to solve as 
many of the anagrams as 
possible. 
 
V
i
s
u
a
l
 
C
o
g
n
i
t
i
v
e
 
T
a
s
k
s
 
  Spot the difference:   As you perform your 
exercise try to spot 
the differences 
between the two 
photos. 
 
 Find-a-word:       
As you perform your 
exercise try to find 
some of the hidden 
words in this word 
find. 
 
 
 
 Mix and match:      
As you perform your 
exercise, try to 
match one set of 
letters with another 
set in the next 
column to form a 
full word. 
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 Secondary Motor Tasks 
M
o
t
o
r
 
T
a
s
k
s
 
  In Beat to Music: 
Perform the exercise in 
time with the beat of 
music or metronome. 
E.g., this may include 
warming up to music, or 
stepping in time to a 
beat.  
 
 
 
 Manual Task:             
A simple manual task 
may include performing 
a catching or stepping 
activity with extra 
stimulus. E.g., while 
seated on the Swisse 
ball the participant 
concentrates on 
catching a weighted 
ball; during a stepping 
activity, the participant 
has to step onto 
coloured discs.  
  Secondary Manual Task: 
Combining a secondary 
body movement such as 
raising the arms out the 
front of the body or bicep 
curls while performing a 
lower body exercise.   
 
 Include a more challenging 
surface when performing 
the exercise. Once the 
participant is able to 
perform an exercise with 
ease on a solid surface 
challenge them by adding 
more complex surfaces 
(stability ball or foam mat). 
 
 
 Combination of Tasks: 
Combining a secondary 
body movement with a 
lower body exercise while 
standing on an unstable 
surface. 
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3.6.2 Structure of the dual-task functional power training program 
The 26-week program consisted of an initial 2 week phase acting as a familiarization 
period followed by 3 x 8 week blocks (mesocycles) which were each divided into 
smaller microcyles (Table 3.10).  
 
Weeks 1-2: Orientation 
The emphasis on the initial 2 weeks of training was to teach the participants the basic 
exercise training principles and the correct technique for each of the prescribed 
exercises. A particular focus of this phase was educating the participants about the 
importance of speed of movement, the key component of the high velocity functional 
training program. As a result, the intensity of training during this period was relatively 
low. 
 
Weeks 3-10: Skill-up (mesocycle #1) 
This phase of training was divided into two phases; the skill phase (weeks 3 to 6) and 
the challenge phase (weeks 7 to 10). During the skill phase, there was a focus on 
improving muscle strength and introducing a series of basic postural control strategies 
to optimise balance and mobility. The latter included exercises that focused on both 
the skill to maintain balance (voluntary control) and recover balance (automatic 
postural correction). Examples of these exercises are shown in Table 3.9. Resistance 
was also increased in individual exercises where appropriate, and secondary tasks were 
introduced if the trainer felt the participant was capable of performing them. During 
weeks 7-10, secondary motor or cognitive tasks were introduced if they had not been 
previously added to an individual’s program, and resistance was increased on 
individual exercises whilst maintaining the speed of movement. For example, a 
participant may have performed a ball squat as their functional power training exercise, 
whilst simultaneously performing a visual cognitive task (Table 3.9). Progressions 
were dependent on the participant’s functional abilities and their RPE. 
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Table 3.10: Structure of the 26-week PACE-IT training program including example functional exercises with secondary tasks. 
Mesocycles Microcycle  
Weeks Training Phase Weeks Phase Objective Balance/ mobility   High-velocity training 
 
1 to 2 
Orientation 
(Familiarization) 
 
1 to 2 Learning 
Phase 
To improve neuromuscular function, 
technique, speed of movement and safety 
during exercise.  
2 x 20 reps or 2 x 30 
seconds                           
2 x10 reps 
 
 
 
 
3 to 10 
 
 
 
Skill-up 
3 to 6 Skill 
Phase 
Introduce a series of postural control 
strategies to optimise balance and mobility, 
increase resistance and introduce simple 
secondary tasks if appropriate. 
2 x 20 reps or 2 x 30 
seconds                           
2 x 10-15 reps 
 
 
 7 to 10 Challenge 
Phase 
Introduce motor and/or cognitive tasks 
while increasing the resistance of the 
exercise and maintaining the speed of the 
movement.  
2 x 20-50 reps or 2 x 
30-60 seconds                
2 x 15 reps 
 
 
 
11 to 18 
 
 
Training Gains 
11 to 14 Skill 
Phase 
Maximise muscle power and challenge the 
systems that contribute to balance. 
2 x 30-50 reps or 2 x 
30-60 seconds         
 
2 x 10-15 reps 
 
  15 to 18 Challenge 
Phase 
To challenge the functional power and 
secondary exercises in terms of magnitude 
and complexity of movement.  
2 x 30-50 reps or 2 x 
30-60 seconds         
 
2 x 15 reps 
 
 
 
19 to 26 
 
 
Pushing the 
Envelope 
19 to 22 Skill 
Phase 
Optimize muscle power while transitioning 
to multi secondary tasks 
2 x 30-50 reps or 2 x 
60 seconds  
2 x10-15 reps 
 
  23 to 26 Challenge 
Phase 
Maintain the speed of movement and 
increase resistance and complexity of the 
exercises.  
2 x 20-30 reps or 2 x 
60 seconds  
2 x 15 reps                      
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Weeks 11-18: Training Gains (mesocycle #2) 
This phase of training was divided into two phases; the skill phase (weeks 11 to 14) 
and the challenge phase (weeks 15 to 18). During the skill phase, a focus was placed 
on maximising muscle power and challenging the multiple systems that contribute to 
balance, including the sensory (somatosensory, visual and vestibular systems) and 
motor systems (generation of body movement such as gait), in increasing skill. For 
example, a participant may have performed dynamic lunges with the leading foot on a 
dura-disc, whilst remembering a shopping list. In weeks 15-18, functional power and 
dual task exercises were progressed to become more challenging in terms of both the 
magnitude and complexity of movement and skill. For example, a participant may have 
performed partnered back rows (functional power training), while both were seated on 
a Swisse ball (secondary motor task). 
 
Weeks 19-26: Pushing the Envelope (mesocycle #3) 
This phase of training was divided into two phases; the skill phase (weeks 19 to 22) 
and the challenge phase (weeks 23 to 26). During the skill phase, training focused on 
optimising muscle power while transitioning to multi dual-task exercises to optimize 
speed of movement, functional performance and mobility, with activities specifically 
related to common tasks of daily living. In the final weeks of the intervention (weeks 
23-26), these exercises were further progressed through an increase in resistance and 
complexity. For example, participants may have performed a squat on a bosu-ball 
(functional power training) whilst performing bicep curls (secondary motor task) and 
figuring out a list of anagrams (secondary cognitive task) (Table 3.9). As a balance-
mobility example, participants may have been required to perform a tandem walk on 
a foam beam in time with music (balance and secondary motor task), whilst throwing 
a medicine ball (secondary motor task) and reciting men’s names beginning with D 
(secondary cognitive task). 
 
3.7 Outcome measures 
As already discussed, this thesis is part of a larger 18-month trial which aimed to assess 
the effectiveness of the intervention on fall rates in older adults. For this thesis the 
focus was on the first 26 weeks of the intervention. The main outcome measures for 
this thesis are cognitive function, HR-QoL and inflammatory and neurological 
markers. Other variables (covariates) of interest assessed included: anthropometry, 
BMI, body composition [total body fat-free mass (muscle mass), fat mass and 
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percentage body fat], medication usage and depressive status, lifestyle factors, muscle 
function (Timed Up and Go and choice stepping reaction time test under single and 
dual-task conditions, four square step test), functional gait under single and dual-task 
conditions, muscle strength and power (grip strength and sit to stand), and APOE and 
BDNF genetic polymorphisms. A summary of all the measures is shown in Table 3.11. 
The Deakin University research team visited enrolled retirement villages for 
assessment at baseline and 26 weeks after the commencement of the intervention. 
 
Primary Outcome Measures  
 
3.7.1 Cognitive measures 
Domains of cognitive function were assessed through the CogState computerized 
cognitive battery (CogState Ltd, Melbourne, Australia). The CogState tasks are 
designed for easy and repeated administration with minimal practice or learning effects 
(Falleti et al. 2006; Wild et al. 2008), are standardized for the Australian population, 
and do not require any strategy formation or rule learning (Falleti et al. 2006; 
Westerman et al. 2001). CogState has been validated and found to be reliable in a range 
of participant age groups and clinical populations, and can be completed successfully 
with limited computer experience making it suitable for use with older adults (Collie 
et al. 2003; Darby et al. 2014; Lim et al. 2012; Lim et al. 2013). Furthermore, CogState 
measures a wide range of core neurocognitive domains, including psychomotor speed, 
executive function, reaction time, working memory, divided attention and learning, in 
a reliable and sensitive manner (Collie et al. 2003). These measures have correlated 
well (r=0.49–0.83) with similar conventional neuropsychological measures including 
the Trail Making Test Part A and B, Rey Complex Figure Test- Delayed Recall, Brief 
Visual Memory Test, and Grooved Pegboard test (Lezak 2004; Maruff et al. 2009). In 
addition, these cognitive domains have relevance to older adults, and have been shown 
to improve following exercise, including PRT (Chang et al. 2012; Liu-Ambrose & 
Donaldson 2009). 
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 Table 3.11: PACE-IT trial outcome measures. 
 
 Variables Data Collection Method   
Primary Outcome Measures  Baseline 26 weeks 
Cognitive Function Executive Function/Visuospatial learning/Memory  Groton Maze Learning Test x x 
 Simple Reaction Time/ Processing speed Detection Task x x 
 Choice Reaction Time/ Visual attention Identification Task x x 
 Visual Learning & Memory/ Attention One Card Learning Task x x 
 Working Memory/ Attention One Back Task x x 
HR-QoL and well-being Health-Related Quality of Life SF-36 v2 x x 
 Satisfaction with Life/ Well-being Personal Well-being Index  x x 
Inflammatory markers IL-6, IL-1β, TNF-α, IL-10, IL-4, IL-8, C-reactive protein Fasted serum sample x x 
Neurological markers IGF-1, Vascular Endothelial Growth Factor (VEGF) Fasted serum sample x x 
 Brain Derived Neurotrophic Factor (BDNF) Fasted serum sample x x 
 Amyloid Beta 40 and 42 (Aβ 1-40,  Aβ 1-42) Fasted plasma sample x x 
Secondary Outcome Measures    
Well-being Depressive Status Depression Anxiety and Stress Scale x x 
Genetic polymorphisms BDNF and APOE Fasted whole blood sample x x 
Body composition Fat-free mass, fat mass and % body fat Bioelectrical Impedance (TANITA Scales) x x 
Anthropometry Height, Weight and BMI Standardised methods x x 
Muscle power Concentric power 5 second Sit to Stand x x 
Muscle strength  Grip strength Hand Dynamometer x x 
Muscle function  Mobility and Dual-task Cost  TUG and CSRT (Single and Dual-task), FSST x x 
Functional gait Gait speed and Dual-task Cost Zeno walkway (Single and Dual-task) x x 
Physical Activity  Energy Expenditure  CHAMPS Questionnaire x x 
Cognitive errors  Errors under single and dual-task conditions  TUG, CSRT, FSST x x 
Other variables of interest    
Medication usage/ medical Medication, Medical History Lifestyle Questionnaire x x 
Adverse Events Adverse Events Adverse Event Forms and Interview 3 months x 
Program Adherence Exercise adherence Exercise Cards x x 
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For all studies within this thesis, a battery of five tests were used; Groton Maze 
Learning test, Detection task, Identification task, One Card Learning task, and One 
Back task, which are adaptations of standard neuropsychological and experimental 
psychological tests. These tests are sensitive to cognitive change (Falleti et al. 2006), 
and the specific battery can be analysed collectively to provide a composite score of 
executive function, memory and processing speed/attention. The battery was presented 
on a personal PC computer, and completed under the guidance of a researcher. Prior 
to each task, a script of instructions was verbally presented to the participants, which 
was followed by a practice test for each task, which endeavoured to maximise test-
retest reliability. After the practice trial, and during the study test, no further 
instructions were given by the instructor, unless the participant was showing genuine 
signs of difficulty or asked for help. Responses were indicated using the computer 
keyboard and a mouse. The timing of tasks and collection of response data was under 
the control of the software program. A brief description of the five tests is provided 
below.  
 
Groton Maze Learning test 
The Groton Maze Learning Test (GMT) is a measure of executive function, memory 
and spatial problem solving. After completing a practice trial, participants are shown 
a 10 by 10 grid of tiles, within which is hidden a 28-step pathway. Participants are to 
logically determine the pathway that extends from one corner of the grid (start) to the 
other (end), and are then required to remember this pathway for four subsequent trials, 
through trial and error feedback. Participants are required to begin the task by clicking 
on the blue tile in the top left hand corner with the mouse or keypad (Figure 3.2.a). 
This tile then lights up with a green tick before returning to blue. Participants are then 
required to click on adjacent tiles one at a time, until they find the correct tile. If the 
next correct tile in the pathway is clicked on, a green tick will momentarily appear 
before returning to blue (Figure 3.2.b). If an incorrect tile has been selected, a red cross 
will appear (Figure 3.2.d). If an incorrect tile has been selected, participants must click 
on the last correct tile they selected and select another adjacent tile, before continuing 
along the path using the same process. Participants are asked not to double back along 
the path or select tiles that are located diagonally to a correct tile. Participants complete 
the path when they reach the tile in the bottom right hand corner of the grid, indicated 
by a red circle (Figure 3.2.a). 
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The total number of errors made in attempting to learn the same hidden pathway on 
five consecutive trials at a single session is the main performance measure. Lower 
scores on this test equate to better performances. There are 20 alternate forms for this 
task which are selected in pseudo-random order, so that a participant would not repeat 
the same maze over two testing sessions. 
 
 
 
 
 
 
Figure 3.2: Groton Maze Learning Test; clockwise from top left: a) screen shown 
at commencement of maze task highlighting the blue tile from which participants begin 
maze; b) correct tile selection which results in tile reverting to blue; c) participant 
shown completing CogState task; d) incorrect tile selection which results in a red cross 
appearing, and red concentric circles which act as the endpoint for the maze task. 
 
 
 
a b 
d c 
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Detection task 
The Detection (DET) task is a measure of simple reaction time and processing speed 
that is shown to reflect psychomotor function. In this task, a generic joker card is 
presented face down in the centre of the computer screen (Figure 3.3.a). When this 
card flips over (to reveal the joker (Figure 3.3.c), participants are required to press the 
“Yes” key (denoted as K on the keyboard) as quickly as possible. They will hear an 
error sound if they have been premature in their response (i.e. have pressed the key 
before the card has flipped over). The task ends after 35 correct trials have been 
recorded. The primary performance measure for this task is speed of performance, or 
reaction time in milliseconds (speed). The mean of reaction times for correct responses 
are used, normalized using a log10 transformation, and a lower score equates to a better 
performance. 
 
 
 
 
Figure 3.3: Detection Task; clockwise from top left: a) screen shown at 
commencement of DET task highlighting patterned back of face down card; b) 
participant shown completing CogState task; c) example of red joker card that flips up 
during DET task. 
a b 
c 
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Identification task 
The Identification (IDN) task is a measure of choice reaction time shown to measure 
visual attention. This task is similar to the Detection task, in that a playing card is 
shown face down in the centre of the screen. When the card flips over to reveal the 
picture (either a red joker or black joker shown in equivalent numbers in random 
order), the participant is required to indicate the colour of the joker (i.e. black or red) 
in response to the question “Is the card red”? (Figure 3.4). Participants are required to 
press the “Yes” key (K on the keyboard) if it is red or the “No” key (D key on the 
keyboard) if it is not red. The task ends after 30 correct responses have been recorded. 
The primary performance measure for this task is speed of performance, or reaction 
time in milliseconds (speed). The mean of reaction times for correct responses is used, 
normalized using a log10 transformation, and a lower score equates to a better 
performance.  
 
One Card Learning task 
The One Card Learning (OCL) task is a continuous visual recognition learning task 
that assesses attention, and visual recognition memory. In this task, a playing card is 
shown face down in the centre of the screen (Figure 3.3.a). When the card flips over, 
participants must indicate as quickly and accurately as possible whether or not they 
have seen that card previously in this task. This card can be any playing card except 
the jokers (as shown in Figure 3.4). If the participant has seen the card, they are 
required to press the “Yes” key (K on the keyboard), or the “No” key (D on the 
keyboard) if they have not. 
 
If the participant responds before the card has flipped over an error sound will be heard, 
and if the participant answers incorrectly, another distinct error tone will be sounded. 
In this task, six cards are randomly drawn from the deck and repeated throughout the 
task. The first response from the participant will always be ‘no’, as no previous cards 
have been presented. The primary performance measure for this task is the proportion 
of correct answers (accuracy), or the arcsine proportion correct, which results from 
normalization using an arcsine square-root transformation. Higher scores equal better 
performances. The test stops after 88 presentations. 
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Figure 3.4: Identification Task; left) example of red joker card that flips up during 
IDN task; right) example of black joker card that flips up during IDN task.
 
 
One Back Task 
The One Back (ONB) task assesses working memory and attention. A playing card is 
shown face down in the centre of the screen, and when it flips over, participants must 
decide whether the card displayed is exactly the same (same suit and same value) as 
the card presented immediately prior to that card, responding as quickly as possible. 
This card can be any playing card except the jokers (as shown in Figure 3.4). 
Participants are required to use the appropriate ‘yes’ and ‘no’ keys on the keyboard 
(Figure 3.5). If the participant incorrectly identifies the card, an error sound will be 
heard, and the first response from the participant will always be ‘no’, as no previous 
cards have been presented. The primary performance measure for this task is speed of 
performance, or reaction time in milliseconds (speed). The mean of reaction times for 
correct responses is used, normalized using a log10 transformation, and a lower score 
equates to a better performance. The test concludes after 30 correct trials. 
 
Scoring 
Performance measures from the four tasks in the CogState Brief Battery (IDN, DET, 
OCL and ONB) and the GMT were scored according to standard protocols (Lim et al. 
2012; Maruff et al. 2013). Results for a task were only included in analyses if they met 
a completion criteria specific for our age group, as listed in Table 3.12.  
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Figure 3.5: One Back task; top) schematic example of a sequence which would require 
a ‘yes’ response; and bottom) example of a sequence which would require a ‘no’ 
response.
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Table 3.12: Description of the cognitive tasks used in the CogState computerized 
test battery. 
Test name 
(Abbreviation) 
Cognitive 
domain 
Outcome 
measure 
Task Completion 
Criteria 
Groton Maze 
Learning Test 
(GMT) 
Executive function, 
memory, 
visuospatial 
learning 
Total number of 
errors  
Five complete trials 
and at least 140 
correct moves  
 
Detection Task  
(DET) 
Simple reaction 
time, speed of 
processing 
Mean of the log 10 
transformed 
reaction times for 
correct responses 
(Log10 
milliseconds) 
At least 27 
responses made  
Identification 
Task  
(IDN) 
Choice reaction 
time, visual 
attention 
Mean of the log 10 
transformed 
reaction times for 
correct responses 
(Log10 
milliseconds) 
At least 23 
responses made  
One Card 
Learning Task 
(OCL) 
Visual memory, 
attention 
Arcsine 
transformed correct 
responses/total 
responses 
At least 66 
responses made  
One Back Task  
(ONB) 
Working memory, 
attention 
Mean of the log 10 
transformed 
reaction times for 
correct responses 
(Log10 
milliseconds) 
At least 24 
responses made  
Individual raw scores for each task were transformed into a Z-score using the mean 
and standard deviation (SD) of the total sample in the study, according to the 
equations: 
 
Baseline Z-Score = [(participant score on test minus baseline group mean for test) 
divided by the baseline group SD for test] 
 
26-week Z-Score = [(participant score on the test at 26 weeks minus baseline group 
mean for test) divided by baseline group SD for test] 
 
For each participant, the Learning-Working memory composite score was then 
computed by averaging the standardized scores (Z-scores) for the OCL and ONB tasks, 
and the Psychomotor function-Attention composite score was computed by averaging 
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the standardized scores (Z-scores) for the DET and IDN tasks. The latter four tests 
comprise the CogState Brief Battery (DET, IDN, OCL, ONB) (Lim et al. 2012), which 
provides a composite measure of learning and working memory, and psychomotor 
function and attention (Fredrickson et al. 2009; Lim et al. 2012; Maruff et al. 2013). 
A composite was also constructed from the Z-scores of all five tests to measure global 
cognitive function. Higher scores on these composites indicate better performance 
(Steinberg et al. 2015). 
 
3.7.2 Health-related quality of life and well-being measures 
Short-form (SF)-36® v2™ questionnaire 
Health-related quality of life (HR-QoL) was measured with the Short Form 36® 
version 2™ (SF-36® v2™) questionnaire (Ware Jr & Sherbourne 1992). The SF-36® 
has been established as valid and reliable in both interview and survey formats 
(Benjamin‐Coleman & Alexy 1999), with high reliability (α=0.77–0.92) in people 
aged 65 years and older (Benjamin‐Coleman & Alexy 1999; Walters, Munro & Brazier 
2001). The SF-36® also demonstrates practicality as a self-completed instrument and 
in community-based surveys demonstrates reliable internal consistency and construct 
validity for people over 65 years of age (Walters, Munro & Brazier 2001). 
 
The SF-36®v2™ consists of 36 items which contribute to eight domains of HR-QoL: 
physical functioning, role limitations resulting from physical health problems, bodily 
pain, social functioning, general mental health, role limitations resulting from 
emotional problems, vitality, and general health problems (Ware Jr & Sherbourne 
1992). The extent or frequency with which participants experienced each item was 
described on either a 5 or 6-point Likert scale such as 1, ‘‘None of the time,’’ to 5, 
‘‘All of the time.’’ 
 
The domain of physical functioning (PF) examines whether or not a limitation exists 
in performance of physical activities such as shopping, dressing, or bathing. Role–
physical (RP) and role–emotional (RE) refer to the presence of problems with work or 
other daily activities as a result of physical health and mental health, respectively. The 
bodily pain (BP) component addresses whether or not the respondent was limited in 
daily activities due to pain. Social functioning (SF) items assess the impact of physical 
and emotional health on social activities and the extent of the identified problem. 
Mental health (MH) focuses on how often feelings of anxiousness, nervousness, 
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happiness, and depression were present. The vitality domain includes questions about 
energy levels (VT). The general health component (GH) describes how the 
respondent’s self-rated health compares to others, and any changes in health status 
over the past year.  
 
The SF36-v2 was used with permission from the Medical Outcomes Trust (Boston, 
MA, USA). The scores for the SF-36® are based on a 0 to 100 scale; with higher scores 
indicating a better quality of life. Scores for the eight subscales were calculated 
according to the summative method of calculating the mean of the items for each 
subscale, before being converted to Australian norm-based scores according to 
previously published guidelines (Hawthorne et al. 2007). The use of norm-based 
weights gives each domain score a mean of 50 and a standard deviation of 10, allowing 
change in scores to be assessed on a comparable scale. Basing the weights on 
Australian data (from the 2004 South Australian Health Omnibus Survey) (Hawthorne 
et al. 2007) helped to account for cultural differences between populations in the way 
in which health and QoL are viewed (Hawthorne et al. 2007). Responses from the eight 
subscales or domains were then converted into two separate overall summary scores 
representing perceived physical and mental health: the physical component summary 
(PCS) and the mental component summary (MCS) scores (Australian Bureau of 
Statistics 1995). The PCS and MCS were calculated based on a factor analysis of the 
eight domains among participants in the 2004 South Australian Health Omnibus 
Survey (Hawthorne et al. 2007). An overall composite of HR-QoL was also created 
by averaging the weighted means of the eight subdomains. 
 
Depression Anxiety and Stress Scale (DASS-21) 
The Depression Anxiety and Stress Scale (DASS)-21 is a short-form of the DASS 
(Lovibond & Lovibond 1995), and is a 21-item self-report measure and was used to 
assess the severity of depression, anxiety and stress in an individual (Henry & 
Crawford 2005). The DASS-21 has high reliability (α=0.93), exhibits high convergent 
validity with other measures of anxiety and depression (Henry & Crawford 2005), and 
good discriminative and construct validity (Antony et al. 1998). The scale has been 
extensively validated (Crawford & Henry 2003) and is suitable for use with a non-
clinical and older sample (Simpson et al. 2006). Excellent internal consistencies for 
the three subscales have also been reported (Crawford & Henry 2003). The DASS- 21 
takes less time to complete than the DASS, which reduces participant burden, and can 
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be used in lieu in of multiple scales (Gloster et al. 2008), but is not meant to act as a 
diagnostic tool for anxiety or depression. Each factor is measured by seven items 
whereby participants rate the extent to which they experienced the symptoms 
described in that item over the past week on a 4-point Likert scale from 0, ‘‘Did not 
apply to me at all,’’ to 3, ‘‘Applied to me very much or most of the time’’. Scores 
range from 0 to 21 on each subscale, which are graded to different severities of anxiety, 
depression and stress (Paukert et al. 2010). The sum of each subscale was used as a 
covariate in assessing QoL outcomes.   
 
Personal Well-being Index Scale and Satisfaction with Life as a Whole Scale 
The Personal Wellbeing Index (PWI) scale (Cummins et al. 2003) is an indicator of 
personal well-being that assesses satisfaction with life (SWL) as a whole as well as 
eight items of satisfaction.  Each item corresponds to a QoL domain such as standard 
of living, achievement in life, personal health, personal relationship, personal safety, 
community-connectedness, future security and spirituality/religion. SWL is measured 
as a single-item question that asks ‘How satisfied are you with your life as a whole’ (0 
= Very Dissatisfied; 5 = Neutral; 10 = Very Satisfied). The PWI also generates a 
composite variable, calculated by averaging satisfaction scores from the eight 
satisfaction domains, and gives an overall perspective of an individual’s satisfaction 
with life.  
 
Extensive psychometric analyses have shown the PWI to be a valid, reliable and 
sensitive instrument within the Australian population (Cummins et al. 2003). The 
index has demonstrated excellent stability over time, with the adult version reporting 
good internal reliability (Cronbach’s α between 0.70 and 0.85), and good test-retest 
reliability across a 1-2 week interval with an intra-class correlation coefficient of 0.84 
(Lau, Cummins & McPherson 2005). A correlation of 0.78 with the Satisfaction with 
Life Scale (Diener et al. 1985) has been reported (International Wellbeing Group 
2006). As the PWI has not yet been utilised in an exercise intervention trial, this 
represented a unique opportunity to determine its effectiveness in detecting changes in 
life satisfaction following a long-term exercise intervention. The mean SWL value of 
74.48, generated by the PWI across previous Australian surveys, is consistent with the 
‘gold standard’ value of 75.0 for Western populations determined by Cummins 
(Cummins 1995, 1998). 
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3.7.3 Inflammatory, neurological and hormonal markers 
Blood samples were obtained at baseline and 26 weeks by a trained nurse at each 
retirement village, or a local pathology clinic if participants were unavailable on the 
date of collection.  Fasting venous blood samples were drawn between 8-10 am, and 
collected in 8.0-mL anticoagulant-free vacutainer tubes (Becton Dickinson, Franklin 
Lakes, NJ, USA) for sera analyses, and 6.0 mL anticoagulant 
ethylenediaminetetraacetic acid (K2EDTA) tubes (Becton Dickinson, Franklin Lakes, 
NJ, USA) for plasma analysis. Samples were transported to Deakin University, 
Burwood, in a portable cooler at approximately 4oC, before being spun for 10 minutes 
at 3000 revolutions per minute in a refrigerated centrifuge (4oC). Serum was then 
aliquoted into 2 ml ‘O’ ring storage tubes (Anachem, Luton, Bedfordshire, UK), and 
kept at -80oC before analysis in batches. 
 
All inflammatory and neurological markers were analysed off-site at Cardinal Bio-
Research (New Farm, QLD, Australia), with the exception of serum IGF-1 and high 
sensitive CRP, which were analysed at Royal Melbourne Hospital (Parkville, Victoria, 
Australia). All samples were analysed in duplicate, and to reduce inter-assay variation 
a batch analysis was performed, with baseline and 26-week samples from each village 
analysed together.  
 
Serum IL-4, IL-6, IL-1β, IL-8, TNF-α and IL-10 were measured using the Milliplex T 
Cell high-sensitivity human cytokine panel (Merck Millipore, Australia) as per 
manufacturers’ recommendations. All analyses recorded an intra-assay % coefficient 
of variation (%CV) of <11% and an inter-assay %CV of <16%. High sensitive CRP 
was quantified by Latex immunoassay (CRP Vario CRP16, Abbott Diagnostics, USA, 
ARCHITECT c8000) according to manufacturer’s instructions, and its inter-assay 
%CV ranged from 2.50 to 5.03 %. Inflammatory markers falling below the detection 
threshold were assigned the value for the assay’s lowest detectable limit (all pg/mL, 
IL-4: 1.0; IL-6: 0.36; IL-1β: 0.1; IL-8: 0.06; TNF-α: 0.07; IL-10: 0.4). 
 
Serum concentrations of BDNF and VEGF were determined by enzyme-linked 
immunosorbent assay (ELISA) using a commercially available ELISA set (Duo Kit 
ELISA; R & D Systems, Minneapolis, MN, USA) as per manufacturer’s instructions. 
Serum IGF-1 concentrations were determined by a chemiluminescence immunoassay 
method using a Liaison IGF-1 reagent (DiaSorin S.p.A., Italy) and Liaison XL 
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analyser. The detection limit for IGF-1 by this method was 3 ng/mL and the inter-assay 
%CV ranged from 0.89 to 2.30 %. Plasma levels of Aβ 1-40 & Aβ 1-42 were measured 
by the assay for plasma INNO-BIA Aβ forms (Fujirebio, Europe) following 
manufacturer’s instructions. Biomarker concentrations falling below the detection 
threshold were assigned the value for the assay’s lowest detectable limit (Aβ 1-40: 
0.17 pg/mL; Aβ 1-42: 1.0 pg/mL).  
 
The single nucleotide polymorphisms were genotyped as described by manufacturer 
(Agena Bioscience, San Diego, USA) for BDNF (rs6265), APoE-ε3 (rs7412) and 
APoE-ε4 (rs429358) using matrix-assisted laser desorption/ionization time-of-flight 
mass spectroscopy (MALDI-TOF MS). Assays for polymerase chain reaction (PCR) 
and extension reactions were designed with the MassARRAY Assay Design 4.0 
software (Agena Bioscience).  The initial PCR step involved 45 cycles with an 
annealing temperature of 56◦C. The PCR products were treated with shrimp alkaline 
phosphatase for 15 minute at 37oC and denatured at 85oC for 5 minutes. The final 
iPLEX extension step involved 40 cycles of lots of 5 cycles between 52oC and 85oC. 
The resulting iPLEX extension products were desalted using SpectroCLEAN resin 
(SEQUENOM, San Diego, USA), then spotted on SpectroCHIPs GenII 
(SEQUENOM, San Diego, USA) and analysed with the MassARRAY Analyser 
Compact MALDI-TOF MS (Agena Bioscience, San Diego, USA). 
 
Secondary Outcome Measures  
3.7.4 Anthropometry and body composition 
Height was measured to the nearest 0.1 cm with a portable stadiometer (Surgical and 
Medical PE87), without shoes and with minimal clothing. Body weight and body 
composition were assessed using a whole body Bioelectrical Impedance (BIA) 
segmental body composition scale (TANITA BC-418, Tanita, Japan), unless a 
pacemaker was fitted. This is a single-frequency (50Hz) BIA device that uses eight 
polar electrodes that can provide a measure of whole body and segmental (arms and 
legs) fat mass (FM), and fat-free mass (FFM). An algorithm incorporating impedance, 
age, and height was used to estimate percentage fat mass. To standardize the 
measurement of weight and body composition, participants were instructed to refrain 
from eating a meal one to two hours prior to the testing and to ensure normal hydration 
status. Participants were measured wearing light clothing, standing erect and 
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barefooted, and were classified as “standard” body type for the measurement. Body 
Mass Index (BMI) was calculated according to the equation (weight (kg)/height (m2). 
 
3.7.5 Functional measures 
3.7.5.1 Functional muscle strength and power 
Isometric muscle strength 
Bilateral maximal isometric grip strength was assessed using a hand-held 
dynamometer (Jamar dynamometer, Asimov Engineering Co., Los Angeles, USA). 
Participants were instructed to sit on a standard height chair (45 cm) with the shoulder 
adducted and neutrally rotated, elbow flexed at 90 degrees, forearm neutral and hand 
slightly extended. Participants were instructed to perform one practice trial followed 
by two maximal effort muscle contractions by squeezing the handle of the 
dynamometer as forcefully as possible. A 60-second rest was provided between trials. 
Peak force (in kg) was recorded with the highest score used for analysis. This test has 
been described previously and has excellent test-retest reliability (Bohannon & 
Schaubert 2005).  
 
Lower limb muscle power  
Functional lower limb muscle power was assessed using five consecutive sit-to-stands 
(5-STS) (Regterschot et al. 2014). Participants were fitted with a tri-axial 
accelerometer (x-BIMU Bluetooth Kit, x-io Technologies Limited, Ascot, UK, 
gyroscope ±2,000°/s, accelerometer ±16 g, 16-bit A/D conversion, sampled at 256 Hz) 
at the right hip, and were instructed to perform each STS as rapidly as possible. For 
each complete STS, the mean concentric power relative to body weight (W/kg) was 
calculated based on the product of acceleration and velocity in line with previous 
research (Regterschot et al. 2014).  
 
3.7.5.2 Functional mobility 
The Timed up-and-go test (TUG), four-square step test (FSST), and choice stepping 
reaction time test (CSRT) were used to assess lower limb muscle function. Each of 
these tests were performed in the participant’s own footwear. The use of a gait-aid was 
recorded at baseline and 26 weeks (e.g., walking stick, four wheeled walking frame) 
and the change in status was included as a covariate categorised as: “no change”, 
“started using a gait aid at 26 weeks”, or “used a gait aid at baseline but not at 26 
weeks”. 
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Timed up-and-go test 
The TUG test is a measure of dynamic balance using three commonly performed 
functional activities of daily living: standing and sitting, walking, and turning 
(Podsiadlo & Richardson 1991), and has an interrater reliability of 0.99 (Shumway-
Cook, Brauer & Woollacott 2000). Participants were seated in a chair (height 45 cm) 
that was placed at the end of a marked 3-meter walkway. On the command ‘go’, 
participants were instructed to stand up, walk at a comfortable speed for 3 meters, turn 
back to the chair and sit down. The test was performed under both single- and dual-
task conditions. The dual-task condition involved participants completing the task 
while counting backwards in threes from a randomly selected number less than 100. 
All participants were given a practice trial and one test run. Participants who required 
an indoor walking aid (cane or walker) performed the test with their aid. A stopwatch 
was used to record the time taken (in seconds) to complete each test. Prior to 
completing the dual-task TUG test, the participant’s cognitive ability while seated was 
assessed by asking them to count backwards aloud in threes from a randomly generated 
number less than 100. Once ten subtractions were completed, the number of counting 
errors were recorded. The number of counting errors that occurred whilst completing 
the TUG test (dual-task condition) was also recorded for all participants.  
 
‘Dual-task cost’, which represents the change in performance with the addition of a 
second task, was calculated as: 
 
Dual-task TUG performance minus single TUG task performance divided by single 
TUG task performance x 100 
  
Where a lower score equates to better performance.  
 
Four square step test  
The FSST provides a measure of dynamic balance and stepping speed in four 
directions (Dite & Temple 2002). Participants were instructed to step forward, 
sideways, and backwards over four canes resting flat on the floor in a cross formation. 
The test began with the participant moving first in a clockwise direction and returning 
in a counter-clockwise direction to the start square. Participants were instructed to 
complete the task as quickly as possible without touching or stepping on the canes and, 
if possible, to face forward during the entire sequence. They were also instructed to 
ensure that both feet make contact with the floor in each square. After 1 practice trial, 
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participants completed the test and the time taken (in seconds) to complete the 
sequence was measured with a stopwatch and recorded as the final score. The test has 
been shown to have a high test-retest reliability of 0.98 (Dite & Temple 2002).  
 
Choice stepping reaction time test  
The choice stepping reaction time (CSRT) test measures a participant’s ability to step 
as quickly as possible onto one of four foot panels (Lord & Fitzpatrick 2001) with the 
element of cognitive demand present in the task associated with processing speed  
(Lord & Fitzpatrick 2001) and choice reaction time, as assessed in the CogState test 
battery. Participants stood on a non-slip choice reaction mat (0.8 x 0.8 m) that 
contained four rectangular panels (32 x 13 cm), one in front of each foot and one to 
the side of each foot. One panel per trial illuminated on a computer screen in front of 
the participant, in random order, and participants were instructed to step onto the 
corresponding panel on the mat as quickly as possible. Following a practice trial, 
participants completed a single trial that involved 12 target stepping actions in which 
12 green arrows appeared in a random sequence (single-task condition). Following this 
trial, participants completed the same activity but with the addition of a dual-task. For 
this trial, participants were asked to step when a green arrow appears and to not step 
when a purple arrow appears. A total of 8 green arrows and 4 purple panels were 
displayed in a random sequence. The average response time (in milliseconds) was 
measured as the time period between the illumination of an arrow and the foot making 
contact with it. This response time was subdivided into: 1) decision time; measured 
from the illumination of the arrow to movement initiation (lift off), and 2) movement 
time; measured from movement initiation to foot contact with the arrow/mat (‘step 
down’). Therefore, movement time was measured as: 
 
Response time minus decision time  
 
Dual-task costs during CSRT for response time, decision time and movement time 
were also assessed for each variable as:  
 
Dual-task CSRT time minus single CSRT time divided by single CSRT time x 100  
 
A lower percentage indicates better dual-task function.  
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Functional gait 
Gait function was assessed using the ProtoKinetics Zeno system (ZenoMetrics LLC, 
Peekskill, NY, USA), which comprised a computerised walkway with the 
ProtoKinetics Movement Analysis Software (PKMAS) programme. The 
ProtoKinetics Zeno walkway system is a 2-foot wide by 16-foot long mat that contains 
a 16- level pressure sensing pad with 18,432 pressure sensors arranged in a grid pattern 
with a spatial resolution of 0.5 cm and a sampling frequency of 120 Hz. Participants 
were asked to perform 6 trials on the Zeno system, wearing comfortable footwear, at 
their preferred walking speed, and with their usual indoor walking aid if required. Two 
different gait conditions were assessed: 1) simple walking (single-task condition), and 
2) walking while counting backwards in 7s from a computerised derived random 
number between 70 and 99 (cognitive dual task). For the cognitive dual task, the 
number of errors in counting backwards were recorded and averaged over three trials. 
For each walking trial, participants started 1 m behind the walkway, and on the 
command ‘go’ they walked the length of the Zeno mat to a cone that was placed 1 m 
past the end of the walkway. All participants were given standardised verbal 
instructions followed by one practice trial for each walking condition. Participants 
were not given any instruction to prioritise attention to either the dual task or walking. 
Gait velocity (m/s) was calculating using the mean of the three trials for each 
condition. ‘Dual-task cost’ represents the change in performance (gait speed) with the 
addition of a second task (counting), and was calculated as: 
 
Dual-task gait speed minus single-task gait speed divided by single-task gait speed  
 x 100 
 
A lower percentage indicates better dual-task function. 
 
In addition, each participant’s cognitive ability whilst not undertaking a secondary task 
was measured. Participants were asked to count backwards aloud by 7s from a 
randomly generated number less than 100, while standing still for 20 seconds, during 
which the number of errors were recorded. The order of the single and dual-task 
conditions were randomised across participants. 
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3.7.6 Health and medical history, medication use and smoking status 
Participant health and medical history (present or past diagnosis of health conditions 
listed in Appendix E), current medication usage, education level attained, and smoking 
status were assessed by questionnaire, due to their influence on cognitive function and 
HR-QoL. Medications were classified into categories including antihypertensives, 
lipid-lowering, nonsteroidal anti-inflammatories, pain relievers, anti-depressants, 
neurological medications, sleeping medication, dietary supplements and other. 
Participants were also required to report any changes to medications or any new 
medications prescribed between baseline and 26 weeks. Smoking history was 
categorised as “current smoker”, “ex-smoker” or “non-smoker”. The highest level of 
education attained by the participant was recorded according to six categories 
including “no education”, “primary school”, “some high school”, “completed high 
school”, “technical/trade certificate” and “university/tertiary level”. 
 
Employment status and ethnicity were measured, with participants’ employment status 
classified as “retired/not employed”, “part-time employment”, home duties” and 
“other”. Race was categorised as Caucasian or Non-Caucasian, based on country of 
birth and parents’ ethnicity. Non-Caucasian countries included Sri Lanka, India, South 
Africa, and Fiji.   
 
3.7.7 Habitual physical activity  
Total leisure and recreational physical activity (PA) was evaluated using the 
Community Healthy Activities Model Program for Seniors (CHAMPS) questionnaire. 
This questionnaire has been designed for use in older adults and has been shown to be 
reliable, valid and sensitive to the changes in PA behaviour (Stewart et al. 2001). At 
each assessment, participants recorded their weekly frequency and duration of 
participation in a range of physical and leisure activities during a ‘typical week’, 
during the preceding four weeks. The results were then reported as estimated kilojoules 
per week spent in moderate to high intensity physical and leisure-time activities.  
 
3.7.8 Exercise adherence 
Compliance with the PACE-IT exercise program was assessed by attendance at the 
supervised exercise sessions, which was documented by the trainers. Participants were 
contacted by the trainers or research staff if they missed ≥2 consecutive sessions. 
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Compliance was calculated by dividing the total number of sessions attended by the 
total number of sessions available, multiplied by 100.   
 
3.7.9 Adverse events 
For participants in the exercise group, any adverse event sustained during the exercise 
program (e.g., illness or injury), was recorded by trainers on the reverse side of the 
training card, recorded the event in the ‘Adverse Events Log’, completed an adverse 
events form which identified the type and severity of the event, and reported the event 
to the investigators immediately. Participants in both groups were interviewed via 
telephone or in person, at 13 weeks and 26 weeks after their intervention had begun to 
determine whether they had experienced an adverse event. An adverse event was 
defined as any health-related unfavourable or unintended medical occurrence (sign, 
symptom, syndrome, illness) that developed or worsened during the period of 
observation in the trial. Reported adverse events were assessed for seriousness, 
expectedness and causality following the National Institute of Ageing guidelines 
(Office for Human Research Protections 2007) (Appendix F). 
 
3.8 Statistical analyses 
3.8.1 Sample size calculations 
The sample size for this trial was based on the larger aims of the project, which was 
designed to prevent falls. Based on previous research in Australia (Barnett et al. 2003; 
Sanders et al. 2010), it was anticipated that approximately 45% of the usual care 
control group would experience a fall throughout the study. To detect a 40% reduction 
in the rate of falls (for example, from 45% to 27%) in the DT-FPT group, it was 
estimate that 118 participants per group would be required (2-tailed, P<0.05 and power 
of 0.8). This allowed for a 15% loss to follow-up due to death or withdrawal from the 
study. To account for cluster randomisation, a conservative intra-cluster correlation 
coefficient of 0.01 was assumed (Elley et al. 2005), giving a design effect of 1.19, 
assuming approximately 15 to 20 participants were recruited per village. This would 
give a sample size of 140 per group (280 participants from approximately 15 villages). 
This sample size would also provide sufficient power (0.9, 2-tailed, P<0.05) to detect 
significant and clinically meaningful differences in many of the secondary functional 
outcome measures. 
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For cognitive function outcomes, the focus was on measuring changes in executive 
function, processing speed and memory. Evidence suggests that these measures of 
cognitive function show the greatest sensitivity to increased physical activity or 
exercise training in older adults. (Colcombe & Kramer 2003; Liu-Ambrose & 
Donaldson 2009; Liu-Ambrose et al. 2010) To our knowledge, no previous studies 
have used the CogState cognitive battery to measure changes in response to exercise, 
and thus it is difficult to estimate the magnitude of any effect size for this measure in 
this study. Thus, sample size calculations were based on the predicted effect of the 
intervention on Stroop test performance, a measure of executive function for which 
there is normative data, and the digit-span test which assesses working memory. Based 
on previous research from exercise interventions (Liu-Ambrose et al. 2010) a 12% 
improvement is expected in the DT-FPT group and a 10% deterioration in the usual 
care group in executive function (based on a conservative SD of 40%). This would 
provide a modest effect size of 0.55. Assuming a 20% attrition rate and using an alpha 
level of less than 0.05 (two-tailed), it was estimated that with 53 participants per group 
we would have 80% power to detect the above differences after 26 weeks (106 
participants in total). In addition, past research of working memory indicates that PRT 
results in an absolute mean performance change of 0.5 with a 0.5 reduction in a control 
group (Cassilhas et al. 2007). Based on a conservative SD of 1.5, it was estimated that 
37 participants would be needed in each group (74 in total), to detect these differences 
over 26 weeks at a power of 80% and using an alpha level of less than 0.05 (two-
tailed), whilst also allowing for a 20% attrition rate. To account for cluster 
randomisation, we assumed a conservative intracluster correlation coefficient of 0.01 
(Elley et al. 2005), giving a design effect of 1.19, assuming 20 participants are 
recruited per village. To detect changes in working memory, this equates to a sample 
size of 105, after taking into consideration design effect and a 20% attrition rate. 
Therefore, to detect changes in executive function, 151 participants would be required. 
Thus, the current sample size of 300 (required for the aims of the larger project) and 
the 26-week intervention is sufficient to detect a significant effect of the intervention 
on measures of cognitive function in our cohort of older adults.  
 
For the sub-scales of the SF-36, the effects of PRT on SF-36 are mixed, but raw 
differences of 15 to 52 points for the various sub-scales have been reported for the 
original version (Teixeira et al. 2010), while the SF-36 v2 has recorded change scores 
between 1-50 following PRT interventions in older adults (Cassilhas et al. 2007; Oh 
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et al. 2015). Hence a change of 10 points in the DT-FPT groups was anticipated with 
a small age-related change (decrease) in the controls. In various patient groups a 5 to 
10% change is regarded as the minimal important difference. To detect a conservative 
5% change in norm-based values (2.5 points) using a SD of 10 in PCS and MCS over 
26 weeks, at a power of 80% and using an alpha level of less than 0.05 (two-tailed), it 
was estimated that 128 participants would be required. Given the design effect of 1.19, 
and allowing for a 20% attrition rate, this would require 183 participants in total. 
However, based on previous research, PRT has produced an absolute mean change of 
10.0 with a 6.0 reduction in a control group for the PCS (Canuto Wanderley et al. 
2015). Based on a conservative SD of 20, it was estimated that 37 participants would 
be needed in each group (74 in total), to detect these differences over 26 weeks at a 
power of 80% and using an alpha level of less than 0.05 (two-tailed), whilst also 
allowing for a 20% attrition rate and design effect. In addition, an 11% improvement 
in physical functioning has been previously reported following PRT and a 1% decrease 
in a usual care control group for physical functioning, providing a modest effect size 
of 0.3 (de Vreede et al. 2007). Using this data, with the same power requirements as 
above, 37 participants would be required in each group, with 53 required in each group 
(106 overall) to allow for the design effect and attrition. Thus, our sample size of 300 
was sufficient to detect intervention changes.  
 
3.8.2 Statistical methods 
All statistical analyses were conducted on an intention-to-treat basis using STATA 
statistical software release 14.0 (STATA, College Station, TX, USA). Baseline 
characteristics between the groups were compared by independent t-tests for 
continuous variables and chi-square tests for categorical variables. All data was 
checked for normality prior to analysis. Multicollinearity between potential covariates 
was also investigated via the variance inflation factor. The associations between 
inflammatory and neurological markers and cognition, HR-QoL and well-being were 
assessed with generalized linear models, adjusting for the variability between clusters 
(villages), and demographic and physiological covariates. The effect of the 
intervention on the primary and secondary outcome variables was analysed using 
General Linear Mixed Models with random effects, adjusting for the variability 
between clusters (villages) and within a cluster (participants within the same village). 
The group (DT-FPT or CON) was the fixed effect, and clusters (retirement village) 
and the unit of analysis (participants), were included as random effects to account for 
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the clustered design. An additional model was run based on analysis of covariance 
(ANCOVA) and adjusted for baseline values for the outcome measure and clustering. 
Due to non-normality after log-transformation, the associations between inflammatory 
cytokines and cognition, HR-QoL and well-being were additionally assessed with 
generalized linear models with a gamma distribution, adjusting for the variability 
between clusters (villages). Analyses of SF-36v2 utilized published ‘weightings’ most 
relevant to this population. Covariates included in the models included: age, sex, BMI, 
medication, education and CVD risk, due to their potential effect on the outcome 
measures.   
 
All data is presented as means ± SD or 95% CI unless stated. Changes in the outcome 
measures are expressed as either the absolute or percentage change from baseline. 
Between-group differences were calculated by subtracting the within-group changes 
from baseline for the DT-FPT group from the within-group changes for the usual care 
group after 26 weeks. The significance level was set at P<0.05, or smaller if Bonferroni 
corrections were made for multiple comparisons. 
 
For further per protocol statistical analysis, participants undertaking the exercise 
program were categorised according to their commitment to the classes in terms of the 
percentage they attended. Participants attending exercise classes were classified by 
“<50% compliance”, and “≥50% compliance”. This cut-off was selected based on an 
individual attending at least one of their exercises classes per week.  
 
3.9 Ethics and Funding 
The study was approved by the Deakin University Human Research Ethics Committee: 
Project number 2103-051, “Effects of dual-task functional power training on falls in 
the elderly: An 18-month community based RCT”. This study is also registered with 
the Australian New Zealand Clinical Trials Registry (ACTRN12613001161718). This 
study was funded by a NHMRC grant, project ID 1046267. 
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4. Chapter 4 
Associations between inflammatory and neurological markers and 
cognitive function, health-related quality of life and well-being in 
older adults residing in retirement villages. 
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Student declaration  
The PhD student contributed significantly to the recruitment campaign outlined in 
Chapter 3, and managed the trial for a significant portion of their candidature. This 
included screening expressions of interest and subsequent appointment scheduling, the 
testing of all 300 participants at baseline and those at 26-week follow-up, and 
correspondence with participants and villages. The student was also responsible for 
the development, analysis and reporting contained within the following chapter.  
 
4.1 Introduction 
Cognitive ageing is not a uniform process and may range from unnoticeable declines 
in cognitive functioning (Christensen et al. 1999; Yaffe et al. 2010), to more 
substantial impairments leading to chronic conditions such as dementia and 
Alzheimer’s disease (AD) (World Health Organization 2012). The identification and 
attenuation of mechanisms that contribute to cognitive decline or dementia is therefore 
important for the maintenance of functional independence. Low grade, chronic 
systemic inflammation, which is often seen with ageing (Franceschi et al. 2000), has 
been associated with age-related cognitive decline, dementia, and AD (Engelhart et al. 
2004; Hofman et al. 1997; Sartori et al. 2012), however its relationship with cognitive 
processes in healthy older adults remains unclear. Higher levels of pro-inflammatory 
cytokines such as CRP and IL-6 have been associated with poorer cognitive 
performance in some studies in healthy older adults (Schram et al. 2007; Yaffe et al. 
2003), but there are conflicting reports as to whether the rate of decline in cognitive 
function varies by inflammatory status (Alley et al. 2008; Dik et al. 2005; Weuve et 
al. 2006). The sensitivity of different cognitive assessments in detecting subclinical 
cognitive change in healthy older adults, and the level of adjustment for confounders 
(i.e. basic demographics vs. genetic and lifestyle factors) may explain these 
discrepancies. To date, few studies have used a large array of inflammatory or 
neurological markers with an extensive battery of neuropsychological tests to 
investigate the relationship between biomarkers and cognition (Chi et al. 2017; Trollor 
et al. 2012). While composite inflammatory summary scores derived from a 
combination of various pro- and anti-inflammatory markers have demonstrated 
inverse associations with psychomotor speed and memory in some studies in older 
adults (Chi et al. 2017; Trollor et al. 2012), it is not clear whether specific 
inflammatory markers are related to cognition or whether composite scores might 
provide greater insight into this relationship.  
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Neurofibrillary tangles and the deposition of amyloid-β (Aβ) peptides into senile 
plaques may also contribute to brain neurodegeneration (Akiyama et al. 2000), and 
plasma levels of Aβ have emerged as potential biomarkers for the development of 
cognitive disease (Koyama et al. 2012; Song et al. 2011). Meta-analytic data has 
indicated that a lower Aβ (1-42): Aβ (1-40) ratio is associated with an elevated risk for 
cognitive decline or AD (Koyama et al. 2012), however any relationships between 
plasma levels of Aβ (1-42) and Aβ (1-40) and cognitive function remain to be clarified. 
The trajectory of ageing in the human brain may also be influenced by growth factors 
such as brain derived neurotrophic factor (BDNF), insulin-like growth factor (IGF-1) 
and vascular endothelial growth factor (VEGF), all of which are critical for 
neurogenesis, angiogenesis and synaptic plasticity (Cotman, Berchtold & Christie 
2007; Voss et al. 2013). Evidence from human studies has associated age-related 
reductions in IGF-1 and BDNF with deteriorations in cognitive function (Aleman & 
Torres-Aleman 2009; Arwert, Deijen & Drent 2005; Gunstad et al. 2008; Landi et al. 
2007; Shimada et al. 2014), which may place older adults at risk for neurodegenerative 
disease in later life (Laske et al. 2011; Westwood et al. 2014). Conflicting findings 
have reported both lower and elevated levels of circulating VEGF in adults with AD 
[as reviewed in (de Almodovar et al. 2009)], however the relationship between 
cognitive function and VEGF is yet to be tested in healthy older adults. There is also 
evidence that the relationship between circulating biomarker concentrations and 
cognition may be under gender and genetic influence. For instance, there is some 
evidence that older women have higher basal levels of circulating BDNF (Golden et 
al. 2010; Trajkovska et al. 2007), while the carriage of a Met allele from the BDNF 
gene is associated with poorer cognitive performance in both older men and women 
(Gajewski et al. 2011; Mandelman & Grigorenko 2012; Miyajima et al. 2008; Raz et 
al. 2009). Furthermore, older adults possessing the ε4 variant of the APOE gene coding 
for apolipoprotein-E may have a greater risk for cognitive decline and degeneration 
(Alzheimer’s Association 2015; Poirier et al. 1993; Sperling et al. 2011). Despite these 
findings, there is a lack of uniformity in the tests used to measure cognitive function, 
and the various circulating growth factors incorporated in these studies. Given these 
inconsistencies, the current study will differ from prior studies in its assessment of a 
comprehensive battery of inflammatory and neurological markers, while controlling 
for a range of confounders and genotypes. 
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There is some evidence which suggests that circulating levels of neurological and 
inflammatory markers may also influence well-being in older adults, with stressful 
experiences and negative emotional states associated with higher levels of 
inflammatory markers and lower levels of BDNF (Duman & Monteggia 2006; Kiecolt-
Glaser et al. 2002). Higher levels of pro-inflammatory cytokines have also been 
significantly associated with poor self-rated health and lower well-being in 
community-dwelling older adults (Unden et al. 2007). Despite these findings, it 
remains unclear as to whether serum inflammatory levels are linked to self-reported 
ratings of health and well-being in older adults. Further, while IGF-1 has shown no 
association with psychological well-being in a small sample of older adults (Unden et 
al. 2002), the relationships between several neurological markers (e.g., BDNF, VEGF, 
Aβ isoforms) and health-related quality of life (HR-QoL) and well-being, remain 
untested.  
 
The aim of this cross-sectional study is to identify the associations between various 
inflammatory and neurological markers and their composite scores with cognitive 
function, well-being and HR-QoL in older adults residing independently in retirement 
villages. A secondary aim is to assess whether genetic polymorphisms (APOE and 
BDNF gene) and sex differences affect these associations. It is hypothesised that pro-
inflammatory cytokines, Aβ biomarkers and an inflammatory composite will be 
inversely associated with cognitive function, HR-QoL and well-being. It is also 
expected that higher levels of anti-inflammatory cytokines and growth factors will be 
associated with better cognitive function, HR-QoL and well-being. Finally, it is 
hypothesised that non-ε4 carriers (APOE gene) and non-Met carriers (BDNF gene) 
will show stronger associations in these relationships.  
 
The following chapter will outline the specific study design and methodology used to 
investigate the above research questions. For the purposes of this chapter, only the 
methodology that pertains to the present study will be presented.  
 
4.2 Methods 
A detailed description of the methods for this study has been provided in Chapter 3. A 
brief summary of the study participants, design and measurements is provided below.   
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4.2.1 Study design  
This cross-sectional study utilizes baseline data from an 18-month intervention trial 
designed to examine the effects of a novel dual-task exercise-cognitive/motor program 
on falls prevention, health and well-being, for which the study design has been 
described in detail in Chapter 3.  
	
4.2.2 Participants 
Three hundred older adults (81 men and 219 women) aged 77.4 ± 6.8 (mean ± SD) 
interested in participating in the intervention were recruited in three rolling cohorts, 
from independently living retirement villages in the greater metropolitan and regional 
areas of Melbourne. All participants were 65 years and over and deemed to be at 
increased risk of falls based on a questionnaire adapted from Sanders et al. (Sanders 
et al. 2009). Of the 300 enrolled in the trial, 269 provided a venous blood sample and 
are included in this analysis. 
 
4.2.3 Measurements  
All testing was conducted on-site at the 22 retirement villages enrolled in the study. A 
detailed description of the outcome measures used in this study are provided in Chapter 
3, and a brief outline is provided below.  
 
Anthropometry and body composition 
Height and body weight were measured using standard techniques, via portable 
stadiometer (Surgical and Medical PE87) and TANITA scales (TANITA BC-418, 
Tanita, Japan), from which BMI was calculated. 
 
Cognitive measures 
Domains of cognitive function were assessed through the CogState computerized 
cognitive battery [Groton Maze Learning Test (GMT): executive function, memory, 
visuospatial learning; Detection Task (DET): processing speed; Identification task 
(IDN): visual attention; One Card Learning task (OCL): attention and visual memory; 
One Back task (ONB): working memory, attention] (CogState Ltd, Melbourne, 
Australia). As per the CogState protocol, the reaction time scores of IDN, DET and 
ONB were log10 transformed, while the square root of the proportion of correct 
responses on the OCL task was arcsine transformed (Lim et al. 2015). Individual raw 
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scores for each task were then transformed into a Z-score using the mean and standard 
deviation (SD) of the total sample in the study, according to the following equation: 
 
Baseline Z-Score = [(participant score–baseline mean for test)/ baseline group SD for 
test] 
 
From these individual Z-Scores, composites were created for the following:  
 Global cognitive function (GCF): average for GMT, DET, IDN, OCL, and ONB  
 Learning-Working memory (L-WM): average for OCL and ONB 
 Psychomotor function-Attention (Psy-Att): average for DET and IDN 
 CogState Brief Battery (CBB): combination of L-WM and Psy-Att; average for 
DET, IDN, OCL and ONB  
 
Higher scores on these composites indicate better performance (Steinberg et al. 2015). 
Previous research has also used the CogState battery to categorize people at increased 
risk of mild cognitive impairment (MCI). To categorise MCI, participants scoring ≤-
1.0 SD (Z-score) on at least three of the five individual cognitive tests were classified 
as having mild cognitive impairment [based on personal communication with 
CogState Pty. Ltd and (Maruff et al. 2013)].  
 
From the 269 participants, one participant did not wish to complete any of the five 
CogState tests, and was therefore excluded from analyses involving individual 
cognitive tests and composites. For GMT, two participants did not complete the test 
due to physical incapacity (e.g., hand surgery), and three participants failed the task 
criteria as described in Table 3.11. These five participants were not included in 
analyses for GCF. One participant failed the task criteria for OCL and was therefore 
not included in analyses of the L-WM, CBB or GCF composites. 
 
Health-related Quality of Life (SF-36® v2™) 
The Short Form 36® version 2™ (SF-36® v2™) was used to measure HR-QoL (Ware 
Jr & Sherbourne 1992) and reported using Australian norm-based scores according to 
previously published guidelines (Hawthorne et al. 2007). Summary scores for each of 
the eight subscales and two overall summary scores [physical component summary 
(PCS) and the mental component summary (MCS)], were used in this analysis 
(Hawthorne et al. 2007). An overall composite of HR-QoL was also created by 
averaging the weighted means of the eight subdomains. Analysis of SF-36v2 utilized 
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published ‘weightings’ most relevant to this population (Hawthorne et al. 2007). One 
participant provided incomplete answers to the SF-36 section pertaining to general 
health, and was therefore not included in analyses for this domain, and the PCS and 
MCS composites. 
 
Satisfaction with Life (Personal Well-being Index, PWI) 
Satisfaction with life (SWL) was used as a proxy of well-being (Cummins et al. 2003), 
and was assessed via the Personal Wellbeing Index (PWI), using a single-item measure 
of SWL and a composite variable derived by averaging satisfaction scores on eight life 
domains. One participant chose not to answer the optional SWL single item question.  
 
Depression Anxiety and Stress Scale (DASS-21) 
The Depression Anxiety and Stress Scale (DASS)-21 is a 21-item self-report measure 
and was used to assess symptoms of depression, anxiety and stress over the past week 
(Henry & Crawford 2005). Each factor is measured by seven items on a 4-point Likert 
scale, and scores range from 0 to 21 on each subscale, with higher scores indicating 
greater anxiety, depression or stress (Paukert et al. 2010). These subscales are each 
multipled by two, and the sum of the depression subscale was used as a covariate in 
assessing cognitive function outcomes, as an increased susceptibility to depression has 
been associated with an increased risk of cognitive function (Geerlings 2000; Paterniti 
2002).  
 
Inflammatory, neurological and hormonal markers 
Blood samples were obtained at baseline via the methods outlined in Chapter 3. Serum 
concentrations of IL-4, IL-6, IL-1β, IL-8, TNF-α, IL-10, BDNF, VEGF, IGF-1 and 
CRP, and plasma levels of Aβ (1-40) & Aβ (1-42) were analysed along with 
polymorphism data for the APOE and BDNF genes. Blood samples were provided by 
269 participants; the reasons for non-collection were: illness/could not attend 
collection at allocated time (n=17), participant withdrawal from study before blood 
collection (n=8), and an inability of the nurse to collect a sufficient sample (n=6). For 
four participants, IGF-1 and CRP were not analysed due to a lack of stored samples. 
Polymorphism data was derived from baseline samples, or 26-week samples if a 
baseline sample was not available to minimise missing data, as these physiological 
traits do not change over time. Participants were categorised as possessing at least one 
copy of the ε4 allele from the APOE gene (ε4 carrier) or no copies of this 
polymorphism (non-ε4), and by BDNF genotype; at least one copy of the Met allele 
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(Met-carrier), or no copies (Val/Val homozygotes). In total, polymorphism data was 
provided by 282 participants, which incorporates all participants in this study. 
 
Concentrations of inflammatory cytokines were standardised to a Z-score based on the 
sample mean and pooled SD. From these Z-scores, composites consisting of only pro- 
(IL-6, IL-1β, IL-8, TNF-α, CRP) and only anti-inflammatory cytokines (IL-4 and IL-
10) were calculated (Chi et al. 2017), with higher Z-scores representing a greater 
circulating pro- or anti-inflammatory state respectively. A single composite 
inflammatory Z-score was also created using all seven biomarkers by summing 
individual Z-scores in the appropriate direction: pro-inflammatory Z-scores were 
regarded as positive while anti-inflammatory Z-scores were assigned negative values 
(Chi et al. 2017). A higher composite Z-score therefore represented a higher level of 
inflammation. The Aβ (1-42): Aβ (1-40) ratio was calculated by dividing the plasma 
values of Aβ (1-42) by Aβ (1-40).  
 
Health and medical history, and medication use  
Participant health and medical history (present or past diagnosis of health conditions 
listed in Appendix E), current medication usage (antihypertensive, lipid-lowering, 
anti-depressant, NSAIDs), employment status (“retired/ not employed”, “part-time 
employment’, “home duties/other”), race (“Caucasian”/ “Non-Caucasian”), education 
level attained (“primary/some high school”, “completed high school/technical or trade 
certificate”, and “University/tertiary level”), and smoking status (current, Ex, or non-
smoker), were assessed by questionnaire. Participants were deemed to be at 
cardiometabolic risk if they satisfied at least one of the following: taking 
antihypertensive medication/diagnosis of hypertension by doctor, taking lipid- 
lowering medication, had type 2 diabetes, had suffered a heart attack, heart disease, or 
angina (all Yes or No) [adapted from (Chi et al. 2017; Wildman et al. 2008)]. 
 
Habitual physical activity  
Total leisure and recreational physical activity (PA) was evaluated using the 
Community Healthy Activities Model Program for Seniors (CHAMPS) questionnaire 
(Stewart et al. 2001). The results were then reported as estimated caloric expenditure 
per week (converted from kcal/week to kJ/week) spent in moderate to high-intensity 
leisure and physical activities. One participant provided incomplete data for the 
CHAMPS questionnaire and was not included in analyses.  
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4.2.4 Statistical analyses 
All statistical analyses were conducted using STATA statistical software release 14.0 
(STATA, College Station, TX, USA). We tested for multicollinearity of covariates via 
the variance inflation factor and no collinearity was detected. All data and their 
residuals were checked for normality prior to analysis. Due to non-normality, the 
following biomarkers were log transformed prior to analysis; IL-4, IL-6, IL-1β, IL-8, 
TNF-α, IL-10, VEGF, CRP, Aβ (1-40) and Aβ (1-42). One data point for IL-4, IL-8 
and CRP were removed as outliers, as they were between 15-40 standard deviations 
above the mean. Samples that were below the lowest detectable limit were assigned 
the lowest detectable concentration for their assay as described in Chapter 3. The 
relationships between age, BMI and PA with cognition and HR-QoL were assessed 
using General Linear Mixed Models with random effects, adjusting for the variability 
between clusters (villages). For the main analysis, associations between inflammatory 
and neurological markers and cognitive function, HR-QoL and well-being were 
analysed using the same statistical method. The associations between cognitive 
function and neurological and inflammatory markers were initially assessed by 
adjusting for age and sex (Model 1) and additionally adjusting for education level, 
DASS-21 depression score, BMI, cardiometabolic status, and smoking history (model 
2). In two extensions of the second model, APOE or BDNF polymorphisms were also 
included as a covariate for the associations between biomarkers and cognition, HR-
QoL and well-being outcome measures (model 2 + presence or absence of ApoE-ε4 
genotype; model 2 + presence or absence of BDNF Met allele). For statistical analysis, 
only participants with data for all covariates used in the models (i.e. age, sex, education 
level, DASS-21 depression score, BMI, cardiometabolic status, and smoking status, 
APOE and BDNF genotype) were included in the analysis, hence the final sample size 
was 268. Secondary outcome measures were adjusted for sex where appropriate. Due 
to non-normality after log-transformation, the associations between IL-1β, IL-4, IL-10 
and Aβ (1-42) and cognition, HR-QoL and well-being were additionally assessed with 
generalized linear mixed models with a gamma distribution, adjusting for the 
variability between clusters (villages). 
 
Interactions between ApoE-ε4 carrier status, each Aβ isoform (1-40, 1-42) and 
combined inflammation Z-scores, and cognitive function, HR-QoL and well-being, 
were determined with linear mixed models. The influence of BDNF Met carrier status 
on relationships between BDNF and cognition, HR-QoL and well-being, were also 
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conducted. As serum concentrations of BDNF and IGF-1 may display sex differences 
in circulation (Komulainen et al. 2008), linear mixed models were conducted to 
determine if sex had any influence on the relationships of these biomarkers with 
cognition, HR-QoL and well-being.  
 
All data are presented as means ± SD or β-coefficients with 95% CI. The significance 
level was set at P<0.05. Bonferroni correction to the type 1 error rate was implemented 
to account for multiple comparisons, with the adjusted value being set at P<0.006 for 
HR-QoL subdomains (0.05 divided by eight tests), P<0.01 for cognitive domains 
(GMT, DET, IDN, OCL and ONB; 0.05 divided by five tests), and P<0.025 for PCS, 
MCS, L-WM and Psy-Att composites.  
 
4.3 Results 
Baseline characteristics 
The characteristics of the 268 participants included in this study are provided in Table 
4.1. Overall 72% were women, and the average age was 77.4 ± 6.9 years (mean ± SD). 
The average BMI was 29.1 kg/m2, with 106 (40%) classified as obese (BMI ≥ 30), and 
43% were ex/current smokers (nine were current smokers). Half (50%) of the 
participants were taking lipid-lowering medication, 72% were on antihypertensive 
medication, and 70% of participants were taking three or more prescribed medications 
(Table 4.1). A total of 262 participants (98%) possessed at least one chronic health 
condition, and 149 (56%) possessed ≥3 conditions. For education, 161 (60%) 
participants completed high school, and of these a further 71 (26%) attained additional 
tertiary qualifications (Table 4.1). Nearly all participants were Caucasian (99%). 
Overall 94% of participants were retired or not employed. A total of 18 (7%) 
participants met the CogState criterion for MCI (≤-1.0 SD in three separate cognitive 
measures) (Maruff et al. 2013), despite passing the cognitive screening test. HR-QoL 
scores relative to normative data for Australian adults aged over 75 years (Hawthorne 
et al. 2007) revealed that participants were on average ±0.4 SD of the norm-based 
scores for all measures (Table 4.2). For PWI data, participants on average scored 
slightly higher (80.0 ± 13.3) than the current normative range for Australians over 65 
years (77.5 – 79.7 points) (Fuller-Tyszkiewicz et al. 2016).  
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Table 4.1: Participant characteristics. 
Characteristics  
N 268 
Women, n (%) 194 (72%) 
Age, year 77.4 ± 6.9 
Height, cm 161.9 ± 0.1 
Weight, kg 76.4 ± 15.4 
BMI (kg/m2) 29.1 ± 5.1 
Smoking status  
Current/ Ex-Smoker, n (%) 116 (43%) 
Non smoker 152 (57%) 
Physical activity, kJ/week 5318 ± 6213 
DASS-21-Depression  2.0 ± 6.0 
ApoE-ε4 carrier, n (%) 77 (29%) 
BDNF-Met carrier, n (%) 87 (33%) 
Number of health conditions, n 3.0 ± 2.0 
Presence of Cardiometabolic Risk Factors, n (%) 230 (86%) 
Employment Status   
     Retired / Not employed, n (%) 252 (94%) 
     Part time employment, n (%) 7 (3%) 
Home duties / Other, n (%) 9 (3%) 
Race, Caucasian, n (%) 264 (99%) 
Education  
Primary/ Some High School, n (%) 107 (40%) 
Completed High School/Technical-Trade Certificate, n (%) 90 (34%) 
University/Tertiary level, n (%) 71 (26%) 
Antihypertensive therapy, n (%) 192 (72%) 
Lipid-lowering therapy, n (%) 134 (50%) 
NSAIDs, n (%) 35 (13%) 
Anti-depressant therapy, n (%) 58 (22%) 
Diabetic medication, n (%) 34 (13%) 
Neurological medication, n (%) 7 (3%) 
Analgesics (non-NSAIDs), n (%) 28 (10%) 
Sleep aids, n (%) 22 (8%) 
Medications taken, n (%)  
0 11 (4%) 
1 33 (12%) 
2  36 (13%) 
≥ 3  188 (70%) 
Values are mean ± SD except DASS-21-Depression subscale score and Number of 
health conditions (median ± Interquartile Range). ApoE: apolipoprotein; BDNF: brain 
derived neurotrophic factor; BMI: body mass index; DASS: Depression, anxiety and 
stress scale; NSAID: Nonsteroidal anti-inflammatory drug. Neurological medication 
includes anti-Parkinson and anti-epileptic medication.   
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Table 4.2: Mean values for cognitive function, HR-QoL and well-being. 
Cognitive Function   Raw scores 
Groton Maze Learning Test – Errors  87.1 ± 39.2 
Detection task – Speed a 2.59 ± 0.09 
Identification task– Speed a 2.76 ± 0.07 
One Card Learning task  – Accuracy a 0.93 ± 0.10 
One Back task – Speed a 2.98 ± 0.10 
HR-QoL    Norm-based scores 
Subdomains  
   Physical Functioning 40.2 ± 11.0 
   Role Physical 45.0 ± 10.1 
   Bodily Pain 44.5 ± 11.5 
   General Health  47.2 ± 8.45 
   Vitality 49.1 ± 9.62 
   Social Functioning 49.2 ± 9.32 
   Role Emotional 47.0 ± 11.6 
   Mental Health 49.7 ± 9.05 
Composite Scores  
   Physical component summary (PCS)  42.7 ± 10.3 
   Mental component summary (MCS)  51.5 ± 9.22 
   Overall HR-QoL 46.5 ± 7.68 
PWI    Raw scores 
Satisfaction with Life single item 79.0 ± 17.4 
PWI Composite 80.0 ± 13.3 
Values are means ± SD. Subdomains of SF-36 are presented as norm-based scores and 
composites from SF-36 scales. a Means and SD are calculated on data pre-transformed 
by CogState software. HR-QoL: health-related quality of life; PWI: Personal Well-
being Index.  
 
Outcome measures 
The number of missing data points for each category contributing to the final sample 
size of 268 is presented in Appendix G. Mean raw scores for each CogState task are 
presented in Table 4.2, along with norm-based scores for each subdomain of the SF-
36 and the Component Summary Scores, the mean PWI composite and the single item 
Satisfaction with Life score. Raw scores for each subdomain of the SF-36 are 
presented in Appendix H, while untransformed cytokine concentrations for each 
inflammatory and neurological marker of the 268 participants included in analyses, 
are presented in Appendix I.  
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4.3.1 Relationships between age, BMI and physical activity with cognition HR-QoL, 
well-being, and inflammatory and neurological markers 
Age was significantly associated with lower cognitive performance, including 
executive function (GMT: β= -0.04, P<0.001), attention (IDN: β= -0.03, P=0.001), 
working memory (ONB: β = -0.04, P<0.001), global cognitive function (GCF; β = -
0.03, P<0.001), Learning-Working memory composite (L-WM: β= -0.03, P<0.001), 
Psychomotor function-Attention composite (Psy-Att: β= -0.02, P=0.013) and a 
composite of processing speed, attention, learning and working memory (CBB; β = -
0.02, P<0.001), after adjusting for multiple comparisons. R values for these 
associations are presented in Table 4.3. In contrast, age was not significantly 
associated with any HR-QoL scores or concentrations of inflammatory and 
neurological markers after adjusting for multiple comparisons.    
 
Higher BMI were associated with lower scores in the HR-QoL domains of physical 
functioning (β= -0.52, P<0.001), general health (β= -0.30, P=0.003), vitality (β= -0.34, 
P=0.003), physical component summary (β= -0.48, P<0.001), and global QoL (β= -
0.26, P=0.004) after adjusting for multiple comparisons (Table 4.3). Higher BMI was 
also associated with lower scores in the Personal Wellbeing Index composite (β= -
0.41, P=0.011) and Satisfaction with Life single-item score (β= -0.41, P=0.048). A 
greater BMI was associated with higher concentrations of CRP (β= 0.07, P<0.001), 
but not with any other inflammatory markers. There were no associations between 
BMI and any measure of cognition.  
 
Higher levels of physical activity (kJ/week) were associated with higher scores in a 
number of HR-QoL measures, including physical functioning (β= 0.002, P<0.001), 
role physical (β=0.001, P=0.001), bodily pain (β=0.001, P=0.005), general health 
(β=0.001, P<0.001), vitality (β=0.002, P<0.001), physical component summary (β = 
0.002, P<0.001), global QoL (β=0.001, P<0.001), and the Personal Wellbeing Index 
composite (β=0.001, P<0.036) (Table 4.3). Physical activity levels were not associated 
with any measure of cognition, however a greater energy expenditure was associated 
with lower levels of IL-8 (β= -0.0001, P=0.008), Aβ (1-40) (β= -0.00003, P=0.046), 
and VEGF (β= -0.0001, P=0.006). 
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Table 4.3: Associations between age (years), BMI (kg/m2) and physical activity 
(kJ/week), with cognition Z-scores, HR-QoL, well-being, and concentrations of 
inflammatory and neurological markers. 
 r value 
 
Age BMI Physical Activity 
Cognition    
  Groton Maze Test (executive function) -0.32 † 0.13  0.07 
  Detection (processing speed)      -0.10 0.05 0.04 
  Identification (attention) -0.21 † 0.09 0.05 
  One Card Learning (attention/memory)      -0.11 0.05 0.03 
  One Back (working memory) -0.26 † 0.12 0.07 
  Global cognitive function (GCF) -0.30 † 0.12 0.07 
  Learning-Working memory (L-WM) -0.24 † 0.11 0.06 
  Psychomotor function-Attention (Psy-Att) -0.18 * 0.08 0.05 
  CogState Brief Battery (CBB):  -0.24 † 0.11 0.07 
HR-QoL    
   Physical Functioning -0.15    -0.24 †    0.27 † 
   Role Physical -0.14        -0.14     0.20 † 
   Bodily Pain 0.12  -0.14       0.17 ** 
   General Health  0.10     -0.18 **    0.21 † 
   Vitality 0.01     -0.18 **    0.29 † 
   Social Functioning -0.01 -0.10 0.12 
   Role Emotional -0.14  -0.04 0.09 
   Mental Health 0.05 -0.04  0.16  
   Physical component summary (PCS)  -0.02    -0.24 †    0.26 † 
   Mental component summary (MCS)  -0.01 -0.00 0.09 
   Global HR-QoL -0.03      -0.17 **    0.25 † 
Well-being    
Satisfaction with Life 0.10    -0.12 * 0.04  
Personal Wellbeing Index 0.10    -0.15 *    0.13 * 
Inflammatory Cytokines    
   IL-6 0.13 0.08 0.17 
   TNF-α -0.05 -0.05 0.07 
   IL-1β -0.05 0.06 0.09 
   IL-10 0.03 0.11 0.08 
   IL-4 -0.04 0.08 0.07 
   IL-8 0.10 -0.04      0.21 ** 
  CRP -0.01    0.34 † 0.09 
Growth and Neurological Markers    
   Aβ (1-40) 0.15 -0.06    0.06 * 
   Aβ (1-42) 0.07 -0.02 0.04 
   BDNF -0.11 -0.04 0.04 
   IGF-1 -0.08 -0.06 0.02 
   VEGF -0.01  0.06      0.17 ** 
N.B. IL-6, TNF-α, IL-1β, IL-10, IL-4, IL-8, CRP, Aβ (1-40), Aβ (1-42), VEGF were log-transformed. 
† P≤0.001, ** P≤0.01. *P<0.05. Aβ: amyloid beta; BDNF: brain derived neurotrophic factor; CRP: C-
reactive protein; IGF-1: insulin-like growth factor-1; IL-1β: interleukin-1 beta; IL-4: interleukin-4; IL-
6: interleukin-6; IL-8: interleukin-8; IL-10: interleukin-10; TNF-α: tumor-necrosis factor alpha; 
VEGF: vascular endothelial growth factor. 
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4.3.2 Cognitive function and inflammatory markers  
No significant associations were observed between any single inflammatory marker or 
the composite inflammatory scores, and the Z-scores for any cognitive outcome 
measure (Tables 4.4 and 4.5). After additionally adjusting for APOE and BDNF 
genotypes in the fully adjusted model, there were no changes to the reported 
associations.  Similarly no associations were detected after non-parametric analyses 
(mixed models with a gamma distribution).  
 
4.3.3 Cognitive function and neurological markers (BDNF, IGF-1, and VEGF) 
Greater concentrations of BDNF were associated with better global cognitive function 
(GCF; P=0.035), attention (IDN; P=0.008), Psychomotor function-Attention 
composite (Psy-Att; P=0.009), and a composite of processing speed, attention, 
learning and working memory (CBB; P=0.039). For composite cognitive score results 
refer to Table 4.6 and for the individual cognitive domain results refer to Appendix J. 
These significant associations persisted after additionally adjusting for APOE or 
BDNF genotypes in the fully adjusted model (BDNF and IDN: P=0.005; GCF: 
P=0.025; Psy-Att: P=0.009; CBB: P=0.028). In subsequent sensitivity analyses, these 
associations did not persist after the removal of individuals classified as MCI (n=18), 
and adjustment for multiple comparisons.  
 
Higher concentrations of IGF-1 were associated with lower Z-scores in visual learning 
(OCL) in unadjusted models (P=0.004), and this association persisted after adjusting 
for all covariates (model 2, P=0.006), and multiple comparisons. An inverse 
relationship was detected between serum IGF-1 and the learning/memory composite 
(L-WM; P=0.024), but this did not persist after adjustment and accounting for multiple 
comparisons (model 2, P=0.034). No significant associations were detected between 
VEGF and any cognitive outcome. Selected associations detected for BDNF and IGF-
1 with cognition are presented in Figures 4.1 and 4.2.  
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Table 4.4: Associations between cognitive function and inflammatory markers.  
 IL-6 TNF-α IL-1β IL-10 IL-4 IL-8 CRP 
                    n 
β-value  
(95% CI) 
β-value   
(95% CI) 
β-value  
(95% CI) 
β-value  
(95% CI) 
β-value  
(95% CI) 
β-value  
(95% CI) 
β-value  
(95% CI) 
Model 1         
GMT 262 -0.02 (-0.10, 0.14) -0.003 (-0.17, 0.18) 0.04 (-0.04, 0.11) 0.02 (-0.05, 0.09) -0.01 (-0.08, 0.07) -0.02 (-0.21, 0.17) 0.04 (-0.08, 0.15) 
DET 267 -0.09 (-0.22, 0.04) 0.03 (-0.16, 0.22) 0.01 (-0.08, 0.09) -0.02 (-0.09, 0.06) 0.03 (-0.05, 0.11) -0.02 (-0.22, 0.19) 0.05 (-0.07, 0.17) 
IDN 266 0.02 (-0.10, 0.14) 0.12 (-0.05, 0.30) 0.02 (-0.06, 0.10) -0.02 (-0.09, 0.05) 0.06 (-0.01, 0.13) 0.02 (-0.17, 0.22) 0.01 (-0.10, 0.13) 
OCL 266 0.05 (-0.09, 0.18) -0.004 (-0.19, 0.18) 0.02 (-0.07, 0.10) 0.01 (-0.06, 0.10) -0.02 (-0.10, 0.06) 0.05 (-0.16, 0.26) 0.06 (-0.07, 0.18) 
ONB 267 -0.03 (-0.15, 0.10) 0.11 (-0.06, 0.28) -0.01 (-0.09, 0.07) -0.01 (-0.08, 0.06) 0.02 (-0.05, 0.09) 0.05 (-0.15, 0.24) 0.06 (-0.05, 0.18) 
GCF 262 -0.01 (-0.09, 0.07) 0.03 (-0.08, 0.15) 0.004 (-0.05, 0.06) -0.01 (-0.05, 0.04) 0.01 (-0.04, 0.05) -0.01 (-0.14, 0.12) 0.03 (-0.04, 0.11) 
L-WM 266 -0.01 (-0.09, 0.11) 0.05 (-0.09, 0.19) 0.001 (-0.06, 0.07) 0.01 (-0.05, 0.06) -0.002 (-0.06, 0.06) 0.05 (-0.11, 0.21) 0.06 (-0.03, 0.16) 
Psy-Att 267 -0.04 (-0.15 0.07) 0.08 (-0.08, 0.24) 0.01 (-0.06, 0.08) -0.02 (-0.08, 0.05) 0.04 (-0.02, 0.11) -0.01 (-0.19, 0.17) 0.03 (-0.07, 0.13) 
    CBB 266 -0.01 (-0.10, 0.08) 0.06 (-0.07, 0.20) 0.01 (-0.05, 0.07) -0.002 (-0.05, 0.05) 0.02 (-0.04, 0.07) 0.02 (-0.13, 0.16) 0.04 (-0.04, 0.12) 
Model 2         
GMT 262 0.03 (-0.09, 0.16) 0.02 (-0.15, 0.20) 0.04 (-0.04, 0.11) 0.03 (-0.04, 0.10) -0.004 (-0.08, 0.07) -0.01 (-0.20, 0.18) 0.02 (-0.10, 0.15) 
DET 267 -0.09 (-0.22, 0.05) 0.05 (-0.13, 0.24) 0.004 (-0.08, 0.09) -0.01 (-0.08, 0.06) 0.03 (-0.05, 0.11) -0.01 (-0.21, 0.20) 0.04 (-0.09, 0.17) 
IDN 266 0.02 (-0.10, 0.15) 0.14 (-0.04, 0.31) 0.01 (-0.06, 0.09) -0.02 (-0.09, 0.05) 0.06 (-0.01, 0.14) 0.04 (-0.16, 0.23) -0.01 (-0.13, 0.11) 
OCL 266 0.06 (-0.08, 0.20) 0.02 (-0.17, 0.20) 0.01 (-0.07, 0.10) 0.03 (-0.05, 0.11) -0.02 (-0.10, 0.06) 0.05 (-0.16, 0.26) 0.05 (-0.08, 0.19) 
ONB 267 -0.01 (-0.14, 0.11) 0.13 (-0.04, 0.30) -0.01 (-0.09, 0.07) -0.002 (-0.07, 0.07) 0.04 (-0.04, 0.11) 0.06 (-0.13, 0.25) 0.05 (-0.07, 0.17) 
GCF 262 -0.002 (-0.08, 0.08) 0.05 (-0.07, 0.17) 0.003 (-0.05, 0.05) 0.001 (-0.05, 0.05) 0.01 (-0.04, 0.06) 0.01 (-0.12, 0.13) 0.02 (-0.05, 0.10) 
L-WM 266 0.03 (-0.08, 0.13) 0.07 (-0.07, 0.21) 0.002 (-0.06, 0.07) 0.02 (-0.04, 0.07) 0.01 (-0.05, 0.07) 0.06 (-0.10, 0.22) 0.05 (-0.05, 0.15) 
Psy-Att 267 -0.04 (-0.15, 0.08) 0.09 (-0.07, 0.25) 0.01 (-0.06, 0.08) -0.02 (-0.08, 0.05) 0.05 (-0.02, 0.12) 0.01 (-0.17, 0.18) 0.02 (-0.09, 0.12) 
CBB 266 -0.005 (-0.10, 0.09) 0.08 (-0.05, 0.21) 0.002 (-0.06, 0.06) -0.0001 (-0.05, 0.05) 0.02 (-0.03, 0.08) 0.03 (-0.11, 0.17) 0.03 (-0.06, 0.12) 
All values represent β values and 95% confidence interval (CI). Data not available for CRP, n=4; and outliers removed for IL-8, IL-4 and CRP; n=1. Model 1: adjusted for age and sex, Model 2: adjusted for 
age, sex, education, DASS-21 depression subscale score, BMI, cardiometabolic status, and smoking status. Additionally adjusted for APOE and BDNF genotype. All models adjusted for clustering. Aβ: 
amyloid beta; BDNF: brain derived neurotrophic factor; CBB: CogState Brief Battery; CRP: C-reactive protein; DET: Detection task; GCF: Global cognitive function; GMT: Groton Maze Learning Test; 
IDN: Identification task;  IGF-1: insulin-like growth factor-1; IL-1β: interleukin-1 beta; IL-4: interleukin-4; IL-6: interleukin-6; IL-8: interleukin-8; IL-10: interleukin-10; L-WM: Learning-Working memory 
composite; OCL: One Card learning task; ONB: One Back task; Psy-Att: Psychomotor function-Attention composite; TNF-α: tumor-necrosis factor alpha; VEGF: vascular endothelial growth factor. N.B: All 
markers log-transformed.   
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Table 4.5: Association between single-inflammatory composite Z-score, cognitive 
function Z-scores, and HR-QoL and well-being scores.  
  Model 1  Model 2  
Measure n β-value (95% CI) p-value β-value (95% CI) p-value 
GMT 262 0.01 (-0.15, 0.17) 0.921 -0.01 (-0.17, 0.15) 0.935 
DET 267 -0.03 (-0.20, 0.14) 0.655 -0.04 (-0.21, 0.13) 0.661 
IDN 267 -0.01 (-0.17, 0.15) 0.940 -0.01 (-0.17, 0.15) 0.914 
OCL 266 0.08 (-0.10, 0.26) 0.396 0.06 (-0.12, 0.24) 0.486 
ONB 267 0.08 (-0.10, 0.26) 0.813 0.003 (-0.16, 0.17) 0.970 
GCF 262 0.01 (-0.09, 0.12) 0.780 0.001 (-0.10, 0.10) 0.985 
L-WM  266 0.05 (-0.09, 0.18) 0.508 0.03 (-0.11, 0.16) 0.684 
Psy-Att 267 -0.01 (-0.16, 0.13) 0.854 -0.02 (-0.17, 0.12) 0.779 
CBB 266 0.02 (-0.10, 0.13) 0.775  0.004 (-0.11, 0.12) 0.949 
PF 268 -0.26 (-2.15, 1.62) 0.785 -0.38 (-2.03, 1.27) 0.651 
RP 268 0.20 (-1.53, 1.93) 0.819 0.07 (-1.39, 1.54) 0.923 
BP 268 -1.28 (-3.24, 0.67) 0.197 -1.34 (-3.14, 0.44) 0.140 
GH 267 -0.80 (-2.28, 0.68)  0.290 -0.93 (-2.24, 0.37)  0.162 
VT 268 -0.27 (-1.95, 1.41)  0.754 -0.57 (-1.96, 0.83)  0.427 
SF 268 1.27 (-0.37, 2.91) 0.129 1.03 (-0.33, 2.40) 0.139 
  RE 268 0.68 (-1.36, 2.71) 0.515 0.27 (-1.41, 1.94) 0.754 
MH 268 0.27 (-1.32, 1.87) 0.738 -0.26 (-1.39, 0.86) 0.648 
PCS 267 -0.81 (-2.57, 0.95) 0.369 -0.80 (-2.38, 0.78) 0.323 
MCS 267 0.83 (-0.80, 2.46) 0.318 0.41 (-0.82, 1.63) 0.516 
GQoL 268 -0.25 (-1.23, 0.73) 0.615 -0.25 (-1.23, 0.73) 0.615 
SWL 267 -0.70 (-3.75, 2.36) 0.654 -1.27 (-4.02, 1.49) 0.368 
PWI  268 -1.02 (-3.35, 1.32) 0.394 -1.34 (-3.42, 0.75) 0.208 
All values represent β values and 95% confidence interval (CI). Model 1: adjusted for 
age and sex, Model 2 adjusted for age, sex, education, DASS-21 depression subscale 
score, BMI, cardiometabolic status, and smoking status. All models adjusted for 
clustering. BP: bodily pain; CBB: CogState Brief Battery Composite; DET: Detection 
task; GCF: Global cognitive function; GH: general health; GMT: Groton Maze 
Learning Test; GQoL: overall HR-QoL composite; HR-QoL: health-related quality of 
life; IDN: Identification task; L-WM: Learning-Working memory composite; MCS: 
mental component summary; MH: mental health; OCL: One Card Learning task; 
ONB: One Back task; PCS: physical component summary; PF: physical functioning; 
Psy-Att: Psychomotor function-Attention composite; PWI: Personal Well-being Index 
composite; RE: role emotional; RP: role physical; SF: social functioning; SWL: 
Satisfaction with Life single item score; VT: vitality. N.B: Inflammatory composite 
was log-transformed. 
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Figure 4.1: Associations between serum levels of brain derived neurotrophic factor 
(BDNF), insulin-like growth factor-1 (IGF-1), and cognitive performance for 
Detection task (DET); processing speed,  Identification task (IDN);  visual attention, 
and One Card Learning task (OCL); attention and visual memory, with trend line fitted 
where significant. 
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Figure 4.2: Associations between serum levels of brain derived neurotrophic factor 
(BDNF), insulin-like growth factor-1 (IGF-1), and cognitive performance for the 
Learning/working memory composite (L-WM), Psychomotor function-Attention 
composite (Psy-Att), CogState Brief Battery (CBB), combination of Learning-
Working memory and Psychomotor function-Attention composites, and global 
cognitive function (GCF), with trend line fitted where significant. 
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4.3.4 Cognitive function and amyloid-β (Aβ) peptides 
Lower concentrations of Aβ (1-42) were associated with higher Z-scores for the CBB 
composite in model 1 (P=0.037), but this was attenuated in model 2 (P=0.045), and 
was no longer significant after additionally adjusting for APOE genotype (P=0.065) 
(Table 4.6). No associations between the Aβ (1-42): Aβ (1-40) ratio and cognition were 
observed for any domain, and no other significant associations were detected, as 
presented in Table 4.6 and Appendix J.  
 
4.3.5 HR-QoL, well-being and inflammatory and neurological markers  
There were no significant associations between any measures of HR-QoL or well-
being and markers of inflammation, with the exception that higher concentrations of 
CRP were associated with lower scores in vitality (P=0.004), and a higher score in the 
pro-inflammatory composite Z-score was also associated with lower scores in vitality 
(β= -2.06; 95% CI: -3.49, -0.62; P=0.005) (Tables 4.5 and 4.7, Appendix K). These 
associations persisted even after adjustment for all covariates and APOE genotype. 
 
No significant associations were observed between neurological markers and any 
HR-QoL domain, or well-being measures (Appendix L and M). A summary of all 
associations is provided in Table 4.8.  
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 Table 4.6: Association between cognitive function composite scores and the various circulating growth and neurological markers.  
 
n 
Aβ (1-40) Aβ (1-42) BDNF IGF-11 VEGF 
β-value (95% CI) β-value (95% CI) β-value (95% CI) β-value (95% CI) β-value (95% CI) 
Model 1        
     GCF  262 -0.12 (-0.28, 0.04) -0.06 (-0.13, 0.003)  0.01 (0.001, 0.02) * -0.01 (-0.02, 0.01) -0.06 (-0.15, 0.03) 
     L-WM 266 -0.12 (-0.31, 0.07) -0.09 (-0.18, -0.004)  0.01 (-0.004, 0.02) -0.02 (-0.04, -0.003) * -0.03 (-0.14, 0.09) 
     Psy-Att  267 -0.20 (-0.43, 0.02) -0.08 (-0.17, 0.02) 0.01 (0.003, 0.02) ** -0.005 (-0.02, 0.02) -0.09 (-0.22, 0.04) 
     CBB  266 -0.16 (-0.33, 0.03) -0.08 (-0.16, -0.005) * 0.01 (0.0004, 0.02) * -0.01 (-0.03, 0.003) -0.06 (-0.16, 0.05) 
 Model 2       
     GCF  262 -0.12 (-0.28, 0.04) -0.06 (-0.13, 0.01)       0.01 (0.001, 0.17) *† -0.01 (-0.02, 0.01) -0.07 (-0.16, 0.02) 
     L-WM  266 -0.12 (-0.31, 0.07) -0.08 (-0.17, 0.01)  0.01 (-0.003, 0.02) -0.02 (-0.04, -0.001)  -0.04 (-0.16, 0.08) 
     Psy-Att  267 -0.19 (-0.41, 0.03) -0.08 (-0.17, 0.02) 0.01 (0.004, 0.02) **† -0.003 (-0.02, 0.02) -0.10 (-0.23, 0.03) 
     CBB  266 -0.15 (-0.33, 0.03) -0.08 (-0.15, -0.002) * 0.01 (0.001, 0.02) *† -0.01 (-0.03, 0.005) -0.07 (-0.17, 0.04) 
All values represent β values and 95% confidence interval (CI). 1 Data not available for four participants. Model 1: adjusted for age and sex, Model 2: 
adjusted for age, sex, education, DASS-21 depression subscale score, BMI, cardiometabolic risk status, and smoking history. Additionally adjusted for 
APOE and BDNF genotype. All models adjusted for clustering. * P<0.05, ** P≤0.01, † significant after adjusting for APOE or BDNF genotype. Aβ: 
amyloid beta, BDNF: brain derived neurotrophic factor, CBB: CogState Brief Battery composite, GCF: Global cognitive function composite; IGF-1: 
insulin-like growth factor-1; L-WM: Learning-Working memory composite; Psy-Att: Psychomotor function-Attention composite; VEGF: vascular 
endothelial growth factor. N.B: adjusted value set at P<0.01 for cognitive domains (GMT, DET, IDN, OCL and ONB; 0.05 divided by five tests), and 
P<0.025 for L-WM and Psy-Att composites, P<0.05 for CBB and GCF. Concentrations of Aβ (1-40), Aβ (1-42) and VEGF were log-transformed. 
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Table 4.7: Association between HR-QoL and well-being composite scores with individual circulating inflammatory markers.  
 n 
IL-6 TNF-α IL-1β IL-10 IL-4 IL-8 CRP 
β-value (95% CI) β-value (95% CI) β-value (95% CI) β-value (95% CI) β-value (95% CI) β-value (95% CI) β-value (95% CI) 
HR-QoL         
PCS         
  Model 1 267 -1.07 (-2.42, 0.28) 0.21 (-1.68, 2.10) -0.30 (-1.16, 0.57) -0.41 (-1.17, 0.36) -0.34 (-1.12, 0.44)  -2.12 (-4.16, -0.06) § 1.30 (-2.52, -0.09) §  
  Model 2 267 -0.47 (-1.69, 0.75) 0.29 (-1.38, 1.95) -0.16 (-0.93, 0.60) -0.08 (-0.77, 0.60) 0.02 (-0.68, 0.72)  -1.76  (-3.60, 0.08)  0.68 (-1.87, 0.51) 
MCS         
Model 1 267 -0.79 (-2.01, 0.42) -0.21 (-1.91, 1.49) -0.28 (-1.05, 0.50) -0.42 (-1.10, 0.27) -0.39 (-1.09, 0.32) -0.38 (-2.28, 1.53) 0.07 (-1.08, 1.23) 
Model 2 267 -0.18 (-1.13, 0.76) 0.89 (-0.42, 2.20) -0.40 (-1.00, 0.19) -0.08 (-0.61, 0.45) -0.20 (-0.75, 0.36) 0.33 (-1.12, 1.78) -0.12 (-1.05, 0.81) 
GQoL         
   Model 1 268 -0.87 (-1.88, 0.13) 0.04 (-1.35, 1.43) -0.18 (-0.82, 0.46) -0.32 (-0.89, 0.25) -0.31 (-0.89, 0.27) -1.37 (-2.93, 0.19) -0.71 (-1.64, 0.22) 
   Model 2 268 -0.34 (-1.09, 0.42) 0.63 (-0.40, 1.66) -0.24 (-0.72, 0.22) -0.07 (-0.49, 0.36) -0.08 (-0.51, 0.36) -0.84 (-1.98, 0.31) -0.46 (-1.20, 0.27) 
Well-being         
SWL         
  Model 1 267 -0.43 (-2.73, 1.87) -1.51 (-4.72, 1.69) 0.45 (-1.01, 1.91) 0.13 (-1.17, 1.43) -0.41 (-1.74, 0.92) -1.05 (-4.64, 2.53) -0.70 (-2.89, 1.48) 
  Model 2 267 0.41 (-1.74, 2.56) -0.58 (-3.51, 2.35) 0.61 (-0.73, 1.94) 0.78 (-0.42, 1.98) 0.13 (-1.12, 1.37) -0.34 (-3.61, 2.92) -0.26 (-2.37, 1.85) 
PWI          
  Model 1 268 -0.89 (-2.65, 0.87) -0.81 (-3.26, 1.64) -0.04 (-1.15, 1.08) 0.28 (-0.72, 1.27) -0.73 (-1.75, 0.29) -1.48 (-4.22, 1.26)   -0.92 (-2.56, 0.73) 
  Model 2 268 -0.28 (-1.89, 1.33) -0.42 (-2.61, 1.78) 0.12 (-0.89, 1.12) 0.71 (-0.19, 1.61) -0.29 (-1.21, 0.64) -1.03 (-3.48, 1.42)   -0.47 (-2.05, 1.12) 
All values represent β values and 95% confidence interval (CI). Data not available for CRP, n=4; and outliers removed for IL-8, IL-4 and CRP; n=1. Model 1: adjusted for age and sex, 
Model 2: adjusted for age, sex, education, DASS-21 depression subscale score, BMI, cardiometabolic status, and smoking status. Additionally adjusted for APOE and BDNF genotype. 
All models adjusted for clustering. § not significant after adjusting for multiple comparisons. CRP: C-reactive protein; GQoL: overall HR-QoL composite; HR-QoL: health-related 
quality of life; IL-1β: interleukin-1 beta; IL-4: interleukin-4; IL-6: interleukin-6; IL-8: interleukin-8; IL-10: interleukin-10; MCS: mental component summary; PCS: physical 
component summary; PWI: Personal Well-being Index composite; SWL: Satisfaction with Life single item score; TNF-α: tumor-necrosis factor alpha. N.B: All values log-transformed.  
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Table 4.8: Summary of significant associations between inflammatory and neurological markers, cognitive function and HR-QoL. 
 Cognitive Function HR-QoL 
Biomarker Model 1 Model 2 Model 2 + genotype Model 1 Model 2 Model 2 + genotype 
IL-6 - - - - - - 
TNF-α - - - - - - 
IL-1β - - - - - - 
IL-8 - - - -   
CRP - - - VT (-) VT (-) VT (-) 
IL-10 - - - - - - 
IL-4 - - - - - - 
Aβ (1-40)  - - - - - - 
Aβ (1-42)  CBB (-) CBB (-) - - - - 
BDNF IDN (+), GCF (+), 
Psy-Att (+), CBB (+) 
IDN (+), GCF (+), 
Psy-Att (+), CBB (+) 
IDN (+), GCF (+), 
Psy-Att (+), CBB (+)  - - 
IGF-1 OCL (-), L-WM (-) OCL (-) OCL (-) - - - 
VEGF - - - - - - 
Pro-inflammatory 
Composite - - - VT (-) VT (-) VT (-) 
Anti-inflammatory 
Composite - - - - - - 
Inflammatory 
Composite - - - - - - 
(-): significant inverse association, (+): significant positive association after correction for multiple comparisons. Model 1: adjusted for age and sex, Model 2: adjusted for age, sex, education, DASS-
21 depression subscale score, BMI, cardiometabolic status, and smoking status. Model 2 additionally adjusted for BDNF or APOE genotype. Aβ: amyloid beta; BDNF: brain derived neurotrophic 
factor; CRP: C-reactive protein; CBB: CogState Brief Battery composite; GCF: Global cognitive function; HR-QoL: health-related quality of life; IDN: Identification task; IGF-1: insulin-like growth 
factor-1; IL-1β: interleukin-1 beta; IL-4: interleukin-4; IL-6: interleukin-6; IL-8: interleukin-8; IL-10: interleukin-10; L-WM: Learning-Working memory composite; OCL: One Card Learning task; 
Psy-Att: Psychomotor function-Attention composite; TNF-α: tumor-necrosis factor alpha; VEGF: vascular endothelial growth factor; VT: vitality subdomain.
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4.3.6 Interactions 
Genotype interactions  
No interaction effects were detected between BDNF polymorphisms and the 
associations between serum BDNF concentrations and cognitive function. Similarly, 
no significant interaction effects were detected between APOE polymorphisms and the 
relationship between Aβ (1-40) concentrations and cognitive function. However, an 
interaction was observed between executive function (GMT) and Aβ (1-42) (β=0.26; 
95% CI: 0.02, 0.50; P=0.033) by APOE status. Non- ɛ4 carriers of the APOE gene 
displayed a non-significant inverse association between GMT and Aβ (1-42) (β= -
0.07; 95% CI: -0.20, 0.06; P=0.273) whereas ɛ4 carriers showed a positive non-
significant association with GMT (β=0.13; 95% CI: -0.07, 0.32; P=0.201). 
Furthermore, an interaction effect was detected between the L-WM composite Z-score 
and the composite inflammation score by APOE polymorphism status (β = -0.35; 95% 
CI: -0.66, -0.04; P=0.027). For non- ɛ4 carriers of the APOE gene, there was a non-
significant positive association between L-WM and the inflammatory composite (β= 
0.13; 95% CI: -0.02, 0.28; P=0.100) while for ɛ4 carriers there was a non-significant 
inverse association with L-WM (β= - 0.22; 95% CI: -0.51, 0.07; P=0.135). No other 
significant interactions were detected between APOE polymorphisms and the 
associations between inflammatory concentrations or composites, and cognitive 
function. 
 
No significant interactions were detected between APOE or BDNF polymorphisms, 
neurological markers [BDNF, IGF-1, VEGF, Aβ (1-40) and Aβ (1-42)] and any HR-
QoL or well-being variable.  
 
Sex interactions 
Sex had no influence on the associations of any inflammatory or neurological markers 
with any cognitive function, HR-QoL, or well-being variable.  
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4.4 Discussion  
The main findings from this study in independently living older adults were that higher 
levels of serum BDNF were significantly associated with better cognitive function 
across multiple domains, including psychomotor function, attention, working-memory 
and global cognitive function. There were no other associations between the various 
neurological and inflammatory markers with any cognitive measures, with the 
exception of the unexpected finding that higher serum IGF-1 levels were associated 
with poorer visual memory and attention. For HR-QoL and well-being, there were no 
significant associations between any inflammatory or neurological markers, with the 
exception that higher levels of CRP and the pro-inflammatory composite were 
associated with lower perceptions of vitality. Finally, polymorphisms of the APOE 
gene showed differential relationships in the associations between the inflammatory 
composite scores and learning/working memory, and Aβ (1-42) and executive 
function, but no other interactions by APOE or BDNF polymorphism or sex were 
detected.  
 
Inflammation and cognitive function  
Considerable evidence has demonstrated that age-related low grade inflammation is 
associated with cognitive decline, dementia, and AD (Engelhart et al. 2004; Godbout 
& Johnson 2009). However any relationship between inflammation and cognitive 
processes in healthy older adults remains unclear, and mixed data seen in non-
cognitively impaired populations is largely accounted for by known predictors of 
cognition such as age, socioeconomic status, and education (Dik et al. 2005). In our 
study, we found that no individual inflammatory cytokines or composite scores were 
associated with any measure of cognitive function, which may be explained by our 
participants’ characteristics. The current study sample was comprised of ‘apparently 
healthy’ older adults living in retirement villages who volunteered for a health and 
well-being exercise trial. Although older age was significantly associated with poorer 
cognitive performance across multiple domains in our study, only 7% of our 
participants were informally classified as MCI (three or more cognitive measures with 
a Z-score ≤-1.0 SD). This may have stemmed from our selection of older adults with 
low-cognitive impairment (those who answered ≥8 correct answers on the short 
portable mental status questionnaire). Previous research has reported that up to 19% 
of older adults in the general community may be categorised as MCI (Gauthier et al. 
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2006), although it is difficult to compare across studies that use different cognitive 
measures. Subclinical changes in cognitive function may also be harder to discriminate 
in a cohort such as ours that has a low incidence of objectively measured cognitive 
impairment.  
 
Previous research has shown that older individuals with higher levels of inflammation 
display poorer cognitive performances or are more likely to experience cognitive 
decline (Gorelick 2010; Schram et al. 2007). As only 7% of our participants were 
classified as MCI, our sample may not possess the same associated risks for increased 
inflammation and cognitive decline as cohorts with a higher prevalence of cognitive 
impairment. Indeed, previous studies have demonstrated associations between specific 
inflammatory markers and MCI sub-types (Álvarez et al. 2007; Trollor et al. 2010). 
This may have contributed to our null findings. In support of this notion, age was not 
significantly associated with concentrations of any inflammatory marker. 
Furthermore, in our study, only 30% of participants had a baseline CRP level >3 mg/L, 
which is considered elevated and confers a high-risk of cardiovascular disease 
(Pearson et al. 2003). Previous research has shown that a combination of CVD and 
greater inflammation may be associated with cognitive impairment, as multiple 
inverse relationships between inflammation and domains of cognitive function were 
detected in older adults (>85 years) with a history of CVD, but were not found for 
older adults with no history (Van Exel et al. 2003). Thus, the lack of any significant 
association between the inflammatory cytokines and cognition in our study may be a 
result of a relatively healthy cohort of older adults.  
 
While many of the participants in our study reported having a chronic condition(s) that 
has been associated with increased systemic inflammation (40% were obese; 72% 
were hypertensive; 86% had one or more cardiometabolic risk factors), we excluded 
those with unstable cardiovascular disease or respiratory disorders. Furthermore, all 
our results essentially remained unchanged after adjusting for common chronic 
diseases (e.g., hypertension, type 2 diabetes, depression), and the vast majority were 
receiving medication for their conditions. Previous research has shown that 
antihypertensive drug treatment can reduce the incidence of dementia (Forette et al. 
1998), and cognitive decline in hypertensive older adults (Guo et al. 1999), through a 
reduction in the number of cerebrovascular events (Psaty et al. 1997) and preventing 
the development and progression of lesions, plaques and neurofibrillary tangles which 
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are associated with cognitive degeneration in hypertensives (Sparks et al. 1995). 
Furthermore, antihypertensive medication may reduce the symptoms of CVD that are 
associated with higher levels of inflammation (Hansson & Hermansson 2011; Ridker 
et al. 2000). In part support of our findings, studies investigating the relationships 
between aggregates of inflammatory markers and cognitive function have shown 
inconsistent, yet marginal inverse relationships with standardized performances in 
working memory (Trollor et al. 2012) and processing speed (Heringa et al. 2014) in 
non-cognitively impaired and healthy older adults. However, no cross-sectional 
associations were found between individual or composite markers of inflammation and 
standardized scores in cognitive function in a large sample of community-dwelling 
healthy older adults (>75 years), after  adjusting for similar covariates to our analysis 
(e.g., CVD risk, smoking, APOE genotype) (Chi et al. 2017). These findings add 
further support to our suggestion that the relationship between inflammation and 
cognitive function may be weaker in relatively healthy older adults without any 
evidence of cognitive deficit.  
 
BDNF and cognitive function  
It is well accepted that BDNF plays an important role in the survival, maturation, and 
maintenance of developing neurons (Christie et al. 2008), and can modulate plasticity 
in the adult brain (Cotman, Berchtold & Christie 2007; Voss et al. 2013). In our study, 
we found that higher levels of serum BDNF were associated with greater performance 
in attention and reaction time and higher scores in composites including working 
memory and learning, psychomotor function and attention, and global cognitive 
function. In contrast, no associations were detected with executive function or specific 
domains of memory. In part support of these mixed findings, previous research in older 
adults has also reported conflicting findings with regard to whether serum BDNF 
concentrations are associated with cognitive function, and the specific cognitive 
domains that are associated with BDNF concentrations (Driscoll et al. 2012; Gunstad 
et al. 2008; Shimada et al. 2014). For instance, in a previous study involving 
community dwelling adults over 65 years, higher levels of serum BDNF were found 
to be positively associated with processing speed and a component of memory, but no 
relationships were found with global cognitive function and executive function 
(Shimada et al. 2014). Furthermore, enhanced long-term memory and global cognitive 
function were observed with higher serum BDNF concentrations in healthy older 
adults, but no associations were observed with executive function and processing 
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speed among other domains (Gunstad et al. 2008). Together, this data and our findings 
suggest that BDNF levels may contribute to improved performance in broader 
cognitive domains, while specific higher-order cognitive abilities such as executive 
function and working memory may not benefit from greater concentrations of BDNF. 
This is somewhat puzzling given that central BDNF is highly concentrated in the 
hippocampus, where it facilitates learning and memory through a modulation of 
synaptic plasticity (Bramham & Messaoudi 2005), contributes to the induction of long-
term potentiation (Lu, Christian & Lu 2008) and decreases apoptotic processes in 
hippocampal neurons (Almeida et al. 2005; Murer et al. 1999). Furthermore, the 
hippocampus-orbitomedial prefrontal circuit also integrates working memory and 
executive function (Wall & Messier 2001), which suggests that BDNF may have 
different roles in these brain regions that are unrelated to memory function and 
executive function.  
 
A possible reason for the lack of an association between BDNF and working memory 
in our study is that memory function may only diminish with considerable decreases 
in BDNF or in late stages of cognitive decline and dementia. A similar concept has 
previously been demonstrated, whereby a 1 SD decrease in BDNF in older women 
increased the risk for lower scores in several tests assessing working memory 
(Komulainen et al. 2008). Despite a higher percentage of older females in our sample, 
we adjusted for sex and additionally, and did not observe any sex-interactions in the 
associations between BDNF and any cognitive domain. This reasoning may also 
explain why associations between BDNF and other domains did not persist in 
sensitivity analyses, however the CogState defined classification of MCI may not 
possess the sensitivity of other criteria.Given the inconsistent relationships of BDNF 
with domains of cognitive function, higher levels of BDNF may instead have more 
important roles in reducing the risk of neurodegeneration across a continuum of health 
states (Swardfager et al. 2011), as low circulating levels of BDNF are associated with 
age-related neuronal loss (Foster, Rosenblatt & Kuljiš 2011; Ziegenhorn et al. 2007).  
 
IGF and cognitive function  
Emerging evidence has identified IGF-1 as a key contributor to cognitive functioning 
in older adults, however we found no associations between IGF-1 and cognitive 
function, aside from an inverse relationship with working memory. In contrast, a  2005 
meta-analysis including 13 cross-sectional studies reported that IGF-1 levels were 
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positively associated with selected domains of cognition in older adults, including 
processing speed and executive function (Arwert, Deijen & Drent 2005), while other 
studies have shown that higher IGF-1 levels were associated with greater performance 
in cognitive tasks measuring attention (Bellar et al. 2011), and global cognitive 
function (Okereke et al. 2007; Rollero et al. 1998). However these studies displayed 
methodological differences to our research (e.g., some included only men or women, 
and/or had a restrictive age range) making direct comparison difficult. The different 
methodologies and demographics between our study and previous research may 
therefore be a factor in our divergent findings. A further suggestion for our general 
lack of findings is based on previous speculation that differences in cognitive function 
may only be viewed with substantially higher or lower levels of IGF-1 in a sample 
(Licht et al. 2014). As our sample consisted of relatively healthy older adults, this 
cohort may have demonstrated a narrower range of IGF-1 concentrations which may 
reflect the homeostatic control of this hormone as it regulates the secretion of growth 
hormone via negative feedback (Sonntag, Ramsey & Carter 2005). Indeed, we found 
that serum IGF-1 concentrations were not associated with age in our cohort. Therefore, 
while some previous studies in healthy older adults have shown positive findings 
between IGF-1 and cognitive function (Arwert, Deijen & Drent 2005), these may be 
more apparent in cohorts of older adults with greater variability in their IGF-1 levels, 
compared to our sample.     
 
In an unexpected result we found that higher levels of IGF-1 were associated with 
worse performance in a task measuring visual memory and attention, which may be 
underscored by physiological mechanisms. A number of brain regions possess 
receptors for IGF-1, however the highest concentrations are in the hippocampus and 
prefrontal cortex (Trejo et al. 2004; van Dam & Aleman 2004). Previous research has 
predominantly indicated associations between IGF-1 and cognitive speed, or motor 
performance (Arwert, Deijen & Drent 2005), which are primarily coordinated by the 
prefrontal cortex. However, given that IGF-1 is crucial for neurogenesis in the 
hippocampus (Lindholm et al. 1996) and its receptors are also prominent in the 
prefrontal cortex and limbic areas such as the hippocampus and amygdala (Adem et 
al. 1989; van Dam & Aleman 2004), it is unusual that positive associations with 
memory function or attention are not observed in the literature (Bellar et al. 2011). Our 
finding of an inverse association is supported by a recent investigation whereby older 
adults (>60 years) categorised into higher tertiles of IGF-1 showed lower processing 
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capacity (Tumati et al. 2016). It has been proposed that higher levels of IGF-1 may 
reflect a compensatory response to ongoing disease that can compromise cognitive 
function (Tumati et al. 2016). For example, higher levels of IGF-1 have been 
associated with an increased risk for cardiovascular diseases (Juul et al. 2002) and 
cancer (Pollak, Schernhammer & Hankinson 2004), while lower levels of IGF-1 may 
be associated with a reduced activity of the insulin/IGF signalling system which has 
been linked to longevity (Junnila et al. 2013; Suh et al. 2008) and a lower risk of 
cognitive impairment (Euser et al. 2008). Further to this idea, cognitive function may 
speculatively operate most effectively within optimum levels of IGF-1 in a curvilinear 
relationship, in a similar manner to the observed relationship between cognition and  
testosterone (Matousek & Sherwin 2010; Muller et al. 2005), whereby higher 
concentrations of IGF-1 may potentially impair particular cognitive abilities. Further 
data is however needed to confirm these assumptions.  
 
Genotype interactions  
There is some evidence to support the notion that older adults possessing the ε4 variant 
of the APOE gene coding for apolipoprotein-E may have a greater risk for cognitive 
decline and degeneration (Alzheimer’s Association 2015; Poirier et al. 1993; Sperling 
et al. 2011). In our study, genetic polymorphisms of APOE influenced the associations 
between Aβ (1-42) and executive function, and the relationship between the 
inflammatory composite and working memory and learning. While these mixed 
findings are difficult to interpret, a tentative explanation for the first observation is that 
higher levels of Aβ (1-42) unexpectedly have a greater deleterious impact on executive 
function in non-ε4 carriers. The APOE-ε4 polymorphism has implications for 
cognitive health, as the apolipoprotein-E protein coded by this variant may 
inappropriately bind and clear cholesterol and phospholipids which are required for 
redistribution in myelin and neuronal membranes (Boyles et al. 1989; Mahley 1988), 
and brain re-innervation processes in regions vulnerable to ageing (Poirier et al. 1993). 
Furthermore, ApoE proteins can bind to forms of Aβ (Wisniewski et al. 1993), whose 
deposition into senile plaques is also linked to neurodegeneration (Akiyama et al. 
2000). It would therefore be expected that the expression of ApoE-ε4 in conjunction 
with higher levels of Aβ (1-42) peptides may contribute to the poorer performances 
observed in executive function, however this was not observed in ε4 carriers. A 
potential explanation is that the expression of the ε4 variant may be more deleterious 
in older adults with cognitive impairment or disease (Nacmias et al. 2004; Small, 
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Basun & Bäckman 1998). Since the majority of our participants were not classified as 
having MCI, this polymorphism may have had minimal effects on cognition. Cross-
sectional studies with healthy older adults have reported mixed evidence, with a meta-
analysis reporting a small domain-specific effect of the ApoE-ε4 genotype on global 
cognitive function, episodic memory and executive function, which diminishes with 
ageing (Small et al. 2004). Despite these findings, these studies investigated 
associations rather than interaction effects, which may not be comparable to our 
analysis. Furthermore, there is mixed evidence that the APOE-ε4 allele in combination 
with CVD or chronic disease may increase the risk of cognitive decline in older adults, 
rather than genetic factors alone (Haan et al. 1999; Helkala et al. 1995; Liu et al. 2010). 
Therefore, it could be speculated that the interaction of ApoE with Aβ may be disease-
dependent in conferring cognitive risk to older adults. Alternatively, the negative 
effects of the ε4 allele could be ameliorated or offset by lifestyle habits which lower 
disease risk (e.g., increased physical activity, balanced diet) or other compensatory 
mechanisms.  
 
In our study we also found that higher Z-scores in the inflammatory composite score 
adversely impacted working memory and learning in ε4 carriers, compared to non-ε4 
carriers. Possession of the ε4 allele is linked to higher inflammation (Jofre‐Monseny, 
Minihane & Rimbach 2008), and therefore a reasonable mechanistic assumption for 
our expected observation may be that inflammation interacts with the ApoE-ε4 protein 
differently to other ApoE variants, in exerting cognitive deficits. However, there is 
little evidence available to support our findings in healthy older adults, with a stronger 
association between inflammatory markers and cognitive decline in carriers of the ε4 
allele previously reported in adults aged over 85 years (Schram et al. 2007), while 
another study reported no interaction between these elements (Dik et al. 2005). As a 
potential mechanism underscoring our findings, a number of studies have 
demonstrated that ApoE-ε4 carriers have smaller hippocampal volumes than that of 
non-carriers, in both healthy older adults and AD patients (Cohen et al. 2001; 
Juottonen et al. 1998). This has implications for episodic memory performance, given 
the reliance of this cognitive aspect on the hippocampus (Nyberg et al. 1996), however 
hippocampal volume loss has not always corresponded with detectable memory 
changes (Cohen et al. 2001). Nonetheless, inflammation has been associated with 
poorer memory in older adults (Schram et al. 2007; Trollor et al. 2012), and therefore 
our finding suggests that the ε4 polymorphism may exacerbate a potentially 
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deleterious relationship between inflammation and memory, however the implications 
and underlying mechanisms of this discovery require further investigation.  
 
Inflammation and HR-QoL 
Another key finding from our study was that higher levels of inflammation were not 
associated with any measure of HR-QoL or well-being, apart from the observation that 
higher concentrations of CRP and the pro-inflammatory composite were associated 
with lower scores in vitality. In relation to our mostly null findings, a previous study 
involving 73 adults aged over 65 years found that higher levels of both TNF-α and IL-
1β were associated with poor self-rated health, lower energy, and lower well-being 
(Unden et al. 2007). However it is unclear how the scales used by these authors 
compare to the SF-36 or Personal Wellbeing Index we employed, in a larger sample. 
Similarly, in a cross-sectional study of healthy older adults who provided care for a 
spouse with dementia, lower global scores of self-rated health (measured through a 
single-item measure) were associated with higher levels of serum CRP and IL-6 , even 
after controlling for demographics, depressive symptoms, and objective diagnoses of 
health conditions (Christian et al. 2011). However, in this study only one subscale of 
the SF-36 (physical functioning) was inversely associated with inflammatory levels 
(Christian et al. 2011). Based on these findings and our results, it remains unclear as 
to whether higher inflammatory levels may impair perceptions in broader HR-QoL 
assessments such as global health or vitality. In contrast, ratings in more specific 
domains (e.g., social functioning, role emotional) may be more preferentially shaped 
by external factors (i.e. social support, companionship) (García et al. 2005), rather than 
intrinsic physiological factors.  
 
Our finding that higher levels of CRP and a composite of all pro-inflammatory markers 
were associated with lower perceptions of vitality may have a psychophysiological 
bases. An initial line of reasoning for this finding is that higher levels of CRP and other 
pro-inflammatory cytokines may increase the risk for functional disability (e.g., 
muscle loss) and disease (e.g., arthritis, osteoporosis, CVD) (Ferrucci et al. 2001; 
Ferrucci et al. 2005; Ferrucci et al. 1999), which diminishes perceptions of energy 
levels and the ability to carry out physical tasks. However, it is also established that 
the brain and peripheral immune system form a bidirectional communication network, 
whereby acute psychological and physical stress can produce sequelae similar to an 
immune response, including the release of pro-inflammatory cytokines and symptoms 
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of ‘sickness’; social withdrawal, depressive symptoms and sleep disturbances, which 
can be perpetuated by inflammatory release [for review see (Maier & Watkins 1998; 
Turnbull & Rivier 1999)]. Due to limited data linking HR-QoL and inflammation, the 
direction of the significant inverse relationship we observed between pro-
inflammatory levels and vitality is not clear. Alternatively, higher perceptions of 
vitality may contribute to lower inflammatory levels, as positive social relationships 
are associated with lower pro-inflammatory levels in older adults (Eisenlohr‐Moul & 
Segerstrom 2013; Friedman 2011; Friedman et al. 2007). Furthermore, greater 
perceptions of vitality may confer a greater desire to participate in exercise which can 
reduce inflammatory levels. However, these relationships require further 
investigation.  
 
BDNF, IGF-1 and HR-QoL  
As previously discussed, BDNF has critical roles in neurogenesis and synaptic 
plasticity, however a disruption of these processes has been observed in stress and 
mood disorders, which has led to speculation that a recession of BDNF and other 
growth factors may be key factors in the pathogenesis of mood disorders (Pittenger & 
Duman 2008), which may also underscore impairments in  HR-QoL. We observed no 
significant associations between any of the neurological markers and HR-QoL or well-
being, however it is possible that these findings may relate to the characteristics of our 
participants (e.g., healthy older adults with little evidence of cognitive impairment or 
depression). Moreover, while the DASS-21 depression subscale does not provide a 
formal diagnosis of depression, 13% of participants had scores above the normal range 
at baseline (>9) which is indicative of mild to severe depression, and aligns with 
estimates from previous studies in retirement villages (e.g., 15% measured by Geriatric 
Depression Scale) (Merom et al. 2016). Lower concentrations of BDNF have been 
consistently observed in individuals with mood disorder or chronic stress (Sen, Duman 
& Sanacora 2008), and older adults with late-onset geriatric depression (Shi et al. 
2010), compared to healthy controls. Therefore as the recession of BDNF below a 
certain threshold is linked to disordered well-being in adults, healthy older adults such 
as ours would be expected to have higher concentrations which do not contribute to 
the pathophysiology of poorer well-being. In addition, a previous review has reported 
that lower levels of BDNF disrupt neuroplasticity, and therefore lower concentrations 
of BDNF may have a common role in both the pathophysiology of depression and 
impaired cognitive function in ageing (Pittenger & Duman 2008). It is therefore 
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possible that the inverse relationship between well-being and BDNF may be more 
apparent in older adults with cognitive impairment who also display reduced levels of 
BDNF (Laske et al. 2007; Yu et al. 2008), rather than in a sample of cognitively 
healthy older adults as found in our study. Future studies are needed to establish 
whether a decrease in BDNF in healthy older adults may be associated with impaired 
cognitive function, which in turn affects HR-QoL and well-being, or whether these 
relationships are specific to clinical populations. 
 
The relationship between IGF-1 and well-being in older adults is unclear, with one 
study detecting weak but positive relationships between IGF-1 and psychological well-
being in 20-44 year old adults, which did not persist into middle or older age (Unden 
et al. 2002). In partial support of these findings, we found no relationships between 
IGF-1 and HR-QoL and well-being in healthy older adults. Receptors for IGF-1 are 
prominent in the prefrontal cortex and limbic areas (e.g., hippocampus, amygdala) 
(van Dam & Aleman 2004), which regulate depressive symptomatology (Dere, Pause 
& Pietrowsky 2010). Despite the location of these receptors, IGF-1 may instead trigger 
processes important for cognitive function in these regions (Fernandez et al. 2007). 
This mixed data implies that well-being may only be disturbed when IGF-1 levels drop 
below a certain threshold, but the optimal level for health benefits remains unknown.  
Nevertheless, given the neuroprotective roles of IGF-1 as well as BDNF and VEGF, 
and the interrelatedness of well-being and cognition, the connection between these 
growth factors and perceived health should be further investigated.   
 
Strengths and Limitations 
The strengths and limitations of this intervention will be discussed in detail in Chapter 
8, and therefore only the strengths and limitations unique to this study will be 
presented. There are several strengths to this study. To our knowledge, this is one of 
the few studies to associate inflammatory and neurological markers with HR-QoL as 
measured by the SF-36, while the CogState battery and the PWI have not been 
previously used with independently living older adults, but allow the measurement of 
individual and composite domains. In addition, the current study analysed a wide array 
of biomarkers which attempted to identify candidate markers for impaired and 
enhanced cognition and well-being in older adults. This study also had some 
limitations. Firstly, due to the cross-sectional design no inferences about causality can 
be made. Second, an assumption in the construction of the total composite Z-scores 
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for inflammation was that all markers were equally important and were therefore 
assigned equal weightings, which may not be biologically valid. Third, our findings 
are based on circulating levels of inflammation and neurological markers, which may 
vary from brain levels, depending on the biomarker. However, direct measurements of 
brain levels are not currently available at a population level. Fourth, although we 
controlled for multiple lifestyle, demographic and genetic factors and corrected for 
multiple comparisons, it is possible that spurious significant outcomes may have arisen 
due to the number of statistical comparisons performed. Fifth, we may not have had 
statistical power to allow for moderation analyses, which although is a potential 
limitation, in the context of this thesis these analyses were exploratory opportunities. 
Finally, as our sample may be regarded as relatively high-functioning with little racial 
diversity, it is unknown as to how generalizable the reported findings are to 
community-dwelling older adults. For example, compared to estimates of Australians 
with a mean age of 75 and over, our participants had a higher prevalence of 
hypertension (70% vs 46%) and hyperlipidemia (50% vs 26%) (Australian Bureau of 
Statistics 2015b). Furthermore, 26% of our participants received a university or tertiary 
education compared to only 9% of the Australian population over 65 years (Australian 
Institute of Health and Welfare 2015). Finally, only 1% of our sample were non-
Caucasian which may be representative of Australian older adults, however this 
proportion in other studies of community dwelling adults outside of Australia ranges 
from 5% (Chi et al. 2017) to 41% (Yaffe et al. 2003).  
 
In conclusion, the majority of circulating levels of inflammatory and neurological 
makers were not associated with any measure of cognitive function in independently 
living older adults, but we did find that serum BNDF levels were positively associated 
with better cognitive function across multiple domains, including psychomotor 
function, attention, working-memory and global cognitive function. Furthermore, 
there was some evidence that associations between amyloid beta (Aβ 1-42) and 
executive function, and the composite inflammatory score with working memory and 
learning were under the influence of APOE genetic polymorphisms. Well-being and 
HR-QoL displayed no associations with any inflammatory and neurological markers, 
except that heightened CRP levels and greater scores in a composite of pro-
inflammatory cytokines in older adults were associated with lower perceptions of 
vitality. Further longitudinal studies are needed to test whether changes in these 
biomarkers can predict cognitive or HR-QoL changes over longer time periods. 
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5. Chapter 5  
Effects of a dual-task functional power training program                                  
on cognitive function in older adults. 
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Student declaration  
The following chapters (5-7) present analyses, results and discussions pertaining to the 
26-week DT-FPT intervention component of the larger 18-month NHMRC-funded 
PACE-IT trial. Under the guidance of my primary supervisor, my role was to collect 
and analyse the data arising from the trial that was relevant to my thesis aims, as 
presented in these chapters, draft and write the results, prepare all tables and figures, 
and compose the discussion sections with assistance from my supervisory team.  
 
5.1 Introduction  
Age-associated cognitive decline and dementia are growing public health concerns for 
which there is no cure. Physical exercise such as aerobic training, progressive 
resistance training (PRT) or the combination have been shown to produce some 
cognitive benefits in healthy older adults (Angevaren et al. 2008; Colcombe & Kramer 
2003; Etnier et al. 1997; Smith et al. 2010), but questions still remain with regard to 
the optimal type and dose (frequency, intensity, duration) of training. Cognitive 
training interventions involving the repetition of mental exercises (e.g., remembering 
word lists, locating visual information) have also shown somewhat mixed effects for 
improving cognitive function in older adults with varying cognitive ability (Kueider 
et al. 2012; Reijnders, van Heugten & van Boxtel 2013). However, there is still 
uncertainty as to whether these cognitive benefits are associated with improvements 
in functional tasks of everyday living such as walking while carrying on a 
conversation, or remembering a shopping list (Noack, Lövdén & Schmiedek 2014; 
Ratner & Atkinson 2015; Verghese et al. 2010; Zelinski 2009). Whether a combination 
of these formats have additive cognitive benefits for older adults is an area of recent 
interest, and has been investigated through combined exercise-cognitive training 
formats which include sequential training; where exercise training is followed by or 
preceded by cognitive/motor training on the same day or separate days, and 
simultaneous dual-task training; whereby exercise is performed concurrently with a 
secondary attention-demanding cognitive and/or motor task. Reviews including both 
sequential and simultaneous dual-task training have assessed the ability of these types 
of programs to improve functional and cognitive abilities in older adults (Lauenroth, 
Ioannidis & Teichmann 2016; Zhu et al. 2016). This is of clinical relevance as 
maintaining or improving dual-task performance is important as many older adults 
experience an age-related decline in the ability to simultaneously divide attention 
between a primary and secondary task, such as carrying on a conversation while 
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walking (Verhaeghen & Cerella 2002). Significantly, this decline has been associated 
with an increased risk for dementia (Montero-Odasso et al. 2017), and falls (Beauchet 
et al. 2009).  
 
Several systematic reviews addressing the benefits of combined cognitive and exercise 
training have indicated that sequential dual task training exerts mixed effects on 
cognitive function (Lauenroth, Ioannidis & Teichmann 2016; Law et al. 2014a; Zhu et 
al. 2016), with limited added benefits compared to either cognitive or physical training 
alone (Fabre et al. 2002; Oswald et al. 2006; Shah et al. 2014). For example, a 2016 
meta-analysis reported small beneficial effects of sequential or simultaneous exercise-
motor training on cognitive abilities when compared to a control group (ES: 0.29, 
P=0.001) and exercise alone (ES: 0.22, P<0.01); there were no significant differences 
when compared to a cognitive training group (Zhu et al. 2016). However, in nearly all 
previous reviews the cognitive benefits provided by sequential and simultaneous dual-
task studies were not separated (Lauenroth, Ioannidis & Teichmann 2016; Law et al. 
2014a; Zhu et al. 2016). Due to considerable differences in the training elements 
between simultaneous and sequential studies (e.g., provision of cognitive training with 
exercise vs. separate training, different training formats, and intervention lengths), 
study design and control group characteristics (e.g., factorial designs vs. treatment and 
control groups), the collective benefits reported from combined training may not 
accurately reflect the distinct advantages offered by either simultaneous or sequential 
exercise-cognitive training (Lauenroth, Ioannidis & Teichmann 2016; Zhu et al. 2016). 
As such, the optimal type(s) of exercise training within simultaneous cognitive-
exercise interventions is not known, as studies have incorporated a variety of training 
modalities including aerobic, PRT and functional training (stepping), as well as 
exergaming (Lauenroth, Ioannidis & Teichmann 2016; Zhu et al. 2016).  
 
High velocity-PRT, or power training, has gained considerable interest in recent years 
for its greater capacity to improve measures of functional performance in older adults 
compared to traditional PRT performed at slower speeds (Steib, Schoene & Pfeifer 
2010; Tschopp, Sattelmayer & Hilfiker 2011). Whether power training can also 
improve cognitive function in healthy older adults remains uncertain, as to date the 
effects of power training on cognitive function have only been assessed in cognitively 
impaired populations (Strassnig et al. 2015; Yoon et al. 2017). There were positive 
findings for global cognition following 12 weeks of elastic band based power training 
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in cognitively impaired older women compared to a control group (Yoon et al. 2017), 
while improvements in working memory and processing speed in overweight adults 
with schizophrenia have been detected following 8 weeks of machine-based power 
training (Strassnig et al. 2015). Furthermore, 10-14% improvements in simple and 
choice reaction time have been observed following 4 weeks (50 minutes, five times 
per week) of multimodal training including elastic-based functional training (motor 
activities, PRT, reaction speed) and aerobic training, compared to a recreational 
physical activity program (e.g., games, aerobic training) in community-dwelling older-
adults (Ponce-Bravo et al. 2015). To our knowledge, no studies have evaluated the 
efficacy of functional power training (FPT), which involves functional movements 
that resemble activities of daily living (ADLs) (e.g., stepping, squats, lunges) 
performed with a rapid concentric phase and slower eccentric phase, performed 
simultaneously with cognitive-motor training, on cognitive function in healthy older 
adults.  
 
Cognitive function may also be influenced by genetic factors, and polymorphisms 
including the possession of a Met allele from the brain derived neurotrophic factor 
(BDNF) gene have been reported to alter the activity-dependent secretion of this 
growth factor which can impair cognition (Miyajima et al. 2008; Raz et al. 2009). 
Further, the APOE-ε4 variant coding for the apolipoprotein E protein has been 
identified as an important predictor for the development of Alzheimer’s disease and 
cognitive decline, and associates with poorer cognitive performance in healthy and 
cognitively impaired older adults (Kuller et al. 1998; Liu et al. 2013; Yaffe et al. 1997). 
Despite this data, it is currently unknown as to whether these polymorphisms moderate 
the effect of exercise on cognitive performance in older adults, but may underlie 
potential changes in cognition following a dual-task exercise intervention.  
 
Therefore, the aim of this study was to assess whether a 26-week dual-task functional 
power training (DT-FPT) program could improve cognitive function compared to 
usual care in older adults at increased risk for falls living independently in retirement 
villages. Secondary aims were: 1) to determine whether the response to the 
intervention varied by genetic factors (i.e. presence of a Met allele within the BDNF 
gene and/or ε4 variant of the APOE gene), and 2) to evaluate the efficacy of the 
intervention on muscle function and dual-task functional performance. It was 
hypothesised that this form of training would improve cognitive function compared to 
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a usual care group, and that carriers of Met and ε4 alleles would exhibit poorer changes 
in cognitive function, compared to non-carriers. Similarly, it was expected that DT-
FPT would improve muscle function and dual-task functional performance.  
 
5.2 Methods 
The following section will outline the specific study design and methodology used to 
investigate the effect of a DT-FPT intervention on cognitive function in older adults. 
For the purposes of this chapter, only a brief overview of the methodology that pertains 
to the present study will be presented. Detailed descriptions of the methods for this 
study have been provided in Chapter 3.   
 
5.2.1 Participants 
Three hundred older adults (81 men and 219 women) aged 77.4 ± 6.8 years (mean ± 
SD) and at risk of falls were recruited in three rolling cohorts over a 14-month period, 
from 22 independent living retirement villages in the greater metropolitan and regional 
areas of Melbourne. One participant withdrew from the study after baseline testing and 
requested that all data be erased, hence the final number was 299.  
 
5.2.2 Study design 
This was a community-based, cluster randomised controlled trial in which older adults 
living in 22 retirement villages who were at increased risk of falling, were randomly 
allocated to: 1) an exercise program involving functional dual-task power training with 
challenging balance/mobility activities that were performed simultaneously with a 
secondary attention-demanding motor or cognitive task (DT-FPT) (n=11 villages), or 
2) a usual care control group (n=11 villages). The primary aim of the main RCT was 
to evaluate the efficacy of the intervention on the rate of falls (Daly et al. 2015), but 
the focus of this study (thesis) was on the effect of the intervention on cognitive 
function. Baseline and follow-up data from the 26-week intervention was used in this 
study.  
 
5.2.3 Intervention  
Villages with participants allocated to the exercise intervention undertook two 45-60 
minute group-based and supervised exercise sessions per week, for 26 weeks. Each 
training session involved four components; 1) a warm-up consisting of rhythmic and 
range of motion exercises, 2) 2-3 challenging balance and mobility exercises which 
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simulated common daily functional tasks, 3) high-velocity functional power training 
consisting of 5-6 lower leg exercises, one supplementary exercise (for the upper 
limbs), and one core stability/postural exercise, and 4) a cool-down. All programs were 
progressed according to the participant’s level of improvement and their self-reported 
rating of perceived exertion on the 10-point Borg RPE scale (Borg 1982). The target 
rating was 4 to 6 on this scale. Dual-task training components were performed 
simultaneously with the challenging balance/mobility and FPT exercises, and involved 
a combination of cognitive, visual and motor tasks. Participants in the usual care 
control group continued with their normal physical activity habits and received usual 
care from their medical practitioner and community services, as well as information 
booklets on falls prevention and physical activity as outlined in Chapter 3.   
 
5.2.4 Measurements  
All testing was conducted on-site at each retirement village at baseline and 26-week 
follow-up testing.  A detailed description of the outcome measures used in this study 
are provided in Chapter 3, and a brief outline is provided below.  
 
Anthropometry and body composition 
Height and body weight were measured using standard techniques, via portable 
stadiometer (Surgical and Medical PE87) and TANITA scales (TANITA BC-418, 
Tanita, Japan), from which BMI was calculated. Body composition (whole body fat 
percentage, fat mass and fat-free mass) was also assessed using bioelectrical 
impedance (TANITA BC-418, Tanita, Japan).  
 
Cognitive measures 
Domains of cognitive function were assessed through the CogState computerized 
cognitive battery [Groton Maze Learning Test (GMT): executive function, memory, 
visuospatial learning; Detection task (DET): simple reaction time, processing speed; 
Identification task (IDN): choice reaction time, visual attention; One Card Learning 
task (OCL): attention and visual memory; One Back task (ONB): working memory, 
attention] (CogState Ltd, Melbourne, Australia). The main outcome measures for these 
tasks were reaction time of correct responses (IDN, DET, ONB), proportion of correct 
responses (OCL), and total number of errors (GMT). As per the CogState protocol, the 
reaction time scores of IDN, DET and ONB were log10 transformed, while the square 
root of the proportion of correct responses on the OCL task was arcsine transformed 
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(Lim et al. 2015). Individual raw scores for each task were then transformed into a Z-
score using the mean and standard deviation (SD) of the total sample in the study, 
according to the following equations: 
 
Baseline Z-Score = [(participant score at baseline minus baseline group mean for 
test)/ baseline group SD for test] 
26-week Z-Score = [(participant score at 26 weeks minus baseline group mean for 
test)/ baseline group SD for test)] 
 
From these individual Z-Scores, composites were created for the following: global 
cognitive function (GCF: average for GMT, DET, IDN, OCL, and ONB), Learning-
Working memory (L-WM: average for OCL and ONB), Psychomotor function-
Attention (Psy-Att: average for DET and IDN), and the CogState Brief Battery (CBB: 
average for DET, IDN, OCL and ONB). Higher scores on these composites indicate 
better performance (Steinberg et al. 2015). To categorise MCI, participants scoring ≤ 
-1.0 SD (Z-score) on at least three of the five individual cognitive tests were classified 
as having mild cognitive impairment [based on personal communication with 
CogState Pty Ltd and (Maruff et al. 2013)].  
  
Health and medical history, and medication use  
Participant health and medical history (present or past diagnosis of health condition 
e.g., heart attack, type 2 diabetes; in Appendix E), current medication usage 
(antihypertensive, lipid-lowering, anti-depressant, NSAIDs, sleeping medication, 
neurological medication and pain relievers), employment status (“Retired/ Not 
employed”, “Part time employment’, “Home duties/other”), race (“Caucasian”/ “Non-
Caucasian”), education level attained (“Primary/some high school”, “Completed high 
school/Technical or Trade Certificate”, and “University /Tertiary level”, and smoking 
status (Current, Ex, or Non-smoker), were assessed by questionnaire. Participants were 
deemed to be at cardiometabolic risk if they satisfied at least one of the following: 
taking antihypertensive medication or diagnosis of hypertension, taking lipid-lowering 
medication, had type 2 diabetes, had suffered a heart attack, heart disease, or angina 
(all Yes or No).		
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Depression Anxiety and Stress Scale (DASS-21) 
The Depression Anxiety and Stress Scale (DASS)-21 is a 21-item self-report measure 
that was used to assess symptoms of depression, anxiety and stress over the past week 
(Henry & Crawford 2005). Each factor is measured by seven items on a 4-point Likert 
scale, and scores range from 0 to 21 on each subscale, with higher scores indicating 
greater anxiety, depression or stress (Paukert et al. 2010). These subscales were each 
multipled by two, and the sum of the depression subscale was used as a covariate in 
assessing cognitive function outcomes, as an increased susceptibility to depression has 
been associated with poorer cognitive function (Geerlings 2000; Paterniti 2002).  
 
Adverse events  
For participants in the exercise group, any adverse event sustained during the exercise 
program (e.g., illness or injury) was recorded. An unblinded researcher interviewed 
participants in both groups at 13 and 26 weeks after their intervention had begun to 
determine whether they had experienced an adverse event. This determined whether 
any adverse events in the DT-FPT group were beyond those experienced during usual 
care. 
 
Exercise adherence 
Compliance with the exercise program was assessed by attendance at the supervised 
exercise sessions, and was calculated by dividing the total number of sessions attended 
by the total number of sessions available over the 26 weeks, multiplied by 100.   
 
Habitual physical activity  
Leisure and recreational physical activity, reported as estimated kilojoules (kJ) per 
week spent in moderate to high-intensity physical and leisure time activities (converted 
from kcal/week), was evaluated using the Community Healthy Activities Model 
Program for Seniors (CHAMPS) questionnaire (Stewart et al. 2001).  
 
Muscle strength and power 
Bilateral maximal isometric grip strength of the dominant and non-dominant hand was 
assessed using a hand-held dynamometer (Jamar dynamometer, Asimov Engineering 
Co., Los Angeles, USA). Lower limb muscle power was measured during five 
consecutive chair sit-to-stands (5-STS).  
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Muscle function  
Functional mobility was assessed by the Timed up and Go test (TUG) and choice 
stepping reaction time (CSRT) test, under single (CSRT: responding to arrows of same 
colour; TUG: standard performance) and dual-task conditions (CSRT: while 
responding to arrows of alternating colours; TUG: while counting backwards in 3s), 
and the Four Square Step Test (FSST). Lower times equate to better performance. 
Change in the use of a gait-aid between baseline and 26 weeks was included as a 
covariate for these tasks, categorised as: ‘no change’, ‘started using a gait aid at follow-
up’, or ‘used a gait aid at baseline but not at follow-up’.  
 
Dual-task cost for the time taken to complete the TUG test and for the response, 
decision and movement times for CSRT were assessed as:  
 
Dual-task TUG performance minus single TUG task performance divided by single 
TUG task performance x 100  
 
Dual-task CSRT time minus single CSRT time divided by single CSRT time x 100 
 
A lower percentage in both scenarios indicates better dual-task function. 
 
Counting errors while seated and under dual-task conditions (TUG while counting 
backwards in 3s) were also recorded. 
 
Functional gait  
Gait speed was measured using the ProtoKinetics Zeno system (ZenoMetrics LLC, 
Peekskill, NY, USA),	under single and dual-task conditions (walking while counting 
backwards in 7s). Counting errors under both single (standing) and dual-task 
conditions (walking), and change in the use of a gait aid were also recorded.  
 
Dual-task cost for gait speed was assessed as: 
 
Dual-task gait speed minus single-task gait speed divided by single-task gait speed x 
100  
 
A lower percentage indicates better dual-task function. 
 
Genotyping 
To determine whether the cognitive responses to the intervention varied by genotype 
(i.e. BDNF and APOE), polymorphism data was derived from blood samples taken at 
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baseline or 26 weeks. Blood samples and hence polymorphism data was not provided 
by 18 participants due to withdrawal before collection (n=12), didn’t attend either 
blood collection (n=1), and couldn’t collect sample from participant (n=5). 
Participants were categorised as possessing at least one copy of the ε4 allele from the 
APOE gene or no copies of this polymorphism, and by BDNF genotype; at least one 
copy of the Met allele, or Val/Val homozygotes. 
 
5.2.5 Statistical analyses 
Sample sizes for this study were based on calculations reported in Chapter 3. All 
statistical analyses were conducted on an intention-to-treat basis using STATA 
statistical software release 14.0 (STATA, College Station, TX, USA). Baseline 
characteristics between the groups were compared by independent t-tests for 
continuous variables and chi-square tests for categorical variables. All data was 
checked for normality prior to analysis, with a number of variables requiring log 
transformation (see below). The effect of the intervention on the primary (cognition) 
and secondary (function and body composition) outcome variables was analysed using 
general linear mixed models with random effects, adjusting for the variability between 
clusters (villages) and within a cluster (participants within the same village). The group 
(DT-FPT or CON) was the fixed effect, and clusters (retirement village) and the unit 
of analysis (participants), were included as random effects to account for the clustered 
design. The effect of the intervention on cognitive function was initially assessed by 
adjusting for age, sex and education (model 1), before additionally adjusting for 
DASS-21 depression subscale score at baseline, BMI, cardiometabolic status, smoking 
history and BDNF Met- and ApoE-ε4 carrier status (model 2). An additional model 
was run based on analysis of covariance (ANCOVA) that adjusted for baseline values 
for the outcome measure and clustering (model 3). The secondary outcome measures 
included grip strength and lower limb muscle power, gait speed, muscle function (i.e. 
TUG, FSST), anthropometry (i.e. BMI and weight) and body composition (i.e. fat-free 
mass, fat mass, body fat percentage), and were adjusted for sex (model 1), and 
additionally adjusted for baseline values (model 2) with ANCOVA. Performance 
times for TUG, FSST and CSRT and grip strength, were not normally distributed and 
were log-transformed. Two outliers were removed for FSST as they were greater than 
10 SDs above the mean. Change in the use of a gait aid between baseline and 26 weeks 
was additionally included as a covariate for TUG, FSST, CSRT and gait speed. A per-
protocol analysis was also conducted on those in the training group meeting ≥50% 
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adherence to the exercise program. To determine if genotype influenced the response 
to the intervention, the interactions between ApoE-ε4 carrier status by group allocation 
and time, and BDNF Met-carrier status by group allocation and time, were also 
conducted using linear mixed models. To determine if the response of cognitive 
function to the intervention varied by sex, the interactions between sex (male or 
female) by group allocation and time, were also conducted. All data are presented as 
means ± SD or 95% CI unless stated. Within-group changes in cognitive function are 
expressed as the absolute change in Z-scores from baseline, while selected secondary 
outcome measures are expressed as the absolute or percentage change from baseline. 
Between-group differences for the change over time were calculated by subtracting 
the within-group changes from baseline for the DT-FPT group from the within-group 
changes for the usual care control group after 26 weeks. The significance level was set 
at P<0.05.  
 
5.3 Results 
Baseline characteristics 
Three hundred participants aged between 65-96 years (mean SD; 77.4 ± 6.8) were 
recruited in three cohorts over 14 months, from 22 eligible retirement communities. 
The average size of each cluster (village) was 14 participants, and 73% of the 
participants were women (Table 5.1). On average, participants had a mean BMI of 
29.0 kg/m2 with 117 (39%) classified as obese (BMI ≥30). In terms of education, 182 
(61%) participants completed high school, and of these a further 125 (42%) attained 
additional tertiary or technical qualifications (university or technical certificate). 
Nearly all participants were Caucasian (98%). Ninety-four percent of participants were 
retired or not employed. Using the MCI classification of at least three CogState tests 
with a Z-score of <-1.0, 22 (7%) of our participants met this criterion with an equal 
proportion between the groups [DT-FPT: 11 (7%); CON 11: (8%), Chi square 
P=0.858], despite passing the cognitive screening test. Comparison of the baseline 
characteristics between the groups revealed that there were a higher proportion of 
women in the control group (P=0.001), which may explain the significant between 
group difference in height (P=0.001) (Table 5.1). Males were on average 12.6 cm (95% 
CI: 10.9, 14.3; P<0.001) taller than females, and on average 9.9 kg (95% CI: 6.1, 13.6; 
P<0.001) heavier.  
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Table 5.1: Baseline characteristics of participants randomised to the dual task 
functional power training group (DT-FPT) and the usual care control (CON) group.   
Characteristics DT-FPT CON 
n 155 144 
Women, n (%) 101 (65%) ‡ 118 (82%) 
Age, years 77.2 ± 6.6 77.7 ± 7.2 
Height, cm  163.2 ± 9.1 ‡ 160.0 ± 8.0 
Weight, kg  77.7 ± 16.0 74.3 ± 14.1 
BMI (kg/m2)  29.1 ± 5.2 29.0 ± 4.9 
Smoking status, n (%)   
     Current/ Ex-Smoker 72 (46%) 56 (39%) 
     Non-smoker 82 (53%) 86 (60%) 
DASS-21-Depression 2.0 ± 6.0 2.0 ± 6.0 
ApoE-ε4 carrier, n (%) 42 (29%) 39 (28%) 
BDNF Met carrier, n (%) 50 (34%) 42 (31%) 
Number of health conditions  3.1 ± 2.0 3.0 ± 2.0 
Presence of cardiometabolic risk factors, n (%) 136 (88%) 118 (82%) 
Employment Status, n (%)   
     Retired / Not employed 145 (94%) 133 (94%) 
     Part time employment 4 (3%) 3 (2%) 
     Home duties / Other 5 (3%) 6 (4%) 
Race   
    Caucasian     151 (98%) 139 (98%) 
    Non-Caucasian 3 (2%) 3 (2%) 
Education, n (%)   
    Primary/Some High School  57 (37%) 57 (40%) 
   Completed High School/ Technical Trade Cert. 50 (32%) 49 (34%) 
   University/Tertiary level 47 (30%) 36 (25%) 
Values are mean ± SD except DASS-21-Depression subscale score and Number of 
health conditions (median ± Interquartile Range). ApoE: apolipoprotein; BDNF: brain 
derived neurotrophic factor; BMI: body mass index; DASS: Depression, anxiety and 
stress scale. ‡ P<0.001 versus CON. Does not include missing data for smoking history 
[DT-FPT: n=2 (1%), CON: n=2 (1%)], employment status [DT-FPT: n=2 (1%), CON: 
n=2 (1%)], race [DT-FPT: n=2 (1%), CON: n=2 (1%)], and education [DT-FPT: n=2 
(1%), CON: n=2 (1%)]. 
 
Study Attrition 
Of the 300 participants randomised to the intervention, 156 from 11 villages were 
allocated to the DT-FPT group and 144 from 11 villages to the usual care CON group. 
In total, 67 participants (22%) were unable to complete the 26-week follow-up testing. 
Of these, 49 participants withdrew from the trial, and there was no significant 
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difference between the groups [DT-FPT, n=31 (10%); CON, n=18 (6%), Chi-square 
P=0.084]. Of the 31 participants that withdrew from the DT-FPT group, the reasons 
were illness/did not receive GP approval (n=15), time commitments (n=12), and self-
reported difficulties with some of the study requirements (e.g., questionnaire burden, 
difficulties performing arithmetic in the dual-task conditions) (n=4). Of the 18 
participants that withdrew from the CON group, the reasons were illness/did not 
receive GP approval (n=4), time commitments (n=5), and self-reported difficulties 
with the study (n=9) (Table 5.2).  
 
A further 18 did not withdraw from the study but did not complete follow-up testing 
at 26 weeks for the following reasons:  ill health at time of testing (DT-FPT, n=7; 
CON, n=8) and unable to be contacted/lost to follow-up (DT-FPT, n=2; CON, n=1) 
(Table 5.2). Overall, a total of 233 of the 300 participants (78%) completed the 26-
week trial and attended follow-up testing (DT-FPT, n=116; CON n=117). 
 
Comparison of the participants that completed the intervention (n=233) and those that 
withdrew or did not attend 26 weeks testing (n=66), revealed that there were 
differences in some of the baseline characteristics. Those attending follow-up testing 
at 26 weeks had significantly higher Z-scores in GMT (P=0.009), DET (P=0.016), 
IDN (P=0.005), ONB (P=0.008), GCF (P=0.002), L-WM (P=0.025), Psy-Att 
(P=0.003), CBB (P=0.002), and 5-STS power (P=0.047), TUG dual-task cost 
(P=0.047), single-task gait speed (P=0.04), and CSRT movement (single-task) 
(P=0.02), response (P=0.02) and decision times (dual-task) (P=0.03), compared to 
those who withdrew or did not attend testing (Appendix N). The study flow chart is 
shown in Chapter 3. 
 
Missing data 
Analyses for the effects of the intervention on main and secondary outcome measures 
were based on the following participant numbers, which represents those with data at 
baseline and 26 weeks, with reasons for missing data noted where applicable. 
Cognitive function (n=232), body composition (n=221), anthropometry (n=233), 
functional mobility [timed up and go (n=233), four square step test (n=230), choice 
stepping reaction time (n=233)], gait speed (n=233), muscle strength (n=232), muscle 
power (n=230) and genetic polymorphisms (n=233). Numbers of participants with 
missing data are presented in Appendix O. 
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Table 5.2: Cluster size per village, retention of participants at 26 weeks follow-up testing, number of participants from each village who did not 
attend 26 weeks testing in the dual task functional power training (DT-FPT) or usual care control (CON), and average exercise compliance of 
villages in the intervention group. 
DT-FPT  CON 
   Reasons for participants not attending follow-up  
    Reasons for participants not attending follow-up 
Village 
No. 
Baseline 
cluster 
size, 
n 
Retention  
n (%) 
WD, 
n  
Ill / 
NA, n 
Lost to 
follow up, n 
Mean 
Compliance
(%) 
 
Village 
No. 
Baseline 
cluster 
size, 
n 
Retention 
n (%) 
WD, 
n  
Ill / NA,  
n 
Lost to   
follow up, n 
2 11  10 (91%) 1  0 0 62.7 ± 28.7  1 12  9 (75%) 1 2  0 
3 12  10 (83%) 2  0 0 61.5 ± 31.2  5 7  7 (100%) 0 0  0 
4 11  9 (82%) 2  0 0 44.9 ± 36.8  6 8  5 (63%) 3 0  0 
8 5  5 (100%) 0 0 0 74.5 ± 13.8  7 16  10 (63%) 4 1 1 
10 10  9 (90%) 0 1 0 48.2 ± 22.4  9 17 13 (77%) 3 1  0 
13 19  14 (74%) 1  3 1 38.2 ± 26.1  11 14  13 (93%) 1 0  0 
14 21  12 (57%) 7  1 1 42.8 ± 37.9  12 23  20 (87%) 3 0  0 
15 15  10 (67%) 4  1 0 61.3 ± 34.1  16 12  10 (83%) 1 1  0 
17 16  12 (75%) 4  0 0 47.8 ± 40.4  18 8  8 (100%) 0 0  0 
21 21  14 (67%) 6  1 0 39.6 ± 27.0  19 15  13 (87%) 0 2  0 
22 15  11 (73%) 4  0 0 59.9 ± 29.3  20 12  9 (75%) 2 1  0 
Total 156 116 (74%) 31 7 2 50.1 ± 32.3  Total 144 117 (81%) 18 8 1 
WD: Withdrawals, Ill/NA: ill or not available for 26-week testing.
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Medication, smoking status and chronic conditions 
At baseline nearly half (49%) of the participants were taking lipid-lowering 
medication, and 71% were on antihypertensive medication, with no significant 
differences between the groups (Table 5.3, Chi square all P>0.160). Nearly 70% of 
participants were taking three or more prescribed medications at baseline (Table 5.3). 
There were no differences between the groups for the changes to medication usage 
(type, dose, or number) after 26 weeks (Chi-square all P>0.05) (Table 5.4). Forty three 
percent of participants were ex/current smokers (10 were current smokers) with an 
equal proportion between each group (Chi-square, P=0.204) (Table 5.1). A total of 287 
participants (96%) possessed at least one chronic health condition [DT-FPT, n=150 
(97%); CON, n=137 (96%)] (as outlined in Appendix E), and 167 (56%) possessed ≥3 
conditions [DT-FPT, n=91 (59%); CON, n=76 (54%)] (Table 5.1). There were no 
differences between the groups in the number of health conditions (P=0.623) or 
proportion of participants with chronic health conditions at baseline (Chi-square, 
P=0.872). At 26 weeks, 48 participants reported the onset of a new disease(s) [DT-
FPT, n=21 (18%); CON, n=27 (23%)], with the majority reporting one new disease 
[DT-FPT, n=15 (13%); CON, n=21 (18%)]. There were no significant changes (or 
between group differences) in the number of diseases (P=0.544), the number of new 
diseases (P=0.432), or the proportion of participants with new diseases over the 
intervention (Chi-square, P=0.528).  
 
Table 5.3: Baseline medications taken by participants randomised to the dual task 
functional power training group (DT-FPT) and the usual care control (CON) group.   
Medications taken DT-FPT CON 
n 154 142 
Antihypertensive therapy, n (%) 112 (72%) 101 (70%) 
Lipid-lowering therapy, n (%) 82 (53%) 63 (44%) 
NSAIDs, n (%) 18 (12%) 22 (15%) 
Anti-depressant therapy, n (%) 37 (24%) 31 (22%) 
Diabetic medication, n (%) 16 (10%) 18 (13%) 
Neurological medication, n (%) 4 (3%) 4 (3%) 
Analgesics (non-NSAIDs), n (%) 17 (11%) 16 (11%) 
Sleep aids, n (%) 11 (7%) 14 (10%) 
Medications taken, n (%)   
0 4 (3%) 7 (5%) 
1 19 (12%) 19 (13%) 
2  24 (15%) 16 (11%) 
≥ 3  107 (69%) 100 (70%) 
NSAID: Nonsteroidal anti-inflammatory drug. Neurological medication includes anti-Parkinson and 
anti-epileptic medication. Does not include missing data for DT-FPT: n=2 (1%), CON: n=2 (1%).
Chapter 5  
 
211 
Table 5.4: Change in medications taken by participants randomised to the dual task functional power training group (DT-FPT) and the usual care 
control (CON) group over the 26-week intervention.  
  Medication Type / Number Dose of Medication 
Medication No change (%)* Taking at baseline (%)* 
Commenced 
Medication 
Increased 
Number No change Increased Dose Decreased Dose 
Antihypertensives        
      DT-FPT 106 (91%) 81 (70%) 4 (3%) 6 (5%)  111 (96%) 2 (2%) 3 (3%) 
CON 105 (90%) 84 (72%) 2 (2%) 10 (9%)   108 (92%) 4 (3%) 5 (4%) 
Lipid-lowering        
      DT-FPT 115 (99%) 61 (53%) 1 (1%) 0 (0%) 113 (97%) 2 (2%) 1 (1%) 
CON 114 (97%) 54 (46%) 2 (2%) 1 (1%)  116 (99%) 0 (0%) 1 (1%) 
NSAIDs        
DT-FPT 114 (98%) 12 (10%) 2 (2%) 0 (0%) 115 (99%) 0 (0%) 1 (1%) 
CON 115 (98%) 18 (15%) 2 (2%) 0 (0%)   117 (100%) 0 (0%) 0 (0%) 
Anti-depressants        
DT-FPT 113 (97%) 26 (22%) 1 (1%) 2 (2%)       115 (99%) 1 (1%) 0 (0%) 
CON 115 (98%) 25 (21%) 1 (1%) 1 (1%)       115 (98%) 2 (2%) 0 (0%) 
Diabetic         
DT-FPT 114 (98%) 13 (11%) 0 (0%) 2 (2%)   116 (100%) 0 (0%) 0 (0%) 
CON  117(100%) 18 (15%) 0 (0%) 0 (0%)  117 (100%) 0 (0%) 0 (0%) 
Neurological        
DT-FPT 115 (99%) 2 (2%) 1 (1%) 0 (0%)  116 (100%) 0 (0%) 0 (0%) 
CON 116 (99%) 3 (3%) 1 (1%) 0 (0%)  117 (100%) 0 (0%) 0 (0%) 
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Analgesics        
DT-FPT 115 (99%) 9 (8%) 1 (1%) 0 (0%)      115 (99%) 1 (0%) 0 (0%) 
CON 110 (94%)  12 (10%) 5 (4%) 2 (2%) 117 (100%) 0 (0%) 0 (0%) 
Sleeping aids         
DT-FPT 116 (100%) 9 (8%) 0 (0%) 0 (0%) 116 (100%) 0 (0%) 0 (0%) 
CON 117 (100%) 12 (10%) 0 (0%) 0 (0%) 117 (100%) 0 (0%) 0 (0%) 
* Denotes percentage of participants followed up from DT-FPT (n=116) and CON (n=117) at 26-week testing. NSAID: Nonsteroidal anti-inflammatory 
drug. Neurological medication includes anti-Parkinson and anti-epileptic medication. There were no participants that reported a reduction in the number 
or cessation of medication over the 26-week period.
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Exercise adherence 
Mean (±SD) adherence to the exercise program was 50 ± 32% (median 58%, range 0 
to 98%), which was equivalent to approximately one session per week. A breakdown 
of adherence by cluster is provided in Table 5.2. Overall, 25 (16%) participants 
attended no exercise sessions [10 men (6% of men in DT-FPT), 15 women (10%)], 
and 91 (59%) attended at least one session per week (≥50% attendance) throughout 
the entire 26-week intervention [35 men (65% of men in DT-FPT), 56 women (55%)]. 
A histogram of the exercise adherence is shown in Figure 5.1.  
 
Adverse Events 
Overall 15 musculoskeletal complaints/injuries, or other adverse events were reported 
by 13 of the 156 participants in the DT-FPT group throughout the 26-week 
intervention (Table 5.5). These complaints were received from participants in six of 
11 villages, with five villages reporting no adverse events. Eight of the 15 exercise-
related adverse events were reported from one village alone. Two of the 15 complaints 
(13%) were pre-existing injuries aggravated by the participation in the exercise 
program. Eight events were resolved without sequel, four events persisted without 
requiring treatment, and three of the reported injuries required some form of treatment 
(e.g., icing, medication, health professional review). No participants withdrew from 
the program due to their injury, however two participants discontinued temporarily 
due to feeling faint/ nauseous and bronchitis, for a period of one and three weeks 
respectively. Of the 15 adverse events, five were deemed to be related to the exercise 
program, seven were possibly related and three were unrelated. For 10 participants 
who reported an injury or complaint, the exercise trainers were able to modify their 
exercise program, and all participants sustaining an adverse event returned for follow-
up testing. 
 
Habitual physical activity  
No significant within group changes or between group difference for the change were 
detected in the amount of energy spent in moderate to high-intensity physical and 
leisure activities throughout the intervention [mean change DT-FPT: 558 (95% CI, -
485, 1600); CON: 19.6 (95% CI, -838, 877) kJ/week; P=0.351)].  
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Figure 5.1: Exercise adherence histogram for all participants randomised to the dual-
task functional power training group. 
 
 
Table 5.5: Number and percentage of musculoskeletal and health complaints reported 
by participants in the dual task functional power training group.  
Nature of injury/complaint Complaints, n (%) 
Bronchitis 1 (6.7%) 
Skin sensitivity from ankle weights 2 (13%) 
Dizziness 3 (20%) 
Lower back pain 3 (20%) 
Knee pain 1 (6.7%) 
Shoulder Pain 2 (13%) 
Foot pain 1 (6.7%) 
Fall 1 (6.7%) 
Strained muscle 1 (6.7%) 
Total 15 (100%) 
 
Cognitive Function  
At baseline the DT-FPT group had significantly higher scores in executive function 
(GMT) (P=0.007), and Learning-Working memory (P=0.049) compared to CON 
(Table 5.6). The number of participants successfully completing each CogState test 
and those contributing to the overall composite scores are shown in Table 5.6.  
Following the 26-week intervention, there was a trend for an unadjusted mean 0.20 
SD (95% CI, 0.01, 0.39) net benefit for the change in choice reaction time/visual 
attention (IDN) scores in DT-FPT compared to CON after adjusting for age, sex and 
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education [group-by-time interaction, P=0.064 (model 1)], which was due to a non-
significant 0.08 SD increase in DT-FPT (P=0.17) and a non-significant 0.12 SD 
decrease in CON (P=0.23). However, this between group difference became 
significant after adjusting for baseline values (P=0.020). Similarly, there was a trend 
for a 0.18 SD (95% CI, 0.01, 0.36) net benefit for the change in the composite 
Psychomotor function-Attention score in DT-FPT relative to CON [group-by-time 
interaction, P=0.063 (model 1), which was significant after adjusting for baseline 
values (P=0.030). This was due to a small 0.06 SD decrease in DT-FPT (P=0.467), 
and a significant 0.24 SD reduction in CON (P=0.001) (Table 5.6). For the CogState 
Brief Battery, which provides a measure of processing speed, attention, visual learning 
and working memory, there was a trend for a small net 0.06 SD (95% CI, -0.06, 0.17) 
benefit in DT-FPT compared to CON (group-by-time interaction, P=0.050) in the fully 
adjusted model. There were no other between group differences for the change over 
time or within-group changes with the exception of the following: processing 
speed/reaction time (DET) Z-scores decreased by 0.20 SD in DT-FPT (P=0.05) and 
0.36 SD in CON (P<0.001), and the composite score of Learning-Working memory 
increased by 0.14 SD (P=0.004) in CON (Figure 5.2). No significant sex, BDNF or 
APOE genotype interactions were detected for the change in any cognitive measure 
(Table 5.7).  
 
In the per-protocol analysis, which included participants in DT-FPT achieving ≥50% 
adherence to the program, similar results to those reported above were observed. There 
was a significant 0.27 SD (95% CI, 0.06, 0.48) net benefit for the change in choice 
reaction time/visual attention (IDN) scores in DT-FPT compared to CON (group-by-
time interaction, P=0.001) after adjusting for baseline values, which was due to a non-
significant 0.15 SD increase in DT-FPT and a non-significant 0.12 SD decrease in 
CON (Appendix P). There was also a greater net benefit [0.19 SD (95% CI, 0.001, 
0.38)] for the change in the Psychomotor function-Attention composite score in DT-
FPT relative to CON (group-by-time interaction, P=0.006) after adjusting for baseline 
values, which was explained by no change in DT-FPT (-0.05 SD; P=0.382) and a 
significant 0.24 SD decrease in CON (P=0.001). There was a trend for a small 0.11 
SD net benefit for the change in processing speed/reaction time (DET) in DT-FPT 
compared to CON (group-by-time interaction, P=0.051), which was due to a smaller 
decrease in DT-FPT compared to CON group (DT-FPT -0.25 SD, P=0.006; CON -
0.36 SD, P<0.001).  
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Table 5.6: Mean baseline cognitive performance Z-Scores, the within-group changes relative to baseline and net between-group differences for 
the change after 26 weeks in the dual-task functional power training (DT-FPT) and control (CON) groups.    
 Baseline Values and Within Group Changes  
                    DT-FPT  CON Intervention Effects 
 n Mean ± SD or (95% CI) P-value n 
Mean ± SD or 
(95% CI) P-value 
Net Difference 
(95% CI) 
P- values 
Model 1 | Model 2 | Model 3 
GMT (Executive function)       
  Baseline  151 0.15 ± 1.00 ‡  138 -0.17 ± 1.03    
  ∆ 26 weeks 113 0.01 (-0.13, 0.15) 0.511 113 0.05 (-0.10, 0.20) 0.351 -0.04 (-0.25, 0.16) 0.776 | 0.664 | 0.558 
DET (Psychomotor function)       
  Baseline  154 0.02 ± 1.02  144 -0.02 ± 0.98    
  ∆ 26 weeks 115 -0.20 (-0.38, -0.02)  0.050 117 -0.36 (-0.54, -0.19)  0.000 0.16 (-0.08, 0.41) 0.245 | 0.203 | 0.099 
IDN (Attention/Choice reaction time)       
  Baseline  154 -0.01 ± 1.01  144 0.01 ± 1.00    
  ∆ 26 weeks 115 0.08 (-0.05, 0.21) 0.174 117 -0.12 (-0.25, 0.02) 0.228 0.20 (0.01, 0.39)  0.064 | 0.131 | 0.020 
OCL (Visual learning)        
  Baseline  153 0.08 ± 1.00  144 -0.09 ± 0.99    
  ∆ 26 weeks 114 0.07 (-0.11, 0.25) 0.195 117 0.20 (0.01, 0.38)  0.067 -0.13 (-0.38, 0.13) 0.668 | 0.679 | 0.453 
ONB (Working memory)       
  Baseline  154 0.09 ± 1.05  144 -0.09 ± 0.94    
  ∆ 26 weeks 115 0.06 (-0.05, 0.18) 0.160 117 0.09 (-0.03, 0.22) 0.071 -0.03 (-0.19, 0.14) 0.729 | 0.494 | 0.736 
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Global cognitive function       
  Baseline  151 0.08 ± 0.69  138 -0.05 ± 0.62    
  ∆ 26 weeks 113 0.00 (-0.07, 0.08) 0.572 113 -0.03 (-0.10, 0.04) 0.535 0.03 (-0.07, 0.14)  0.447 | 0.549 | 0.078 
Learning-Working Memory       
  Baseline  153 0.09 ± 0.83 ‡  144 -0.09 ± 0.73    
  ∆ 26 weeks 114 0.06 (-0.04, 0.17) 0.112 117 0.14 (0.04, 0.25)  0.004 -0.08 (-0.22, 0.07) 0.411 | 0.317 | 0.817 
Psychomotor function-Attention       
  Baseline  154 0.003 ± 0.89  144 -0.003 ± 0.88    
  ∆ 26 weeks 115 -0.06 (-0.18, 0.06) 0.467 117 -0.24 (-0.37, -0.11)  0.001 0.18 (0.01, 0.36)  0.063 | 0.085 | 0.030 
CogState Brief Battery       
  Baseline  153 0.05 ± 0.74  144 -0.05 ± 0.69    
  ∆ 26 weeks 114 0.01 (-0.08, 0.09) 0.635 117 -0.05 (-0.13, 0.03) 0.379 0.06 (-0.06, 0.17)  0.336 | 0.452 | 0.050 
Baseline values are means ± SD; within and between-group (net) differences are unadjusted means with 95% CI. Net differences (95% CIs) were 
calculated by subtracting within-group changes from baseline for the CON group from within-group changes for the DT-FPT group after 26 weeks. 
Missing data points at 26-week testing were due to failing requirements of cognitive test (DT-FPT, n=2; CON, n=2) and unable to complete cognitive 
test (DT-FPT, n=1; CON, n=2).  P-values for time and group-by-time interaction terms were derived from linear mixed models with random effects 
after accounting for the following covariates: Model 1: age, sex and education level; Model 2: age, sex, education level, cardiometabolic status, 
baseline DASS-21 depression subscale score at baseline, APOE genotype and BDNF genotype and smoking history. P-values for Model 3 were 
derived from ANCOVA, adjusting for baseline differences and covariates in Model 1. ‡ P<0.05 vs CON. DET: Detection task; GMT: Groton Maze 
Learning Test; IDN: Identification task; OCL: One Card Learning task; ONB: One Back task. 
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Figure 5.2: Mean (±SEM) absolute changes in Psychomotor function (Detection 
Task), Attention/choice reaction time (Identification task), Psychomotor function-
Attention Composite, Learning-Working Memory Composite, CogState Brief Battery 
and Global Cognitive Function Z-scores in the dual-task functional power training 
(DT-FPT) and control (CON) group after 26 weeks. * P=0.05, ** P<0.01, † P≤0.001, 
within-group change relative to baseline, and between-group differences after 
adjusting for baseline values (denoted by line and p-value).  
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Table 5.7: Interactions between intervention effects on cognitive function, group 
allocation, time, APOE and BDNF genotype status, and sex. 
 
Cognitive test 
Interaction Term (P-value) 
APOE BDNF Sex 
  Groton Maze Test (executive function) 0.572 0.596 0.108 
  Detection (processing speed) 0.447 0.565 0.869 
  Identification (attention) 0.594 0.624 0.154 
  One Card Learning (attention/memory) 0.354 0.785 0.797 
  One Back (working memory) 0.674 0.076 0.685 
  Global cognitive function (GCF) 0.891 0.646 0.787 
  Learning-Working Memory (L-WM) 0.388 0.324 0.946 
  Psychomotor function-Attention (Psy-Att) 0.487 0.897 0.352 
  CogState Brief Battery (CBB): 0.877 0.505 0.490 
 
Body composition 
Comparison of the groups at baseline for body composition revealed that there were 
no significant differences after adjusting for sex (Table 5.8). Significant increases in 
weight [mean change 0.43 kg (95% CI, 0.05, 0.80); P=0.024], BMI [0.21 kg/m2; (95% 
CI, 0.05, 0.36) P=0.009] and fat mass [0.37 kg (95% CI, -0.01, 0.74); P=0.048] were 
detected in the CON group following the 26-week intervention, but there were no 
changes in the DT-FPT group and no between-group differences in these measures 
after adjusting for baseline differences (Table 5.8). No other within group changes or 
between group differences were detected in any other body composition measures 
(total body percentage fat, fat mass or fat-free mass). In the per-protocol analysis 
which included those in DT-FPT achieving ≥50% adherence to the program, all results 
remained unchanged (Appendix Q). 
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Table 5.8: Mean baseline body composition variables, within-group changes relative to baseline and net between-group differences for the change after 
26 weeks in the dual-task functional power training (DT-FPT) and control (CON) groups.    
 Baseline Values and Within Group Changes  
 DT-FPT CON Intervention Effects 
 n Mean ± SD or (95% CI) P-value n 
Mean ± SD or 
(95% CI) P-value 
Net Difference 
(95% CI) 
P- values 
Model 1 | Model 2 
Weight         
  Baseline, kg  154 77.7 ± 16.0   144 74.3 ± 14.1    
  ∆ 26 weeks 116 -0.24 (-0.66, 0.19) 0.292 117 0.43 (0.05, 0.80)  0.024 -0.67 (-1.23, -0.10)  0.022 | 0.105 
BMI         
  Baseline, kg/m2 154 29.1 ± 5.2  144 29.0 ± 4.9    
  ∆ 26 weeks 116 -0.06 (-0.21, 0.09) 0.461 117 0.21 (0.05, 0.36) 0.009 -0.26 (-0.48, -0.05)  0.017 | 0.075 
Fat mass         
  Baseline, kg  148 29.3 ± 10.6  139 29.5 ± 8.9    
  ∆ 26 weeks 110 0.18 (-0.48, 0.83) 0.558 111 0.37 (-0.01, 0.74)  0.048 -0.19 (-0.94, 0.55) 0.626 | 0.990 
Total body fat         
  Baseline, % 148 36.9 ± 8.2  139 39.1 ± 6.7     
  % ∆ 26 weeks 110 0.37 (-0.24, 0.99) 0.239 111 0.21 (-0.22, 0.64) 0.332 0.17 (-0.58, 0.91) 0.675 | 0.624 
Fat-free mass           
  Baseline, kg 148 48.8 ± 9.8   139 45.0 ± 8.3    
  ∆ 26 weeks 110 -0.42 (-0.89, 0.06) 0.098 111 0.00 (-0.34, 0.34) 0.985 -0.42 (-1.00, 0.16) 0.180 | 0.413 
Baseline values are means ± SD; within and between-group (net) differences are unadjusted means of absolute and percentage change with 95% CI. Net differences (95% CIs) were calculated 
by subtracting within-group percentage changes from baseline for the CON group from within-group percentage changes for the DT-FPT group after 26 weeks. Missing data points at 26-
week testing were due to injury (DT-FPT, n=2; CON, n=1) or the presence of a pacemaker (DT-FPT, n=4; CON, n=5). P-values for time and group-by-time interaction terms were derived 
from linear mixed models with random effects after accounting for sex (Model 1), and from ANCOVA after adjusting for sex and baseline values (Model 2). BMI: body mass index. 
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Muscle strength, power and function 
A total of 11 participants used a gait aid during TUG at baseline [DT-FPT, n=5 (3%); 
CON, n=6 (4%)] and 12 used one at 26-week testing [DT-FPT, n=5 (3%); CON, n=7 
(5%)]. Six participants who did not require an aid at baseline used one at 26 weeks 
[DT-FPT, n=2 (2%); CON, n=4 (3%)], while two participants did not require an aid at 
26 weeks after using one at baseline [DT-FPT, n=1 (1%); CON, n=1 (1%)]. For FSST, 
four participants used a gait aid at baseline [DT-FPT, n=2 (1%); CON, n=2 (1%)] and 
nine used one at 26-week testing [DT-FPT, n=4 (3%); CON, n=5 (3%)]. Seven 
participants who did not require an aid at baseline used one at 26 weeks [DT-FPT, n=3 
(2%); CON, n=4 (3%)], while two participants did not require an aid at 26 weeks after 
using one at baseline [DT-FPT, n=1 (1%); CON, n=1 (1%)]. Three participants did not 
undergo testing for these measures at baseline as they required a four wheeled frame. 
 
There were no differences between the groups at baseline for grip strength, 5-STS 
muscle power, FSST or TUG performance after adjusting for sex (Tables 5.9 and 
5.10). Following the 26-week intervention, there were no changes in any measure of 
grip strength or TUG performance (single or dual-task) for either group (Table 5.9), 
but there was a significant net 3.7% improvement in FSST in DT-FPT compared to 
CON (interaction, P=0.034). This was due to a significant 4.9% decrease in the time 
taken to complete FSST in DT-FPT (P=0.006) compared to a 1.2% decrease in CON 
(P=0.526). There was also a significant net 7.3% benefit in favour of the DT-FPT 
group for 5-STS muscle power (interaction, P<0.001), which was due to a significant 
5.6% increase in DT-FPT (P<0.001) and a 1.7% decrease in CON (P=0.072). All 
results remained unchanged after adjusting for baseline values and in the per-protocol 
analyses (Appendix R and S). 
 
Counting errors during TUG single and dual-task conditions are shown in Table 5.11. 
Under single-task conditions, 122 participants [DT-FPT, n=64 (55%); CON, n=58 
(50%)] recorded no change in counting errors, 60 decreased counting errors [DT-FPT, 
n=30 (26%); CON, n=30 (26%)], and 50 participants increased the number of errors 
over the intervention [DT-FPT, n=22 (19%); CON, n=28 (24%)] (IQR: 1; range: 7). 
Under dual-task TUG conditions, 144 participants [DT-FPT, n=76 (66%); CON, n=68 
(59%)] recorded no change in counting errors, 46 decreased counting errors [DT-FPT, 
n=20 (17%); CON, n=26 (22%)], and 42 participants increased the number of errors 
over the intervention [DT-FPT, n=20 (17%); CON, n=22 (19%)] (IQR: 0; range: 5). 
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Table 5.9: Mean baseline muscle function variables, within-group changes relative to baseline and net between-group differences for the change after 
26 weeks in the dual-task functional power training (DT-FPT) and control (CON) groups.    
 Baseline Values and Within Group Changes  
  DT-FPT  CON Intervention Effects 
 n Mean ± SD or (95% CI) P-value n 
Mean ± SD or 
(95% CI) P-value 
Net Difference 
(95% CI) 
P- values 
Model 1 | Model 2  
TUG - Single-task          
  Baseline, sec 154 8.8 ± 3.1   144 9.5 ± 3.0    
   % ∆ 26 weeks 116 -1.5 (-4.5, 1.5) 0.285 117 1.3 (-1.7, 4.3) 0.480 -2.8 (-7.0, 1.4) 0.237 | 0.109  
TUG - Dual-task         
  Baseline, sec 153 12.3 ± 6.8  143 13.6 ± 6.6    
  % ∆ 26 weeks 116 -1.0 (-5.8, 3.9) 0.484 116 -0.7 (-6.0, 4.6) 0.587 -0.3 (-7.3, 6.8) 0.938 | 0.658  
TUG - DT cost         
  Baseline, % 153 38.4 ± 39.4  143 44.0 ± 55.3    
 % ∆ 26 weeks 116 1.7 (-4.3, 7.6) 0.893 116 -3.8 (-11.6, 3.9) 0.242  5.5 (-4.3, 15.2) 0.351 | 0.305 
FSST         
  Baseline, sec 153 10.1 ± 3.8  142    11.0 ± 4.4    
  % ∆ 26 weeks 113 -4.9 (-8.5, -1.2)  0.006 117 -1.2 (-5.1, 2.8) 0.526  -3.7 (-9.1, 1.6)    0.176 | 0.034 
Baseline values are means ± SD; within and between-group (net) differences are unadjusted means of absolute and percentage change with 95% CI. Net differences (95% 
CIs) are calculated by subtracting within-group changes from baseline for the CON group from within-group percentage changes for the DT-FPT group after 26 weeks. 
Log-transformed values of TUG DT-Cost were used in analysis but percentages are presented as absolute values. Percentages for TUG and FSST were calculated as log-
transformed within-group and between-group changes x 100. Missing data points at 26-week testing were due to walker (DT-FPT, n=1), unwillingness to undergo test 
(CON, n=1) or removal of outliers (DT-FPT, n=2).  P-values for time and group-by-time interaction terms were derived from linear mixed models with random effects 
after accounting for sex and change in gait aid (Model 1), and from ANCOVA after adjusting for sex, change in gait aid, and baseline values (Model 2). DT: dual-task; 
FSST: four square step test; sec: seconds; TUG: Timed Up and Go.
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Table 5.10: Mean baseline muscle function/strength and functional gait performance within-group changes relative to baseline and net between-group 
differences for the change after 26 weeks in the dual-task functional power training (DT-FPT) and control (CON) groups.    
 Baseline Values and Within Group Changes  
     DT-FPT                          CON Intervention Effects 
 n Mean ± SD or (95% CI) P-value n 
Mean ± SD or 
(95% CI) P-value 
Net Difference 
(95% CI) 
P- values 
 Model 1 | Model 2   
Grip strength (D)         
  Baseline, kg  154 26.4 ± 9.1   144 23.2 ± 7.7    
  % ∆ 26 weeks 115 0.3 (-2.0, 2.6) 0.649 116 -1.4 (-4.4, 1.6)  0.438 1.7 (-2.1, 5.5) 0.341 | 0.465 
Grip strength (ND)           
  Baseline, kg 154 24.4 ± 8.8   143 21.4 ± 7.2    
  % ∆ 26 weeks 116 1.7 (-1.0, 4.3) 0.171 116 0.1 (-3.0, 3.2) 0.864 1.6 (-2.5, 5.6)  0.440 | 0.659 
5-STS power         
  Baseline, W/kg  154 4.7 ± 0.83  142    4.5 ± 0.83    
  % ∆ 26 weeks 115 5.6 (3.5, 7.8)  0.000 115 -1.7 (-3.9, 0.6) 0.072   7.3 (4.2, 10.4)    0.000 | 0.000 
Gait speed - Single-task         
  Baseline, m/s 154 1.20 ± 0.22   144 1.15 ± 0.23    
   ∆ 26 weeks 116 -0.02 (-0.05, 0.01) 0.190 117 -0.01 (-0.03, 0.02) 0.771 -0.02 (-0.05, 0.02) 0.487 | 0.984  
Gait speed - Dual-task         
  Baseline, m/s 153 0.90 ± 0.27  143 0.87 ± 0.27    
  ∆ 26 weeks 116 0.03 (-0.01, 0.1) 0.057 116 0.01 (-0.02, 0.03) 0.436 0.02 (-0.03, 0.06) 0.398 | 0.415 
Gait speed - DT cost         
  Baseline, %  153 25.3 ± 16.4  143 24.7 ± 15.4    
 ∆ 26 weeks 116 -3.5 (-5.9, -1.1) 0.002 116 -1.2 (-3.1, 0.7) 0.173 -2.3 (-5.3, 0.8) 0.117 | 0.295 
Baseline values are means ± SD; within and between-group (net) differences are unadjusted means of absolute and percentage change with 95% CI. Net differences (95% CIs) were calculated by subtracting within-group percentage 
changes from baseline for the CON group from within-group percentage changes for the DT-FPT group after 26 weeks. Percentages for grip strength are calculated as log-transformed within-group and between-group changes x 100. 
Missing data points at 26-week testing were due to injury (DT-FPT, n=1; CON, n=2), unwillingness to undergo test (CON, n=1), or removal of outliers (DT-FPT, n=1; CON, n=1). P-values for time and group-by-time interaction terms 
were derived from linear mixed models with random effects after accounting for sex (Model 1), and from ANCOVA after adjusting for sex and baseline values (Model 2). Functional gait models also adjusted for change in gait aid. 5-
STS: five sit-to-stand test; D: dominant hand; DT: dual-task; m/s: metres per second; ND: non-dominant hand; W/kg: power relative to body weight. 
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Table 5.11: Number and proportion of participants with counting errors during timed 
up and go (TUG) and functional gait testing at baseline and 26 weeks in the dual-task 
functional power training (DT-FPT) and control (CON) groups.    
Counting Errors, n 
DT-FPT CON 
Baseline 
(n=153) 
26 weeks 
(n=116) 
Baseline 
(n=143) 
26 weeks 
(n=116) 
TUG – Single-task  
  0 (no errors) 85 (55%) 78 (67%) 81 (57%) 69 (59%) 
  1 41 (27%) 19 (16%) 32 (22%) 27 (23%) 
  2 15 (10%) 9 (8%) 21 (15%) 9 (8%) 
  ≥3 12 (8%) 10 (9%) 9 (6%) 11 (10%) 
TUG – Dual-task     
  0 (no errors) 114 (75%) 87 (75%) 94 (66%) 79 (68%) 
  1 31 (20%) 20 (17%) 38 (27%) 34 (29%) 
  2 6 (4%) 8 (7%) 11 (7%) 3 (3%) 
  ≥3 2 (1%) 1 (1%) 0 (0%) 0 (0%) 
Gait speed – Single-task    
  0 (no errors) 80 (52%) 67 (58%) 73 (51%) 50 (43%) 
  1 45 (29%) 26 (22%) 38 (27%) 45 (39%) 
  2 24 (16%) 15 (13%) 25 (17%) 13 (11%) 
  ≥3 4 (3%) 8 (7%) 7 (5%) 8 (7%) 
Gait speed - Dual-task    
  <1 error 103 (67%) 81 (70%) 95 (66%) 71 (61%) 
  >1-2 40 (26%) 27 (23%) 36 (25%) 40 (35%) 
  >2-3 6 (4%) 6 (5%) 8 (6%) 4 (3%) 
  ≥3 4 (3%) 2 (2%) 4 (3%) 1 (1%) 
N.B: Gait dual-task was mean counting errors over 3 walking trials. Does not include 
missing data at baseline due to unwillingness to count backwards (DT-FPT, n=2), and 
at baseline and 26 weeks due to an unwillingness to count backwards (CON, n=1). 
 
Gait speed  
A total of eight participants used a gait aid during functional gait testing at baseline 
[DT-FPT, n=4 (3%); CON, n=4 (3%)] and 11 used one at 26-week testing [DT-FPT, 
n=4 (3%); CON, n=7 (5%)]. Seven participants who did not require an aid at baseline 
used one at 26 weeks [DT-FPT, n=3 (2%); CON, n=4 (3%)], while three participants 
did not require an aid at 26 weeks after using one at baseline [DT-FPT, n=2 (1%); 
CON, n=1 (1%)]. There were no differences between the groups at baseline for gait 
speed after adjusting for sex (Table 5.10). Following the 26-week intervention, there 
were no changes in any measure of single or dual-task gait speed or counting errors, 
except that dual-task cost for gait speed improved by 3.5% in the DT-FPT group only 
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(P=0.002). All other results remained unchanged after adjusting for baseline values 
and in the per-protocol analysis (Appendix T), except that gait velocity under dual-
task conditions increased by 0.04 m/s in DT-FPT in per-protocol analysis (P=0.035).  
 
Counting errors during single and dual-task gait conditions are provided in Table 5.11. 
During single-task counting, 105 participants [DT-FPT, n=56 (48%); CON, n=49 
(42%)] recorded no change in counting errors, 63 decreased counting errors [DT-FPT, 
n=29 (25%); CON, n=34 (29%)], and 64 participants increased the number of errors 
over the intervention [DT-FPT, n=31 (27%); CON, n=33 (29%)] (IQR: 2; range: 13). 
During dual-task walking, 54 participants [DT-FPT, n=22 (19%); CON, n=32 (27%)] 
recorded no change in counting errors, 83 decreased counting errors [DT-FPT, n=44 
(38%); CON, n=39 (34%)], and 95 participants increased the number of errors, over 
the intervention [DT-FPT, n=50 (43%); CON, n=45 (39%)] (IQR: 0.67; range: 15.3).  
 
Choice stepping reaction time  
A total of nine participants used a gait aid during CSRT at baseline [DT-FPT, n=4 
(3%); CON, n=5 (3%)] and five used one at 26-week testing [DT-FPT, n=3 (2%); 
CON, n=2 (1%)]. Two participants who did not require an aid at baseline used one at 
26 weeks [DT-FPT, n=1 (1%); CON, n=1 (1%)], while four participants did not require 
an aid at 26 weeks after using one at baseline [DT-FPT, n=2 (1%); CON, n=2 (1%)].  
 
There were no differences between the groups at baseline for CSRT variables after 
adjusting for sex (Table 5.12), except that response and decision times were 
significantly higher in CON compared to DT-FPT (P=0.036 and P=0.017 
respectively). There were no changes in single or dual-task function in any CSRT 
variable after adjusting for sex and change in gait aid (model 1). However, there was 
a significant net 3.6% benefit in favour of the DT-FPT group for response time under 
single-task condition (interaction, P=0.046) after additionally adjusting for baseline 
values. This was due to a 1.6% decrease in DT-FPT (P=0.390) and a non-significant 
2.0% increase in CON (P=0.359). Similarly, there was also a significant net 4.3% 
benefit in favour of the DT-FPT group for decision time under single-task condition 
(interaction, P=0.030) after adjusting for sex, baseline values and change in gait aid, 
which was due to a non-significant small 3.0% decrease in time for DT-FPT (P=0.139) 
and a 1.3% increase in CON (P=0.694). All other results remained unchanged after 
adjusting for baseline values and in the per-protocol analysis (Appendix U).  
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Table 5.12: Mean baseline choice stepping reaction time (CSRT) test variables, within-group absolute changes relative to baseline and net between-
group differences for the change after 26 weeks in the dual-task functional power training (DT-FPT) and control (CON) groups.    
 Baseline Values and Within Group Changes  
     DT-FPT                          CON          Intervention Effects 
 n Mean ± SD or (95% CI) P-value n 
Mean ± SD or 
(95% CI) P-value 
Net Difference 
(95% CI) 
P-values 
 Model 1  | Model 
CSRT - Single-task         
  Response time         
  Baseline, ms  154 1129 ± 222   144 1174 ± 251    
   ∆ 26 weeks 116 -18.0 (-56.3, 20.3) 0.390 117 23.2 (-13.8, 60.3) 0.359  -41.2 (-94.3, 11.8)  0.245 | 0.046 
  Decision time         
  Baseline, ms  154 830 ± 174  144 862 ± 174    
  ∆ 26 weeks 116 -25.1 (-57.5, 7.3) 0.139 117 11.4 (-21.8, 44.5) 0.694 -36.5 (-82.6, 9.7)  0.204 | 0.030  
  Movement time         
  Baseline, ms 154 299 ± 79  144 312 ± 87    
  ∆ 26 weeks 116 7.1 (-7.2, 21.3) 0.468 117 12.1 (-0.9, 25.0) 0.232 -5.0 (-24.2, 14.2) 0.858 | 0.508 
CSRT - Dual-task         
  Response time         
  Baseline, ms  154 1231 ± 209  143 1297 ± 271 ‡    
  ∆ 26 weeks 116 14.2 (-21.7, 50.2) 0.763 117 13.5 (-23.8, 50.9) 0.830 1.0 (-50.9, 52.3) 0.892 | 0.727 
  Decision time         
  Baseline, ms  154 932 ± 164  143 987 ± 197 ‡     
  ∆ 26 weeks 116 4.7 (-25.4, 34.8) 0.900 117 2.6 (-28.3, 33.5) 0.572 2.1 (-40.8, 45.0) 0.712 | 0.764 
  Movement time         
  Baseline, ms  154 299 ± 83  143 311 ± 117    
 ∆ 26 weeks 116 9.3 (-5.5, 24.2) 0.356 117 11.0 (-8.6, 30.7) 0.203 -1.7 (-26.2, 22.8) 0.723 | 0.378 
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Dual-task Cost         
  Response-DT Cost         
  Baseline, % 154 10.3 ± 13.4   143 11.7 ± 16.7    
  ∆ 26 weeks 116 2.1 (-1.8, 6.0) 0.290 117 -1.5 (-5.0, 2.1) 0.776 3.6 (-1.7, 8.8) 0.336 | 0.956 
  Decision-DT Cost         
  Baseline, %  154 14.0 ± 15.9  143 16.3 ± 17.5    
  ∆ 26 weeks 116 3.2 (-1.5, 8.0) 0.757 117 -1.8 (-2.4, 9.7) 0.768 5.0 (-1.3, 11.3) 0.665 | 0.818 
  Movement-DT Cost         
  Baseline, %   154 1.5 ± 19.5  143 1.2 ± 33.1    
  ∆ 26 weeks 116 0.3 (-5.3, 5.9) 0.546 117 -0.2 (-6.6, 6.2) 0.493 0.5 (-8.0, 9.0) 0.975 | 0.260 
Baseline values are means ± SD; within and between-group (net) differences are unadjusted means of absolute and percentage change with 95% CI. Net 
differences (95% CIs) were calculated by subtracting within-group percentage changes from baseline for the CON group from within-group percentage 
changes for the DT-FPT group after 26 weeks, however analyses were performed using log-transformed values. P-values for time and group-by-time 
interaction terms were derived from linear mixed models with random effects after accounting for sex and change in gait aid (Model 1), and from ANCOVA 
after adjusting for sex, change in gait aid and baseline differences (Model 2). ‡ P<0.05 baseline differences. DT: dual-task; ms: milliseconds. 
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5.4 Discussion  
The main finding from this 26-week cluster randomised controlled trial in older adults 
residing in independent living retirement villages was that a group-based dual-task 
functional power training (DT-FPT) program was associated with significant 
improvements in a number of cognitive domains, including choice reaction time and 
attention, along with a maintenance in psychomotor ability and attention, compared to 
a usual care control group. In contrast, there were no marked effects of the intervention 
on global cognitive function, executive function, working memory or learning. With 
regard to some of the physiological outcome measures, the DT-FPT program was 
associated with a significant improvement in functional muscle power (5-STS ability), 
mobility (four-square step test) and response and decision stepping times (CSRT) 
under a single-task condition. However, there was no effect of the intervention relative 
to controls on any other measure of function including single or dual-task gait speed 
or muscle strength. In comparison to controls the DT-FPT intervention was associated 
with a maintenance of weight, BMI and fat mass, but there was no effect on fat-free-
mass (muscle).  
 
Effects on psychomotor function-processing speed and reaction time 
It is widely accepted that ageing is associated with a reduction in processing speed and 
reaction time (Der & Deary 2006; Salthouse 2012), which can lead to a decrease in 
physical function and an increased risk of falls (Anstey et al. 2009; Lord & Fitzpatrick 
2001). In our study, we found that indices of processing speed and reaction time 
(psychomotor function) decreased by 0.12 to 0.36 SD over 26 weeks in the usual care 
control group. In contrast, our DT-FPT intervention was able to maintain or attenuate 
these age-related reductions. For instance, the mean changes in psychomotor function 
(DET), attention/choice reaction time (IDN) and the composite score incorporating 
psychomotor speed and attention in the DT-FPT group were -0.20 SD, +0.08 SD  and 
-0.06 SD respectively. Although the significant mean net 0.18 to 0.20 SD benefits 
observed for attention-choice reaction time (IDN) and the psychomotor speed-
attention composite in the DT-FPT group may appear modest, from a clinical 
perspective they are important as they would be equivalent to a delay in cognitive 
decline for reaction time and Psychomotor function-Attention of approximately 6.7 to 
10 years, when compared to cross-sectional data collected from our sample at baseline 
(as reported in Chapter 4). Pooled data at baseline showed a significant 0.03 SD per 
year deterioration in choice reaction time/visual attention (IDN) and 0.02 SD reduction 
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in the Psychomotor function-Attention composite. Previous longitudinal studies 
examining the rates of cognitive decline for processing speed and reaction time are not 
comparable to ours (Fozard et al. 1994; Salthouse 2009; Schaie 1989), due to our use 
of standardized scores from CogState tests across a 26-week period. Further, 
prospective studies utilising the CogState computerised test battery (3-12 months) 
(Darby et al. 2014; Darby et al. 2012; Lim et al. 2013) provide mixed findings in 
comparison to the significant declines witnessed in our control group. For instance, a 
smaller, non-significant performance decrement in absolute values of DET speed  
(-0.02 vs. -0.03 log10 milliseconds for our study), but a larger deterioration in IDN 
speed (-0.04 vs. -0.01 log10 milliseconds) has been noted over a shorter timeframe (3 
months) in healthy older adults compared to our controls (Lim et al. 2013). 
Furthermore, absolute performance scores did not change for DET, IDN, OCL or ONB 
over 12 months in a sample of 263 healthy older adults (Darby et al. 2012), however 
this sample was younger (mean age 65 years) than our control group, who may show 
lower rates of deterioration compared to our cohort. The significant declines for DET, 
IDN and the Psychomotor function-Attention composite within the control group may 
yet reflect natural age-related cognitive decline, which were attenuated in DT-FPT.  
 
To our knowledge, this is the first DT-FPT intervention to evaluate changes in 
cognition in older adults, and there are several elements of our training program that 
may have contributed to the cognitive improvements. Firstly, participants were 
prescribed a functional power and mobility/balance training program in conjunction 
with visual cognitive tasks such as spotting differences between two pictures and 
finding the odd number from a number sequence. These cognitive tasks require quick 
target detection and discrimination and engage higher-order processing abilities (Ball, 
Edwards & Ross 2007), which may have contributed to the improvements (or 
maintenance) in psychomotor function. Second, we prescribed secondary motor tasks 
which focused on timing and the synchronisation of movement to music or visual cues 
(e.g., walking in time to music, catching and quickly throwing a ball to a partner), as 
well as fast, coordinated movements (e.g., touching different body parts in different 
sequences, multi-directional stepping). Finally, the improvements in choice reaction 
time/visual attention (IDN) may also be related to the challenging balance exercises 
which included walking on a foam beam or performing exercise on an unstable 
surface, and thus required participants to initiate rapid reactions for trunk/limb 
adjustment.  
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Although we are unable to determine which exercise training element(s) and/or 
secondary cognitive-motor tasks may have been most important in terms of the 
cognitive benefits we observed, collectively the findings from our study add to 
previous research which has shown that dual-task exercise-cognitive training in older 
adults can improve various cognitive domains (e.g., executive function, processing 
speed, attention, and working memory) (Nishiguchi et al. 2015; Schoene et al. 2015; 
Theill et al. 2013; Yokoyama et al. 2015). For instance, a 12-week intervention in 
community-dwelling older adults who performed motor tasks and movement 
sequences as quickly as possible, concurrently with moderate-intensity aerobic 
training and PRT (60 minutes, twice weekly), displayed greater improvements in 
simple and choice reaction time in comparison to a group that performed exercise only 
and a control group (Leon et al. 2015). In contrast, 10 to 12-week simultaneous dual-
task studies in healthy community-dwelling older adults involving aerobic and/or PRT 
combined with memory training (Theill et al. 2013), or arithmetic and word games 
(Yokoyama et al. 2015) as secondary tasks, reported no beneficial effects on reaction 
time/processing speed. While the underlying reason(s) for the lack of any beneficial 
effects in these studies remain uncertain, it may relate to the shorter duration of the 
interventions (10-12 weeks), and/or that these training programs focused on improving 
fitness and/or muscle strength rather than functional performance.  
 
The performance of functional tasks may be innately cognitively demanding which 
provides an enriched environment for cognitive improvement. For example, a 10-week 
exercise intervention involving functional task movements in 83 older adults with mild 
cognitive impairment living in the community reported improvements in cognition and 
functional status (Law et al. 2014b). Furthermore, improvements in simple and choice 
reaction time have been observed following 4 weeks (50 minutes, five times per week) 
of multimodal training which included elastic-based functional training (motor 
activities, resistance exercises, reaction speed), compared to a recreational PA program 
(e.g., games, aerobic training) in community-dwelling older-adults (Ponce-Bravo et al. 
2015). This limited data suggests that the use functional training may have therefore 
contributed to the improvements we observed in processing speed and reaction time, 
however these benefits may also have also resulted from the use of secondary motor 
tasks associated with the functional training that challenged proprioception, reaction 
time, and/or information processing. This may also explain why several previous 
Chapter 5  
231 
 
multimodal exercise studies employing aerobic, coordination and balance training 
have reported some benefits for processing speed in older adults (Rikli & Edwards 
1991; Voelcker-Rehage, Godde & Staudinger 2011), while aerobic training and PRT 
provide mixed benefits for this cognitive ability in healthy older adults (Colcombe & 
Kramer 2003; Kelly et al. 2014).  
 
Effect of the intervention on choice stepping reaction time 
Accompanying the net cognitive benefits in processing speed and reaction time, the 
DT-FPT intervention resulted in a modest, but significant 4% net improvement in 
reaction time, specifically decision and response times during the single-task condition 
of the CSRT test, compared to controls. The observed improvement in decision time 
indicates a reduction in central processing delay (Baylor & Spirduso 1988; MacRae et 
al. 1996) and suggests that our training program had a significant effect on the 
premotor component of reaction time (stimulus presentation to initiation of movement; 
decision time), rather than the contractile component (initiation of muscle contraction 
to foot placement on the arrow; movement time) (Spirduso, Francis & MacRae 1995). 
Furthermore, this improvement in decision time may have driven the benefits we 
observed for overall CSRT response time in DT-FPT. Previous exercise interventions 
utilizing aerobic and/or PRT in older adults have reported mixed effects in terms of 
their ability to modulate the premotor component of reaction time (Baylor & Spirduso 
1988; Panton et al. 1990; Spirduso et al. 1988), or whole body reaction time 
(Kalapotharakos et al. 2006; Kalapotharikos et al. 2004). To our knowledge, no studies 
have evaluated the effects of high-velocity resistance or power training on these 
measures. However, in partial support of the beneficial effects of our DT-FPT program 
on measures of processing speed, decision time and response time, a previous 16-week 
computerised step-pad training intervention produced a 4% improvement in 
processing speed assessed via hand reaction time and digit and number matching in 
older adults living in retirement villages compared to a control group, along with 10-
15% improvements in movement and decision times during CSRT under single-task 
conditions (Schoene et al. 2015). In contrast to the training program in this study, 
multi-directional functional stepping performed with various dual-task activities was 
only one aspect of our program, which may help to explain our smaller improvement 
in decision time. Furthermore, the improvements we observed for CSRT suggest that 
DT-FPT may facilitate a transfer of benefits to unlearned tasks, as opposed to gains in 
tasks that were similarly encountered in training (i.e. stepping). While it is unclear as 
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to whether our improvements for CSRT are clinically meaningful, a longer premotor 
time during CSRT has been identified as a risk factor for falls (Wang et al. 2016) which 
suggests that our improvement in decision time following DT-FPT may be important 
for our older adults at risk of falls. 
 
The improvements in CSRT response and decision time under the single-task 
conditions (and FSST time which provides a measure of dynamic balance and 
coordination) in our study are most likely related to components of our dual-task 
exercise program that incorporated challenging functional training to optimise static 
and dynamic balance and mobility, together with the high-velocity functional 
movements targeted at improving speed of movement and lower limb power. Indeed, 
the inclusion of single and double-leg static and dynamic balance training in our 
program may have also allowed participants in the DT-FPT intervention to quickly 
transfer their foot to a certain position with less hesitation due to a greater sense of 
control over hip and knee flexors, and a more stable base of support. A greater degree 
of neuromuscular control and balance following moderate and high-intensity PRT has 
previously been described as a contributing factor to significant improvements in a 
task similar to CSRT (Kalapotharikos et al. 2004). In addition, previous research has 
reported that power training can improve neural drive or motor unit activation 
(recruitment) in leg musculature (Häkkinen et al. 1998; Hazell, Kenno & Jakobi 2007; 
Macaluso & De Vito 2004), which may also help to explain our positive findings. 
Consistent with our results, several intervention trials in either healthy community 
dwelling older adults or those residing in retirement villages have reported significant 
improvements in CSRT following 12 months of a group-based multicomponent 
(aerobic, strengthening, coordination and balance) program (Lord et al. 2003), or 8 
weeks of cognitive-step training which improved several aspects of CSRT (Schoene 
et al. 2013).  Similarly, a 12-month study which used a combination of machine-based 
power training, dynamic functional exercise and balance training, demonstrated a 6% 
improvement in dynamic mobility (FSST) in independently living older adults (mean 
age 67 years), compared to a usual care control group (Gianoudis et al. 2014). 
However, in contrast to our study this program also incorporated weight-bearing 
impact exercises (e.g., box jumps, lateral hopping) which may have contributed to the 
improvements in functional mobility. Nevertheless, the above findings suggest that a 
combination of functional power and balance/mobility training incorporating rapid 
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stepping may provide an ideal stimulus to improve multiple functional domains, 
particularly reaction time, in older adults.  
 
Effect of the intervention on attentional abilities 
Another important finding from our study was that participants undergoing DT-FPT 
were able to maintain attentional abilities compared to controls. This is likely related 
to several specific aspects of our exercise and cognitive-motor intervention. Firstly, 
functional exercises were completed in a multi-task setting which required a 
distribution of attention between movement components (e.g., walking while 
balancing on a beam, ensuring correct technique whilst performing power training). 
Second, our attention-demanding visual, cognitive and motor secondary tasks were 
designed to engage multiple domains of cognitive function, including executive 
abilities encompassing aspects of attention (e.g., alerting and orienting, selective and 
visual attention). For example, the execution of stepping exercises required sustained 
attention of obstacle location (step) while also dividing attention between step-ups and 
a secondary cognitive or motor task. Likewise, our functional exercises were 
completed whilst identifying and fixating on visual objects (visual cognitive task), 
which meant switching attention between the physical exercise and the secondary 
task(s), along with focused concentration. Similar training elements have been shown 
to improve attention when included as part of a cognitive training program (Reijnders, 
van Heugten & van Boxtel 2013). While no studies have specifically investigated the 
effects of DT-FPT on attention, there is some evidence that simultaneous and 
sequential combined exercise-cognitive trials can improve attentional abilities 
(Oswald et al. 2006; Schoene et al. 2015; Yokoyama et al. 2015). For example, a 12-
week trial in community dwelling older adults involving low-intensity PRT and 
walking performed in accordance to changing auditory cues, along with arithmetic and 
word games, produced a significant improvement in an aspect of attention, compared 
to a group that performed exercise training alone (Yokoyama et al. 2015). Despite the 
use of a different exercise format in this study compared to our trial, the use of 
secondary cognitive or motor tasks that require or maintain sustained or divided 
attention appears to be an important factor for improving attention in older adults.  
 
Effect on executive function, working memory-learning and global cognition 
Despite the positive effects of our DT-FPT intervention on several cognitive domains, 
a number of factors are likely to explain why we observed no benefits to various other 
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domains such as executive function, visual learning, working memory or global 
cognition. It is possible that the inconsistent findings are related to the low-intensity 
modality of our training program, the modest and/or lack of changes in various 
functional measures, muscle strength or body composition (fat-free mass), the health 
status of our participants, and/or the modest compliance to the dual task functional 
training program. Despite including secondary tasks that endeavoured to activate 
executive abilities and higher-order processing [e.g., working memory (remembering 
lists) and cognitive flexibility (anagrams)], our program had no effect on executive 
function, global cognition or working memory. In part support of our findings, 
community-dwelling older adults in a 12-week study who performed motor tasks and 
movement sequences as quickly as possible (e.g., walking course, manipulating 
objects; 60 minutes three times per week), displayed no changes in attention or 
executive function, despite greater improvements in reaction time under single and 
dual-task conditions in a driving task, in comparison to a control group (Marmeleira, 
Godinho & Fernandes 2009). Several previous reviews that have reported a positive 
influence of combined cognitive-exercise programs on cognition in older adults also 
indicate that exercise duration and intensity may moderate the cognitive benefits 
available (Lauenroth, Ioannidis & Teichmann 2016; Law et al. 2014a; Zhu et al. 2016). 
In addition, two meta-analyses of exercise trials reported that moderate-high intensity 
aerobic training, PRT or the combination, performed for 45-60 minutes per session, 
were associated with benefits to cognitive function (e.g., psychomotor function, 
executive function, working memory, attention) in older adults (Colcombe & Kramer 
2003; Northey et al. 2017). Although the duration of our exercise sessions (~60 
minutes, twice a week) align with these findings, the intensity of our training could be 
considered low-moderate given that the focus was on challenging balance/mobility 
activities and high-velocity functional movements in which the training loads were 
only manipulated through weighted vests, therabands, and relatively light (0.5 to 10 
kg) hand-held weights and ankle weights. However, one study investigating the effects 
of high-velocity PRT on cognitive function found that 12 weeks of both high-velocity 
and slow-velocity elastic-based PRT (60 minutes, twice a week) improved global 
cognitive function compared to a control group in cognitively impaired older women 
aged over 65 years (Yoon et al. 2017). While only one cognition domain was assessed 
in this trial, the findings provide some evidence that this mode of training may improve 
cognition, but perhaps the benefits are only apparent in those with initial impairment. 
This will be discussed in further detail below.  
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As described previously, our program consisted of high-velocity functional PRT using 
elastic bands of different resistance and bodyweight exercises alone or with limited 
use of dumbbells. When compared to other exercise formats such as moderate-
intensity aerobic training and/or PRT, our format may have been insufficient for 
stimulating specific neurobiological mechanisms that have been associated with 
particular exercise-induced cognitive gains from moderate-intensity exercise (Kirk-
Sanchez & McGough 2014). Currently there is uncertainty as to which training 
variables (mode, intensity, frequency or duration) are critical for cognitive 
improvements, but there is evidence for some consistent benefits with aerobic training 
(Angevaren et al. 2008; Etnier et al. 2006). In contrast to our findings, improvements 
in executive function, global cognition or memory in older adults have typically been 
observed in dual-task exercise programs including moderate intensity aerobic training 
(above 60% of HRmax) with and without PRT (Anderson-Hanley et al. 2012; Gill et al. 
2016; Kayama et al. 2014; Maillot, Perrot & Hartley 2012; Theill et al. 2013). As our 
program aimed to improve functional performance rather than strength or aerobic 
fitness, dual-task exercise protocols with these objectives may be able to activate more 
sensitive mechanisms that lead to improved cognition in domains such as executive 
function and memory. For example, an improvement in neural correlates in prefrontal 
and temporal cortical regions of older adults (e.g., increased neurogenesis, plasticity, 
hemodynamic activity, brain volume, activation patterns) have been observed 
following moderate-intensity aerobic training, balance and hand-eye coordination 
training, and PRT, and are thought to play a role in higher order executive control and 
memory (Voelcker-Rehage & Niemann 2013). Further cognitive adaptations are 
speculated to stem from the promotion of neurotransmitter availability (e.g., 
noradrenaline, adrenaline) following aerobic training, which assists with memory 
storage and retrieval (Etnier et al. 2006; Zornetzer 1985), while increased cerebral 
perfusion (Kashihara et al. 2009) during exercise is linked to elevated oxygen and 
glucose transport to the brain which may improve cognitive function (Chodzko-Zajko 
& Moore 1994).  
 
We hypothesized that the rapid muscular contractions which were a feature of our DT-
FPT program might improve cognitive function via the release of various circulating 
neuroprotective growth factors such as BDNF and IGF-1, however this was not 
observed (as will be discussed/presented in Chapter 7). Increased levels of these 
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growth factors are thought to mediate the effects of exercise on improved cognition 
(Cotman, Berchtold & Christie 2007). While this will be discussed in more detail in 
Chapter 7, increases in muscle and circulating levels of these factors have coincided 
with improvements in cognition in older adults following moderate-high intensity PRT 
(Cassilhas et al. 2010), aerobic training (Erickson et al. 2011), multimodal exercise 
(Vaughan et al. 2014), and dual-task exergaming (Anderson-Hanley et al. 2012). For 
example, 12 weeks of moderate-high intensity exergame-based cycling (45 minutes, 
five times per week, HRR 60%) significantly increased BDNF compared to traditional 
cycling of the same intensity in community-dwelling older adults, and these increases 
were linked to concomitant improvements in several assessments of executive 
function, but no improvements in memory were detected (Anderson-Hanley et al. 
2012). Despite this limited finding for neurotrophin release following dual-task 
exercise, it is possible that a lack of exercise-induced improvement in BDNF may yet 
underlie our findings for executive function, global cognition, working memory and 
the Learning-Working memory composite. Moreover, the induction of BDNF 
promotes neurogenesis and synaptogenesis in the hippocampus, which restores 
dysfunctional neural circuits and leads to improvements in memory (Mattson, 
Maudsley & Martin 2004). On the other hand, of the few dual-task studies that have 
improved aspects of memory in older adults, these trials have primarily required 
participants to remember specific sequences of stepping and walking in accordance to 
visual and auditory commands or with mental tasks (Gill et al. 2016; Nishiguchi et al. 
2015), or included memory training as the only secondary cognitive task (with 
treadmill exercise) (Theill et al. 2013). Furthermore, these interventions have not 
affected other domains such as attention and processing speed. We included similar 
types of secondary tasks to these studies in our training program, but also used many 
other cognitive and motor tasks that did not rely on memory storage and retrieval. 
However, dual-task exercise protocols that use training components specific to 
memory processes, may be more effective for training-induced gains in this domain.  
 
The modest compliance to the dual-task intervention (mean ~50%) is also likely to 
have contributed to the mixed findings we observed on the various cognitive domains. 
Participants were asked to train twice a week, but the 50% compliance means that they 
only completed one training session per week, which is equivalent to, on average, ~20 
hours of training throughout the 26-week intervention. While the optimal dose of 
exercise needed to improve various cognitive domains in older adults remains 
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uncertain, in partial support of our mixed findings a previous 16-week dual-task 
computerised stepping intervention (20 minutes, three times per week, total dose ~16 
hours) in older adults living in retirement villages that reported similar low levels of 
compliance, only detected improvements in eight of 19 outcomes related to cognitive 
function compared to a control group (Schoene et al. 2015). In this study, they also 
found that higher adherers to the program (23% with at least twice per week training) 
improved more in tasks related to executive function compared to low adherers, but 
low adherers improved more in processing speed and visual scanning, a finding that is 
in part consistent with our results. While it is difficult to explain these findings, several 
shorter 12-week dual-task interventions incorporating exergaming (twice weekly, 60 
minutes) (Maillot, Perrot & Hartley 2012) or low-moderate intensity PRT, stepping 
and walking performed with verbal and motor tasks (once weekly, 90 minutes) 
(Nishiguchi et al. 2015), both reported more consistent improvements across multiple 
cognitive domains in community-dwelling older adults with compliance that ranged 
from 92-98%. While no dual-task exercise studies have established whether a dose-
response relationship exists for cognitive performance, it is likely that our modest 
compliance together with the relatively low dose and intensity of training were 
contributing factors to our mixed findings.  
 
Effects on muscle strength and power  
The relatively low intensity nature of our training program with the focus on functional 
movement, along with the fact that many of our exercises were performed with 
attention-demanding tasks which may compromise power output, is also likely to 
explain our modest gains in muscle power and lack of effects on muscle (grip strength) 
strength, which may in turn be associated with the inconsistent findings for cognitive 
function. We observed a 7% net benefit for the changes in lower limb muscle power 
(sit-to-stand performance) in the DT-FPT group, along with modest 4% improvements 
in mobility (four-square step test) and the CSRT tests. In part support of our findings, 
a 14% improvement in leg extensor muscle power was detected following 12 weeks 
(three times a week) of functional power training (therabands, weight vests) in healthy 
older women compared to a non-exercising control group (de Vreede et al. 2005). In 
addition, functional outcomes (balance and coordination and daily performance) were 
greater compared to the control group. Similar to our findings, a 12-month multimodal 
exercise intervention performed twice weekly in older adults who had fallen in the 
previous year reported a net 5% improvement in chair rise time compared to a control 
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group, despite no change in muscle strength (Patil et al. 2015). Although the gains in 
muscle power in our study (and the above trials) are considerably lower than that 
observed in a number of previous trials using high-intensity power training (i.e. 37-
97% gains) (Fielding et al. 2002; Pereira et al. 2012), it is important to note that these 
studies utilised machine-based protocols using a greater resistance (e.g., >70% of 
1RM). However, it is also noteworthy that such changes in knee extensor muscle 
power do not always translate to greater functional improvements (Byrne et al. 2016). 
A review including 31 power training studies has reported that training with lower 
loads (20-40% 1RM) can produce equivalent gains in muscle power and functional 
outcomes (e.g., timed up and go, balance, stair climbing) compared to higher (>70% 
1RM) training loads (Byrne et al. 2016). Thus, while the gains in functional muscle 
power in our study are modest, there is some evidence that a 9-10% improvement in 
leg extensor power represents a clinically meaningful improvement in mobility limited 
older adults (Kirn et al. 2016). While further research is needed to determine what 
might represent a clinically meaningful improvement in functional muscle power, our 
findings provide some evidence that DT-FPT may be an effective strategy for 
improving functional capacity, and combined with our program’s benefit to processing 
speed and functional mobility (FSST and CSRT time), may enhance an older adult’s 
ability to process and react to situational obstacles, allowing them to correct a misstep 
or restore a loss of balance in preventing a fall. 
 
Effects on body composition 
It is possible that the lack of change in weight or fat mass in the DT-FPT group in our 
trial may have contributed to the mixed findings we observed for the various cognitive 
domains. Previous research has been mixed regarding whether obesity and its related 
constructs (higher body fat, weight and BMI) are associated with an increased risk of 
cognitive decline in older adults (Cronk et al. 2010; Kanaya et al. 2009; Spauwen et 
al. 2017; West & Haan 2009). This association may relate to the increase in CVD risk 
factors and vascular disease (Gorelick et al. 2011; Gustafson 2008) that are associated 
with obesity (Lavie, Milani & Ventura 2009), and/or the release of pro-inflammatory 
markers and metabolites from adipose tissue (Craft 2009; Yaffe et al. 2004). However 
there is controversy as to whether fat loss is necessary for effective neurocognitive 
interventions, as a higher BMI appears to be protective for cognitive decline and 
disease in older adults but is most likely the result of confounding variables (e.g., 
weight loss due to comorbid health conditions, weight loss that results from cognitive 
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decline) (Stillman et al. 2017). In our study, we observed no between-group changes 
in weight or fat mass following our 26-week DT-FPT intervention, although 
participants in the usual care control group did experience a small but significant gain 
in weight and fat mass. There is some meta-analytic evidence that diet-induced losses 
in weight or fat mass are associated with low-order improvements in cognitive 
function, particularly in memory and attention/executive function in obese middle-
aged adults (Siervo et al. 2011), with improvements in these domains associated with 
2.5 kg/m2 reductions in BMI in another meta-analysis that also included exercise 
interventions (Veronese et al. 2017). Therefore our lack of changes in weight or fat 
mass following DT-FPT may have influenced our findings for cognition.  
 
To our knowledge few studies have assessed the effect of change in body fat mass on 
cognitive performance in healthy community dwelling older adults (Dao et al. 2013; 
Han et al. 2009). Pooled results from a 12-month high-intensity PRT and 
balance/toning trial with community-dwelling older women demonstrated that reduced 
sub-total body fat mass was independently associated with better performance in 
executive abilities (Dao et al. 2013). However no other domains were assessed for 
their potential relationship. Although we did not conduct similar analyses, this data 
suggests that decreases in body fat may influence improvements in cognition, which 
may partially explain our findings. Indirect measures of body fat have also been 
associated with cognitive function, as pooled data from a group of MCI older adults 
receiving 12 months of nutritional counselling or usual care demonstrated that 
decreases in BMI were associated with improvements in memory, executive function 
and global cognition (Horie et al. 2016). In contrast to our findings, both a 12-week 
moderate-intensity exergaming intervention, and cycling alone, showed numerous 
within-group improvements in cognitive domains such as memory and visuospatial 
skills, along with improvements in percent abdominal fat, fat mass, and weight 
(Anderson-Hanley et al. 2012), however no attempts were made to associate changes 
in body composition and cognition. Further research is needed to clarify these 
relationships between adiposity and cognition in older adults.  
 
Emerging evidence suggests that a loss of lean muscle mass and muscle function 
(strength and performance) may be associated with impaired cognitive function and 
dementia, and structural degeneration of brain regions (Boyle et al. 2009; Burns et al. 
2010; Spauwen et al. 2017). It has been suggested that this may due to the shared risk 
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factors of MCI and sarcopenia (e.g., low-grade inflammation, malnutrition, and 
sedentary lifestyle) (Baumgart et al. 2015; Nishiguchi et al. 2016; Tolea & Galvin 
2015). Indeed, an improvement in strength has been identified as one of the 
mechanisms through which PRT may indirectly confer cognitive benefits to older 
adults (Forte et al. 2013; Mavros et al. 2017). Our inconsistent findings with regard to 
the mixed results on cognition may therefore be partially attributed to the lack of 
change we observed in muscle strength or fat-free mass. As already discussed, this was 
most likely due to the focus of DT-FPT on optimizing speed of movement via the use 
of light training loads rather than peak muscle force. Further to this, moderate 
correlations have been observed between hand-grip strength and simple reaction time, 
and arm-strength and CRT following 4 weeks of multimodal functional training, 
however no other cognitive domains were assessed (Ponce-Bravo et al. 2015). In 
addition, these authors also noted that strength gains greater than 20-23% may be 
required for benefits in reaction time, which we did not observe.  To our knowledge, 
no dual-task exercise studies have investigated whether improvements in lean muscle 
mass or muscle strength are associated with, or mediate improvements in, cognitive 
function. Nonetheless, dual-task exercise studies that failed to show increases in 
isometric or dynamic limb strength have also shown inconsistent effects across 
cognitive abilities such as executive function, attention and memory (Anderson-
Hanley et al. 2012; Schoene et al. 2015). Conversely, 12-week high-velocity elastic-
based PRT program (60 minutes, twice a week) improved global cognitive function 
and isometric grip strength compared to a control group, as well as leg strength in the 
PRT group, in cognitively impaired older women aged over 65 years (Yoon et al. 
2017). Whether these cognitive improvements were mediated by gains in muscle 
strength remains to be determined, and additional research is needed to determine if 
any strength benefits available from various dual-task exercise formats may contribute 
to improvements in cognition.  
 
Healthy status of participants 
Another likely explanation for the mixed findings on cognitive function and functional 
measures is that we only included relatively healthy older adults who were living 
independently in retirement villages. Older adults with lower baseline levels of 
cognition (e.g., MCI) may have greater scope for improvement compared to healthy 
older adults, especially in memory function (Petersen et al. 1999). Our sample was 
cognitively intact as only 7% of our participants were informally classified as MCI. 
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Conversely, previous research has shown that dual-task cognitive-exercise programs 
produce more consistent cognitive benefits in older adults with cognitive impairment 
or dementia (Gill et al. 2016; Kounti et al. 2011; Suzuki et al. 2012). For instance, 20 
weeks of low-intensity walking, motor and balance training performed in accordance 
to visual and auditory cues improved executive function, global cognition, attention 
and visuospatial ability in older adults with MCI (90 minutes, once per week), with 
only memory unchanged, compared to a control group (Kounti et al. 2011). The 
healthy nature of our sample may have also contributed to our inconsistent findings 
for body composition and functional measures. Although 86% of our participants had 
one or more cardiometabolic risk factors, the vast majority were receiving medication 
for their conditions. Furthermore, baseline scores for gait speed (6% below 0.8 m/s 
cut-off) and grip strength (males 21% below 26 kg cut-off; females 20% below 16 kg 
cut-off) indicate that the vast majority were well-functioning older adults (Studenski 
et al. 2014). In part support of our notion, older MCI women undertaking a 12-week 
study with elastic-based HV-PRT showed a large improvement in handgrip strength 
and muscle mass compared to a control group (60 minutes, twice a week) (Yoon et al. 
2017), which suggests that the characteristics of our cohort may have limited their 
capacity for functional improvement.  
 
Effects on dual task functional performance 
An unexpected finding in our study was that DT-FPT did not improve dual-task 
performance across a range of functional measures, which may relate to the nature of 
the tasks that were completed in training, and the healthy nature of our sample. Some 
positive effects for dual-task performance have been reported in a review of non-
exercise based dual-task training studies in older adults (Wollesen & Voelcker-Rehage 
2013), however studies with positive findings have mostly assessed tasks that also 
formed the basis of their training program (e.g., walking/balancing whilst counting 
backwards or performing motor tasks). By comparison, our training program included 
FPT that was performed with more naturalistic secondary attention-demanding tasks 
(e.g., naming animals, visual detection, and manipulating objects) largely while sitting 
or standing. Importantly, these exercises differed considerably from our functional 
assessments such as walking over 10m while counting backwards from sevens, and 
may explain why only a significant within-group improvement in DT-FPT for gait 
speed dual-task cost was observed. In addition, while secondary tasks were prescribed 
to participants, the ability of a participant to successfully complete these activities 
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during functional power training was not recorded. Therefore if a participant chose to 
focus more on the execution of a physical exercise rather than the secondary task, then 
the cognitive-motor challenges would not have provided the same stimulus for 
improving dual-task capabilities, which may have also influenced our findings. 
Previous studies investigating dual-task exercise have also attributed their null 
findings for gait speed (Theill et al. 2013) and other functional performance (Plummer-
D'Amato et al. 2012) under dual-task conditions to a dissimilarity between training 
elements (e.g., functional balance and agility training or treadmill walking with 
cognitive tasks) and assessment, however it is more likely that their shorter 
intervention lengths may have been contributing factors  (4 to 10 weeks). In part 
support of our findings, 26 weeks of low-intensity walking/dancing performed with 
motor tasks in accordance to musical cues had no effect on gait speed or balance under 
single or dual-task conditions in community welling older adults, using a secondary 
task which involved counting backwards in ones (Trombetti et al. 2011). Although no 
other functional outcomes were assessed, this may support the contention that 
improvements in dual-task ability do not carry-over to untrained dual tasks (Silsupadol 
et al. 2009). In a further example, gait velocity whilst walking at a fast pace under 
dual-task conditions (counting backwards in sevens) significantly improved in older 
adults living in aged care after 12 weeks of multimodal training (aerobic and PRT) 
plus computerised step dancing (~55 minutes twice a week), compared to a group that 
performed multimodal training (Pichierri et al. 2012). However no effects for dual-
task performance at usual pace were detected, which is what we assessed and may be 
more reflective of real-life, and no other functional measures were assessed. Therefore 
dual-task performance effects may depend on a familiarity between training elements 
and assessment tasks.  
 
Of further consideration, our failure to detect significant differences between DT-FPT 
and control for dual-task performance may relate to the healthy and cognitively intact 
nature of our cohort. As stated above, only 6% of participants recorded a gait speed 
below the cut-point considered to represent functional impairment, while around 67% 
of participants recorded on average less than one counting error for functional gait 
under dual-task conditions. Therefore, the majority of participants may have already 
been performing at their functional ceiling for this task at baseline. Interventions with 
frail or cognitively impaired older adults have shown different effects, as TUG 
performance under dual-task conditions (counting and naming animals) improved by 
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17 to 27% following 12 weeks of a twice-weekly power and balance training program 
with frail nonagenarians compared to a stretching group, however gait velocity under 
single or dual-task conditions did not change (Cadore et al. 2014). As a point of 
difference to our study, dual-task cost was not assessed for any task by these authors, 
while their participants had functional values at baseline which would be classified as 
sarcopenic, and therefore may have had a greater capacity for improvement. Similarly 
older adults with dementia demonstrated a 21% reduction in dual-task cost for gait 
velocity (counting backwards in 3s) following a 12-week training protocol involving 
PRT, functional (e.g., walking and stepping) and balance training performed 
concurrently with cognitive and motor tasks, compared to flexibility training  
(Schwenk et al. 2010). However in this study, no significant effects for dual-task cost 
were observed when participants counted forward in twos, and this was attributed to 
an inadequate challenge to attentional resources by this secondary task, which did not 
impair dual-task performance relative to single-task. It is possible that for our healthy 
older adults, the dual-task conditions featured in our testing may have also provided 
an inadequate challenge to attentional capacity at baseline and follow-up. Collectively, 
vulnerable cohorts may be more amenable to improvements in aspects of divided 
attention and dual-task function.   
 
Interactions with BDNF and APOE  
Cross-sectional evidence suggests that possession of the Met allele of the BDNF gene 
(Miyajima et al. 2008; Raz et al. 2009) is associated with poorer cognitive 
performance, while the ApoE-ε4 genotype exerts a small adverse effect on global 
cognition, processing speed and executive functioning in healthy older adults (Small 
et al. 2004; Wisdom, Callahan & Hawkins 2011). Despite these associations, the 
response of cognitive function to our intervention did not vary by genetic 
polymorphisms. While few exercise trials have investigated the interactions between 
exercise and genotype (Leckie et al. 2014; Nascimento et al. 2015; Rahe et al. 2015a), 
a limited number do provide some support for our findings (Nascimento et al. 2015; 
Rahe et al. 2015a). For example, the carriage of an ε4 allele was predictive of 
improvement in a verbal fluency task in older adults following a 7-week sequential 
program involving aerobic and PRT with cognitive training, however no interactions 
between treatment (exercise or control) and genotype were reported (Rahe et al. 
2015a). Further, in a 16-week study involving older adults with MCI, significant 
improvements in global cognitive function were detected following multimodal 
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exercise (aerobic and PRT, three times per week) compared to a control group, and 
these improvements were independent of BDNF genotype (Nascimento et al. 2015). 
However the cognitively impaired cohort used in this study may show a different 
response to structured exercise compared to our older adults. It has been suggested that 
any deleterious impact of the Met allele on cognition may be diminished in late 
adulthood (i.e. 75 years), due to the independent effects that dementia, impairment and 
age-related disease have on cognitive function (Erickson, Miller & Roecklein 2012), 
which may partially explain why no interactions were observed.  Given this limited 
data, future studies could assess whether the effects of dual-task training are influenced 
by genetic polymorphisms.  
 
Strengths and Limitations 
The strengths and limitations of this intervention will be discussed in detail in Chapter 
8, and therefore only the strengths and limitations unique to this study will be 
presented. There were several strengths to this study. It is the first RCT to investigate 
cognitive changes following a dual-task functional power training program, and 
possessed a comprehensive battery of functional tests. Second, this form of group-
based training was well-tolerated with minimal adverse events reported.  In addition, 
the classes were held on-site and scheduled away from other village activities, in order 
to maximize participation. Third, the cluster randomisation avoided the likelihood of 
intervention contamination due to the program being conducted within each village 
site. Fourth, this study was powered for the larger aims of the trial (falls) and therefore 
cognitive function was a secondary outcome. However, this meant that our sample size 
was one of the largest recruited for a dual-task exercise intervention, which provides 
additional statistical power for detecting cognitive changes. Fifth, while the CogState 
battery has not been previously used in exercise interventions to assess cognitive 
function in older adults, it displays minimal practice and learning effects. This battery 
also measured cognitive abilities that were not specifically developed during training, 
and can therefore indicate a wider transfer of cognitive gains. Finally, the blinding of 
researchers during the intervention minimised the potential for researcher bias.  
 
This study had a number of limitations. First, the modest compliance to the training 
program (~50%) may have limited the scope of the findings, even though per protocol 
results were not substantially different to those in the intention to treat analysis. 
Second, the combination of functional power training with cognitive/motor training in 
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the one intervention precludes determination of which component (or both) were 
driving any positive findings. The inclusion of comparative cognitive training, or 
functional power training groups may address this limitation. Third, the length of our 
intervention was greater than typically witnessed in many of the previous dual-task 
studies. However longer exercise intervention or follow-up periods (i.e. 1-year) have 
produced more consistent cognitive benefits (Kelly et al. 2014), and may be required 
to slow cognitive decline or alter a disease path (Winblad et al. 2016). Furthermore, 
some intervention effects (i.e. cognitive improvements) may take at least a year to 
emerge following an intervention (Rahe et al. 2015b). Fourth, the tasks contained 
within the CogState battery have been validated against standardized 
neuropsychological assessments (Maruff et al. 2009), however using this test battery 
rather than traditional cognitive assessments (e.g., Trail making test, Mini-Mental 
State Examination), makes it harder to compare our findings to other studies. In 
addition, the CogState battery of tasks has not been extensively used in exercise 
interventions (Shah 2014); instead typically used to detect cognitive impairment in 
older adults (Lim et al. 2012; Maruff et al. 2013). While this battery is capable of 
measuring cognitive abilities not developed during DT-FPT, its sensitivity in 
measuring cognition following an exercise intervention requires further testing. Fifth, 
our uptake of participants from retirement villages was poor (10%), and therefore it is 
unclear how generalizable our results are to independently living adults or community-
dwelling older adults. Furthermore, while an unequal gender balance may be observed 
at retirement villages, our sample may have contained an even higher proportion of 
women (73%) than found in these villages. In addition, measurements were conducted 
in the residents’ village, and therefore conditions were not uniform across villages in 
terms of room space and noise, however baseline and follow-up testing were 
conducted in the same location. Finally, the sample comprised relatively healthy and 
well-functioning older people, so findings cannot be generalised to frail older adults 
who may not be able to safely undertake the supervised DT-FPT program. Further 
detail about the study strengths and limitations will be discussed in Chapter 8. 
 
Summary and Conclusion 
In conclusion, 26 weeks of DT-FPT produced significant improvements in processing 
speed and attention in older adults living independently in retirement villages, but had 
no effect on global cognitive function, executive function or working memory. The 
DT-FPT program was associated with a significant improvement in lower-limb power, 
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dynamic mobility and rapid stepping response and decision times compared to 
controls, but there were no other significant changes in functional mobility or gait 
under single or dual-task conditions, muscle strength, or dual-task cost. Similarly, the 
DT-FPT group displayed a maintenance of weight, BMI and fat mass relative to 
controls who experienced an increase, but there was no effect of the intervention on 
fat-free-mass. In conclusion, these findings indicate that DT-FPT provides some 
cognitive benefits to healthy older adults which may delay an onset of cognitive 
decline, while this training format can also improve functional capacity. Collectively 
these improvements may maintain an older adult’s ability to perform everyday 
activities which can prolong functional independence. Further studies are needed to 
determine if DT-FPT can provide greater benefits to adults with MCI or dementia.
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6. Chapter 6 
Effects of a dual-task functional power training program on health-
related quality of life and well-being in older adults. 
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6.1 Introduction 
The transition from middle to older age can bring about unique and overwhelming 
lifestyle changes, including a change in residence, retirement, the onset of illness and 
functional impairment, and even the loss of friends and family. These age-related 
changes can compromise physical and psychological health, and negatively impact 
quality of life (QoL) (Arent, Landers & Etnier 2000), which can contribute to a host 
of emotional and physiological co-morbidities and deprive an individual of their 
independence. Compounding these deficits, age-related declines in cognitive function 
have been associated with decreased social interaction and/or decrements in well-
being and QoL (Bassuk, Glass & Berkman 1999; Llewellyn et al. 2008; Maki et al. 
2014). Furthermore, there is evidence that age-related losses in muscle mass, strength 
and function are associated with physical disability, increased risk of falls and a loss 
of functional independence, which have been linked to reduced QoL (Fielding et al. 
2011; Landi et al. 2012; Rizzoli et al. 2013; Sayer et al. 2006). Therefore interventions 
that can exert a positive effect on cognitive function, and improve muscle strength and 
function may also have benefits for QoL and well-being in older adults (Canuto 
Wanderley et al. 2015).  
 
Exercise and regular physical activity have proven to be effective behavioural 
strategies for the treatment of poor mental health and stress (Arent, Landers & Etnier 
2000; Wipfli, Rethorst & Landers 2008), and can enhance well-being in older adults 
(Katula, Rejeski & Marsh 2008; Rejeski & Mihalko 2001). In particular, exercise is 
thought to activate therapeutic pathways that facilitate actual or perceived benefits for 
mental health and well-being (e.g., increased serotonin release, regulation of stress 
hormone release, self-efficacy) (Barbour, Edenfield & Blumenthal 2007; Strohle 
2009). The effects of exercise can be measured through Health-Related Quality of Life 
(HR-QoL), which is widely recognized as a subjective rating of QoL that is primarily 
influenced by the health status of an individual (Guyatt, Feeny & Patrick 1993). In 
addition, HR-QoL accounts for psychosocial and physical influences (Revicki 1989), 
which are more likely to be altered by an exercise intervention, as opposed to broader 
physical, psychological, social and environmental factors that are measured by QoL 
instruments. Accumulating evidence from observational studies suggests that regular 
participation in physical activity is positively associated with HR-QoL in older adults 
(Pucci et al. 2012; Rejeski & Mihalko 2001), however meta-analyses of randomised 
controlled trials (RCT) have provided mixed evidence as to whether different modes 
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of exercise can modify HR-QoL and overarching perceptions of QoL in older adults 
(Kelley et al. 2009; Netz et al. 2005). Furthermore, these studies have not provided 
any information regarding the optimal dose of exercise required to elicit changes in 
HR-QoL. Previous research has shown that aerobic training is an effective modifier of 
perceived psychological health and well-being (Gillison et al. 2009; Netz et al. 2005), 
but displays mixed benefits in the psychological domains of HR-QoL (e.g., mental 
health) (Awick et al. 2015; Canuto Wanderley et al. 2015; Sillanpaa et al. 2012). 
Further, meta-analyses have indicated that progressive resistance training (PRT) can 
improve HR-QoL and well-being, particularly on perceptions of physical function 
(Kelley et al. 2009; Netz et al. 2005). However, the effectiveness of PRT for improving 
HR-QoL is mixed across various intervention studies (Cassilhas et al. 2007; de Vreede 
et al. 2007; Kanemaru et al. 2010; Sillanpaa et al. 2012), which may result from 
variations in intervention lengths, self-report measures (e.g., WHOQOL-BREF vs SF-
36), participant characteristics (e.g., initial health status) and training exposure (e.g., 
training frequency and session length).  
 
Recently, high-velocity PRT (HV-PRT or power training) programs have been shown 
to be more effective than traditional PRT for improving muscle function (Tschopp, 
Sattelmayer & Hilfiker 2011), which may contribute to the improved perceptions of 
physical function and overall well-being in older adults that have been observed 
following power training (Katula, Rejeski & Marsh 2008; Ramirez-Campillo et al. 
2016; Sayers et al. 2003). Other studies have explored the role of cognitively 
challenging (or dual-task) exercise training (e.g., dancing in time to music, 
exergaming), but the effect on measures of HR-QoL have been mixed (Eyigor et al. 
2009; Franco et al. 2012; Karahan et al. 2015; Keogh et al. 2014; Lee et al. 2015; Oh 
et al. 2015). Cognitive training alone has been proposed as another modality that may 
positively influence QoL as a consequence of improving cognitive function, but there 
is only limited and inconclusive evidence regarding whether these interventions can 
improve QoL in adults over 60 years of age (Giuli et al. 2016; Kwok et al. 2013). 
Whether a combination of exercise and cognitive training, either sequential or 
simultaneous dual-task training, can modify HR-QoL outcomes in older adults 
remains uncertain. One 30-week intervention trial that combined coordination/balance 
training performed twice a week and cognitive training performed once a week over 
separate sessions in community-dwelling older adults detected improvements in 
subjective health ratings five years post–intervention, but not immediately after the 
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intervention (Oswald et al. 2006). However, the effects of simultaneous dual-task 
cognitive-exercise training on HR-QoL in older adults has not yet been examined. 
 
Satisfaction with Life (SWL) is a cognitive judgement about one’s own QoL (Diener 
1994), and is considered a proxy measure of QoL and well-being (Diener 2000; Guérin 
2012). Observational studies have reported positive associations between self-reported 
physical activity levels and SWL in healthy middle-aged and older adults (Elavsky et 
al. 2005; Rejeski & Mihalko 2001). However, structured exercise interventions 
involving aerobic training and/or PRT have shown mixed effects in their ability to 
improve SWL in older adults (Awick et al. 2015; Mihalko & McAuley 1996; Rejeski 
& Mihalko 2001). While this conflicting data may result from variation in the methods 
used to assess SWL, as well as the type and dose of exercise prescribed, there is some 
evidence to support the role of multimodal training as an approach to enhance broader 
determinants of well-being (Brown et al. 2009; Kohut et al. 2006). Furthermore, there 
is some preliminary data indicating that HV-PRT (Katula, Rejeski & Marsh 2008) and  
cognitively challenging exercise (e.g., dancing) (Kosmat & Vranic 2016) can also 
enhance SWL. The ability of cognitive training to improve SWL or subjective well-
being as a function of improved cognitive performance has also been assessed in a 
limited number of studies, but has been mostly ineffective for modifying these well-
being outcomes (Bureš et al. 2016; Shatil et al. 2014). Given this limited data which 
suggests that SWL may be modified through exercise training, a combination of 
exercise and cognitive training performed simultaneously in a dual-task training 
context has not been previously assessed, but may improve SWL in older adults living 
in retirement villages. Notably, retirement villages can provide the setting for high 
levels of social interaction and an active lifestyle (Buys 2001), which may not be found 
in the general community.  
 
Therefore, the aim of this study was to evaluate the effect of a 26-week dual-task 
functional power training program (DT-FPT) on HR-QoL and SWL in older adults 
living independently in retirement villages. A secondary aim was to determine whether 
the response to the intervention varied by sex. It was hypothesised that this program 
will improve domains of HR-QoL and well-being, but there would be no differences 
between the sexes.  
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6.2 Methods 
The following section will outline the specific study design and methodology used to 
investigate the effect of a DT-FPT intervention on HR-QoL, SWL and well-being in 
older adults. For the purpose of this chapter, only the methodology that pertains to the 
present study will be presented. A detailed description of the methods for this study 
has been provided in Chapter 3.   
 
6.2.1 Participants 
Three hundred older adults (81 men and 219 women) aged 77.4 ± 6.8 (mean ± SD) at 
risk of falls were recruited in three rolling cohorts, from 22 independently living 
retirement villages in the greater metropolitan and regional areas of Melbourne. One 
participant withdrew from the study after baseline testing and requested that all data 
be erased, hence the final number was 299. 
 
6.2.2 Study design 
This was a community-based, cluster randomised controlled trial in which older adults 
residing in retirement villages, who are at increased risk of falling, were randomly 
allocated to: 1) an exercise program involving functional power training with 
challenging balance/mobility activities that was performed simultaneously with a 
secondary attention-demanding motor or cognitive task (DT-FPT) (n=11 villages), or 
2) a usual care control group (n=11 villages). The primary aim of the main RCT was 
to evaluate the efficacy of the intervention on the rate of falls, but the focus of this 
study was on the effect of the intervention on HR-QoL and well-being. Baseline and 
follow-up data from the 26-week intervention was used in this study.  
 
6.2.3 Intervention  
Villages with participants allocated to the exercise intervention undertook two 45-60 
minute group-based and supervised exercise sessions per week, for 26 weeks. Dual-
task training components were performed simultaneously with challenging 
balance/mobility and functional power training exercises, and involved a combination 
of cognitive, visual, and motor tasks, as described in detail in Chapter 3. Participants 
in the usual care control group continued with their normal physical activity habits and 
received their usual care from their medical practitioner and community services.  
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6.2.4 Measurements  
All testing was conducted on-site at each retirement village at baseline and 26 weeks.  
A detailed description of the outcome measures used in this study is provided in 
Chapter 3, and a brief outline is provided below. The reasons for, and number of 
missing data-points for each outcome measure at 26 weeks follow-up testing are 
described in Chapter 5 unless otherwise specified. 
 
Anthropometry  
Height and body weight were measured using standard techniques, via portable 
stadiometer (Surgical and Medical PE87) and TANITA scales (TANITA BC-418, 
Tanita, Japan), from which BMI was calculated. 
 
Health-related Quality of Life (SF-36® v2™) 
The Short Form 36® version 2™ (SF-36® v2™) was used to measure HR-QoL (Ware 
Jr & Sherbourne 1992) and reported using Australian norm-based scores according to 
previously published guidelines (Hawthorne et al. 2007). Summary scores for each of 
the eight subscales and two overall summary scores [physical component summary 
(PCS) and the mental component summary (MCS)], were used in the analysis 
(Hawthorne et al. 2007). A global composite of HR-QoL was also created by averaging 
the weighted means of the eight subdomains. Analysis of SF-36v2 data utilized 
published ‘weightings’ most relevant to this population (Hawthorne et al. 2007).  
 
Satisfaction with Life (Personal Well-being Index, PWI) 
Satisfaction with life (SWL) was used as a proxy of well-being (Cummins et al. 2003), 
and was assessed via the Personal Wellbeing Index (PWI), using a single-item measure 
of SWL and a composite variable derived by averaging satisfaction scores on eight life 
domains.  
 
Depression Anxiety and Stress Scale (DASS-21) 
The Depression Anxiety and Stress Scale (DASS)-21 is a 21-item self-report measure 
and was used to assess symptoms of depression, anxiety and stress over the past week 
(Henry & Crawford 2005). These subscales were each multipled by two, and the sum 
of the depression subscale was used as a covariate in assessing HR-QoL outcomes, as 
depressive symptomology is linked to health perceptions.  
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Health and medical history, and medication use  
Participant health and medical history, current medication usage, employment status, 
race, education level attained and smoking status were assessed by questionnaire 
according to the categories outlined in Chapter 5. Participants were assessed for   
cardiometabolic risk as described in Chapter 5.  
 
Adverse events  
For participants in the exercise group, any adverse event sustained during the exercise 
program (e.g., illness or injury) was recorded. An unblinded researcher interviewed 
participants in both groups at 13 and 26 weeks after their intervention had begun to 
determine whether they had experienced an adverse event. This determined whether 
any adverse events in the DT-FPT group were beyond those experienced during usual 
care. 
 
Exercise adherence 
Compliance with the exercise program was assessed by attendance at the supervised 
exercise sessions, and was calculated by dividing the total number of sessions attended 
by the total number of sessions available over the 26 weeks, multiplied by 100.   
 
Habitual physical activity  
Leisure and recreational physical activity (PA), reported as estimated kilojoules (kJ) 
per week spent in moderate to high-intensity physical and leisure activities, was 
evaluated using the Community Healthy Activities Model Program for Seniors 
(CHAMPS) questionnaire (Stewart et al. 2001).  
 
6.2.5 Statistical analyses 
Sample sizes for this study were based on calculations reported in Chapter 3. All 
statistical analyses were conducted on an intention-to-treat basis using STATA 
statistical software release 14.0 (STATA, College Station, TX, USA). Baseline 
characteristics between the groups were compared by independent t-tests for 
continuous variables and chi-square tests for categorical variables. All data was 
checked for normality prior to analysis, but did not require transformation. The effect 
of the intervention on primary and secondary outcome variables was analysed using 
general linear mixed models with random effects, accounting for the variability 
between clusters (villages) and within a cluster (participants within the same village). 
The group (DT-FPT or CON) was the fixed effect, and clusters (retirement village) 
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and the unit of analysis (participants), were included as random effects to account for 
the clustered design. The effect of the intervention on HR-QoL and SWL was initially 
assessed by adjusting for age and sex (model 1), before additionally adjusting for the 
DASS-21 depression subscale score at baseline and cardiometabolic status (model 2). 
An additional model was run based on analysis of covariance and adjusted for baseline 
values for the outcome measure and clustering (model 3). A per-protocol analysis was 
also conducted on those in the training group meeting ≥50% adherence levels to the 
exercise program. To determine if the response of HR-QoL and well-being to the 
intervention varied by sex, the interactions between sex (male or female) by group 
allocation and time, were also conducted. All data are presented as means ± SD or 
95% CI. Changes in HR-QoL and well-being are expressed as the absolute change in 
norm-based scores from baseline. Between-group differences were calculated by 
subtracting the within-group changes from baseline for the DT-FPT group from the 
within-group changes for the usual care control group after 26 weeks. The significance 
level was set at P<0.05.  
 
6.3 Results 
This study used data obtained from the 26-week trial, some of which was presented in 
Chapter 5. This results section will therefore report only the unique and pertinent 
aspects of this study as they relate to HR-QoL and well-being, and will refer to the 
results from Chapter 5 at other times.  
  
Baseline characteristics 
Three hundred participants aged between 65-96 years were recruited in three cohorts 
over 14 months, from 22 eligible retirement communities. Baseline characteristics of 
this sample are presented in Table 5.1. Missing data for each category is presented in 
Appendix O. All mean HR-QoL norm-based scores were below 50, with the exception 
of the mental health domain. However, relative to normative data for Australian adults 
aged over 75 years (Hawthorne et al. 2007), the participants were on average within 
±0.4 SD for all measures (Table 4.2). For PWI, on average participants scored at the 
higher end of the range (mean  SD: 79.8 ± 13.1) relative to the current normative 
range for Australians over 65 years (77.5 – 79.7 points) (Fuller-Tyszkiewicz et al. 
2016). Comparison of the baseline characteristics between the groups revealed that 
there were a higher proportion of women in the control group (P<0.001) (Table 5.1). 
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Study Attrition 
Of the 300 participants randomised to the intervention, 156 from 11 villages were 
allocated to the dual-task functional power training (DT-FPT) group and 144 from 11 
villages to the usual care control group. As reported in Chapter 5, 49 (16%) of 
participants withdrew from the study over the 26-week intervention, which included 
one participant who requested for all data to be erased, hence the final sample size was 
299.  In addition, 18 participants (6%) did not attend 26 weeks testing due to illness 
and failure to be contacted (i.e. lost to follow-up) which was not different between 
groups [DT-FPT, n=9 (6%); CON, n=9 (6%), Chi-square P=0.861]. Therefore, a total 
of 233 of the 300 participants (78%) returned for 26 weeks follow-up testing, with the 
reasons for withdrawal outlined in Chapter 5. In addition to these 233 participants, 
three participants provided questionnaire data but could not undergo functional testing 
due to extended illness, hence 236 participants (79%) provided questionnaire data at 
26 weeks follow-up testing and are included in HR-QoL and well-being analyses. The 
proportion of participants that did not provide data was not significantly different 
between the groups (DT-FPT, n=38; CON, n=26, Chi-square P=0.183 respectively). 
Comparison of the participants that provided data and those that withdrew or did not 
provide questionnaire data, revealed that there were no differences in the baseline 
characteristics, with the exception that those attending 26 weeks follow-up testing or 
providing questionnaire data (n=236), had significantly higher scores in physical 
functioning (P=0.013), social functioning (P=0.038), role emotional (P=0.022), global 
HR-QoL (P=0.041), and PWI average (P=0.013), compared to those who withdrew or 
did not attend testing (Appendix V). 
 
Missing data 
At baseline, SF-36, PWI and DASS-21 questionnaires were not completed by two 
participants (DT-FPT: n=1; CON: n=1), while one participant provided incomplete 
responses for some subdomains of the SF-36 (CON: n=1) and was excluded from 
analysis for GH, PCS and MCS composites and the global composite HR-QoL 
measure. Analyses for the effects of the intervention on main and secondary outcome 
measures were based on the following participant numbers, which represents those 
with complete data at baseline and 26 weeks; health-related quality of life (n=236) and 
satisfaction with life (n=236). However, one participant in DT-FPT did not wish to 
answer the optional SWL single-item question at baseline or 26 weeks, and therefore 
analysis for this item is based on n=235.  
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Medication and chronic conditions, habitual physical activity  
Baseline and intervention data for medication usage, chronic conditions and habitual 
PA are presented in Chapter 5. Briefly, at baseline nearly half (49%) of the participants 
were taking lipid-lowering medication, and 71% were on antihypertensive medication, 
with no significant differences between the groups (Chi square all P>0.160). Nearly 
70% of participants were taking three or more prescribed medications at baseline. 
There were no differences for the changes to medication usage (type, dose, or number) 
after 26 weeks (Chi-square all P>0.05). Forty three percent of participants were 
ex/current smokers (10 were current smokers) with an equal proportion between each 
group (Chi-square, P=0.204) (Table 5.1). A total of 287 participants (96%) possessed 
at least one chronic health condition [DT-FPT, n=150 (97%); CON, 137 (96%)], and 
167 (56%) possessed ≥3 conditions [DT-FPT, n=91 (59%); CON, n=76 (54%)], and 
there were no differences between the groups in the number of health conditions or 
proportion of participants with chronic health conditions at baseline (P=0.623 and Chi-
square, P=0.872). The number of new diseases and proportion of participants with new 
diseases over the intervention were not different between groups (P=0.495, and Chi-
square, P=0.415, respectively). 
 
Exercise adherence and adverse events 
As reported in Chapter 5, mean (±SD) adherence to the exercise program was 50 ± 
32% (median 58%, range 0 to 98%), which was equivalent to approximately one 
session per week. A breakdown of adherence by cluster is provided in Table 5.2. 
Overall 15 musculoskeletal complaints/injuries, or other adverse events were reported 
by 13 of the 156 participants in the DT-FPT group throughout the 26-week 
intervention (Table 5.5). Of the 15 adverse events, five were deemed to be related to 
the exercise program, seven were possibly related and three were unrelated. However 
no participants withdrew from the program due to their injury, and all participants 
sustaining an adverse event continued exercising and returned for follow-up testing. 
 
Health-related quality of life 
There were no significant differences between groups for any of the norm-based SF-
36 scores, or SWL measures at baseline. The mean baseline scores and within group 
changes, and between group differences for the change over time for each SF-36 
subdomain and composite scores are shown in Table 6.1, while raw scores for HR-
QoL subdomains are presented in Appendix W. For the subdomain role-physical, there 
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was a significant net benefit in the DT-FPT compared to CON group after adjusting 
for covariates in model 3 only (P=0.037). For the physical functioning subdomain, 
there was also a net benefit in DT-FPT relative to CON after adjusting for covariates 
in models 1 and 2 (both P<0.05 after adjusting for age, sex, DASS-21 depression 
subscale score at baseline and cardiometabolic disease risk), but this was not 
statistically significant after adjusting for baseline values (model 3, P=0.069). For 
global HR-QoL, there was a trend for greater net benefits in DT-FPT compared to 
controls (P<0.08). For all other HR-QoL measures, there were no significant within 
group changes in either DT-FPT or CON and no between group differences over time 
(Table 6.1 and Figure 6.1), with the exception of the following: 1) the physical 
functioning subdomain decreased in CON (P=0.008) after 26 weeks, but this change 
was not significantly different from DT-FPT after adjusting for covariates in model 3 
(P=0.069); and 2) there was a significant reduction in the social functioning subdomain 
in CON (P=0.039) after 26 weeks, but no between group difference was detected in 
any model. All results remained the same in the per-protocol analysis which included 
those in DT-FPT achieving ≥50% adherence to the program (Appendix X), with the 
exception that after adjusting for baseline values there was a significant net benefit for 
the change over time in DT-FPT compared to CON for social functioning (P=0.039), 
PCS (P=0.032) and global HR-QoL (P=0.037), along with role physical (P=0.007). 
Trends for a significant net benefit for the change in physical functioning (P=0.06) and 
role-emotional (P=0.05) were also detected in DT-FPT compared to CON in the per-
protocol analysis.  
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Table 6.1: Mean baseline HR-QoL norm-based and PWI scores, the within-group changes relative to baseline and net between-group differences 
for the change after 26 weeks in the dual-task functional power training (DT-FPT) and control (CON) groups.   
 Baseline Values and Within Group Changes  
 DT-FPT CON Intervention Effects 
 n Mean  (95% CI) 
P-value n Mean  
(95% CI) 
P-value Net Difference  
(95% CI) 
P- values 
Model 1| Model 2 | Model 3 
Physical functioning         
  Baseline  154 40.3 ± 11.1  143 39.5 ± 11.4    
  ∆ 26 weeks 118 0.29 (-0.95, 1.54) 0.570 118 -1.65 (-2.77, -0.53)  0.008 1.94 (0.27, 3.60)  0.037 | 0.036 | 0.069 
Role physical         
  Baseline  154 45.0 ± 10.1  143 44.2 ± 10.5    
  ∆ 26 weeks 118 0.55 (-1.08, 2.17) 0.424 118 -1.73 (-3.57, 0.11) 0.123 2.28 (-0.17, 4.72)  0.118 | 0.111 | 0.037 
Bodily pain         
  Baseline  154 45.0 ± 11.0  143 43.4 ± 11.9    
  ∆ 26 weeks 118 0.19 (-1.77, 2.14) 0.974 118 -0.70 (-2.43, 1.03) 0.603 0.89 (-1.71, 3.48) 0.677 | 0.706 | 0.414 
General health         
  Baseline  154 47.6 ± 8.05  142 46.8 ± 9.14    
  ∆ 26 weeks 118 0.38 (-0.75, 1.51) 0.469 118 0.74 (-0.42, 1.91) 0.164 -0.36 (-1.98, 1.25) 0.677 | 0.696 | 0.947 
Vitality           
  Baseline  154 48.8 ± 9.68  143 48.9 ± 9.58    
  ∆ 26 weeks 118 -0.10 (-1.33, 1.13) 0.858 118 0.13 (-1.28, 1.53) 0.720 -0.29 (-2.09, 1.63) 0.830 | 0.842 | 0.718 
Social functioning         
  Baseline  154 49.2 ± 9.52  143 49.3 ± 9.31    
  ∆ 26 weeks 118 -0.09 (-1.94, 1.75) 0.944 118 -2.28 (-4.22, -0.34)  0.039 2.18 (-0.48, 4.84) 0.142 | 0.113 | 0.137 
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Role emotional         
  Baseline  154 46.4 ± 12.1  143 46.9 ± 11.5    
  ∆ 26 weeks 118 1.29 (-0.67, 3.26) 0.088 118 -1.33 (-3.58, 0.92) 0.354 2.62 (-0.35, 5.59)  0.142 | 0.113 | 0.064 
Mental health         
  Baseline  154 49.6 ± 9.03  143 50.0 ± 9.05    
  ∆ 26 weeks 118 0.60 (-0.71, 1.91) 0.436 118 -0.17 (-1.51, 1.16) 0.988 0.77 (-1.09, 2.64) 0.441 | 0.412 | 0.893 
PCS         
  Baseline  154 43.0 ± 10.4  142 41.7 ± 10.4    
  ∆ 26 weeks 118 0.07 (-1.19, 1.33) 0.909 118 -1.01 (-2.15, 0.14) 0.131 1.07 (-0.63, 2.77) 0.282 | 0.294 | 0.087 
MCS         
  Baseline  154 51.0 ± 9.36  142 52.0 ± 9.29    
  ∆ 26 weeks 118 0.69 (-0.72, 2.10) 0.262 118 -0.62 (-2.10, 0.86) 0.441 1.31 (-0.73, 3.34) 0.174 | 0.110 | 0.244 
Global HR-QoL         
  Baseline  154 46.5 ± 7.66  143 46.1 ± 7.78    
  ∆ 26 weeks 118 0.39 (-0.44, 1.21) 0.315 118 -0.87 (-1.84, 0.09) 0.129 1.26 (0.00, 2.52)  0.069 | 0.067 | 0.076 
Satisfaction with life         
  Baseline  153 79.6 ± 16.7  143 79.0 ± 18.0    
  ∆ 26 weeks 117 0.94 (-1.67, 3.55) 0.506 118 1.19 (-1.21, 3.58) 0.212 -0.25 (-3.77, 3.28) 0.825 | 0.868 | 0.291 
PWI          
  Baseline  154 80.3 ± 12.2  143 79.3 ± 14.1    
  ∆ 26 weeks 118 0.63 (-1.05, 2.30) 0.393 118 0.33 (-1.17, 1.83) 0.443 0.30 (-1.94, 2.53) 0.968 | 0.769 | 0.699 
Baseline values are means ± SD; within and between-group (net) differences are means with 95% CI. Net differences (95% CIs) were calculated by subtracting within-group changes from baseline 
for the DT-FPT group from within-group changes for the CON group after 26 weeks. P-values for time, and group-by-time interaction terms were derived from linear mixed models with random 
effects after accounting for the following covariates: Model 1: adjusted for age and sex, Model 2: adjusted for age, sex, DASS-21 depression subscale score at baseline and cardiometabolic disease 
risk. P-values for Model 3 were derived from ANCOVA, adjusting for baseline differences and covariates in Model 1. HR-QoL: health-related quality of life; MCS: mental component summary; 
PCS: physical component summary; PWI: Personal Well-being Index composite.
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Figure 6.1: Mean (±SEM) change in norm-based scores of the SF-36 domains; 
physical functioning, social functioning, role emotional, role physical, physical 
component summary (PCS), mental component summary (MCS), global health-
related quality of life (HR-QoL), and Personal Well-being Index, in the dual-task 
functional power training (DT-FPT) and control (CON) group after 26 weeks.   
* P<0.05, ** P<0.01 within-group change relative to baseline, and between-group 
differences after adjusting for baseline values (denoted by line and p-value).
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Satisfaction with Life 
There were no significant differences between groups for the satisfaction with life 
single-item score (SWL) or Personal Well-being Index composite (PWI) at baseline, 
and no significant within-group or between-group changes were observed in average 
PWI or the single-item SWL score. All results remained unchanged after adjusting for 
baseline values and in the per-protocol analysis that included those in DT-FPT 
achieving ≥50% adherence to the program (Appendix X). 
 
DASS-21  
There were no significant differences between groups for DASS-21 depression 
subscale scores at baseline, and no significant within-group or between-group changes 
were observed after 26 weeks [mean change DT-FPT: 0.02 (95% CI -0.66, 0.69); 
CON: -0.22 (95% CI -0.92, 0.48) units; P=0.481].  
 
Sex interactions 
No significant sex interactions were detected, except that men showed a greater net 
decrease in the general health subdomain of the SF-36 (P=0.017) and SWL (P=0.049) 
following exercise compared to controls, in comparison to women. For men in the DT-
FPT group (n=54), there was a significant decrease in the general health subdomain 
[mean change DT-FPT: -2.12 (95% CI -3.96, -0.28); CON: 1.09 (95% CI -1.45, 3.62) 
units (P=0.030)] and less improvement in satisfaction with life single-item score [mean 
change DT-FPT: 0.24 (95% CI -3.59, 4.07); CON: 7.62 (95% CI 1.87, 13.4) units; 
(P=0.029)] compared to CON (n=26 older males). In women there were no significant 
differences for the change in the general health subdomain [mean change DT-FPT: 
1.76 (95% CI 0.43, 3.09); CON: 0.69 (95% CI -0.64, 1.97) units (P=0.254)] and SWL 
[mean change DT-FPT: 1.33 (95% CI -2.12, 4.79); CON: -0.21 (95% CI -2.76, 2.34) 
units (P=0.682)] in the DT-FPT compared to CON group.  
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6.4 Discussion  
The main finding from this 26-week trial of dual-task functional exercise training was 
that there were significant improvements in various measures of functional 
performance, but there were no marked effects on HR-QoL or satisfaction with life in 
older adults living independently within retirement villages, with the exception of a 
modest but significant maintenance effect in the role physical subdomain of HR-QoL. 
While this suggests that this form of training may have the potential to reduce the 
impact of physical limitations that may impair the performance of daily activities or 
prohibit an older adult from carrying out their usual role, these findings must be 
interpreted with caution given the lack of any marked changes in any other measures 
of HR-QoL. However, the per protocol analysis that included those with at least 50% 
compliance to the exercise program (mean 75%) found that there were significant net 
benefits for the change over time in the DT-FPT group compared to CON for social 
functioning, the physical component summary score and global HR-QoL, with a trend 
for a significant net benefit for the change in physical functioning (P=0.06) and role-
emotional (P=0.05). Further, secondary analysis exploring sex interactions 
demonstrated that there were no differences for any of the outcome measures, with the 
exception that older men in the training program reported greater net decreases in the 
domain of general health, and less improvement in satisfaction with life, compared to 
the control group.   
 
Compliance, insufficient training frequency and dose and intervention duration 
The finding that DT-FPT was largely ineffective for improving HR-QoL, particularly 
the key domains of PCS and MCS, in our older adults at risk of falls residing in 
independent living retirement villages may be explained by a number of factors.  These 
include the modest or lack of marked changes in the physical functional measures (as 
described in Chapter 5), the relatively low intensity nature and training modes used in 
our training program, the healthy nature of our participants, and the modest 
compliance to the exercise program. An important feature of our study was that 
supervised, individually-tailored exercise training was performed in a group-based 
setting at retirement villages, to encourage compliance to the program and reduce 
barriers to exercise participation (e.g., lack of social support, accessibility to venue, 
transport). Despite these features, exercise compliance was modest (mean ~50%), 
which most likely contributed to the modest improvement in the various physical 
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function measures and reduced social exposure, which may partly explain the 
inconsistent or lack of any marked effects on HR-QoL.  
 
To our knowledge, HR-QoL has not been previously assessed following a dual-task 
cognitive-exercise intervention, however several group-based exercise studies 
conducted within retirement villages have reported similar compliance levels but have 
not assessed HR-QoL (Lord et al. 2003; Tiedemann, Sherrington & Lord 2011). One 
study conducted in independent living retirement villages that reported a similar 
median compliance  (56% vs 58% for our study) did not find any improvement in PCS 
or MCS, or the number of falls, cognitive function, or functional measures (leg 
strength, balance), following 12 months of social dancing programs (60 minutes, twice 
weekly), compared to a control group (Merom et al. 2016). No other domains of the 
SF-36 were reported, and the authors partially attributed their lack of any intervention 
effects to an inadequate training dose. In our study, the average dose after taking into 
account exercise compliance ranged between 20-26 hours (one day per week 45-60 
minutes). While the optimal dose or frequency of exercise to improve HR-QoL 
remains unknown, partially consistent with our findings, an exercise trial prescribing 
one day per week of supervised PRT or multimodal training (aerobic training, PRT 
and balance training) did not show any benefits for HR-QoL (Peig-Chiello et al. 1998). 
 
 In contrast, several interventions in healthy older adults involving cognitively 
challenging dancing (12 weeks, 60 minutes twice a week) (Hui, Chui & Woo 2009), 
water and land based dance-exercise (10 weeks, 60 minutes three times a week) (Oh 
et al. 2015), moderate and high intensity PRT (24 weeks, 60 minutes three times a 
week) (Cassilhas et al. 2007) or high-intensity power training (75% 1-RM, performed 
either twice or three times per week for 12 weeks, 50-70 minute sessions) (Ramirez-
Campillo et al. 2016), all reported positive effects on various measures of HR-QoL. In 
all of these studies exercise compliance ranged from 75% to 96% (equivalent to 
approximately two sessions per week), which suggests that at least two sessions per 
week may be needed to improve measures of HR-QoL in community-dwelling older 
adults. In part support of this notion, the findings from our per-protocol analysis in 
those participants with at least 50% compliance over the 26 weeks (mean 75%), 
revealed that there were significant net-benefits for the DT-FPT group in social 
functioning, role physical, PCS and global HR-QoL compared to the control group, 
along with trends for greater benefits in the physical functioning and role emotional 
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domains. However, whether the net benefits observed in the DT-FPT group are 
clinically meaningful remains to be determined, as previous research has reported that 
in patients with chronic disease, rather than a relatively healthy sample such as ours, 
the minimally important difference for HR-QoL estimates appears to be 0.5 SD 
(Norman, Sloan & Wyrwich 2003). For our purposes this would equate to a change of 
5 units according to norm-based scaling, which we did not observe.  
 
Previous research has shown that small but meaningful improvements in HR-QoL can 
be obtained following exercise interventions lasting between 3-6 months in healthy 
older adults (Gillison et al. 2009). It is therefore likely that the length of our 
intervention (26 weeks) was sufficient for detecting any potential differences in HR-
QoL measures, satisfaction with life and well-being. However, there is some evidence 
that exercise training may result in transient benefits to HR-QoL (e.g., after 1-3 
months), which may not persist in the long-term (e.g., after 26 weeks). Indeed, data 
from two meta-analyses which examined the effects of various exercise types on 
psychological well-being and mood in older adults indicated that positive training 
effects on well-being indices were significantly greater in short-term trials (1 to 12 
weeks) compared to studies lasting longer than 12 weeks (Arent, Landers & Etnier 
2000; Netz et al. 2005). As an example, improvements in life satisfaction emerged 
midway through a functional training program (step-ups, stair climbing, lifting cases) 
at 5 weeks in community dwelling adults aged 70 and over compared to a control 
group, but did not persist at the conclusion of the 13-week intervention (Solberg et al. 
2013). While this intervention was shorter than our 26-week trial, the transient effects 
witnessed in this and other studies has been ascribed in part, to a rapid progress and 
greater mastery experiences (i.e. mastering a task or building skills within a new 
environment) at the beginning of such trials (McAuley et al. 2005), or even the 
perception of functional improvement (e.g., mobility, strength) which collectively 
contribute to initial improvements in HR-QoL and well-being (Solberg et al. 2013).  
 
It is unclear whether these mechanisms may have been at play in our program, however 
initial favourable perceptions of HR-QoL and well-being may be diminished as the 
perceived and actual benefits from exercise become smaller, and/or the motivation to 
continue exercising wanes. Therefore the progressions within our program, and other 
exercise interventions, may have facilitated the continuation of physical adaptations, 
but may have been insufficient to maintain exercise behaviours and perceptions of 
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change, which affected HR-QoL and well-being as a consequence.  Therefore, an 
initial increase in psychosocial (e.g., mastery, self-efficacy) and physical factors may 
provide HR-QoL advantages for interventions of shorter durations, as improvements 
in multiple domains of physical and mental HR-QoL have been detected in 8-12 week 
trials involving virtual-reality led tai-chi (Lee et al. 2015), water-based dance-exercise 
(Oh et al. 2015), and high-intensity power training (Ramirez-Campillo et al. 2016). 
However, whether there were initial improvements in life satisfaction and HR-QoL 
during the initial phases of our training program cannot be determined, since these 
measures were only assessed pre and post-intervention. Similarly, whether  motivating 
factors (extrinsic or intrinsic) or a greater sense of self-efficacy within our participants 
due to modelling, verbal persuasion or arousal had any influence on their HR-QoL 
and/or well-being during the intervention remains unclear, as neither self-efficacy or 
motivation were evaluated.  
 
The relatively low intensity of our training program with the focus on functional 
movement is also likely to explain our modest gains in muscle power (7%) and 
functional mobility (4%), and lack of effects on muscle (grip strength) strength, gait 
speed, and body composition (as reported in Chapter 5). These findings may in turn 
be associated with our inconsistent findings for HR-QoL. Moreover, the lack of 
changes in muscle strength, may have limited our findings for physical domains of 
HR-QoL such as physical functioning, which tended to increase (P<0.07), or PCS 
which showed no change. Indeed, there is some cross-sectional evidence that greater 
muscle strength is associated with higher global HR-QoL in older adults (Gouveia et 
al. 2017).  Furthermore, exercise-induced changes in muscle strength have also been 
associated with improvements in specific HR-QoL domains, particularly physical 
functioning and role physical in healthy older adults (Canuto Wanderley et al. 2015; 
Haraldstad et al. 2017; Torres et al. 2017). For instance, improvements in the domain 
of physical functioning (3 unit increase over intervention) have weakly correlated with 
improvements in leg strength (18% training gain; r=0.295) following 12 weeks of PRT 
in pooled data from two PRT groups of older men (Haraldstad et al. 2017). On this 
basis, it is possible that increased muscle strength may play an important role in HR-
QoL among older adults due to its ability to maintain functionality and mobility, and 
enhance psychological function (i.e. self-efficacy) (Canuto Wanderley et al. 2015; de 
Vreede et al. 2007).  
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Muscle strength did not improve following our DT-FPT program which may reflect 
the objectives of our program in optimising muscle power rather than muscular 
strength, as opposed to PRT. In partial support of this notion, 12 weeks of moderate-
intensity PRT produced greater improvements in isometric strength (11%) and the 
physical functioning domain (12%) of the SF-36 survey compared to a functional 
training group (e.g., carrying objects, rising from a chair to retrieve objects on a shelf), 
in 98 community-dwelling older women, however no other HR-QoL domains were 
affected by training (de Vreede et al. 2007). In part support of our findings, 10 weeks 
of moderate-intensity power training (60 minutes twice a week, up to 60% 1RM) in 
older women with sarcopenic obesity (65-80 years) had no effect on muscular strength, 
power, gait speed, or HR-QoL compared to a control group, however only the physical 
functioning domain was assessed (Vasconcelos et al. 2016). Collectively, these 
findings provide some evidence that training modes which increase muscle strength 
may be more effective in improving HR-QoL, particularly the physical functioning 
domain.  
 
In recent years, there have been reports that sarcopenia and its determinants (low 
muscle mass, decreased muscle strength and/or impaired function) are associated with 
reduced HR-QoL, particularly in terms of the effects of impaired physical function on 
multiple domains of HR-QoL (Beaudart et al. 2015; Iannuzzi-Sucich, Prestwood & 
Kenny 2002; Rizzoli et al. 2013). While the impact of muscle strength on HR-QoL has 
been discussed above, our limited findings for physical and related domains of HR-
QoL may have resulted from a lack of improvement in fat-free mass and/or a reduction 
in body fat mass. Moreover, the DT-FPT group displayed a maintenance of weight, 
BMI and fat mass relative to controls who experienced an increase, however there was 
no effect of the intervention on fat-free-mass (as reported in Chapter 5). Declines in 
muscle mass and physical performance (lower extremity function) have previously 
been associated with a deterioration in PCS in older adults over a 3-year period  
(Trombetti et al. 2016), while higher amounts of body fat can compromise HR-QoL 
(Lebrun et al. 2006; Phillips, Hammock & Blanton 2005). It could be argued that the 
increases in fat mass observed in the control group may be somehow linked to their 
significant decreases in physical functioning and social functioning domains over 26 
weeks. This may relate to our observations in study 1 which showed that a higher BMI 
was associated with lower scores in physical domains of HR-QoL (as presented in 
Table 4.3). However there is no research available that has quantified whether changes 
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in specific amounts of muscle or fat are required for changes in HR-QoL. Furthermore, 
intervention data has returned largely negative findings in regards to whether exercise-
induced changes in fat-free mass or fat-mass are associated with improvements in HR-
QoL following exercise in community-dwelling and independently living healthy 
older adults (Canuto Wanderley et al. 2015; Geirsdottir et al. 2012; Haraldstad et al. 
2017; Torres et al. 2017). For instance, only improvements in the domain of social 
functioning (1 unit increase over intervention) were shown to be weakly correlated 
with improvements in muscle mass (7% training gain; r=0.328) following 12 weeks of 
PRT in pooled data from two PRT groups of older men (Haraldstad et al. 2017). In 
contrast to this minimal positive finding, an 8-month study showed no associations 
between moderate-intensity aerobic and PRT-induced changes in lean muscle mass 
with changes in HR-QoL in community-dwelling older adults (Canuto Wanderley et 
al. 2015). However in this study, muscle mass did not improve in either group relative 
to controls which may have been a factor in these results. It could yet be suggested 
that the lack of exercise-induced improvements in fat-free mass we detected may not 
have provided any advantages for age-related muscle weakness and daily functioning, 
which compromised the benefits available to HR-QoL. Despite these claims, 
improvements in strength and functionality may be more essential than changes in 
body composition for improving HR-QoL during ageing.  
 
In older adults and the elderly there is evidence that physical functionality plays a key 
role in maintaining QoL (Trombetti et al. 2016), with the main drivers being energy, 
freedom from pain, and the ability to undertake activities of daily living and move 
around (Rizzoli et al. 2013). While several previous interventions have reported 
positive effects of power training on physical functionality (Byrne et al. 2016; Hazell, 
Kenno & Jakobi 2007), whether these improvements can directly influence the HR-
QoL of older adults is unclear. In our study, DT-FPT produced an improvement in role 
physical compared to controls, but there was only a trend for a net-benefit in the 
physical functioning subdomain of HR-QoL, and no changes in PCS or other domains 
related to physical aspects (i.e. vitality, general health, bodily pain). It is likely that the 
modest improvements or lack of changes in functional measures (i.e. functional 
mobility, gait speed) may have limited the benefits available for HR-QoL and well-
being from DT-FPT. Higher PCS scores have previously been associated with faster 
gait-speed (r=0.43), reduced time during a functional mobility task (r=-0.34) and 
greater lower body strength (r=0.37) in older adults (Sartor-Glittenberg et al. 2014). 
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Exercise-induced improvements in physical function (distance walked) have also 
predicted improvements in global HR-QoL following a 12–week PRT program in 
healthy older adults (Geirsdottir et al. 2012), while similarly, improvements in 
mobility predicted increases in the physical functioning subdomain and PCS in older 
adults with coronary artery disease (Chen et al. 2014). Collectively, these findings 
support the notion that our modest, but limited improvements in functional outcome 
measures may have affected the capacity of DT-FPT to improve HR-QoL.  
 
The mixed effects of our DT-FPT program on functional measures may have 
contributed to our findings for HR-QoL, which contrast with the positive findings for 
physical functioning, general health, role physical, bodily pain, and vitality that have 
been reported following cognitively-challenging dance-based exercise programs 
(focus on mobility and whole-body speed of movement) (Eyigor et al. 2009; Hui, Chui 
& Woo 2009; Oh et al. 2015). Importantly, improvements in these physical aspects of 
HR-QoL, were ascribed to exercise-induced improvements in functionality such as 
stair climbing, rising from a chair, endurance and functional mobility. It is unclear as 
to whether the combination of functional power training with additional attention-
demanding tasks that we used may have influenced our findings. Other studies 
focusing largely on functional training and/or power training have also reported mixed 
effects in regards to their ability to shape HR-QoL in older adults (de Vreede et al. 
2007; Henwood, Riek & Taaffe 2008; Vasconcelos et al. 2016; Whitehurst et al. 2005), 
however this may also relate to the inconsistent functional benefits reported in these 
trials. In opposition to our findings, 12 weeks of machine-based power training 
performed at 75% 1RM also improved perceptions of physical function in older 
women (assessed via a non SF-36 questionnaire) with concurrent improvements in 
mobility, walking speed, and upper and lower limb muscular strength and power 
compared to a control group (Ramirez-Campillo et al. 2016). While the benefits in this 
trial in comparison to our study may relate to differences in the training intensity (e.g., 
machine-based at 75% 1-RM versus weighted vest, body-weight and dumbbells), the 
limited effect of our intervention on the physical domains of HR-QoL may also be 
related to the inability of DT-FPT to markedly improve functional abilities, which 
influenced our participants’ perceptions regarding their physical limitations in 
performing functional tasks.  
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Role physical / Role emotional 
Our DT-FPT intervention resulted in a significant maintenance effect on the 
subdomain of role-physical and a trend for a greater improvement in role emotional. 
This implies that physical and mental health problems had less impact on work or other 
daily activities (i.e. an older adult’s usual role) in DT-FPT participants, compared to 
controls, with the additional assumption that DT-FPT had a role in attenuating 
potential age-related declines in these domains of HR-QoL. It is unclear as to whether 
our mixed improvements in functional outcomes had any contribution to our 
significant effects for role physical, particularly as this domain assesses the impact that 
detriments in functionality may exert on everyday living. A limited number of trials 
that have attempted to improve functionality via functional training (e.g., carrying 
objects, rising from a chair, changing positions) (de Vreede et al. 2007; Whitehurst et 
al. 2005) and balance training (Barnett et al. 2003; El-Khoury et al. 2015; Nelson et 
al. 2004) have not affected role physical, or role emotional in community-dwelling and 
independently living healthy older adults. It could be argued that inconsistent 
functional improvements from these trials may have influenced these findings, 
however moderate-intensity aerobic training and PRT have also failed to enhance 
scores in these domains despite improving functional performance (Canuto Wanderley 
et al. 2015; Hand et al. 2012). Collectively, this suggests that other elements in our 
program may have contributed to our findings.  
 
The cognitively challenging aspect of our dual-task program (i.e. additional motor or 
cognitive task, walking in time to music, multi-directional stepping) may partially 
explain why we observed positive findings for role-physical and role-emotional in the 
DT-FPT group. Moreover, previous trials involving a variety of cognitively 
challenging elements have shown potential but mixed effectiveness in their ability to 
shape the role-physical and role-emotional domains (Karahan et al. 2015; Lee et al. 
2015; Oh et al. 2015). For example, 10 weeks of water-based cognitively challenging 
dance exercise with older adults provided benefits to both role emotional and role 
physical subdomains, compared to the same exercises performed on land (Oh et al. 
2015). However, 6 to 8 weeks of exergaming in community dwelling women (Lee et 
al. 2015) and outpatients from a rehabilitation clinic (Karahan et al. 2015) only 
produced within-group improvements in role physical. While the reasons behind our 
findings are unclear, dual-task training engages several cognitive abilities (e.g., 
attention) which are mediated through brain regions with links to emotion 
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(Vuilleumier 2005; Yamasaki, LaBar & McCarthy 2002). For example, brain 
structures such as the anterior cingulate cortex form connections with multiple brain 
areas that process sensory, motor, emotional and cognitive information, but are also 
part of the brain’s limbic system which regulates emotional thought and behaviour 
(Bush, Luu & Posner 2000). Therefore, it is possible that dual-task training may have 
altered neural functionality, which also affected emotional representation in the DT-
FPT group, resulting in a trend for improvements in the role emotional domain. As 
part of this hypothesis, an indirect attenuation of emotional problems that could impact 
everyday functioning through dual-task training may have contributed to a reduction 
in perceived physical limitations (role physical), as it has been suggested that poor 
emotional functioning may significantly inhibit the perception of physical benefits 
(Skevington & Wright 2001). However, since we cannot separate the contributions of 
cognitive and physical training in our overall program, it is unclear as to whether 
cognitive stimulation is a main driver in attenuating the perceived impact of emotional 
and physical problems on role performance in our study, or whether factors such as 
peer or social support during training also contribute.  
 
Mental health domains  
It was hypothesised that DT-FPT would improve mental aspects of HR-QoL, however 
this was not observed in the mental health domain or the MCS composite. As a 
potential explanation as to why our DT-FPT program intervention had no effect on 
these mental aspects of HR-QoL, we prescribed a relatively low-moderate intensity 
training program that focused on functional exercises, rather than more intense training 
components involving PRT and aerobically demanding exercise. Previous meta-
analytic data has reported that moderate-intensity PRT and/or aerobic training can 
modify perceived psychological well-being in healthy older adults (Gillison et al. 
2009; Netz et al. 2005), while moderate-high intensity aerobic training has tended to 
produce greater improvements in more specific HR-QoL domains related to mental 
health compared to PRT (Awick et al. 2015; Canuto Wanderley et al. 2015; Sillanpaa 
et al. 2012). Aerobic training in particular is thought to activate therapeutic pathways 
that facilitate actual or perceived benefits for mental health and well-being (e.g., 
increased serotonin release, regulation of stress hormone release, self-efficacy) 
(Barbour, Edenfield & Blumenthal 2007; Strohle 2009). Therefore, the exclusion of 
aerobic training from our program may represent a limitation of the study, in terms of 
the benefits available for mental health and MCS, however it must be noted that our 
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program was designed to reduce falls, rather than improve HR-QOL. In part support 
of our findings, interventions ranging from 12 weeks to 2 years using elements that 
were featured in our program such as power training (Sayers et al. 2003), functional 
training (e.g., carrying objects, rising from a chair) (de Vreede et al. 2007) and balance 
training (El-Khoury et al. 2015) have also failed to improve the mental health domain 
or MCS in community-dwelling older adults with and without functional limitations.  
 
In addition to a lack of aerobic training within our program, the inconsistent functional 
benefits we observed from our program, and our dose of training may have also 
contributed to our findings for mental health. Changes in stair climbing, sit-to-stand 
times, and handgrip strength have previously explained some of the improvements in 
the mental health domain and MCS, following an 8-month exercise trial involving 
PRT and aerobic training in community dwelling older adults (Canuto Wanderley et 
al. 2015). These authors suggested that increases in functional capacity can provide a 
global indicator of health and functioning, which can lead to improvements in mental 
health and well-being. Therefore consistent functional changes may be required to 
elicit improvements in mental and even global HR-QoL.  
 
To our knowledge, a dose-response relationship is yet to be established for HR-QoL 
in structured exercise programs, in terms of whether differences in training frequency, 
intensity and session duration can affect possible benefits for physical and mental 
domains of HR-QoL (Ramirez-Campillo et al. 2016; Rugbeer et al. 2017; Spirduso & 
Cronin 2001). This concept is only partially supported by our findings, as significantly 
higher scores in PCS and global HR-QoL were detected in DT-FPT participants 
attending at least 50% of classes, however an additional exposure to training had no 
supplementary effect on mental aspects of HR-QoL, even though those in per protocol 
analysis attended on average, 75% of classes. This suggests that mental health benefits 
may occur independent of a dose-response relationship, and instead be dependent on 
the training format employed. However, minimal evidence from a systematic review 
of exercise trials in older adults suggests that at least two sessions per week of light-
moderate intensity may be necessary to elicit improvements in self-reported mental 
well-being (Windle et al. 2010). Based on this data, our average training dose for 
participants attending at least 50% of classes may have also been insufficient to 
observe gains in mental HR-QoL (average 1.5 sessions per week). However, this 
review was unable to propose an optimal training type, intervention length or intensity 
Chapter 6  
272 
 
for mental health benefits, and only a few studies in this review used the SF-36, which 
means that the majority of findings are not directly comparable to the current study. 
Given these uncertainties, our training dose, exercise format, or additional factors, may 
have contributed to our program’s inability to improve mental domains of HR-QoL.  
 
Healthy cohort  
Another likely explanation for our inconsistent findings for domains associated with 
physical health (i.e. physical functioning, PCS, general health) and mental health (i.e. 
mental health, MCS, vitality) is that we only included healthy older adults who 
although were at increased risk for falling, were relatively well-functioning. In partial 
support of this notion, a meta-analysis reported that older patients exercising for 
disease rehabilitation (e.g., pulmonary disease) have reported better gains in HR-QoL 
than healthy older adults following a variety of exercise formats (Gillison et al. 2009), 
while there is also evidence that adults with limited functionality may experience 
greater benefits (Liu & Latham 2011). Given this data, our sample may not have had 
the same capacity for improvement in functional measures or HR-QoL. Although our 
sample were at risk of falling, our participants had little evidence of cognitive 
impairment (7% classified as MCI) and they displayed baseline scores for gait speed 
(6% below 0.8 m/s cut-off) and grip strength (males 21% below 26 kg cut-off; females 
20% below 16 kg cut-off) which indicate that the vast majority were well-functioning 
older adults (Studenski et al. 2014). In contrast to our findings, physical (i.e. similar to 
PCS) and mental (i.e. similar to MCS) aspects of HR-QoL improved in adults (aged 
40-69 years) with two or more metabolic risk factors, but not adults with ≤1 risk factor 
(Levinger et al. 2007), following 10 weeks of moderate-high intensity PRT. Although 
86% of our participants had one or more cardiometabolic risk factors, the vast majority 
were receiving medication for their conditions and we excluded those with serious 
chronic diseases or conditions. Furthermore, older adults have been shown to report 
higher scores of HR-QoL compared to middle-aged adults despite the presence of 
chronic health conditions (Rustøen et al. 2005). Therefore, in contrast to our sample, 
HR-QoL may have a greater response to exercise in older adults with a higher severity 
of chronic disease or lower functional capacity. 
 
It has been contended that the presence of intense negative feelings can adversely 
cloud all other aspects of HR-QoL (Skevington & Wright 2001). In our study the 
average HR-QoL summary component and subdomain baseline scores of mental 
health for our participants were only two units below age-based Australian norms (for 
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those aged 75 years and over) and one to three units higher for all other domains 
(Hawthorne et al. 2007). This suggests that our participants may have already been 
experiencing normal to higher levels of HR-QoL, which may have limited the 
exercise-induced improvements possible from DT-FPT. Further, while the DASS-21 
depression subscale does not provide a formal diagnosis of depression, 13% of 
participants had scores above the normal range at baseline (>9) which is indicative of 
mild to severe depression, and aligns with estimates from previous studies in 
retirement villages (e.g., 15% measured by Geriatric Depression Scale) (Merom et al. 
2016). By comparison, other research has estimated the prevalence of depression in 
residential aged-care to be 35% (Snowdon & Fleming 2008), compared to 
approximately 8% in community-dwelling older Australians (Pirkis et al. 2009), 
however this figure was based on older adults independently living and residing in 
aged care. In addition, 23% of our sample were taking anti-depressant medication at 
baseline (Table 5.3), which may have blunted any adverse mental health perceptions. 
Nevertheless, the low proportion of participants in our study that displayed some 
evidence of depression may help to better explain why we observed no improvement 
in the mental health domains of the SF-36 questionnaire.  
 
Ceiling effects for life satisfaction 
Previous research has suggested that life satisfaction may possess homeostatic 
properties which enable it to operate within a narrow range and with great stability in 
an individual (Felce 1997; Fujita & Diener 2005). Furthermore, this construct has been 
shown to be unresponsive to even drastic and immediate changes in life conditions 
such as widowhood and unemployment (Fujita & Diener 2005). Given the reported 
stability of life satisfaction in older adults, an initial explanation for our findings that 
the Satisfaction with Life single-item score or the Personal Well-being Index (PWI) 
did not change may be that external factors such as enrolment in a community-based 
exercise program, and any attendant benefits of this participation, may have had 
minimal to no effect on the life satisfaction of our training group. In partial support of 
this notion, other exercise formats (e.g., aerobic training, PRT, multimodal) have 
consistently failed to detect improvements in life satisfaction despite using a variety 
of intervention lengths (8-32 weeks) and participant groups (e.g., community-
dwelling, aged-care) (Awick et al. 2015; Katula, Rejeski & Marsh 2008; Rejeski & 
Mihalko 2001; Solberg et al. 2013). Furthermore, a previous 13-week RCT in 
community-dwelling older adults involving high-intensity PRT, aerobic training 
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(Nordic walking), or heavy load functional training (step ups, stair climbing, lifting 
cases) failed to detect any effect on life satisfaction (measured through Satisfaction 
with Life Scale) compared to a control group (Solberg et al. 2013). Despite the 
ineffectiveness of exercise trials to improve life satisfaction, none have used the PWI 
and so a comparison of our findings to these outcomes may be difficult due to 
differences in instruments, and exercise prescription.  
 
Another factor that may explain the lack of any effect on life satisfaction in our study 
is that there may be potential ceiling effects in our data. The broad PWI assesses 
several domains which may not be as relevant for some healthy older adults, or as 
highly valued as health concerns (e.g., spirituality, what are you achieving in life). 
Therefore, lower assessments in these items at baseline and follow-up may make 
changes in life satisfaction harder to detect. In line with this notion, older adults 
independently living in retirement villages may possess unique concerns, which differ 
from those of community-dwelling adults or those residing in aged care. The efficacy 
of an exercise intervention may also be influenced by what an older adult finds 
important or meaningful. For some older adults, maintaining or improving functional 
performance may be valued more highly and contribute to a sense of life satisfaction, 
whereas for others a heightened self-efficacy from exercise may be a more critical 
determinant of life satisfaction and HR-QoL (Rejeski, Brawley & Shumaker 1996; 
White, Wojcicki & McAuley 2009). While the extent of these differences cannot be 
estimated in our study, issues such as security and personal safety; elements which 
contribute to the PWI, may be rated higher in residentially-dwelling older adults due 
to the insulated and closed nature of most retirement villages, creating ceiling effects.  
 
It has also been suggested that social relations within an exercise environment are key 
determinants of life satisfaction (McAuley et al. 2000), and enhanced peer 
socialisation may be beneficial in improving psychological well-being in older adults 
(Brown et al. 2009). From these assertions it would be expected that participants 
undergoing dual-task exercise training may derive additional benefits for life 
satisfaction compared to the control group. However the majority of villages we 
targeted promoted socially inclusive activities and most contained clubhouses for 
social events. Therefore, the social atmosphere created within the villages (non-
intervention related) may naturally enhance the well-being of our participants, 
resulting in higher life satisfaction values than community-dwelling adults. For 
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example, at baseline the average values for the PWI were 79.8 for all participants, 
which is slightly higher than Australian norms for adults over 66 (mean 77.5) and 
adults over 76 (mean 79.7) (Capic et al. 2016). As encountered in previous research 
(Awick et al. 2015), high levels of life satisfaction in participants at baseline may have 
limited detectable effects of our intervention.    
 
Sex interactions 
An interesting finding to emerge from our study was that the response to HR-QoL and 
well-being differed by sex. Men undertaking the DT-FPT demonstrated significant 
decreases in the domain of general health compared to men in the control group, and 
men in the control group displayed significantly greater increases in satisfaction with 
life compared to those in DT-FPT, however women did not show these effects. This 
finding partially conflicts with previous research whereby 18 months of multimodal 
exercise (low-moderate intensity aerobic training and PRT) produced more favourable 
results for HR-QoL in older males than females with chronic obstructive pulmonary 
disease (Foy et al. 2001). However sex interaction effects were not explored, and as 
discussed above, the HR-QoL of clinical cohorts may respond differently to exercise.  
Despite our observed sex-interactions, we did not observe any baseline differences 
between men and women in general health or the satisfaction with life score, which 
aligns with population estimates (Capic et al. 2016; Hawthorne et al. 2007), and 
controlling for sex had no influence on the effects of the intervention on general health 
or satisfaction with life. The underlying reasons for our findings are therefore unclear. 
Previous cross-sectional research has shown that both healthy older women (Orfila et 
al. 2006) and older women with heart failure (Riedinger et al. 2001) have worse HR-
QoL ratings than older men. However, in contrast to our study in which 73% of the 
participants were women, these studies included similar proportions of each sex. 
Previous research has suggested that older women may be prone to over-reporting or 
greater discriminatory power for perceptions of morbidity, compared to men who are 
socialized to ignore health complaints (Orfila et al. 2006). Following this line of 
reasoning, women in the DT-FPT group would be expected to be more sensitive to 
perceiving differences in broader domains of general health and life satisfaction than 
older males following the intervention, however these scores were not different 
between groups in older women. Adding to this uncertainty, older men in the DT-FPT 
group did not report any increases in bodily pain, or in new chronic health conditions 
over 26 weeks, which may have otherwise explained poorer general health and 
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satisfaction with life scores. Alternatively, unrealistic expectations of the possible 
benefits from training may have inadvertently decreased perceptions of health and 
well-being if an older male did not feel they had benefited from the program (Shim, 
Russ & Kaufman 2007). As sex interactions were an exploratory opportunity for this 
study, the findings must be interpreted with caution and different findings may occur 
in a more balanced sample of men and women or in a sample with an equal proportion 
of men in each group, or populations with chronic disease(s). 
 
Strengths and limitations 
The strengths and limitations of this intervention have been discussed in Chapter 5 and 
will be discussed in detail in Chapter 8, and therefore only the strengths and limitations 
unique to this study will be presented. There were several strengths to this study. Our 
study is the first RCT to investigate changes in HR-QoL and well-being following a 
dual-task functional power training program. Second, the cluster randomisation 
avoided the likelihood of intervention contamination due to the program being 
conducted within each village site. This also allowed the formation of group-based 
classes that fostered social interaction amongst participants. Third, our sample size 
was relatively large compared to other exercise trials investigating HR-QoL, which 
was a result of the larger aims of the trial being falls, which required a larger sample 
size. Therefore HR-QoL and well-being were secondary outcomes.  
 
This study had a number of limitations. First, there was a modest compliance to the 
training program (~50%), which is consistent with the attendance rates reported in 
other exercise programs in retirement villages (Lord et al. 2003; Merom et al. 2016), 
but nevertheless may have limited the scope of the findings, as evident by the 
additional positive findings for HR-QoL detected in the per protocol analysis. It is 
possible that a greater exposure to training may have allowed more consistent 
functional benefits to emerge which may influence HR-QoL. Second, the combination 
of functional power training with cognitive/motor training in the one intervention 
precludes determination of which component (or both) were driving any positive 
findings for HR-QoL. Although this was not an objective of the program, the inclusion 
of comparative cognitive training, or functional power training groups may reveal the 
components that contribute to any benefits for HR-QoL, while including a social 
activities group may reveal whether structured interventions are more beneficial for 
HR-QoL than usual pastimes. Third, our uptake of participants from retirement 
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villages was poor (10%) and may have contained a higher proportion of women (73%) 
than found in retirement villages. It is therefore unclear how generalizable our results 
are to independently living adults or community-dwelling older adults, especially as 
the lifestyles of independently living adults may differ from community-dwelling 
older adults, which may be reflected in higher HR-QoL and life satisfaction scores. 
Fourth, the well-validated Personal Well-being Index has demonstrated good 
reliability, and correlation with the Satisfaction with Life Scale but has not been used 
in exercise studies before, and therefore its suitability for detecting changes in life 
satisfaction requires further assessment. Further detail about these strengths and 
limitations will be discussed in Chapter 8. 
 
In summary, this 26-week community-based cluster RCT produced a maintenance 
effect for role physical, which implied that our program improved perceptions 
regarding the impact of physical problems on the role and functioning of older adults 
living independently in retirement villages. However, DT-FPT had no effect on the 
majority of HR-QoL domains, satisfaction with life or well-being. While these 
findings may have resulted from the modest or lack of change in various physical 
functional measures following the DT-FPT program, it is more likely that this was due 
to the modest compliance with the training (mean 50%). Indeed, the per protocol 
analysis that included those with at least 50% compliance to the exercise program 
(mean 75%) showed that DT-FPT led to significant net benefit for the change over 
time for social functioning, the physical component summary score and global HR-
QoL, with a trend for a significant net benefit for the change in physical functioning 
and role-emotional. Finally, secondary analyses found that dual-task training was less 
effective in the areas of general health and life satisfaction in older men compared to 
women. In conclusion, this study has shown that supervised DT-FPT conducted within 
retirement villages led to greater net benefits in limited aspects of HR-QoL and 
functional performance in healthy older adults, but was not effective for improving 
well-being, compared to a usual care control group. A higher dose of DT-FPT may 
provide further benefits for HR-QoL in this population. This study adds to the body of 
evidence to support the health and well-being benefits of exercise in older adults.
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7. Chapter 7 
Effects of a dual-task functional power training program on 
inflammatory and neurological markers in older adults. 
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7.1 Introduction 
It is widely accepted that low-grade systemic inflammation accompanies ageing, 
which has been largely attributed to underlying disease(s) and age-related dysfunction 
of the immune system (Brüünsgaard & Pedersen 2003; Krabbe, Pedersen & 
Bruunsgaard 2004). This increased inflammatory activity is thought to contribute to 
the pathological processes associated with various common chronic diseases such as 
cardiovascular disease, type 2 diabetes and cancer (Kritchevsky, Cesari & Pahor 2005; 
Maggio et al. 2006), along with sarcopenia, functional limitation and disability 
(Ferrucci et al. 2001; Visser et al. 2002). Accumulating evidence has also linked 
inflammatory mechanisms to poorer cognitive performance and age-associated 
cognitive decline (Godbout & Johnson 2009), along with neurodegenerative diseases 
including Alzheimer’s disease (AD) and vascular dementia (Engelhart et al. 2004; 
Hofman et al. 1997). Despite these associations, the direction of the relationship 
between cognitive deterioration and inflammation is unresolved in healthy older 
adults.  
 
Given the health risks associated with chronic low-grade systemic inflammation for 
older adults, there has been considerable interest in identifying strategies to reduce 
circulating inflammatory markers. Aerobic training has been shown to reduce 
circulating levels of CRP and TNF-α in healthy older adults (Kohut et al. 2006; Vieira 
et al. 2009), but there is mixed evidence as to whether these benefits are related to 
exercise-induced reductions in weight or body fat (Hammett et al. 2004; Vieira et al. 
2009). Likewise, equivocal evidence surrounds the effects of PRT (Bruunsgaard et al. 
2004; Kohut et al. 2006; Peake et al. 2011) on systemic inflammation in older adults 
with and without various chronic disease(s) (Beavers, Brinkley & Nicklas 2010). 
Differences in participant characteristics, the presence of any chronic disease(s), the 
training type, intensity, and dose and whether training was associated with any changes 
in weight (or fat mass) may explain these inconsistencies. To our knowledge, the 
effects of functional power training on systemic inflammation have not been assessed, 
but 12 weeks of high-intensity power training had no effects on circulating levels of 
pro- and anti-inflammatory cytokines in healthy older adults (70-75 years) (Valls et al. 
2014). Further, 12 weeks of functional bench stepping only improved serum levels of 
the pro-inflammatory marker interferon-γ in older adults with lower levels of high-
density lipoprotein cholesterol (Nishida et al. 2015), but had no effects on eight other 
cytokines. Further, two interventions involving 12 weeks of elastic-band based PRT 
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have shown mixed effects on inflammatory levels in healthy and cognitively impaired 
older adults, with only a within-group change in IL-10 in a training group found 
between both studies, but no changes in pro-inflammatory cytokines despite 
improvements in body composition (Chupel et al. 2017; So et al. 2013). Given the 
inconsistencies between traditional exercise programs, the optimal training format for 
improving inflammation in older adults is unclear. Research on the 
immunomodulatory effects of functional training and power training is lacking, 
however a combination of these training types within a longer training program may 
provide some inflammatory benefits for older adults.  
 
To date, the effects of cognitive training interventions on systemic inflammation have 
not been assessed, and therefore it is unknown as to whether a reduction in 
inflammatory markers may be one of the mechanisms that contributes to the 
improvements in cognition that are observed following such interventions. Exercise 
performed simultaneously with cognitive and motor tasks can provide cognitive 
benefits to older adults (Zhu et al. 2016), and it is plausible that among other factors, 
exercise-induced improvements in inflammatory and neurological mediators may 
underlie these benefits. Accumulating evidence has demonstrated that physical activity 
and exercise training have neuroprotective effects, and circulating levels of 
neurotrophins such as brain derived neurotrophic factor (BDNF), insulin-like growth 
factor (IGF-1) and vascular endothelial growth factor (VEGF), may play a mediating 
role in the relationship between exercise and cognition (Cotman, Berchtold & Christie 
2007). Despite this evidence, the response of BDNF to long-term exercise training in 
older adults has been inconsistently reported, which may relate to differences in 
training dose, intensity and intervention duration between studies (Coelho et al. 
2013b). Regardless, increases in BDNF have been observed in healthy older adults 
following 16 weeks of multimodal exercise (Vaughan et al. 2014) and after 10 to 12 
weeks of various intensities of PRT (Forti et al. 2015; Pereira et al. 2013). Further, 
there is some evidence that these responses may be impaired by possession of a Met 
allele of the BDNF gene (Nascimento et al. 2015). Cognitive training interventions 
have also been shown to increase the secretion of BDNF in adults with chronic disease 
(Angelucci et al. 2015; Pressler et al. 2015), which suggests that the combination of 
cognitive training and exercise may potentially improve BDNF levels. However, to 
date, only two exercise-cognitive training interventions (exergaming; and multimodal 
exercise with cognitive training) have investigated and subsequently reported an 
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increase in circulating BDNF concentrations in healthy older adults following training 
(Anderson-Hanley et al. 2012; Rahe et al. 2015a), but they did not include functional 
power training. Circulating levels of IGF-1 have also been demonstrated to increase 
following short to long-term PRT interventions in older adults (Cassilhas et al. 2007; 
Parkhouse et al. 2000), however no studies have investigated the effects of a cognitive-
exercise intervention on this biomarker. The response of these neurological and 
inflammatory markers to dual-task exercise training is therefore largely unknown, but 
may help to clarify the mechanisms through which dual-task exercise training may 
elicit cognitive benefits in older adults.  
 
Previous research has reported that plasma levels of amyloid beta (Aβ) 1-42 and Aβ 
(1-40), and the ratio between these isoforms, may identify individuals at risk for 
developing mild cognitive impairment or AD (Koyama et al. 2012; Song et al. 2011).  
Lower plasma Aβ 1-42/1-40 ratios have been observed in older adults reporting higher 
levels of physical activity (Brown et al. 2013), however the response of these peptides 
to structured exercise training is poorly understood. Aerobically trained type 2 diabetic 
older adults showed a trend towards lower Aβ (1-42) levels (Baker et al. 2010a), while 
inconclusive findings for Aβ (1-42) and Aβ (1-40) have been reported following dual-
task training involving multimodal exercise performed simultaneously with arithmetic 
and word games in community-dwelling older adults (Yokoyama et al. 2015). As a 
reduction in these markers may coincide with prolonged independence and a lower 
risk for neurodegeneration in older adults, the effects of dual-task functional power 
training on plasma levels of Aβ may be important.  
 
The aim of this study was to examine the effect of a 26-week dual-task functional 
power training program on circulating levels of neurological and inflammatory 
markers in older adults living independently in retirement villages, and whether the 
response of these biomarkers to dual-task training is influenced by APOE and BDNF 
polymorphisms. It was hypothesized that this program would reduce pro-inflammatory 
cytokines and Aβ peptides, and increase levels of anti-inflammatory cytokines and 
growth factors, while the response of these markers would be diminished in carriers of 
the Met allele of the BDNF gene, and the ApoE-ɛ4 polymorphism. 
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7.2 Methods 
The following section will outline the specific study design and methodology used to 
investigate the effect of a DT-FPT intervention on inflammatory and neurological 
markers in older adults. For the purpose of this chapter, only the methodology that 
pertains to the present study will be presented. A detailed description of the methods 
for this study has been provided in Chapter 3.   
 
7.2.1 Participants 
Three hundred older adults (81 men and 219 women) aged 77.4 ± 6.8 (mean ± SD) at 
risk of falls were recruited in three rolling cohorts, from 22 independently living 
retirement villages in the greater metropolitan and regional areas of Melbourne.  
 
7.2.2 Study design 
As reported in Chapters 3-6, this was a community-based, cluster randomised 
controlled trial in which older adults residing in 22 retirement villages, who are at 
increased risk of falling, were randomly allocated to: 1) an exercise program involving 
functional power training with challenging balance/mobility activities that was 
performed simultaneously with a secondary attention-demanding motor or cognitive 
task (DT-FPT) (n=11 villages), or 2) a usual care control group (n=11 villages). The 
primary aim of the main RCT was to evaluate the efficacy of the intervention on the 
rate of falls, but the focus of this study was on the efficacy of the 26-week intervention 
on inflammatory and neurological markers. For this study, baseline and follow-up data 
from the 26-week intervention was used in the analysis.  
 
7.2.3 Intervention  
Villages with participants allocated to the exercise intervention undertook two 45-60 
minute group-based and supervised exercise sessions per week, for 26 weeks. Dual-
task training components involving cognitive, visual, and motor tasks were performed 
simultaneously with challenging balance/mobility and functional power training 
exercises, as described in detail in Chapter 3. Participants in the usual care control 
group continued with their normal physical activity habits and received their usual care 
from their medical practitioner and community services.  
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7.2.4 Measurements  
All testing was conducted on-site at each retirement village at baseline and 26 weeks.  
A detailed description of the outcome measures used in this study are provided in 
Chapter 3, and a brief outline is provided below. The reasons for, and number of 
missing data-points for each outcome measure at the 26-week follow-up testing are 
described in Chapter 5 unless otherwise specified. 
 
Anthropometry and body composition 
Height and body weight were measured using standard techniques, via portable 
stadiometer (Surgical and Medical PE87) and TANITA scales (TANITA BC-418, 
Tanita, Japan), from which BMI was calculated. Body composition (whole body fat 
percentage, fat mass and fat-free mass) was also assessed using bioelectrical 
impedance (TANITA BC-418, Tanita, Japan). 
 
Inflammatory, neurological and hormonal markers 
Blood samples were obtained at baseline and at 26-week follow-up testing via the 
methods outlined in Chapter 3. Briefly, serum concentrations of IL-4, IL-6, IL-1β, IL-
8, TNF-α, IL-10, BDNF, VEGF, IGF-1 and CRP, and plasma levels of Aβ (1-40) & 
Aβ (1-42) were analysed along with polymorphism data for the APOE and BDNF 
genes. Blood samples were collected from 269 participants at baseline. The reasons 
for non-collection were: illness/could not attend collection at allocated time (n=17), 
participant withdrawal from study before blood collection (n=8), and an inability of 
the nurse to collect a sufficient sample (n=6). For four participants, IGF-1 and CRP 
were not analysed at baseline due to a lack of serum available. To minimise missing 
data, polymorphism data was derived from both baseline and 26-week whole-blood 
samples as these physiological traits do not change over time. Participants were 
categorised as possessing at least one copy of the ε4 allele from the APOE gene (ε4 
carrier) or no copies of this polymorphism (non-ε4), and by BDNF genotype; at least 
one copy of the Met allele (Met-carrier), or no copies (Val/Val homozygotes). In total, 
polymorphism data was provided by 282 participants.  
 
Concentrations of inflammatory cytokines were standardised to a Z-score based on the 
sample mean and pooled SD. From these Z-scores, composites consisting of only pro-
inflammatory (IL-6, IL-1β, IL-8, TNF-α, CRP) and only anti-inflammatory cytokines 
(IL-4 and IL-10) were calculated, with higher Z-scores representing a greater 
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circulating pro- or anti-inflammatory state, respectively. A single composite 
inflammatory Z-score was also created using all seven biomarkers by summing 
individual Z-scores in the appropriate direction: pro-inflammatory Z-scores were 
regarded as positive while anti-inflammatory Z-scores were assigned negative values 
(Chi et al. 2017). A higher composite Z-score therefore represented a higher level of 
inflammation. The Aβ (1-42): Aβ (1-40) ratio was calculated by dividing the plasma 
values of Aβ (1-42) by Aβ (1-40).  
 
Health and medical history, and medication use  
Participant health and medical history, current medication usage, employment status, 
race, education level attained and smoking status were assessed by questionnaire 
according to the categories outlined in Chapter 5. Participants were assessed for   
cardiometabolic risk as described in Chapter 5. 	
	
Adverse events  
For participants in the exercise group, any adverse event sustained during the exercise 
program (e.g., illness or injury) was recorded. An unblinded researcher interviewed 
participants in both groups at 13 and 26 weeks after their intervention had begun to 
determine whether they had experienced an adverse event. This determined whether 
any adverse events in the DT-FPT group were beyond those experienced during usual 
care. 
 
Exercise adherence 
Compliance with the exercise program was assessed by attendance at the supervised 
exercise sessions, and was calculated by dividing the total number of sessions attended 
by the total number of sessions available over the 26 weeks, multiplied by 100.   
 
Habitual physical activity  
Leisure and recreational physical activity (PA), reported as caloric expenditure per 
week (kJ/week) spent in moderate to high-intensity leisure and physical activities, was 
evaluated using the Community Healthy Activities Model Program for Seniors 
(CHAMPS) questionnaire (Stewart et al. 2001).  
 
7.2.5 Statistical analyses 
All statistical analyses were conducted on an intention-to-treat basis using STATA 
statistical software release 14.0 (STATA, College Station, TX, USA). Baseline 
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characteristics between the groups were compared by independent t-tests for 
continuous variables and chi-square tests for categorical variables. All data was 
checked for normality prior to analysis. Due to non-normality, the following 
biomarkers were log transformed prior to analysis; IL-4, IL-6, IL-1β, IL-8, TNF-α, IL-
10, VEGF, CRP, Aβ (1-40), Aβ (1-42) and the Aβ (1-42): Aβ (1-40) ratio. One data 
point for each of IL-4, IL-8 and CRP were removed as outliers, as they were >15 
standard deviations above the mean. Samples that were below the lowest detectable 
limit were assigned the lowest detectable concentration for their assay. The effect of 
the intervention on the primary and secondary outcome variables was analysed using 
General Linear Mixed Models with random effects, adjusting for the variability 
between clusters (villages) and within a cluster (participants within the same village). 
The group (DT-FPT or CON) was the fixed effect, and clusters (retirement village) 
and the unit of analysis (participants), were included as random effects to account for 
the clustered design. The effect of the intervention on inflammatory and neurological 
markers was initially assessed by adjusting for age and sex (model 1), before 
additionally adjusting for cardiometabolic status at baseline and BMI (model 2), due 
to their potential effect on the outcome measures. An additional model was run based 
on analysis of covariance (ANCOVA) and adjusted for baseline values for the outcome 
measure and clustering (model 3). In extensions of model 2, BMI was replaced by total 
fat-free mass, or whole-body fat percentage. A per-protocol analysis was also 
conducted on those in the training group meeting ≥50% adherence levels to the 
exercise program. Due to non-normality after log-transformation, intervention effects 
on serum concentrations of IL-1β, IL-4, IL-10 and plasma concentrations of Aβ (1-42) 
were additionally assessed with generalized linear models with a gamma distribution, 
adjusting for the variability between clusters (villages). 
 
To determine if genotype influenced the response of Aβ (1-40), Aβ (1-42), and 
combined inflammation Z-scores to the intervention, the interactions between ApoE-
ɛ4 carrier status by group allocation and time were conducted with linear mixed 
models. Linear mixed models also assessed the influence of BDNF Met-carrier status 
on the response of individual inflammatory markers, neurological markers, and 
inflammatory composites following the intervention. To determine if the response of 
these markers to the intervention varied by sex, the interactions between sex (male or 
female) by group allocation and time were also conducted using linear mixed models.  
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All data are presented as means ± SD or 95% CI.  Changes in inflammatory and 
neurological markers are expressed as the percentage change, which was derived from 
the absolute differences from baseline in the natural log-transformed data multiplied 
by 100. BDNF and IGF-1 did not require such transformation. Between-group 
differences were calculated by subtracting the within-group changes from baseline for 
the DT-FPT group from the within-group changes for the usual care control group 
after 26 weeks. The significance level was set at P<0.05.  
 
7.3 Results 
This study used data obtained from the 26-week trial, some of which was presented in 
Chapter 5. This results section will therefore report only the unique and pertinent 
aspects of this study as they relate to inflammatory and neurological markers, and will 
refer to the results from Chapter 5 on occasions.  
 
Baseline characteristics 
Three hundred participants aged between 65-96 years were recruited in three cohorts 
over 14 months, from 22 eligible retirement communities. The average size of each 
cluster (village) was 14 participants. This study is based on the data from the 268 
participants who provided a complete data set at baseline (blood sample, body 
composition and functional measures). Seventy-two percent of these participants were 
women, and on average, the participants were aged 77.4 ± 6.9 years (mean ± SD), and 
had a mean BMI of 29.1 kg/m2, of which 106 (40%) were classified as obese (BMI 
>30) (Table 7.1). A total of 161 participants completed high school, and of these, 71 
attained additional tertiary qualifications (Table 7.1). Nearly all participants were 
Caucasian (99%). Ninety-four percent of participants were retired or not employed. 
Comparison of the baseline characteristics between the groups revealed that there were 
a higher proportion of women in the control group (P<0.001), which may explain the 
significant between group difference in height (P=0.001) (Table 5.1). Males in the 
sample were taller than females (12.6 cm; 95% CI: 10.8, 14.3; P<0.001), and heavier 
(10.4 kg; 95% CI: 6.50, 14.4; P<0.001).  
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Table 7.1: Baseline characteristics of the subset of participants randomised to the dual 
task functional power training group (DT-FPT) and the usual care control (CON) 
group that provided blood samples and a complete data set at baseline.   
Characteristics DT-FPT CON 
n 140 128 
Women, n (%) 88 (63%) ‡ 106 (83%) 
Age, years 76.9 ± 6.7 77.9 ± 7.2 
Height, cm  163.9 ± 8.8 ‡ 159.8 ± 7.8 
Weight, kg  78.4 ± 16.1 ‡ 74.2 ± 14.2 
BMI (kg/m2)  29.1 ± 5.2 29.0 ± 4.9 
Smoking status, n (%)   
     Current/ Ex-Smoker 65 (46%) 51 (40%) 
     Non-smoker 75 (54%) 77 (60%) 
DASS-21-Depression 2.0 ± 4.0 2.0 ± 6.0 
ApoE-ε4 carrier, n (%) 40 (29%) 37 (29%) 
BDNF Met carrier, n (%) 47 (34%) 40 (69%) 
Number of health conditions  3.0 ± 2.0 3.0 ± 2.0 
Presence of cardiometabolic risk factors, n (%) 124 (89%) 106 (83%) 
Employment Status, n (%)   
     Retired / Not employed 132 (94%) 120 (94%) 
     Part time employment 4 (3%) 3 (2%) 
     Home duties / Other 4 (3%) 5 (4%) 
Race   
    Caucasian     138 (99%) 126 (98%) 
    Non-Caucasian 2 (1%) 2 (2%) 
Education, n (%)   
    Primary/Some High School  55 (39%) 52 (41%) 
    Completed High School/ Technical Trade Cert. 45 (32%) 45 (35%) 
      University/Tertiary level 40 (29%) 31 (24%) 
Values are mean ± SD except DASS-21-Depression and Number of health conditions 
(median ± Interquartile Range). ApoE: apolipoprotein; BDNF: brain derived 
neurotrophic factor; BMI: body mass index; DASS: Depression, anxiety and stress 
scale; DT-FPT: Dual-task functional power training group; CON: Usual care control 
group. ‡ P<0.001 versus CON.  
 
 
Study Attrition, Compliance and Adverse Events  
Information about study attrition, compliance and adverse events are provided in 
Chapter 5 and 6. For this chapter, complete blood samples (baseline and 26 weeks) 
were available for 211 participants (DT-FPT n=108; CON n=103). Of the subset of 
268 participants with a complete data set at baseline (blood, body composition and 
functional measures) who were randomised to the intervention (DT-FPT n=140; CON 
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n=128), 57 (DT-FPT n=32; CON n=25) did not provide blood samples at 6 month 
follow-up testing for the following reasons: withdrawal (DT-FPT, n=22; CON, n=14), 
ill health at 6 month testing (DT-FPT, n=8; CON, n=10) and lost to follow up (DT-
FPT, n=2; CON, n=1). A comparison of the participants that provided blood samples 
(n=211) to those that did not provide samples at 26 weeks (n=57) revealed that there 
were no differences in the baseline characteristics, with the exception that those 
providing both samples had significantly lower levels of CRP (P<0.001) (Appendix 
Y).  
 
Medication, smoking status, chronic conditions and habitual physical activity 
At baseline half (50%) of the subset of 268 participants were taking lipid-lowering 
medication, and 72% were on antihypertensive medication, with no significant 
differences between the groups (Chi square all P>0.142). Over 70% of participants 
were taking three or more prescribed medications at baseline. There were no 
differences for the changes to medication usage (type, dose, or number) after the 26-
week intervention (Chi-square all P>0.05). Forty three percent of participants were 
ex/current smokers (nine were current smokers) with an equal proportion between each 
group (Chi-square, P=0.277) (Table 7.1 & 4.1). Further, 86% of participants satisfied 
the criteria for possessing at least one cardiometabolic risk factor. Based on cut-points 
for serum levels of CRP that correspond to a high risk category for cardiovascular 
disease (>3.0 mg/L) (Pearson et al. 2003), 30% of participants had concentrations 
exceeding this mark. A total of 262 participants (98%) possessed at least one chronic 
health condition [DT-FPT, n=137 (98%); CON, 125 (98%)], and 149 (56%) possessed 
≥3 conditions [DT-FPT, n=81 (58%); CON, n=68 (53%)] (Table 7.1). There were no 
differences between the groups in the number of health conditions or proportion of 
participants with chronic health conditions at baseline (P=0.723 and Chi-square, 
P=0.567), changes in the number of diseases (P=0.544), or the number of new diseases 
(P=0.623), or proportion of participants with new diseases over the intervention (Chi-
square, P=0.321). Intervention data for medication usage and habitual PA are 
presented in Chapter 5, while baseline data for habitual PA is presented in Table 4.1. 
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Missing data 
In summary, 269 of the 300 participants tested at baseline provided blood samples, 
due to the reasons provided in Appendix Z. Of these, one participant did not provide 
basic demographic information (i.e. height, weight) and was excluded from analysis, 
leaving a baseline sample size of 268. From the 233 participants who underwent 26-
week follow-up testing, 226 provided blood samples, with 211 participants providing 
samples at both time-points [DT-FPT, n=108 (69%); CON, 103 (72%)]. Complete 
data for blood samples at both time-points were not provided for the following 
reasons: did not provide a sample at either time point [DT-FPT, n=2 (1%); CON, 2 
(1%)], missed baseline but provided a sample at 26 weeks [DT-FPT, n=5 (3%); 
CON, 10 (7%)], missed 26-week collection due to illness or other reasons [DT-FPT, 
n=8 (5%); CON, 10 (7%)], and withdrawal/loss to follow up [DT-FPT, n=33 (21%); 
CON, 19 (13%)]. 
 
Body composition  
As reported in Chapter 5, no within-group changes or between-group differences were 
detected in any body composition measures (total body percentage fat, fat mass or fat-
free mass) after adjusting for baseline values, apart from small increases in CON for 
fat mass [0.37 kg (95% CI, -0.01, 0.74); P=0.048], weight [0.43 kg (95% CI, 0.05, 
0.80); P=0.024], and BMI [0.21 kg/m2 (95% CI, 0.05, 0.36); P=0.009]. A small net 
benefit for the change in BMI in the DT-FPT relative to CON group [mean net 
difference, -0.26 kg/m2 (95% CI, -0.48, -0.05); P=0.017] was detected, but this was 
attenuated after adjusting for baseline values (P=0.075).  
 
Inflammatory markers 
The mean baseline values, within group changes and between group differences for 
the changes for each inflammatory marker are shown in Table 7.2. At baseline, CON 
had significantly higher levels of the following biomarkers when compared to DT-FPT 
after adjusting for sex:  IL-10 (P=0.008), IL-6 (P=0.001), and TNF-α (P=0.006), and 
higher pro- (P=0.012) and anti-inflammatory composite scores (P=0.001) (Table 7.2). 
Following the 26-week intervention, there was a mean 37.6% net benefit for the 
change in serum IL-4 concentrations in DT-FPT compared to CON (group-by-time 
interaction, P=0.023), which was due to a 30.3% increase in DT-FPT (P=0.024) and a 
non-significant 7.3% decrease in CON (P=0.400) (Figure 7.1). These interactions 
persisted in fully adjusted models (i.e. age, sex, BMI, cardiometabolic status), 
Chapter 7  
290 
 
including in additional models whereby BMI was replaced as a covariate by total fat-
free mass or body fat percentage. In addition, after adjusting for whole body fat 
percentage instead of BMI there was a 5.6% net benefit for the change in serum IL-8 
concentrations in CON compared to DT-FPT (group-by-time interaction, P=0.043), 
which was due to a non-significant 3.2% decrease in DT-FPT (P=0.312) and a 
significant 8.8% decrease in CON (P=0.003) (Figure 7.1). However, after adjusting 
for baseline values the between-group differences for IL-4 and IL-8 were no longer 
significant (P=0.274 and P=0.672 respectively). For all other inflammatory measures, 
including the pro- and anti- inflammatory and global (single) composite scores, there 
were no significant within-group changes or between-group differences for the change 
over time in linear mixed models, or after adjusting for baseline with ANCOVA, with 
the exception that in CON serum IL-10 decreased by 16% (P=0.004) and TNF-α 
decreased by 7% (P=0.026) in DT-FPT.  
 
In the per-protocol analysis which included those participants in DT-FPT achieving 
≥50% compliance to the program, results were similar to the intention to treat analyses, 
except that CON had significantly higher levels of CRP at baseline compared to DT-
FPT after adjusting for sex (P=0.025) (Appendix AA).  
Chapter 7  
 
 
291 
Table 7.2: Mean baseline inflammatory profile, the within-group changes relative to baseline and net between-group differences for the change 
after 26 weeks in the dual-task functional power training (DT-FPT) and control (CON) groups.    
 Baseline Values and Within Group Changes  
 DT-FPT CON Intervention Effects 
 n Mean ± SD or (95% CI) 
P-value n Mean ± SD or 
(95% CI) 
P-value Net Difference 
(95% CI) 
P- values 
Model 1 | Model 2 | Model 3 
IL-6         
  Baseline  140 1.85 ± 1.67  128 3.06 ± 3.61 ‡    
  % ∆ 26 weeks 108 5.3 (-7.7, 18.3) 0.345 103 -5.3 (-21.7, 11.1) 0.325 10.6 (-10.1, 31.3) 0.189 | 0.166 | 0.863 
TNF-α         
  Baseline  140 10.2 ± 5.89  128 12.4 ± 8.68 ‡    
  % ∆ 26 weeks 108 -7.3 (-13.6, -1.1)  0.026 103 1.1 (-8.0, 10.1) 0.855 -8.4 (-19.2, 2.4) 0.269 | 0.267 | 0.184 
IL-1β         
  Baseline  140 1.54 ± 4.25  128 1.95 ± 3.31    
  % ∆ 26 weeks 108 -8.0 (-21.5, 5.5) 0.253 103 -1.2 (-13.9, 11.5) 0.869 -6.8 (-25.2, 11.6) 0.500 | 0.504 | 0.265 
IL-8         
  Baseline  140 13.9 ± 9.08  127 17.1 ± 15.5     
  % ∆ 26 weeks 108 -3.2 (-9.1, 2.8) 0.312 102 -8.8 (-14.6, -2.9)  0.003 5.6 (-2.7, 13.9) 0.166 | 0.170 | 0.672 
CRP           
  Baseline  137 2.76 ± 3.42  126 3.37 ± 3.57    
  % ∆ 26 weeks 106 17.8 (-0.4, 36.1) 0.235 99 4.2 (-8.4, 16.9) 0.694 13.6 (-8.7, 35.9) 0.320 | 0.286 | 0.482 
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IL-10         
  Baseline  140 4.65 ± 8.31  128 9.28 ± 16.8 ‡    
    % ∆ 26 weeks 108 -5.3 (-19.2, 8.6) 0.381 103 -16.4 (-28.1, -4.8) 0.004 11.1 (-6.95, 29.2) 0.236 | 0.215 | 0.588 
IL-4         
  Baseline  140 19.2 ± 38.5  127 32.9 ± 66.3     
  % ∆ 26 weeks 108 30.3 (9.3, 51.2)  0.024 102 -7.3 (-25.8, 11.1) 0.400 37.6 (9.7, 65.5)  0.024 | 0.021 | 0.274 
Single composite inflammatory Z-score       
  Baseline  140 0.02 ± 0.50  128 -0.02 ± 0.91    
 ∆ 26 weeks 108 0.04 (-0.05, 0.12) 0.171 103 -0.08 (-0.18, 0.02) 0.651   0.12 (-0.02, 0.25) 0.465 | 0.489 | 0.306 
Pro-inflammatory Z-Score       
  Baseline  140 -0.12 ± 0.51  128 0.14 ± 0.71 ‡    
  ∆ 26 weeks 108 0.06 (-0.04, 0.15) 0.932 103 -0.10 (-0.19, -0.01)  0.142    0.16 (0.03, 0.28)   0.375 | 0.316 | 0.828 
Anti-inflammatory Z-Score       
  Baseline  140 -0.14 ± 0.57  128 0.16 ± 1.16 ‡    
  ∆ 26 weeks 108 0.02 (-0.03, 0.07) 0.151 103 -0.02 (-0.09, 0.06) 0.036    0.04 (-0.05, 0.12) 0.069 | 0.062 | 0.255 
Baseline values are means ± SD; within and between-group (net) differences are means with 95% confidence intervals (CI), and calculated by 
subtracting within-group changes from baseline for the DT-FPT group from within-group changes for the CON group after 26 weeks. Missing data 
points at 26-week testing were due to insufficient sample (DT-FPT, n=2; CON, n=4) and outliers (CON, n=2).  Percentages are calculated as log-
transformed within-group and between-group changes x 100. Inflammatory Z-scores and changes are presented as raw data, analysis was conducted 
on Z scores constructed from log-transformed concentrations. P-values were derived from linear mixed models with random effects after accounting 
for the following covariates: Model 1: age and sex, Model 2: adjusted for age, sex, BMI, cardiometabolic disease risk. P-values for Model 3 were 
derived from ANCOVA, adjusting for baseline differences and covariates in Model 1. ‡ P<0.05 baseline differences. Cytokine concentrations at 
baseline are presented in pg/mL, except for CRP which is measured in mg/L. CRP: C-reactive protein; IL-1β: interleukin-1 beta; IL-4: interleukin-4; 
IL-6: interleukin-6; IL-8: interleukin-8; IL-10: interleukin-10; TNF-α: tumor-necrosis factor alpha. 
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Figure 7.1: Mean (±SEM) percentage changes in Interleukin-4 (IL-4), Interleukin-10 (IL-10), 
Interleukin-8 (IL-8), C-reactive protein (CRP), Interleuklin-6 (IL-6), and tumor necrosis factor 
alpha (TNF-α) log-transformed serum concentrations, and amyloid beta (Aβ) (1-42) and Aβ 
(1-40) log-transformed plasma concentrations, in the dual-task functional power training (DT-
FPT) and control (CON) group after 26 weeks.* P<0.05, ** P<0.01 within-group change 
relative to baseline.  
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Neurological markers  
At baseline mean serum levels of the neurological markers were similar between the 
groups, with the exception that levels of BDNF were higher in DT-FPT compared to 
CON (P=0.002) and VEGF concentrations were higher in CON compared to DT-FPT 
(P=0.038) after adjusting for sex (Table 7.3). Following the intervention, there was a 
10.5% net benefit (decrease) for the change in Aβ (1-40) detected in DT-FPT 
compared to CON (group-by-time interaction, P=0.003). This was due to a small non-
significant 2.7% increase in DT-FPT (P=0.216), and a significant 7.5% decrease in 
CON (P=0.004) (Table 7.3, Figure 7.1). After adjusting for baseline values the 
significance of the between-group difference for Aβ (1-40) was attenuated (P=0.065). 
There were no significant within-group changes or between-group differences for the 
change over time in other variables, except that Aβ (1-42) concentration increased by 
17.9% in DT-FPT (P=0.019). All results remained unchanged after adjusting for age, 
sex, cardiometabolic status and BMI. In addition, adjusting for the presence of a Met 
allele (BDNF genotype) and ε4 carrier status (APOE genotype) in further models did 
not change the findings. There were no baseline differences for Aβ (1-42): Aβ (1-40) 
ratio between groups, and no within or between-group differences in any measures of 
the Aβ (1-42): Aβ (1-40) ratio [mean change DT-FPT: 0.04 (-0.004, 0.07); CON: 0.02 
(-0.02, 0.06); P=0.823], in any statistical models.  
 
In the per-protocol analysis which included those participants in DT-FPT achieving 
≥50% compliance to the program, results were similar to the intention to treat analyses 
(Appendix BB).  
 
No sex interactions were detected for any inflammatory or neurological measure. 
Similarly, the response of biomarkers to the intervention did not vary by BDNF or 
APOE polymorphisms.  
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Table 7.3: Mean baseline neurological marker concentrations, the within-group changes relative to baseline and net between-group differences 
for the change after 26 weeks in the dual-task functional power training (DT-FPT) and control (CON) groups.    
 Baseline Values and Within Group Changes  
 DT-FPT CON Intervention Effects 
 n Mean ± SD or (95% CI) 
P-value n Mean ± SD or 
(95% CI) 
P-value Net Difference 
(95% CI) 
P- values 
Model 1 | Model 2 | Model 3 
Aβ (1-40)         
  Baseline  140 112.8 ± 50.4  128 109.2 ± 32.8    
  % ∆ 26 weeks 108 -2.73 (-8.1, 2.6) 0.216 102 7.80 (2.3, 13.3)  0.004 -10.5 (-18.1, -2.9)   0.003 | 0.003 | 0.065 
Aβ (1-42)         
  Baseline  140 5.68 ± 6.91  128 4.27 ± 4.92    
  % ∆ 26 weeks 108 17.9 (0.05, 35.8)  0.019 102 13.6 (-6.9, 34.0) 0.143 4.3 (-22.6, 31.2) 0.589 | 0.607 | 0.390 
BDNF         
  Baseline  140 32.6 ± 9.20 ‡  128 28.9 ± 9.80    
  % ∆ 26 weeks 108 -0.1 (-5.5, 5.4) 0.177 103 12.4 (-0.04, 24.8) 0.762 -12.5 (-25.7, 0.74) 0.273 | 0.265 | 0.722 
IGF-1         
  Baseline  137 16.9 ± 5.13  127 16.5 ± 5.08    
  % ∆ 26 weeks 106 1.9 (-1.9, 5.7) 0.606 100 -0.2 (-3.2, 2.8) 0.616 2.1 (-2.8, 6.9) 0.525 | 0.585 | 0.501 
VEGF         
  Baseline  140 341.3 ± 258.4  128 415.6 ± 401.5 ‡    
  % ∆ 26 weeks 108 -6.1 (-15.3, 3.1) 0.148 103 -9.8 (-21.4, 1.8) 0.090 3.6 (-11.0, 18.3) 0.634 | 0.617 | 0.737 
Baseline values are means ± SD; within and between-group (net) differences are means with 95% confidence intervals (CI), and calculated by subtracting within-group changes from baseline for the 
DT-FPT group from within-group changes for the CON group after 26 weeks. Missing data points at 26-week testing were due to insufficient sample (DT-FPT, n=2; CON, n=3). Percentages are 
calculated as log-transformed within-group and between-group changes x 100 except for BDNF and IGF-1 which were not transformed. P-values were derived from linear mixed models with random 
effects after accounting for the following covariates: Model 1: age and sex, Model 2: adjusted for age, sex, BMI, cardiometabolic disease risk. P-values for Model 3 were derived from ANCOVA, 
adjusting for baseline differences and covariates in Model 1. ‡ P<0.05 baseline differences. Concentrations for Aβ and VEGF at baseline are presented as pg/mL, BDNF as ng/mL and IGF as nmol/L.  
Aβ: amyloid beta; BDNF: brain derived neurotrophic factor; IGF-1: insulin-like growth factor-1; VEGF: vascular endothelial growth factor.  
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7.4 Discussion  
The main finding from this study was that a 26-week group-based dual-task functional 
power training program had no effect on circulating levels of any pro- or anti-
inflammatory markers, or neurological markers including serum BDNF, IGF-1, VEGF 
and plasma Aβ, in older adults living in retirement villages. Similarly, the response of 
these biomarkers to dual-task training was not influenced by the possession of a Met 
allele within the BDNF gene, or in carriers of the ApoE-ɛ4 polymorphism. Finally, no 
sex interactions were observed indicating the response of the biomarkers to the 
intervention was no different between older men and women.  
 
Cognitive challenge - neurological markers 
Circulating levels of neurological markers such as IGF-1, BDNF and VEGF are 
thought to play a mediating role in the relationship between physical exercise and 
cognition (Cotman, Berchtold & Christie 2007; Voss et al. 2013), however in our study 
we observed no effect of DT-FPT on the levels of any of these markers. Our dual-task 
exercise program engaged several aspects of cognition including the continual division 
and switching of attention between functional exercise and a secondary task(s), which 
included cognitive tasks that endeavoured to activate executive abilities and higher-
order processing [e.g., working memory (remembering lists), cognitive flexibility 
(anagrams)]. Due to the dual-task nature of our program, it is not clear as to the amount 
of attention that participants paid to performing cognitive/motor tasks, rather than 
physical exercise. However, the collective dose of cognitive training in our program 
may have been inadequate for increases in BDNF and other neurological markers to 
occur. Focused cognitive training interventions lasting 4 to 12 weeks have previously 
been shown to increase circulating BDNF concentrations in cognitively impaired older 
adults with Parkinson’s disease (set shifting training) (Angelucci et al. 2015) and heart 
failure patients (computerised memory training) (Pressler et al. 2015), however it is 
unclear whether these findings relate to our healthier cohort. Furthermore, significant 
increases in BDNF have been demonstrated following 7 weeks of both sequential 
cognitive-exercise training (20 minutes moderate-intensity aerobic and PRT then 70 
minutes cognitive training; twice per week), and cognitive training (90 minutes, twice 
per week) in healthy older adults (Rahe et al. 2015a). In comparison to the greater dose 
of focused cognitive training in both of these training groups (>140 minutes per week), 
it is possible that a lesser exposure to cognitively stimulating training elements in our 
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program (maximum 120 minutes per week but as a secondary task), may have 
contributed to a lack of improvement in BDNF.  
 
Due to the main objectives of our program, cognitive tasks were included as additional 
secondary tasks to create dual-task challenge, rather than a focused training element, 
which may differentiate our findings. However in contrast to our finding, the addition 
of a cognitively challenging element to moderate-high intensity traditional cycling (i.e. 
exergaming, 45 minutes, five times per week, HRR 60%) significantly improved levels 
of BDNF after 12 weeks, compared to cycling alone at the same intensity, in 
independently living older adults (Anderson-Hanley et al. 2012). This evidence further 
suggests that a greater dose of cognitive challenge than we prescribed may be required 
to elicit changes in BDNF, which was also likely affected by our modest compliance 
levels. Although it could be contended that the inclusion of moderate-intensity aerobic 
exercise may have driven these positive findings for BDNF, it also appears that the 
release of BDNF may be dependent on the complexity and/or dose of cognitive 
challenge present in a combined cognitive-exercise intervention. Indeed, BDNF is 
secreted by neurons as an excitatory neurotransmitter, and neuronal activation during 
a cognitive challenge likely increases the release of BDNF into the circulation where 
it plays pivotal roles in facilitating adaptive changes in neuronal circuitry (Marosi & 
Mattson 2014). Thus, the role of cognitive training in increasing levels of neurological 
markers following dual-task exercise requires further research.  
 
Training intensity - inflammatory markers 
To our knowledge, there are no previous dual-task exercise-cognitive training 
interventions which have evaluated changes in circulating inflammatory markers in 
older adults. In our study, there are a number of factors which may explain why we 
observed no improvements in the various inflammatory markers relative to controls, 
including the relatively low-intensity nature of exercise used in our training program 
which may have also informed a lack of any changes in body composition, and that 
compliance to the training was modest (mean 50%). While our control group exhibited 
significant, albeit modest, increases in fat mass (0.37 kg), weight (0.43 kg) and BMI 
(0.21 kg/m2) over the 26-week intervention, the exercise intervention provided no 
benefit to body composition. This is likely related to the fact that our training focused 
on relatively low-intensity high-velocity functional exercises using elastic bands of 
different tension, body-weight and dumbbells, as well as challenging balance and 
Chapter 7  
298 
 
mobility activities, to optimise functional performance rather than induce 
compositional change or weight-loss. Moreover, previous research has shown that 
adipose tissue is a rich source of circulating pro-inflammatory cytokines such as TNF-
α (Kern et al. 2001) and IL-6 (Mohamed-Ali et al. 1997), while weight loss can result 
in a reduction in various inflammatory cytokines (Nicklas, You & Pahor 2005). Thus, 
the low-moderate intensity and objectives of our program may partially explain the 
lack of exercise-induced changes in fat mass and weight in the DT-FPT group, which 
may have affected our findings for inflammatory markers. In partial support of our 
findings, previous studies investigating power training or functional exercise training 
across a range of intensities have also reported little or no effect of these training 
modalities on either fat or lean mass in older adults (de Vos et al. 2005; Patil et al. 
2015; Reid et al. 2014), although these studies did not measure levels of inflammatory 
markers.  
 
There is mixed evidence as to whether exercise training alone can lower various 
markers of systemic inflammation in older adults (Beavers, Brinkley & Nicklas 2010; 
Liberman et al. 2017; Woods et al. 2012), and decreases in inflammation following 
moderate-intensity exercise have been confounded by concomitant losses in total 
and/or central body fat (Vieira et al. 2009; Wanderley et al. 2013). In partial support 
of our findings, low-intensity elastic band PRT did not affect circulating levels of 
multiple inflammatory cytokines such as hs-CRP, TNF-α, IL-6 or transforming growth 
factor-β, or body composition, following a 12-month program in institutionalised older 
adults (Schober-Halper et al. 2016). Further, there were no differences in levels of 
CRP, IL-6, TNF-α or IL-1β following a 12-week (three times per week) intervention 
using elastic based PRT in community-dwelling older adults, despite 4% reductions in 
body fat percentage and 2% increases in fat-free mass compared to a control group (So 
et al. 2013). Although these studies used different exercise modalities to ours, these 
findings support the notion that the intensity and/or modality of our training program 
may have been insufficient for an improvement in the levels of various inflammatory 
markers, which may relate to the lack of between-group differences in body 
composition, particularly fat mass, that we observed following the intervention. 
Further, while it is unclear whether DT-FPT is incapable of activating metabolic 
processes that lead to reductions in adipose tissue (e.g., lipolytic and sympathetic 
nervous system hormone release) (Horowitz & Klein 2000), it has been reported that 
exercise-induced reductions in body fat of up to 10% are required to facilitate 
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inflammatory changes (Fedewa, Hathaway & Ward-Ritacco 2016; Forsythe, Wallace 
& Livingstone 2008; Madsen et al. 2008). Thus, our lack of change in inflammatory 
levels are likely related to an absence of any training-induced improvements in body 
composition.   
 
Our program was designed to be performed at a moderate intensity, particularly with 
the addition of the dual-task components which were anticipated to make the exercises 
more challenging. However, given that our exercise sessions were conducted at 
retirement villages, we were limited in the exercise equipment that could be used, and 
therefore even with progression this moderate training load was hard to achieve and 
maintain for some participants, which may have affected our inflammatory findings.  
Moderate-high intensity exercise has provided some benefit to inflammatory levels in 
older adults (Forti et al. 2016; Kohut et al. 2006; Phillips et al. 2010), which may or 
may not relate to its ability to improve body composition. For example, increases in 
serum IL-8 and the receptor for IL-1 (receptor antagonist IL-1Ra) were demonstrated 
following 12 weeks of high-intensity PRT (80% 1RM) in community-dwelling older 
adults (Forti et al. 2016). However, no changes were observed in a group performing 
the same volume of training but at a lower intensity [1 set of 85-100 repetitions at 20% 
1RM]. Although these authors attributed the increases in IL-8 to angiogenic processes 
rather than pro-inflammatory mechanisms, no between-group differences were 
observed, and this study did not include any measures of body composition. Still, this 
data partially aligns with evidence from several reviews which have reported that 
exercise intensity (especially for PRT) may influence the inflammatory response to 
exercise in older adults (Hayashino et al. 2014; Liberman et al. 2017), with greater 
inflammatory responses to PRT typically observed in adults (healthy and clinical 
cohorts) with intensities greater than 80%1RM (de Salles et al. 2010). Although the 
majority of this evidence is derived from research using PRT, 12 months of high-
intensity power training (80% 1RM) in older adults with type 2 diabetes was associated 
with a trend for a reduction in CRP concentrations, and these reductions were 
associated with losses in total fat mass and increases in lean muscle mass in the training 
group, but not in a control group (Mavros et al. 2014). While it is difficult to compare 
the results from this study to our findings since it included a clinical population of 
older adults that may have exhibited increased inflammation at baseline, these findings 
provide some evidence that high-intensity training may be required to lower 
inflammatory markers, and the greatest benefits may be achieved through fat loss 
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combined with muscle gain and those with some evidence of overt disease (e.g., type 
2 diabetes or cancer).  
 
We observed no between group differences for the change over time in any 
inflammatory marker in our study, although in the DT-FPT group there was a 
significant 7% reduction in the pro-inflammatory marker TNF-α, and a 30% elevation 
in the anti-inflammatory cytokine IL-4, while IL-10 decreased by 16% in the control 
group. This tentatively implies that the intervention may have had a slight anti-
inflammatory effect in the intervention group, as higher systemic levels of TNF-α have 
been consistently associated with impaired functionality and disability (Penninx et al. 
2004; Visser et al. 2002), and can instigate the loss of muscle mass (Bales & Ritchie 
2002; Sakurai, Zhang & Wolfe 1996). In addition, our observed increase in the anti-
inflammatory cytokine IL-4 and the potential maintenance of IL-10 may be important 
for older adults in the DT-FPT group, as lower serum levels of these anti-inflammatory 
cytokines, have been associated with metabolic syndrome (Esposito et al. 2003), 
unstable angina (Smith et al. 2001), and an increased risk of stroke in older adults (Van 
Exel et al. 2002). Nonetheless, as no significant differences were observed between 
intervention groups the functional implications and mechanism(s) underlying these 
within-group changes are not clear.  
 
The potential mechanism(s) underpinning our limited findings are unclear. 
Contracting skeletal muscle produces and secretes several cytokines (called myokines) 
during and after exercise, most notably IL-6 (Maggio et al. 2006; Petersen & Pedersen 
2005; Steensberg et al. 2000), which stimulates the appearance of anti-inflammatory 
cytokines such as IL-1 receptor antagonist, IL-4 and IL-10 in the circulation, which 
collectively inhibit the production of TNF-α and IL-1β (Flynn, McFarlin & Markofski 
2007; Pedersen 2011; Petersen & Pedersen 2005). Despite this pathway, IL-6 
concentrations did not change in any group in our study. Furthermore, previous 
research has shown that the magnitude of IL-6 production is dependent on the amount 
of skeletal muscle recruited (Pedersen 2006; Pedersen 2011), while a higher intensity 
of exercise than found in our program may be needed to stimulate IL-6 (Pedersen, 
Steensberg & Schjerling 2001), and/or downregulate proteolytic signalling pathways 
linked with TNF-α in skeletal muscle (Greiwe et al. 2001; Lambert et al. 2008). While 
our high-velocity power training and functional stepping exercises engaged large 
muscle groups of the lower limbs, it is unlikely that the rapid concentric contractions 
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associated with these exercises may have been of a sufficient intensity or duration to 
upregulate these localised processes within the muscle and circulation. Therefore, 
other physiological mechanisms may have led to our modest changes (e.g., increased 
vagal tone, cortisol and catecholamine release, attenuation of oxidative stress) (Chung 
et al. 2009; Johnston & Webster 2009; Kunz-Ebrecht et al. 2003; Wrona 2006). In 
partial support of our findings, 28 weeks of chair-based elastic-band PRT (50 minutes 
2-3 times a week), had no effect on any inflammatory markers in cognitively impaired 
older women, with the exception of an improvement in serum IL-10 (Chupel et al. 
2017). Although this study differed from ours in terms of format (chair-based PRT), 
sample characteristics, and training dose, it supports the notion that lower intensity 
training may be largely ineffective at lowering circulating inflammatory markers in 
older adults.  
 
Training intensity and modality - neurological markers 
Mixed findings have been reported from acute and long-term studies examining the 
effects of various exercise modalities (aerobic training, PRT, power training, 
multimodal training) on serum BDNF levels (Anderson-Hanley et al. 2012; Coelho et 
al. 2012; Forti et al. 2015; Hvid et al. 2017; Knaepen et al. 2010; Pereira et al. 2013; 
Vaughan et al. 2014; Vedovelli et al. 2017; Walsh et al. 2015), with these 
inconsistencies resulting from population heterogeneity, and differences in type, 
intensity, and duration of the exercise interventions. Nonetheless, a potential factor 
that may explain our findings for BDNF is our inclusion of low-moderate functional 
power training, which even when performed at a higher intensity has not proved 
beneficial for improving levels of inflammatory (Valls et al. 2014) or neurological 
markers (Hvid et al. 2017). Consistent with our findings, 12 weeks of high-intensity 
power training, balance and coordination in mobility-limited older adults (twice per 
week) had no effects on fractions of BDNF or its total levels compared to a control 
group (Hvid et al. 2017). This data and ours suggests that a high taxation of the neural 
system via power training appears to have no effect on circulating BDNF levels, even 
with the addition of a secondary attention-demanding task. Instead, increases in BDNF 
may be stimulated by other metabolic pathways which are activated through moderate-
high intensity exercise (e.g., muscle contraction, increased vascular shear stress, 
energetic challenge, increased parasympathetic tone) (Marosi & Mattson 2014). 
Indeed, in contrast to our program design, the inclusion of aerobic training within a 
multimodal exercise program has been shown to increase circulating BDNF in older 
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adults (Anderson-Hanley et al. 2012; Vaughan et al. 2014). For example, a 3-month 
intervention involving moderate-high intensity aerobic walking combined with PRT 
performed with therabands (60 minutes, three times per week), increased serum levels 
of BDNF in older women residing in a retirement village, relative to a control group 
(Vedovelli et al. 2017). As this sample was recruited from the one retirement village, 
it is unclear as to how representative this sample is of older adults, however this limited 
data supports the notion that the power training component we used in DT-FPT may 
not have been as effective as aerobic training or PRT for improving BDNF.  
 
Homoeostatic regulation  
The lack of intervention effects on circulating levels of BDNF and IGF-1 that we 
observed in our study may stem from several homeostatic mechanisms that attempt to 
preserve growth factor concentrations within a narrow range. That is, in younger and 
older adults, transient post-exercise elevations in BDNF concentrations have been 
demonstrated after acute moderate-high intensity exercise bouts, either in isolation or 
following a structured training intervention, that return to basal levels or lower than 
pre-bout concentrations within 15 to 60 minutes after exertion  (Knaepen et al. 2010; 
Yarrow et al. 2010). This is thought to result from the addition of platelets containing 
BDNF to the blood (exercise-induced thrombocytosis) (Hulmi et al. 2010) and the 
addition of cellular sources of BDNF (e.g., vascular endothelial cells and the brain) 
(Marosi & Mattson 2014; Prigent-Tessier et al. 2013), before the subsequent target-
tissue uptake of BDNF by peripheral or brain tissue (Macaluso & Myburgh 2012). 
Similarly, acute exercise training at a moderate-high intensity can increase circulating 
IGF-1 levels, which can then drop within 10 minutes (Berg & Bang 2004). Due to the 
timing of our blood sample collection, it is unclear as to whether dual-task functional 
power training may have similarly stimulated an initial release of BDNF and IGF-1 
into circulation, which was then matched by an increased sequestration of these growth 
factors from the circulation into tissues (Fernandez et al. 2007). However, these 
processes may explain our lack of change in growth factor levels. In support of this 
notion, basal levels of serum BDNF were not affected following 8 weeks of PRT, 
however an acute increase in serum BDNF was demonstrated following an acute PRT 
bout, both before and after 8 weeks, in healthy older adults, which returned to basal 
circulating levels within 10 minutes (Walsh et al. 2015). Likewise, an acute bout of 
resistance training was able to increase IGF-I plasma concentration in sedentary older 
adults at the end of an 8-week PRT program, however resting IGF-1 levels were 
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unchanged before the acute bout (Bermon et al. 1999). Previous authors have 
suggested that exercise-induced IGF-1 released from the liver and other tissues (e.g., 
muscle) may be quickly sequestered by target tissue in an effort to maintain a 
homeostatic balance of IGF-1 in the systemic circulation (Kraemer et al. 1999; 
Onambélé-Pearson, Breen & Stewart 2010). This is important as IGF-1 regulates 
growth hormone (GH) secretion via negative feedback at the level of the hypothalamus 
and pituitary (Yakar & Isaksson 2016), and therefore a sequestering of IGF-1 would 
serve to augment the mitogenic actions of these factors, while protecting against a 
decline in GH release. Thus, it is possible that the long-term maintenance of such 
elevations in growth factors is not physiologically viable, and may partially explain 
why we observed unchanged levels for neurological markers at follow-up blood 
sampling (26 weeks). 
 
In our study, we collected blood samples within one week of the last training session 
for the training group, however it is uncertain whether any training–induced benefits 
for these measures may have dissipated or been washed-out in this time. Moreover, 
while other studies have attributed null findings for growth factors to a lag in sample 
collection (several days after intervention period) (Hvid et al. 2017), other long-term 
exercise studies that have collected samples up to 48 hours after the last training 
session have also reported no effects on growth factor levels (Borst et al. 2002; Forti 
et al. 2014; So et al. 2013). Brain levels of growth related factors are not currently 
measured in humans, however based on previous evidence (Knaepen et al. 2010), it 
may be plausible to speculate that regular exercise training, such as DT-FPT, may 
elevate central levels of growth factors without seemingly influencing peripheral 
levels, for the reasons outlined above (i.e. post-exercise reuptake of BDNF and IGF-1 
by brain and other tissue). This may explain the inverse relationship between habitual 
PA levels and BDNF commonly observed in physically active younger adults (Huang 
et al. 2014). Moreover, animal studies have also shown that aerobic exercise and 
exogenous injection of IGF-1 can both increase brain uptake of peripheral IGF-1 
without alterations in serum levels (Carro et al. 2000), while aerobic training in 
younger adults has elicited increases in muscle IGF-1 despite a lack of change in serum 
IGF-1 (Eliakim et al. 1998). This has also been shown 24 hours after an acute bout of 
aerobic exercise in younger adults, whereby BDNF mRNA and protein expression was 
increased in the muscle, but not in circulating levels (Matthews et al. 2015). 
Collectively, as the current study was limited to serum sample collection at baseline 
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and 26 weeks, sampling at time points between these two epochs may have revealed 
transient increases in growth factor levels. Despite these hypotheses, whether these 
homeostatic mechanisms operate within older adults following long-term exercise 
training requires further research. 
 
Age-related decline in responsiveness  
There is accumulating evidence that by-products of the GH/IGF-1 (growth hormone/ 
insulin-like growth factor) axis experience a decline with ageing (Sonntag, Ramsey & 
Carter 2005), which may be due to alterations in nutrition, body composition, sleep 
patterns, and levels of physical activity (Sherlock & Toogood 2007). The lack of 
response of IGF-1 to our training program may therefore stem from an age-related 
decline in the functioning and responsivity of the GH/IGF-1 endocrine axis upstream 
under resting conditions and in response to exercise, which leads to reductions in GH 
and IGF-1, and increases in IGF binding protein (IGFBP-1) which inhibits the action 
of IGF-1 (Straub et al. 2001). Furthermore, the capacity for muscle-derived IGF-1 
production may diminish with age due to age-related decreases in muscle mass 
(Giovannini et al. 2008; Goldspink & Harridge 2004). This notion is supported by 
evidence that the hormonal response of older men to 10 weeks of high-intensity PRT 
is inferior to that of younger males (Kraemer et al. 1999), which may have 
ramifications for maintaining muscle mass and strength with ageing (Musarò et al. 
2001; Perrini et al. 2010). An age-associated decrease in the responsiveness of this 
axis was speculated to be a contributing factor in a 6-month PRT program which found 
no differences in IGF-1 following high-intensity PRT (80% 1RM), low-intensity PRT 
(50% 1RM) and a control group of healthy older adults. However, in this study 
participants only completed one set of each exercise for each training condition which 
may have been insufficient for stimulating IGF-1 (Borst et al. 2002).  
 
Age-related responsiveness may also explain our findings for BDNF. Blood samples 
were collected in the morning which eliminated the diurnal variation that BDNF 
displays (Begliuomini et al. 2008), however animal studies have shown that BDNF 
expression is increased by estrogen levels (Simpkins et al. 1997; Singh, Meyer & 
Simpkins 1995). While it is unknown if similar mechanisms operate in humans, as the 
majority of our sample were older women (73%) it is plausible that the decline in sex 
hormones with ageing (estrogen/testosterone) may have blunted the overall expression 
of BDNF in both sexes following our program, even after adjusting for sex differences. 
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Furthermore, very few of our participants reported that they were undergoing hormone 
replacement therapy (n=2), which may lend support to this notion. In addition to age-
related declines in endocrinological pathways, there is growing evidence that a chronic 
inflammatory state, as found with natural ageing, suppresses the GH/IGF1 axis (Leng 
et al. 2004; O’Connor et al. 2008). It could be hypothesized that low-grade elevations 
of pro-inflammatory mediators found in our participants may have blunted the 
response of IGF-1 to our intervention, particularly as we observed no exercise-induced 
ameliorations in the inflammatory environment. Thus, our data does not currently 
support a stimulating effect of dual-task exercise on basal BDNF, IGF-1 and VEGF in 
older adults, and therefore may not provide any therapeutic benefits to cognitive health 
or muscular function through these pathways.  
 
Healthy cohort  
The reason(s) for the lack of any effect of the intervention on circulating inflammatory 
or neurological markers may also relate to the characteristics of our relatively healthy 
sample, who may have possessed lower basal levels of inflammation. Moreover, 
moderate-intensity exercise is speculated to be more consistently beneficial for 
reducing inflammation in populations displaying elevated baseline levels, which may 
or may not stem from obesity or chronic disease (e.g., type 2 diabetes, CVD) (Beavers, 
Brinkley & Nicklas 2010). For example, reductions in TNF-α levels have been 
observed in older patients with chronic heart failure, but not healthy controls following 
12 weeks of aerobic exercise (Larsen et al. 2001). Similarly, 12 months of multimodal 
training (walking and low-intensity strength training) was found to be more effective 
in reducing IL-6 levels in healthy older adults with higher baseline levels of this 
cytokine (Nicklas et al. 2008). It could be argued that as 86% of our participants 
possessed at least one cardiometabolic risk factor, and 56% possessed three or more 
chronic diseases, these may constitute risk factors for elevated inflammation. To this 
point, interesting findings to emerge following our intervention were that production 
of the anti-inflammatory cytokine IL-4 increased by 30% in DT-FPT, and IL-10 
decreased over time in the control group. Related findings involving anti-
inflammatory modification have been typically demonstrated in uncontrolled studies 
involving long-term aerobic training with clinical populations of middle-aged adults 
(i.e. heart disease risk and type 2 diabetics) (Balducci et al. 2010; Goldhammer et al. 
2005; Smith et al. 1999). For example, 6 months of moderate-intensity aerobic training 
in 52 middle-aged adults at high-risk for ischemic heart disease led to an overall 36% 
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increase in mononuclear cell production of IL-4, IL-10 and transforming growth factor 
beta-1 (TGFβ1) (Smith et al. 1999). However, there are several important differences 
between this study and ours, most notably the sampling techniques used and 
population characteristics, which makes comparisons difficult. On the other hand, we 
excluded participants with serious and unstable chronic diseases or conditions, and the 
major chronic diseases present in our sample were hypertension (72%) and 
hyperlipidemia (50%), which were largely controlled by antihypertensive and lipid-
lowering medication. These medications may lower disease symptoms that contribute 
to increased inflammatory levels in otherwise healthy older adults.  
 
It is also possible that the healthy nature of our cohort influenced our findings for 
neurological markers, in terms of a reduced capacity for improvement, as increases in 
IGF-1 have been observed following training in participants with lower baseline levels 
of IGF-1 (LaStayo et al. 2007; Parkhouse et al. 2000). In opposition to our findings, 
sedentary older women aged 60-80 years with low bone mineral density (BMD) 
performing high-intensity PRT (75-80% 1RM) three times a week for 8 months, 
displayed a significant increase in basal IGF-1 levels (70% increase), compared to an 
inactive control  group (Parkhouse et al. 2000). As this study used a different training 
program and methodology for IGF-1 analysis to ours (radioimmunoassay vs. 
chemoluminescence) it is difficult to compare findings (Clemmons 2007). 
Nonetheless, as the training group with lower BMD displayed baseline IGF-1 levels 
that were four times lower than a healthy control group used for comparison, this 
suggests that specific types of exercise may be more effective for elevating circulating 
IGF-1 levels in individuals with lower basal levels of IGF-1. Similarly, previous trials 
have demonstrated positive effects of exercise on BDNF levels in older adults with 
comorbidities and cognitive impairment (Baker et al. 2010b; Coelho et al. 2012; 
Pereira et al. 2013). For example, 10 weeks of PRT increased circulating levels of 
BDNF in older women with depressive symptoms (Pereira et al. 2013), while Coelho 
and colleagues (2012) detected lower baseline levels of circulating BDNF in pre-frail 
elderly women compared to non-frail women, but reported significantly increased 
BDNF levels in both groups following 10 weeks of moderate-high intensity PRT. 
Therefore, in contrast to our relatively healthy group, older adults with suppressed 
levels of BDNF may have a greater capacity for exercise-induced enhancement.  
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Amyloid beta 
Higher levels of Aβ present in the cerebrospinal fluid and circulating plasma may 
contribute to inflammatory processes, and their deposition into senile plaques in the 
brain is a key aspect of AD pathology (Akiyama et al. 2000; Rowe et al. 2007). We 
only observed a trend for a between-group net benefit (decrease) in plasma Aβ (1-40) 
in DT-FPT compared to controls following training, along with an increase in Aβ (1-
42) over time, but the plasma Aβ 42/40 ratio did not change. To the best of our 
knowledge, the current study is one of the few to assess the effect of an exercise 
intervention on plasma levels of Aβ isoforms in humans, and together with mixed data 
from observational and prospective studies, the implications of our findings are 
difficult to interpret. For instance, there is some evidence that older individuals with 
lower Aβ (1-42): Aβ (1-40) ratios possess a significant elevated risk for cognitive 
decline or AD (Koyama et al. 2012), however lower plasma Aβ 1-42/1-40 ratios have 
also been found in older adults reporting higher levels of PA (Brown et al. 2013). 
Furthermore, it has been postulated that decreases in plasma Aβ (1-42) and Aβ (1-40) 
levels coincide with Aβ accumulation in the brain (Graff-Radford et al. 2007; 
Kawarabayashi et al. 2001), which occurs with cognitive decline and an eventual 
progression to AD (Gravina et al. 1995; Koyama et al. 2012). The clinical significance 
of our change in plasma Aβ levels therefore remains unclear, and may depend on the 
cognitive health of an individual at the time of sampling. Given, the inconsistencies 
between previous data, it can be speculated that our findings for Aβ (1-40) may 
constitute the attenuation of a risk factor for cognitive decline in healthy older adults, 
while the significance of our finding for Aβ (1-42) is unclear.  
 
To date, the only other dual-task training study to include Aβ markers reported that 12 
weeks of both multimodal dual-task cognitive exercise training (low-moderate 
intensity walking and PRT performed with arithmetic and motor tasks) and multimodal 
training alone (both three times per week), produced within-group increases in plasma 
Aβ (1-40) and decreases in the Aβ 42/40 ratio. Further, within-group decreases in 
plasma Aβ (1-42) levels were observed in the multimodal training group (Yokoyama 
et al. 2015). These findings appear to contrast with our results, which may be due to 
several factors including the lack of a control group for comparison of training effects, 
a higher compliance (97% vs 50%) and therefore dose of training, and the 
incorporation of aerobic training. Moreover, aerobic training studies have reported 
trends for decreases in Aβ (1-42) relative to a control group, however these studies had 
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a greater training dose compared to our study (four times vs twice per week for 26 
weeks), and included older adults (55-85 years) that possessed risk factors for elevated 
Aβ and inflammatory levels (i.e. MCI and pre-and early type 2 diabetics) (Baker et al. 
2010a; Baker et al. 2010b). Furthermore, it has been reported that the use of enzyme-
linked immunosorbent assays in the studies above may have a lower sensitivity for 
detecting plasma levels of Aβ than the INNO-BIA assay used in our study (Hansson 
et al. 2010). However, our findings for Aβ (1-42) must be interpreted with caution as 
a considerable proportion of these samples fell below the minimum detection level 
(40%), and were hence assigned the lowest concentration for that assay. Given the lack 
of a standardised measure of plasma Aβ and these differences in exercise prescription, 
the true response of Aβ markers to structured exercise is currently unclear and requires 
further research.  
 
The mechanisms underpinning the trend for an 11% reduction in Aβ (1-40) in the 
training group in our study may involve several metabolic processes. Transgenic 
animal models of AD have demonstrated exercise-induced reductions in the load of 
amyloid-β plaques in the brain, through a regulation of amyloid precursor protein and 
other enzymes which collectively enhance the degradation and clearance of Aβ 
peptides (as reviewed in (Ryan & Kelly 2016)). However, this may not accurately 
reflect the dynamics of plasma Aβ production and clearance in healthy older adults. 
Instead, the reduction in Aβ (1-40) in the current study may be underpinned by 
exercise-induced enzymatic changes that target both Aβ and CVD risk factors which 
are linked to AD development (i.e. high levels of cholesterol and/or insulin) (Iadecola 
2010; Kuo et al. 1998). For example, the enzyme that metabolizes insulin; insulin-
degrading enzyme (IDE), also has an important role in the degradation of amyloid 
peptides (Farris et al. 2003). It is therefore possible that a reduction of insulin 
following dual-task exercise may have liberated IDE to reduce circulating Aβ levels, 
although a previous dual-task training study found that a change in Aβ levels did not 
correspond with changes in insulin resistance (Yokoyama et al. 2015). Furthermore, 
as a limitation of our study we did not measure the response of insulin or blood lipids, 
and thus it is not known if these factors were modified.  
 
The decrease in plasma Aβ (1-40) in the current study may reflect a greater clearance 
of this protein following dual-task exercise, which may reduce the risk of 
neurodegeneration in older adults. Our findings partially conflict with some (Koyama 
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et al. 2012; Sundelöf et al. 2008), but not all (Lopez et al. 2008; van Oijen et al. 2006) 
longitudinal data that has associated lower levels of this isoform with a greater risk of 
cognitive decline and AD. As a caveat, these studies typically included older adults 
who already presented with symptoms of cognitive decline, while only the lowest 
tertiles of Aβ (1-40) were associated with cognitive decline and disease. Although the 
physiological underpinnings of previously reported cross-sectional data are 
unresolved, levels of Aβ (1-40) in cerebrospinal fluid do not differ depending on the 
stage of AD, and therefore may be reflective of plasma pools of Aβ (Ghersi‐Egea et 
al. 1996). Together, this tentatively suggests that the trend for an experimental 
decrease in plasma Aβ (1-40) that we observed may contribute to an attenuation of risk 
factors associated with cognitive decline and degeneration in independently living 
older adults. Despite these speculations, it is currently unclear as to whether these 
reductions may correspond to a decreased Aβ load in the brain, and if changes in 
plasma Aβ levels can actually provide any cognitive benefits for older adults. Given 
their emerging links to cognitive health, further research is required to determine the 
clinical significance of exercise-induced changes in Aβ peptides.  
 
Contrary to our hypothesis, we did not detect any interactions between genotype and 
the exercise-induced release of any inflammatory or neurological marker, most notably 
ApoE-ε4 status had no effect on the secretion of plasma Aβ, and Met allele status did 
not influence concentrations of serum BDNF. Apolipoprotein E interacts with Aβ to 
mediate its clearance or conformation (Carter 2005), wherein carriers of the ε4 allele 
show increased amounts of Aβ in the brain compared to non-carriers (Rowe et al. 
2010). However neural effects of this isoform may be offset by higher levels of 
physical activity (Brown et al. 2013), and cognitive engagement (Wirth et al. 2014). 
There is negligible data regarding how genotype and structured exercise interact to 
influence biomarker release in older adults. Although the proportion of ε4 carriers in 
our sample matched population estimates (27%) (Mahley 1988), it is possible that the 
ε4 and Met alleles from the BDNF gene may exert greater interactive effects with 
exercise in older adults with cognitive impairment  or disease (Nascimento et al. 2015), 
rather than the healthy older adults we recruited. Furthermore, interventions that are 
capable of modifying biomarker concentrations, unlike the current study, may be more 
sensitive in detecting interactions.  
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Strengths and limitations  
The strengths and limitations of this intervention have been discussed in Chapter 5 and 
will be discussed in detail in Chapter 8, and therefore only the strengths and limitations 
unique to this study will be presented. Most notably, a strength of this study is that it 
is the first clinical trial to investigate the response of inflammatory biomarkers to dual-
task cognitive-motor exercise, and included an extensive panel of neurological 
markers. Furthermore, the recruitment of healthy older adults independently living in 
retirement villages provides a unique study population that sits between community-
dwelling and adults living in residential care, and is a point of difference to the clinical 
populations that regularly appear in inflammatory studies. There were also limitations 
to this study.  Firstly, although we did not observe any differences in results between 
intention to treat and per protocol analyses, it is likely that the modest level of 
compliance to DT-FPT (~50%) had an impact on our findings. Secondly, as few 
studies have assessed the effect of cognitive training on circulating biomarkers, 
comparisons of our findings were predominantly made to data from interventions 
involving exercise alone, and exercise-cognitive training where available. However, 
as the effects of dual-task training cannot be separated these comparisons may be 
appropriate. Third, our study was restricted to a sample of cognitively healthy older 
Caucasian adults, without unstable neurological or cardiovascular disease. The 
generalisability of the findings to a more racially varied sample with different 
demographics and cognitive abilities may provide different findings, especially in 
terms of the inflammatory response to exercise. Fourth, due to the larger aims of the 
study, factors that influence circulating levels of IGF-1, BDNF and inflammatory 
cytokines were not measured or included in this study (e.g., sleep, training 
background/history, nutritional status), but may have influenced the findings (Irwin et 
al. 2008; Kraemer & Ratamess 2005).  Finally, as we only collected samples at 
baseline and 26 weeks, responses to DT-FPT between these time points may have been 
missed.  
 
In conclusion, this study indicates that 26 weeks of dual-task functional power training 
did not affect circulating levels of inflammatory and neurological markers in relatively 
healthy older adults residing in independent living retirement villages. Furthermore, 
there was no evidence of any interaction by sex or genotype. However, in light of the 
findings that our dual-task functional power training did produce some significant 
improvements in processing speed and attention (discussed in Chapter 5), further 
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research is needed to understand the potential underlying mechanism(s) by which such 
training can improve certain measures of cognitive function.  
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8. Chapter 8 
Summary of key research findings. 
This chapter summarises the main findings of the thesis, including the implications 
of these outcomes for public health, and provides direction for future research. 
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8.1 Summary  
In addition to other age-associated health problems, a decline in cognitive function 
that may occur with ageing (Christensen et al. 1999; Yaffe et al. 2010) may 
subsequently impair functional performance in activities of daily living (Cahn-Weiner 
et al. 2000; Owsley et al. 2002), which can collectively reduce quality of life (QoL). 
Regular exercise (e.g., aerobic training, PRT, power training) (Colcombe & Kramer 
2003; Heyn, Abreu & Ottenbacher 2004; Northey et al. 2017), and cognitive training 
(Martin et al. 2011; Valenzuela & Sachdev 2009), have both been shown to provide 
small-moderate cognitive benefits in healthy and cognitively impaired older adults. In 
addition, a combination of exercise and cognitive/motor training performed 
simultaneously within a dual-task context has also been effective [(Tait et al. 2017); 
Appendix CC]. However, the effects of dual-task functional power training had not 
been tested prior to this thesis, but may improve cognitive function and/or delay age-
associated cognitive decline, while improving functional performance in older adults.  
 
Exercise interventions that exert a positive effect on cognitive function, and/or 
improved muscle strength and function may also provide benefits to quality of life and 
well-being in older adults (de Vreede et al. 2005; Gillison et al. 2009; Liu & Latham 
2011), however it is not known how HR-QoL or well-being respond to dual-task 
exercise. The mechanisms underpinning the improvements in cognition following 
dual-task exercise training are also currently unclear, but may relate to the induction 
of neurological growth factors and/or the attenuation of low-grade systemic 
inflammation, which have so far shown mixed effects in their response to structured 
exercise in older adults (Beavers, Brinkley & Nicklas 2010; Cassilhas et al. 2007; 
Coelho et al. 2013b) and have only received limited attention in dual-task training 
research (Anderson-Hanley et al. 2012; Rahe et al. 2015a). An evaluation of whether 
a dual-task training format can improve circulating levels of neurological and 
inflammatory markers was therefore necessary as beneficial changes in these levels 
may underlie the cognitive improvements observed following dual-task training, and 
also associate with a greater sense of well-being and HR-QoL in older adults. 
Collectively, the studies within this thesis aimed to provide a greater understanding of 
the determinants of cognitive health and well-being in older adults, extend the 
evidence regarding the cognitive benefits available from dual-task exercise, and reveal 
whether this multi-pronged approach can prolong functional independence in 
independently living adults at risk of falls. 
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The discussion sections within each previous chapter (4-7) have outlined the 
limitations and methodological issues pertinent to these studies, however section 8.2 
below will outline the key research findings presented in Chapters 4-7, while 
expanding on the strengths and limitations associated with these studies, and any 
recommendations for further research based on our findings. Following this, the 
conclusions of this collective research will be presented, along with the potential 
implications that this work may have for public health policy and the design of future 
community-based programs.  
 
8.2 Key research findings, limitations and directions for future research  
The key findings presented in the thesis are detailed below: 
Study 1 
The aim of the first study was to identify the associations between various 
inflammatory and neurological markers and their composite scores with cognitive 
function, well-being and HR-QoL in older adults residing independently in retirement 
villages (Chapter 4). A secondary aim was to assess whether genetic polymorphisms 
(APOE and BDNF gene) and sex differences affect these associations. This study 
found that the majority of circulating inflammatory and neurological makers [i.e. IL-
4, IL-6, IL-1β, IL-8, TNF-α, IL-10, VEGF, IGF-1, CRP, Aβ (1-40) and Aβ (1-42)] 
were not associated with cognitive performance in independently living older adults. 
However, polymorphisms of the APOE gene showed differential relationships in the 
associations between Aβ (1-42) and executive function, and inflammation and 
working memory. Higher levels of circulating BDNF were also found to be associated 
with greater performance in psychomotor function, attention, working-memory and 
global cognitive function while an inverse relationship between IGF-1 and visual 
memory and attention was detected. Finally, this study showed that higher levels of 
CRP and the pro-inflammatory composite score were associated with lower 
perceptions of the HR-QoL domain of vitality, however no other significant 
associations were observed between circulating biomarkers and HR-QoL or well-
being. These findings extend the evidence from the few studies that have shown mixed 
findings as to whether levels of inflammatory markers are related to HR-QoL scores.  
  
Study 2 
The aim of study 2 was to assess whether a 26-week dual-task functional power 
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training (DT-FPT) program could improve cognitive function compared to usual care 
in older adults living independently in retirement villages (Chapter 5). Secondary aims 
were to determine whether the response to the intervention varied by genetic factors 
(i.e. presence of Met allele of the BDNF gene or ε4 allele of the APOE gene), and to 
evaluate the efficacy of the intervention on muscle function and dual-task functional 
performance. Following the 26-week intervention, greater improvements in a choice 
reaction time and attention task were detected in the DT-FPT group compared to 
controls, while there was a maintenance effect of DT-FPT in a composite of 
psychomotor function and attention, compared to the usual care control group. A trend 
for greater improvements was also observed in a composite measuring psychomotor 
function, attention, learning and working memory, however the DT-FPT intervention 
did not improve executive function, working memory or global cognitive function. As 
secondary aims, DT-FPT was associated with a significant 7% improvement in 
functional muscle power, a 4% net-benefit for an improvement in mobility (four-
square step test) and 4% improvements in response and decision stepping times 
(CSRT) under a single-task condition, but there was no effect of the intervention 
relative to CON on body composition, muscle strength or other measures of physical 
function under single or dual-task conditions. Similarly, the response of cognitive 
function to the intervention did not differ between genetic polymorphisms of the 
BDNF and APOE genes which has been inadequately investigated, and no sex-
differences were observed in any changes in cognitive performance.  These findings 
extend the evidence from trials which have demonstrated that functional and cognitive 
improvements are available from dual-task exercise with cognitive and/or motor tasks 
in older adults. Furthermore, the findings in this thesis demonstrate that a more 
functionally oriented dual-task exercise program has the potential to improve an older 
adult’s ability to react to a stimuli, and enhance attentional aspects.  
 
Study 3 
The aim of study 3 was to evaluate the effect of a 26-week DT-FPT program on HR-
QoL and well-being in older adults living independently in retirement villages 
(Chapter 6). A secondary aim was to determine whether the response to the 
intervention varied by sex. Dual-task functional power training had little effect on HR-
QoL in older adults, and only the domain of role physical showed a greater 
improvement in the DT-FPT group compared to controls following the intervention. 
A trend for improvement in the role emotional domain was also observed. However, 
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per protocol analyses that included those with at least 50% compliance to the exercise 
program detected a significant net benefit for the change over time in DT-FPT 
compared to controls for social functioning, the physical component summary score 
and global HR-QoL, with a trend for a significant net benefit for the change in physical 
functioning (P=0.06) and role-emotional (P=0.05). No changes were seen in 
satisfaction with life or well-being. A secondary analysis exploring sex interactions 
demonstrated that there were no differences for any of the outcome measures, with the 
exception that older men in the training program reported greater net decreases in the 
domain of general health, and less improvements in satisfaction with life, compared to 
the control group. These findings have not been previously reported from dual-task 
cognitive-exercise studies, and extend the evidence which supports the efficacy of 
exercise for improving HR-QoL. 
 
Study 4 
The aim of the final study was to examine the effect of a 26-week DT-FPT program 
on circulating levels of neurological and inflammatory markers in older adults living 
independently in retirement villages, and whether the response of these biomarkers to 
dual-task training is influenced by APOE and BDNF polymorphisms (Chapter 7). The 
main finding was that the 26-week DT-FPT program had no effect on circulating levels 
of pro- or anti-inflammatory markers, or neurological markers including BDNF, IGF-
1, VEGF and Aβ, in older adults living in retirement villages. Similarly, the response 
of these biomarkers to dual-task training was not influenced by the possession of a 
Met allele within the BDNF gene, or in carriers of the ApoE-ɛ4 polymorphism. No sex 
interactions were observed and therefore the response of the biomarkers to the 
intervention was no different between older men and women.  
 
The next section will provide a more in-depth discussion of the key findings, 
including strengths and limitations, and the directions for future research.  
 
8.2.1 Inflammatory and neurological markers show limited relationships with      
cognition, HR-QoL and well-being 
Considerable evidence has demonstrated that age-related low grade inflammation is 
associated with cognitive decline, dementia, and Alzheimer’s disease (AD) (Engelhart 
et al. 2004; Godbout & Johnson 2009). However any relationship between 
inflammation and cognitive processes in healthy older adults remains unclear, and 
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mixed data reported in non-cognitively impaired populations is largely accounted for 
by known predictors of cognition, such as age, socioeconomic status, and education 
(Dik et al. 2005). In this thesis, no individual inflammatory cytokines or composite 
scores were associated with any measure of cognitive function. This may be partially 
explained by the participant characteristics, as associations between cognition and 
inflammation may be more apparent in cognitively impaired older adults (Álvarez et 
al. 2007; Trollor et al. 2012), compared to the relatively healthy older cohort used in 
this thesis.  
 
Currently there is minimal data outlining the potential relationship between HR-QoL 
and inflammatory or neurological markers in older adults. The significance of the 
findings from study 1 that higher inflammation is associated with poorer subjective 
perceptions of vitality is therefore unclear, particularly as inflammatory and 
neurological markers showed no other significant relationship with domains of HR-
QoL and well-being.  While intervention data is necessary to establish causality, this 
finding implies that higher levels of pro-inflammatory cytokines, including CRP, may 
deprive an older adult of a sense of vitality, which may be a necessary ingredient for 
the successful and purposeful performance of ADLs, and the maintenance of 
functional independence. Age-related health challenges such as physical disability, 
cognitive decline, and any mental health issues, have been associated with an 
inflammatory origin (Ferrucci et al. 2001; Godbout & Johnson 2009). Therefore, 
strategies that reduce low-grade inflammation may alleviate the onset and 
symptomology of these conditions, which may subsequently enhance HR-QoL and 
well-being components in older adults. Considering the other direction of this 
relationship, greater perceptions of vitality may lower inflammatory levels. Indeed, 
limited data has shown that optimism (Brydon et al. 2009) and stress reduction 
techniques (Creswell et al. 2012; Davidson et al. 2003; Irwin et al. 2003; Lavretsky 
2012; Lavretsky & Irwin 2007), may promote health by counteracting stress-induced 
increases in inflammation, but this requires further testing within the emerging field 
of psychoneuroimmunology.  
 
An important set of findings from the first study was that higher levels of BDNF were 
associated with greater performance across multiple cognitive domains. This 
strengthens previous research that has demonstrated the pivotal roles of BDNF in 
facilitating cognitive health (Cotman, Berchtold & Christie 2007). Furthermore, it 
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highlights the importance of maintaining circulating levels of BDNF in older adults 
for continued functional independence and the resistance of cognitive deterioration. 
An important question to be answered was whether sex or genetics exerted any 
influence on these associations in older adults. However BDNF polymorphisms and 
sex did not influence the relationship of any biomarker with cognition, suggesting that 
previously reported interactions between genetics, BDNF concentration, and cognitive 
function, may be age, domain and disease-specific (Erickson et al. 2008). The APOE 
gene was observed to exert some influence on the relationship between combined 
inflammation and working memory/learning, and Aβ (1-42) and executive function, 
however the clinical implications of this interaction are unclear.  
 
Limitations 
Due to the cross-sectional design of this study no inferences about causality and 
directionality can be made between the study variables. In addition, the findings are 
based on circulating levels of inflammation and neurological markers, which may vary 
from brain levels, depending on the biomarker. Direct measurements of brain levels 
are not currently available at a population level. Our sample may be regarded as high-
functioning with little racial diversity (99% were Caucasian), and therefore it is 
unknown as to how generalizable the reported findings are to community-dwelling 
older adults. For example, 26% of our participants received a university or tertiary 
education compared to only 9% of the Australian population over 65 (Australian 
Institute of Health and Welfare 2015).  
 
8.2.2 Dual-task functional power training can improve various cognitive abilities in 
older adults  
The effects of the 26-week intervention on cognitive function were investigated in 
Chapter 5. This study added novelty to the dual-task training literature in that it is the 
first to include a functional power training component, and added a point of difference 
with older adults independently living in retirement villages. Furthermore, while the 
optimal type and dose (frequency, intensity, duration) of exercise required for 
cognitive benefits in older adults remains unclear, this study added important 
information to the exercise neuroscience literature in regards to some of these 
uncertainties. Specifically, this study demonstrated that a 26-week, twice weekly dual-
task training program focusing on functional movement and power training, rather 
than PRT or aerobic training, and performed at a relatively low-moderate intensity, 
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can improve aspects of cognitive function. Dual-task cognitive exercise training has 
produced some benefits to cognitive function in older adults, particularly in the 
domains of executive function (Anderson-Hanley et al. 2012; Barcelos et al. 2015; 
Hars et al. 2014; Nishiguchi et al. 2015; Schoene et al. 2015; Theill et al. 2013; 
Yokoyama et al. 2015) memory (Gill et al. 2016; Nishiguchi et al. 2015). In contrast 
to these studies, no improvements in these domains or global cognition were detected, 
instead it was demonstrated that dual-task functional power training improves 
psychomotor function and attentive abilities, in older adults living independently in 
retirement villages. These improvements were observed despite a modest compliance 
rate (~50%), and therefore further cognitive benefits may be observed with a higher 
dose of training, although this was not explicitly shown in the per protocol analysis. 
The preservation of these cognitive abilities may allow an older adult to maintain their 
functional independence, and continue to perform ADLs (e.g., driving, shopping) at 
an acceptable level. For example, although no improvements in performance under 
dual-task conditions or dual-task cost were observed, the ability to multi-task and react 
to external stimuli when required is a necessary capability for older adults (e.g., talking 
whilst crossing a road, walking while carrying a cup of tea), and is underpinned by 
several cognitive functions including attention and processing speed which improved 
following the intervention. Poorer well-being and cognitive function also display 
associations with lower functional performance (Kim et al. 2005; Padubidri et al. 
2014), and therefore the observed cognitive improvements may hold additional 
importance for prolonging functional capabilities.   
 
A net-benefit for the change in lower-limb muscle power was detected in the DT-FPT 
group which suggests that a relatively low-intensity dual-task power training program 
can provide functional power advantages which have been previously shown 
following more intensive machine-based power training (Pereira et al. 2012; Valls et 
al. 2014), and PRT programs (Hofmann et al. 2016; Liu-Ambrose et al. 2010). DT-
FPT may therefore be an effective strategy for prolonging an older adult’s ability to 
climb stairs, rise from a chair and perform other movements. Combined with our 
program’s benefit to processing speed and functional mobility (FSST and CSRT time), 
this improvement in lower limb power may enhance an older adult’s ability to process 
and react to situational obstacles, allowing them to correct a misstep or restore a loss 
of balance in preventing a fall. Despite these benefits, we observed that DT-FPT had 
no effect on body composition or muscle strength compared to controls, with only 
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limited benefits to muscle function. Emerging, yet controversial evidence suggests that 
a loss of lean muscle mass and muscle function (strength and performance) may be 
associated with impaired cognitive function and structural degeneration of brain 
regions, due to the association of these factors with sarcopenia (Burns et al. 2010; 
Nishiguchi et al. 2016; Tolea & Galvin 2015). However, further data is still needed to 
clarify the relationship between body composition, and cognition in older adults.  
 
Limitations 
Limitations of this trial include the modest compliance to the training program (~50%), 
which may have limited the scope of the findings. Despite this, modest compliance 
rates have been previously reported following exercise interventions in cohorts of 
independently living older adults (Barcelos et al. 2015; Lord et al. 2003; Merom et al. 
2016; Schoene et al. 2015), which suggests that they may possess different priorities 
and characteristics to community-dwelling older adults. In addition, the tasks 
contained within the CogState battery have been validated against standardized 
neuropsychological assessments (Maruff et al. 2009), however using this test battery 
rather than traditional cognitive assessments (e.g., Trail making test, Mini-Mental 
State Examination), makes it harder to compare our findings to other studies. In 
addition, further studies may attempt to validate the measures of the CogState test 
battery within an intervention, especially in comparison to more established measures 
(e.g. Stroop test, trail making test). Another limiting factor of this training format is 
that unlike traditional PRT and aerobic training, the cognitive load of mental and motor 
training cannot be estimated. In our study the cognitive and motor tasks were 
individualised to each participant’s abilities, but it is unknown as to whether tasks are 
prescribed in this same manner in other studies, which may limit a comparison of the 
findings to other research. It is also possible that the implementation of our exercise 
study within control villages led to an enthusiasm that increased participation in 
habitual physical activity/exercise. Nonetheless, PA levels did not change in either 
group throughout the intervention.    
 
Future Recommendations 
Due to the emerging nature of dual-task cognitive-motor research, the effects of dual-
task training are typically evaluated against a passive control group, or physical 
exercise alone. However, factorial studies involving groups undertaking only 
cognitive training and only exercise, may aid in unpacking the intervention 
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components that drive improved cognition in older adults, and reveal any synergistic 
effects. The inclusion of a social activities group may further highlight any HR-QoL 
or cognitive benefits that dual-task training has in comparison to more traditional 
social pastimes, and control for any effect of social activation that group-based training 
may have in comparison to a usual care control group. Further, in the current study 
disease and depression were controlled for, however due to the existing questionnaire 
burden, this study did not record subjective measures of vitality, alertness or fatigue 
on the day of testing or during training, or record sleeping patterns for the weeks 
leading up to the assessment. These factors can affect cognitive performance, 
inflammatory levels and an individual’s physical response to exercise training (Alhola 
& Polo-Kantola 2007; Chennaoui et al. 2015; Irwin et al. 2008). Furthermore, a record 
of training history and alcohol intake were not a priority for this thesis, but can also 
affect cognitive performance (Weissenborn & Duka 2003; Weuve et al. 2004) and 
therefore should be accounted for in future studies.   
 
8.2.3 It is unclear as to whether dual-task functional power training can improve 
HR-QoL and well-being in older adults 
The purpose of Chapter 6 was to determine the effect of a 26-week dual-task functional 
power training program on HR-QoL and well-being in older adults. The response of 
these factors to dual-task training had not yet been assessed, and therefore this study 
provided an initial insight into how cognitive-exercise training may affect perceptions 
of HR-QoL and well-being. Dual-task exercise training improved only one domain of 
HR-QoL compared to CON; role physical, but did not provide any benefits for any 
other domain, composite or global HR-QoL. This limited finding suggests that this 
training format has the potential to reduce the impact of physical limitations that may 
impair the performance of daily activities or prohibit an older adult from carrying out 
their usual role. The CON group decreased over the course of the intervention in the 
domains of physical and social functioning. It could therefore be speculated that dual-
task training may potentially buffer the impact of physical limitations on an older 
adult’s ability to perform everyday tasks such as carrying objects and walking certain 
distances, and the influence of physical and emotional health on social activities. 
Several factors may have contributed to the inability of dual-task training to modify 
HR-QoL domains, including a minimal aerobic component within our program, and 
the lack of more marked improvements in objective functional outcome measures. For 
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instance, mental health benefits for HR-QoL have been demonstrated through 
moderate-intensity aerobic training (Awick et al. 2015; Canuto Wanderley et al. 2015; 
Sillanpaa et al. 2012). In addition, we observed only minimal benefits for muscle 
power and function, but muscle strength did not change. These inconsistent functional 
improvements may have translated to an unchanged perception of physical limitation 
following the program, which informed many of the HR-QoL domains, including 
physical functioning, role-physical, the physical component summary and global HR-
QoL.   
 
Another factor contributing to our lack of findings for HR-QoL was our modest 
training compliance. The training program had no effect on the majority of HR-QoL 
domains in intention-to-treat analyses, however findings from per-protocol analyses 
showed that those attending at least 50% of classes (mean 75%) had further significant 
improvements in social functioning, a physical component summary, and global HR-
QoL, compared to the whole DT-FPT group. This insinuates that a greater dose of DT-
FPT led to more pronounced effects in overall HR-QoL in attenuating the impact of 
other problems (e.g., emotional, mental) on daily living. In addition, we observed 
significantly higher scores of physical functioning, social functioning, role emotional 
and global HR-QoL in those who provided data at both time points compared to those 
who only provided data at baseline, with this latter group mostly comprised of 
withdrawals. This is interesting as it suggests that we may have seen the largest 
improvements in those who withdrew as they had a greater potential for improvement, 
which may have influenced our findings had they been retained. Nonetheless, dual-
task functional power training may yet contribute to breaking down the perceived 
barriers which can cause an older adult to discontinue participation in enjoyable and 
potentially healthy pastimes (e.g., exercise) and adopt a sedentary lifestyle that begets 
further decline and a poorer QoL.  
 
Life satisfaction or well-being did not change through the intervention and may have 
resulted from several factors, including high baseline levels of life satisfaction, and the 
resistance of this construct to modification. There are important questions that cannot 
be currently answered regarding the potential influence that living in a retirement 
village has on life satisfaction, and whether the life priorities of these residents 
correspond or differ to those of community-dwelling older adults. Our cohort 
possessed higher levels of life satisfaction compared to Australian norms, which may 
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be generated through living in a secure and socially accommodating village, and may 
have created ceiling effects. Furthermore, although our participants readily 
volunteered to be part of an exercise program, more socially-oriented activities (e.g., 
lawn bowls, cards) may provide greater pleasure and increase satisfaction to a greater 
extent in these older adults than an unfamiliar exercise program. These social activities 
have been more effective than cognitive training programs in improving life 
satisfaction and well-being (Bureš et al. 2016; Shatil et al. 2014), which suggests that 
there may be inherent elements of familiar and enjoyable pastimes that are more 
effective for maintaining well-being in older adults, compared to unfamiliar training 
programs. Future dual-task exercise studies should include measures of HR-QoL and 
life satisfaction to confirm these findings. 
 
An interesting finding to emerge from our study was that there were no sex differences 
for any of the outcome measures, with the exception that older men in the training 
program reported greater net decreases in the domain of general health, and less 
improvement in satisfaction with life, compared to the control group, whereas women 
did not show such outcomes. The reasons underpinning these finding are unclear, but 
may have resulted from the disproportionate percentage of older women in our sample 
(73%). Furthermore, this finding tentatively suggests that broader domains of HR-QoL 
and satisfaction with life may respond differently to dual-task training in older women. 
Different findings may be reached with a more balanced sample.  
 
Limitations 
As previously mentioned, the compliance rate for the dual-task program was just over 
50%, which likely limited the findings for at least HR-QoL, based on per protocol 
analyses, or alternatively contributed to an underestimation of the program’s 
effectiveness. Also, the sample included relatively healthy, independent living older 
adults with no serious medical conditions, which may limit the generalisability of the 
findings to other groups. Furthermore, it is unclear as to whether the lifestyles of 
independently living adults may differ from community-dwelling older adults, which 
may be reflected in the higher HR-QoL and life satisfaction scores we observed in this 
population.  
 
Future Recommendations 
Internal factors such as self-efficacy have been shown to influence health perception, 
along with the fitness and vitality of individuals (Bize, Johnson & Plotnikoff 2007; 
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Elavsky et al. 2005), and act as mediators in the relationship between PA participation 
and increased HR-QoL. Self-efficacy was not measured in the current thesis, however 
there is strong evidence that this construct is an important determinant of functional 
decline with chronic disease (e.g., (Rejeski & Mihalko 2001), risk of falling (Tinetti, 
Speechley & Ginter 1988), and participation in physical activity (Booth et al. 2000). 
It follows that exercise programs that have attempted to increase self-efficacy through 
a cognitive-behavioural approach have been successful in changing health behaviours 
(as reviewed in (King, Rejeski & Buchner 1998; McAuley & Blissmer 2000)). 
Therefore, embedding elements of theoretical health behaviour models into future 
dual-task interventions (e.g., social-cognitive theory) may improve correlates of HR-
QoL and related psychosocial aspects, whilst enhancing program compliance. In 
addition, further research should consider the social environment in which older adults 
live, especially when recruiting from retirement villages, in terms of the social support 
systems (e.g., fellow residents, managers) available to facilitate PA, and the 
environmental challenges that may be present (e.g., lack of suitable facilities/space for 
exercise, topography of surrounding areas). A disconnect that is yet to be resolved 
concerns how an individual’s health may improve without their perception of these 
improvements being modified, or vice versa (Rejeski & Mihalko 2001). For example, 
cancer patients may indicate enhanced QoL over the course of a treatment without 
their physical health status actually improving. The inclusion of more rounded 
psychosocial variables such as optimism or resiliency would provide a more holistic 
understanding of the factors that contribute to this phenomenon, and could be 
investigated for any potential psychobiological relationships with circulating 
biomarkers. 
 
8.2.4 The most effective exercise modality for the attenuation of inflammation and 
release of growth factors in older adults remains unclear 
Circulating levels of inflammatory or neurological markers did not change in Chapter 
7, and these outcomes are strengthened by our use of an extensive panel of 
neurological markers, including the analysis of composites, which collectively extend 
the findings of previous exercise studies. Our findings therefore suggest that 
reductions in inflammatory markers and/or improvements in anti-inflammatory and 
neurological markers were probably not key contributors to the enhancements in 
cognition detected following training in Chapter 5, and were most likely underpinned 
by other mechanisms. The physiological mechanisms underscoring the lack of 
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response of pro-inflammatory cytokines to our intervention are unclear. Exercise has 
been shown to be more effective in reducing inflammation in populations displaying 
elevated baseline levels, such as type 2 diabetics and obese individuals (Beavers, 
Brinkley & Nicklas 2010). Our sample may have been healthier than these chronic 
populations, and therefore shown less response to the intervention due to relatively 
lower levels of inflammatory mediators. In addition, no between-group differences 
were observed in body composition, however there is mixed evidence from a variety 
of exercise modalities regarding whether a reduction in body fat or its total percentage, 
is necessary for improvements in systemic inflammation to occur (Hammett et al. 
2004; Nicklas et al. 2004; Vieira et al. 2009). Nonetheless, exercise may also reduce 
inflammation via other physiological pathways which were not activated by the 
relatively low-moderate intensity of the dual-task functional power training (e.g., 
hormonal regulation, attenuation of oxidative stress) (Bruunsgaard & Pedersen 2000; 
Chung et al. 2009; van der Poll et al. 1996; Wrona 2006).  
 
The lack of intervention effects on growth factors we observed for BDNF and IGF-1 
may stem from several physiological mechanisms. These include tightly regulated 
homeostatic processes within healthy older adults which prevent increased levels of 
these markers in circulation, and age-related declines in systemic hormonal and 
neurotrophic levels which may blunt the response of these markers to an exercise or 
cognitive stimulus. Our findings indicated that dual-task exercise produced a trend for 
a greater reduction in plasma concentrations of Aβ (1-40), compared to the control 
group. Inflammatory mechanisms may respond to and trigger the neuropathological 
processes leading to Aβ plaque formation (Agostinho, A Cunha & Oliveira 2010; 
Akiyama et al. 2000). Alternatively, amyloid peptides can activate microglia in the 
brain, which initiate an inflammatory response that is initially neuroprotective in 
attempting to clear Aβ deposits (Solito & Sastre 2012), but can become hyperactive 
with ageing, leading to an over-production of pro-inflammatory mediators and 
neuronal loss (Perry, Cunningham & Holmes 2007; Streit et al. 2004). Given this 
information, it could be assumed that a reduction in amyloid peptides may contribute 
to a decrease in pro- inflammatory markers, however no between-group changes to 
circulating levels of inflammatory markers were observed. Collectively, the findings 
from Chapter 7 suggest that for independently living older adults, the DT-FPT program 
was not effective for combating naturally-occurring low-grade inflammation, which 
may also have ramifications for the functional limitation and disability that are 
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associated with chronic low-grade inflammation (Ferrucci et al. 2001; Visser et al. 
2002). However, DT-FPT may play a role in reducing circulating risk factors for 
cognitive deterioration. 
 
Limitations 
The analysis and subsequent interpretation of our data are based on circulating levels 
of biomarkers, rather than local expression of these markers in the brain and muscle. 
Given the challenges of obtaining brain tissue from human subjects this is an 
acceptable limitation. Few studies have assessed the effect of cognitive training or 
combined cognitive-exercise training on circulating biomarkers, and therefore our 
findings were predominantly compared with data from exercise trials. A second 
limitation was that our study was restricted to a sample of cognitively healthy older 
Caucasian adults, without unstable neurological or cardiovascular disease. The 
generalisability of the findings to a more racially varied sample with different 
demographics and cognitive abilities may provide different findings. Thirdly, due to 
the larger aims of the study, factors that influence circulating levels of IGF-1, BDNF 
and pro-inflammatory cytokines were not analysed in any detail (e.g., sleep, training 
background, nutritional status), but could have influenced the findings (Gómez-Pinilla 
2008; Irwin et al. 2008; Kraemer & Ratamess 2005).  
 
Future Recommendations  
The inclusion of further inflammatory (e.g., soluble receptors, macrophage 
inflammatory proteins), neurological (e.g., glial-cell derived neurotrophic factor, 
soluble cell adhesion molecules, plasma tau), oxidative stress (e.g., myeloperoxidase), 
and CVD markers (e.g., lipid profiles, insulin markers) in future dual-task studies may 
help to reveal the underlying physiological mechanisms for any cognitive and 
functional benefits provided by this training format. An investigation of further 
inflammatory and neurological markers would also help to resolve the uncertainty 
surrounding whether pro-inflammatory cytokines directly instigate processes 
detrimental to cognitive structures and muscle function, or whether age-related 
increases in inflammation occur in response to other naturally occurring pathological 
insults that they are unable to defend against and resolve, perpetuating further 
inflammatory release. In addition, functional neuroimaging, functional near-infrared 
spectrometry, and pulse wave analysis may illuminate other neurophysiological 
pathways activated through dual-task training which lead to cognitive benefits.  
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8.3 Conclusions and Public Health implications 
The research presented in this thesis extends the findings of previous studies that have 
investigated the response of cognitive function, HR-QoL, well-being and 
inflammatory and neurological markers to structured exercise in older adults. In light 
of our varied findings for cognitive function and HR-QoL, a collective interpretation 
is challenging, particularly as we observed a lack of biochemical changes in Chapter 
7. Despite an improvement in cognitive performance across multiple cognitive 
domains, the data did not support a stimulating effect of DT-FPT on systemic levels 
of neural growth factors such as BDNF, IGF and VEGF in older adults. These findings 
are unexpected given that higher levels of BDNF were associated with greater 
cognitive performance across several cognitive abilities in Chapter 4. This suggests 
that although higher basal levels of BDNF may provide cognitive advantages, 
concentrations of this marker and other growth factors were not responsive to DT-
FPT, and may not contribute to the cognitive improvements we observed, conflicting 
with two studies which have linked BDNF release to cognitive improvement following 
dual-task training (Anderson-Hanley et al. 2012; Rahe et al. 2015a). This thesis 
therefore address a void in the exercise biomarker literature by demonstrating that a 
twice weekly, relatively low-moderate intensity functional power training program 
performed simultaneously with cognitive and motor tasks for 26 weeks, appears to be 
ineffective for increasing circulating levels of specific inflammatory and neurological 
markers. Age-related increases in inflammation have been linked to lower cognitive 
performance and neurodegeneration, and therefore an attenuation of systemic 
inflammation following exercise may speculatively contribute to improved cognitive 
performance and a reduced risk of cognitive disease in older adults. Although it was 
hypothesised that reductions in circulating levels of pro-inflammatory mediators could 
underpin the cognitive benefits provided by dual-task training, no changes in 
inflammatory levels were detected. This indicates that the improvements in cognitive 
function may have instead been mediated by physiological mechanisms other than 
augmented growth factor release or an anti-inflammatory state, such as increased 
cerebral blood flow (Ide & Secher 2000; Mozolic, Hayaska & Laurienti 2010), or  
neuroplasticity (Colcombe et al. 2004; Erickson et al. 2007; Lustig et al. 2009), 
however these outcomes were not assessed. The clinical and functional significance of 
our findings cannot be currently resolved, particularly as there is a lack of data from 
dual-task exercise studies regarding the response of biomarkers to this exercise format. 
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As a tentative proposal; a reduction in Aβ (1-40), as observed in Chapter 7, may create 
an environment that provides greater advantages for cognitive health (i.e. reduced risk 
of neurodegenerative disease), which may have longer-term ramifications for 
maintained cognitive performance in older adults.  
 
Previous research has been unable to link reductions in inflammation with 
improvements in well-being or subjective health (Kohut et al. 2006; Starkweather 
2007). It is likely that the improvement in the role physical domain of HR-QoL we 
observed, and the trends for improvement in other domains, were unrelated to the 
improvements in inflammatory or neurological markers, and may instead ensue from 
factors related to the nature of the dual-task exercise program (e.g., enhanced 
confidence, improved self-efficacy). This conclusion is supported by our findings from 
Chapter 4 which only reported two significant relationships between inflammation and 
HR-QoL, with higher levels of CRP and the pro-inflammatory composite associated 
with lower scores in the HR-QoL domain of vitality. An amelioration of circulating 
inflammatory conditions may yet lead to benefits for HR-QoL, and future research 
may uncover further psychobiological pathways linking biomarkers to health 
perceptions.  
 
It is believed that the outcomes from this trial could guide the development and 
implementation of future dual-task exercise programs based in the community or in 
retirement villages.  With further developments in the current dual-task protocol (e.g., 
measurable cognitive secondary tasks, greater dose of secondary task), more salient 
changes in cognitive function may emerge, and this exercise program can become an 
accessible and promising low-cost treatment to improve neurocognitive function in 
older adults which may preserve functional independence. Of further importance, the 
findings presented in this thesis suggest that cognitive domains more susceptible to 
deterioration with ageing may be amenable to enhancement (i.e. processing speed, 
attention, reaction time), which may prevent or delay the onset of MCI and dementia.  
 
High-velocity PRT or ‘power training’ has received some interest as an alternative 
training mode to PRT in the past 15 years as it can incorporate light loads and 
functional movements that resemble ADLs (Hazell, Kenno & Jakobi 2007). The 
current training program was structured to reflect functional movements and ADLs, 
however it is unclear whether the exercises were regarded as enjoyable by participants. 
It could be speculated that some aspects of the intervention and the use of functionally 
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familiar exercises may have reduced the anxiety that is often encountered with 
exercise, particularly for first time older exercisers, and contributed to a reduction in 
the impact of physical and emotional health problems on an older adult’s physical 
functioning and ability to carry out their usual role. As further indices of the program’s 
efficacy, self-ratings of bodily pain did not increase over the course of the intervention, 
and a low frequency of adverse events directly related to the training were reported, 
suggesting that this format of exercise is safe and well-tolerated by older adults. In 
contrast, it is difficult to interpret the significance or reasons underpinning our modest 
compliance to the program, as qualitative responses from participants regarding the 
enjoyable and challenging aspects of the training program were not collected, but 
would provide a more accurate assessment of the merits of the program. In this regard, 
participant feedback in regard to the design of dual-task exercise programs may 
identify elements that can improve HR-QoL and cognitive outcomes, and lead to a 
greater rate of adoption in future studies.  
 
It is worth noting that poorer cognitive performances and lower scores in HR-QoL 
domains were observed in dropouts at baseline testing, compared to those who 
continued in the study. This phenomenon has been previously reported (Tiedemann, 
Sherrington & Lord 2011), and implies that aspects of our training may have been 
unfavourable (i.e. dual-task nature), or the intervention in general was too challenging 
or burdensome for some participants who may or may not have had cognitive 
limitations (e.g., perceived length, time commitment). Furthermore, 27% of 
withdrawals cited difficulties with the study as their reason for departure (e.g., 
perceived high questionnaire burden). It is unclear as to whether a diminished 
cognitive capacity or lower perceptions of health were responsible for these 
departures, however several participants who withdrew for this reason reported an 
inability or refusal to count backwards during functional testing as a contributing 
factor to their withdrawal. Although speculative, these inadequacies may have 
inadvertently exposed previously unnoticed cognitive deficits that were quite 
confrontational and challenging to process. It could also be suggested that the low 
compliance we reported may be a reflection of the inherent complexity of the dual-
task program, in that the combination of functional power training with complex 
training elements task may have been too difficult or even unenjoyable for some 
participants, particularly cognitive aspects, which affected their adherence to training. 
Although no specific qualitative data was collected from participants to support this 
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claim, the complexity and potential benefits of future dual-task training programs 
should be weighed against any negative outcomes the program may attract (i.e. low 
compliance, drop outs, injury). Therefore, it should be considered that although this 
format of training was well tolerated and can lead to positive changes, some 
participants with functional and emotional deficits may find the demands of a dual-
task program challenging.  
 
Common barriers to exercise participation for older adults include a lack of access to 
facilities and issues related to self-consciousness with regard to training within 
mainstream fitness centres, lack of social support, time constraints, and lack of focused 
programs (Schutzer & Graves 2004; Trost et al. 2002). This intervention attempted to 
overcome these barriers to exercise participation in the older adult by delivering 
exercise sessions in the participants’ communities. However, the compliance to the 
training program was considerably lower (~50%) than previously reported in the 
majority of exercise and dual-task cognitive-exercise trials, but closer to adherence 
levels reported in studies conducted in retirement villages (Merom et al. 2016; Schoene 
et al. 2015). In this regard, the role and ability of the trainer to facilitate the safe 
delivery of an exercise program and also sustain the compliance and motivation of 
older adults within an intervention trial, requires further investigation and 
consideration, particularly within the setting of a retirement village. Without the 
collection of qualitative and further quantitative data, the underlying reasons for this 
modest compliance rate are unknown, but careful consideration must be given to the 
unique lifestyles of older adults in retirement villages before recruiting from this 
cohort in future studies.  
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Appendix A: Short Portable Mental Screening Questionnaire. 
ID: ________________      Date: ______________ 
Short Portable Mental Status Questionnaire (SPMSQ) 
Instructions: Ask questions 1 to 10 on this list and record all answers. (Ask 
question 4a only if the subject does not have a telephone.) All responses must be 
given without reference to calendar, newspaper, birth certificate, or other aid to 
memory. Record the total number of errors based on the answers to the 10 
questions 
+ - Questions Instructions 
  1. What is the date today? 
____________________________________ 
Correct only when the 
month, date, and year are 
all correct. 
  2. What day of the week is it? 
____________________________________ 
Correct only when the day 
is correct 
  3. What is your street address? 
____________________________________ 
Correct if any description of 
the location is given eg 
street name is acceptable.  
  4. What is your telephone number?   
____________________________________ 
Correct when the number 
can be verified or the 
subject can repeat the 
same number at a later time 
in the interview.  
  5. How old are you? 
____________________________________ 
Correct when the stated 
age corresponds to the date 
of birth. 
  6. When were you born? 
____________________________________ 
Correct only when the 
month, date, and year are 
correct. 
  7. Who is the Prime Minister of Australia now? 
____________________________________ 
Requires only the correct 
last name. 
  8. Who was the PM just before that? 
____________________________________ 
Requires only the correct 
last name 
  9. What was your mother's maiden name? 
____________________________________ 
Needs no verification; it only 
requires a female first name 
plus a last name other than 
the subject’s 
  10. Subtract 3 from 20 and keep subtracting 3 
from each new number you get, all the way 
down. 
____________________________________ 
 
The entire series must be 
performed correctly to be 
scored as correct. Any error 
in the series—or an 
unwillingness to attempt the 
series—is scored as 
incorrect. 
 
  _____  Total Number of Errors 
Scoring: Mental Status is “Abnormal” if client provides more than 2 errors 
Completed Short Portable Mental Status Questionnaire    Passed             Failed  
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Appendix B: Pre-Exercise Screening Tool based on ESSA guidelines. 
Pre-Exercise Screening Tool 
I would now like to ask you a number of questions about your health and medical status 
to help determine if it is safe for you to exercise or whether you need a further 
assessment by your doctor.  
 Yes No 
1. Has your doctor ever told you that you have a heart 
condition or have you ever suffered a stroke? 
  
2. Do you ever experience unexplained pains in your chest 
at rest or during physical activity/exercise? 
  
3. Do you ever feel faint or have spells of dizziness during 
physical activity/exercise that causes you to lose 
balance? 
  
4. Have you had an asthma attack requiring immediate 
medical attention at any time over the last 12 months? 
  
5. If you have diabetes (type I or type II) have you had 
trouble controlling your blood glucose in the last 3 
months? 
  
6. Do you have any diagnosed muscle, bone or joint 
problems that you have been told could be made worse 
by participating in physical activity/exercise? 
  
7. Do you have any other medical condition(s) that may 
make it dangerous for you to participate in physical 
activity/exercise? 
  
 
  IF THEY ANSWERED ‘YES’ to any of the 7 questions, advise   
the participants that they will be required to seek further 
approval from their GP prior to being allowed to participate 
in the exercise program. 
  
IF THEY ANSWERED ‘NO’ to all of the 7 questions, and you 
have no other concerns about their health, they can 
proceed to the study. 
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Appendix C: PACE-IT modified plain language statement, original plain language statement used in recruiting cohort 1, and consent form. 
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PLAIN LANGUAGE STATEMENT AND CONSENT FORM 
 
TO:  Participants 
 
Plain Language Statement  
Date:  23rd January 2014 
Full Project Title:  Effects of dual-task functional power training on falls 
risk in the elderly: An 18-month randomised controlled 
trial. 
Principal Researcher:   Professor Robin Daly 
Associate Researcher(s):  Professor Caryl Nowson, Professor Dennis Taaffe, 
Associate Professor Kerrie Sanders, Professor Keith 
Hill, Dr Dawson Kidgell, Dr Rachel Duckham, Dr Timo 
Rantalainen and Mr Jamie Tait 
 
This Plain Language Statement is 7 pages long. Please make sure you have all the 
pages.  
1. Your Consent 
You are invited to take part in this research project which will investigate the effects 
of a community-based, exercise program incorporating resistance training and 
functional (eg. balance) activities with additional attention demanding tasks (eg. 
stepping in time to music) on muscle function, cognitive health and quality of life in 
older adults. 
This Plain Language Statement contains detailed information about the research 
project. Its purpose is to explain to you as openly and clearly as possible all the 
procedures involved in this project before you decide whether or not to take part in 
it.  
Please read this Plain Language Statement carefully. Feel free to ask questions 
about any information in the document.  You may also wish to discuss the project 
with a relative or friend or your local health worker. Feel free to do this. 
Once you understand what the project is about and if you agree to take part in it, 
you will be asked to sign the Consent Form. By signing the Consent Form, you 
indicate that you understand the information and that you give your consent to 
participate in the research project. 
You will be given a copy of the Plain Language Statement and a signed copy of the 
Consent Form to keep as a record. 
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Participation in this study is voluntary. If you do not wish to take part you are 
not obliged to. If you decide to take part and later change your mind, you are 
free to withdraw from the project at any stage. Your decision whether or not to 
participate will not affect your relationship with Deakin University.     
2. Purpose and Background 
The age-related loss in muscle mass and function (eg balance) in older adults often 
have serious consequences in terms of injury, pain, loss of independence and even 
death. Although the causes of impaired muscle function are varied and complex, the 
ability for your muscles to produce rapid and forceful movements (known as muscle 
power), declines rapidly with age and is thought to be a major contributor to the loss 
in muscle function. In this population, the requirements to produce rapid movements 
often occurs whilst simultaneously performing other attention demanding tasks such 
as walking while maintaining a conversation, carrying objects or watching traffic. 
Therefore, the aim of this study is to investigate whether an exercise program 
incorporating high speed movements with additional attention demanding tasks (eg 
stepping in time to music) can improve muscle performance as well as quality of life 
and cognitive health in adults aged 65 years and over living in the community. 
A total of 280 men and women aged 65 years and over will participate in this project. 
You are invited to participate in this research project because you are aged 65 years 
or over and free of any major health conditions that might limit your participation in 
the training program.  
This study is being sponsored by the National Health and Medical Research Council 
(NHMRC).  
This trial has been initiated by the investigator, Professor Robin Daly.  
3. Procedures – what you will be asked to do  
If you decide to participate in this study you will be asked to read the Participant 
Information sheet and ask any questions you may have. You will then be asked to 
sign the Informed Consent Form. 
To participate in this study you must first pass the initial telephone screening test 
conducted by one of the research staff, be aged 65 years or over and have not 
participated in resistance training or a balance program more than once a week in 
the past 3 months. Before you commence the study, your local doctor may be 
required to complete a health and medical screening form to make sure that you 
don’t have any medical conditions that could affect your participation in this study 
(e.g. unstable heart disease). 
Upon entry into the study, your retirement village or community centre (or one close 
to your home) will be randomly allocated (like the flip of a coin) to one of two groups. 
You will have a one in two chance of being in either group. This is called 
randomisation. This is a standard research method used to ensure that the results of 
a study are true and correct.  
Group 1: Dual-task Functional Power Training 
If you are allocated to this group, you will be prescribed an individually tailored 
exercise program incorporating a combination of resistance (strength) training with 
functional balance and mobility activities which will be conducted at local retirement 
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villages or community centre for 6 months. Throughout the program you will be 
asked to performed additional attention demanding tasks whilst performing the 
exercises (eg. stepping in time to music, carrying or collecting an object whilst 
walking). For the first 6-months, you will be required to attend two supervised 
sessions each week which will last approximately 40-50 minutes. All sessions will be 
supervised by qualified exercise trainers. At the end of the initial 6-months of 
training, you will be asked to participate in a ‘step-down’ less intensive maintenance 
program for another 6-month. During this phase, you will be asked to participate in a 
weekly 1-hour exercise class led by the trained exercise staff or trained volunteers 
within your village. In addition, you will be asked to undertake at least two brisk 
walking sessions per week so that you are participating in approximately 150 
minutes per week, which is the current recommended level of physical activity. At 
the end of 12-months, the program will cease. However, you will be asked to return 
for one final testing session 6 months after the end of the program to establish if 
there are any long-term benefits. During this final 6-months you will not receive any 
support or advice. 
Group 2: Usual Care control group 
If you are allocated to this group, you will receive usual care from your doctor or 
allied health professional but will not be prescribed an individually tailored exercise 
program. However, you will be encouraged to meet the recommended 150 minutes 
per week of physical activity and will receive physical activity and falls prevention 
advice and study newsletters and updates.  
Whether you are allocated into group 1 or group 2 we will collect information from 
you and conduct a number of tests throughout the study. 
 You will be asked to record any falls or injuries you experience during the study 
or any doctor or hospital visits on a special calendar which you will return to us 
monthly via postage-paid mail. 
 You will be required to undergo some simple balance, reaction time and 
walking tests to measure your muscle function and mobility at baseline, 
6, 12 and 18 months. At each of these time points we will also assess 
your body composition by asking you to stand on a set of scales that 
have special foot sensor pads that will send a low, safe signal through 
the body. It takes less than a minute and will provide a measure of your 
muscle and fat mass. We will also measure your functional muscle 
strength and power of your legs and arms on several resistance 
(strength) exercises.  
 You will be asked to complete a general lifestyle and health questionnaire so we 
can obtain information on, education history, cultural background, dieting and 
weight history, smoking history, medical history, use of prescription and non-
prescription medications, and history of falls. We will also measure your weight 
and height at the beginning of the study and after 6, 12 and 18 months. 
 We would also like to assess your independent living skills across a number of 
functional abilities such as using the telephone, shopping and mode of 
transport, by a questionnaire.  
 We will take a small blood sample to assess the effects of the program on a 
number of important hormonal, inflammatory and neural related hormones and 
genetic markers that have been shown to be related to muscle and cognitive 
health and function. A blood sample of 30 mls (1.5 tablespoon) will be taken 
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from a vein in your arm using a needle at baseline, 6, 12 and 18 months.  The 
blood sample will be collected by a trained research nurse in the morning when 
you have had nothing to eat or drink from the night before. 
 We would like to assess your dietary habits and ask you a few questions about 
your exercise/physical activity and TV/computer habits four times over the 
study. We would also like to measure how much time you normally spend 
across the various physical activity intensity levels (sedentary, light, moderate 
and vigorous activity) throughout the week. To do this, you will be fitted with two 
small lightweight waterproof devices called an accelerometer and an 
inclinometer. These devices store information on the frequency and duration of 
time spent sitting and standing and in light and moderate-to-vigorous intensity 
activity. The accelerometer will be worn with a belt at hip height during waking 
hours. The inclinometer will be fixed to the front of your upper thigh with non-
allergenic patches (Tegaderm). You will be requested to wear the inclinometer 
for 24 hours a day and additional patches will be provided to change the 
dressings as required. We will get you to wear these two devices for seven 
consecutive days and to fill in a daily logbook telling us when you put on/took off 
the devices and your sleep times.  
 You will be asked to complete some questionnaires which will assess your 
quality of life, fear of falling, subjective well-being and personality type. You will 
also be asked to complete a simple computer based test and questionnaire to 
assess your cognitive function at baseline, 6, 12 and 18 months.  
 THIS ASPECT IS OPTIONAL: You will also be invited to 
participate in a sub-study which will involve measuring your 
nervous system excitability using a machine called a 
Transcranial Magnetic Stimulation (TMS). This device will 
be used to stimulate the nerve tissue of your brain. TMS is a 
non-invasive, painless and safe technique that has been in 
use world-wide for more than 25 years, and is used 
routinely to investigate the function of the nervous system with very low risk. 
The device comprises of two stimulators with a “figure of 8” stimulator coil as 
shown in the picture. The coil is held over the scalp by the investigator and 
when activated you will notice two light taps on the head (not everyone reports 
this) and an audible clicking sound. This will activate a nerve cell causing the 
muscles in the leg or wrist to contract (twitch) causing a small movement.  We 
will measure this response to assess neural function. The TMS sub-study will 
be conducted at Deakin University and you will be asked to visit the laboratory 
on six separate occasions for testing over an 18-month period (baseline, week 4 
week, week 8 and week 12, and again at 6 months and 12 months. The TMS 
testing will take approximately 45 -60 minutes for each visit.  
There will be continual review and monitoring during your participation in this 
research to enable the early detection of any problems that you may experience. 
4. Possible Benefits 
We cannot guarantee or promise that you will receive any benefits from this project.   
By participating in this project, you will receive information on ways to reduce your 
risk of falling.  
For some people the possible benefits may include improved leg muscle strength, 
balance and mobility and fewer falls. The program may also improve the 
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participants' cognitive function and quality of life. We also expect that the findings 
from this study will make an important contribution to the development of safe and 
practical exercise guidelines for the effective management of falls in older people 
living within the community. 
5. Possible Risks 
Possible risks, side effects and discomforts include the following: 
 The exercise program will involve resistance (weight) training. You may 
experience some minor and transient muscle soreness initially or following the 
muscle and functional testing. However, this form of training has been shown to 
be safe and acceptable in older adults. Precautions have been taken to minimise 
the risk of physical injury to you, but as with all types of exercise there are some 
risks involved such as muscle strain. You will be given advice on how to avoid 
this from occurring, and how to recognise if there might be a problem.  
Furthermore, the exercise program will be monitored at all times by trained staff.   
 When you have a blood sample taken for this study, you might feel pain or be 
light-headed and there is a chance you might get a small bruise on your arm.  
 As transcranial magnetic stimulation (TMS) uses magnetism, there are various 
factors which may exclude you from participating in this study. These include 
having a pacemaker or metal objects like cerebral aneurysm clips inside your 
body. At the start of the study you will be asked a series of questions to 
determine if there are any factors which may stop you from participating in this 
aspect. Although rare, some participants may experience discomforts such as 
local pain on the scalp musculature or a headache following TMS. In normal 
populations, brain seizures have not been reported using TMS. 
There may be additional unforeseen or unknown risks. 
6. Collection of Tissue Samples for Research Purposes 
By consenting to take part in this study, you also consent to the collection, 
storage and use of tissue samples (blood) as specified below.  
The samples will not be labeled with information that directly identifies you. 
The samples will be “coded”, which means that it will be labeled with a number 
that can be linked to you. All samples will be stored securely at Deakin 
University and only the research staff involved in this study will have access to 
the samples.  
Some of the samples will be tested immediately at the end of the study and 
some will be frozen and stored for 10 years following the publication of study 
findings.  We wish to store these samples to conduct further testing to look for 
other hormonal, inflammatory and neural related hormones when and if 
funding for this becomes available in the future. This future testing may be 
conducted by researchers from the present study or by other researchers 
employed by Deakin University. If any changes to the study are made which 
affect how these samples will be used, your samples will not be used, without 
your further consent. These samples will be disposed of according to standard 
laboratory practice, immediately after testing. Genetic material will not be 
retained for any further unspecified genetic testing.  
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7. Other Treatments Whilst on Study 
It is important to tell your doctor and the research staff about any treatments or 
medications you may be taking, including non-prescription medications, vitamins or 
herbal remedies and any changes to these during your participation in the study. 
8. Privacy, Confidentiality and Disclosure of Information 
Any personal information provided by you to the researchers involved with this 
project will remain confidential. It will only be disclosed with your permission, subject 
to legal requirements. 
All collected information will be labelled with a unique study code, and not with your 
name or any other identifying information, which will be kept separate from the 
information collected. All paper copies of this information will be kept in a locked 
filing cabinet in the researcher’s office at Deakin University or in a password 
protected computer. Only researchers involved in this project will have access to this 
information. The information collected from this study will be kept until the end of the 
project and then placed in archives for 10 years from the publication of findings. The 
data may be used in future research which is closely related to this project.  
It is the intention of the researchers to publish the results of this project. In such 
circumstances your identity will not be disclosed. In all cases, information will be 
provided in such a way that you cannot be identified. Any information collected will 
be coded and de-identified, and stored securely in electronic format where only the 
researchers will have access to the data. 
It is desirable that your family doctor be advised of your decision to participate in this 
research project. With your permission, we intend to either send a letter to your 
doctor to inform them of your participation in the study or ask them to complete a 
questionnaire about your past medical history to assess your suitability to participate 
in the research. By signing the Consent Form, you agree to notify or allow us to 
notify your family doctor of your decision to participate in this research project. The 
results of this project will be discussed at national and or international conferences. 
In all cases your identity and personal information will not be disclosed. Information 
will be provided in such a way that you cannot be identified. In accordance with the 
Freedom of Information Act 1982 (Vic), you have the right to access and to request 
collection of information held about you by Deakin University. 
9. New Information Arising During the Project 
Although unlikely, during the research project, new information about the risks and 
benefits of the project may become known to the researchers. If this occurs, you will 
be told about this new information. This new information may mean that you can no 
longer participate in this research. 
Similarly, as you will be monitored during each testing session, if it appears for any 
reason that you or the research staff are at risk by your continued participation in the 
testing session, the person(s) supervising the research will stop your participation. In 
all cases, you will be offered all available care to suit your needs and medical 
condition.  
10. Results of Project 
Upon completion of the project it is anticipated that the results will be submitted for 
publication in a peer-reviewed journal. The results may also be presented orally at a 
scientific meeting in Australia or internationally. If you would like copies of published 
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material arising from the project this can be requested from the principal researcher 
at the conclusion of the project. 
11. Further Information or Any Problems 
If you require further information or if you have any problems concerning this project 
(for example, any side effects), you can contact the principal researcher or associate 
researcher.   
Contact Person Telephone Number 
Professor Robin Daly 03 9244 6040 
Dr Rachel Duckham 03 9246 8305 
12. Other Issues 
If you have any complaints about any aspect of the project, the way it is being 
conducted or any questions about your rights as a research participant, then 
you may contact:   
The Manager, Research Integrity, Deakin University, 221 Burwood Highway, 
Burwood Victoria 3125, Telephone: 9251 7129, research-ethics@deakin.edu.au.  
Please quote project number: 2013-051. 
13. Participation is Voluntary 
Participation in any research project is voluntary. If you do not wish to take part you 
are not obliged to. If you decide to take part and later change your mind, you are 
free to withdraw from the project at any stage. 
Your decision whether to take part or not to take part, or to take part and then 
withdraw, will not affect your relationship with Deakin University. You will also have 
the option to withdraw your data and tissues from the research project if you wish to 
do so. 
Before you make your decision, a member of the research team will be available to 
answer any questions you have about the research project. You can ask for any 
information you want. Sign the Consent Form only after you have had a chance to 
ask your questions and have received satisfactory answers. 
If you decide to withdraw from this project, please notify a member of the research 
team or complete and return the Withdrawal of Consent Form attached. This notice 
will allow the research team to inform you if there are any health risks or special 
requirements linked to withdrawing. 
14. Reimbursement for your costs 
You will not be paid for your participation in this trial. However, no costs will be 
incurred by you for training or during the testing procedures. 
15. Ethical Guidelines 
This project will be carried out according to the National Statement on Ethical 
Conduct in Research Involving Humans (June 1999) produced by the National 
Health and Medical Research Council of Australia. This statement has been 
developed to protect the interests of people who agree to participate in human 
research studies. 
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The ethical aspects of this research project have been approved by the Deakin 
University Human Research Ethics Committee (EC 2013-051).   
16. Termination of the Study 
This research project may be stopped for a variety of reasons. These may 
include reasons such as unacceptable side effects. 
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PACE-IT CONSENT FORM 
 
 
I……………………………………………………………………………………………………………………………of 
          (Please print your full name) 
………………………………………………………………………..……..…………………………………………….,  
(Street address)                                                   (Suburb)                            (Post Code) 
hereby give consent to freely take part in the PACE-IT study to investigate an 
exercise program incorporating high speed movements with additional attention 
demanding tasks (eg. stepping in time to music) can improve muscle performance 
as well as quality of life and cognitive health in adults aged 65 years and over living 
in the community. 
By completing this consent form I acknowledge that: 
1. I have read and understood the attached PACE-IT plain language brochure. I 
freely agree to participate in the trial. I have received a copy of the plain 
language brochure.  
2. I have been given the opportunity to ask the research team any questions 
regarding the trial and my participation in the trial.  
3. My results from this trial may be used anonymously in future research analysis 
and reported in scientific and academic journals or conference meetings 
however my identity will remain anonymous. 
 
As indicated in the optional testing brochure, there is an opportunity for you to 
participate in the OPTIONAL transcranial magnetic stimulation (TMS) testing to 
assess nervous system health and function. Please indicate below if you wish to be 
involved in the optional TMS testing.   
□ I DO consent and wish to receive further information regarding the TMS 
study to determine if I am eligible.  
□  I DO NOT wish to receive further information regarding the TMS study  
 
Participant’s Name (printed) …………………………………………………………….. 
Signature ……………………………………………… Date: ………………………… 
Please mail or fax this form to: 
Professor Robin Daly 
Deakin University 
Centre for Physical Activity and Nutrition Research (C‐PAN) 
221 Burwood Highway 
Burwood, Victoria 3125 
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Appendix D:  Example PACE-IT Exercise Card. 
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Appendix E: Frequency of health conditions reported by participants. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Health condition    
Stroke, n=24 Epilepsy, n=1 
Alzheimer’s Disease, n=0 Neurological/Brain damage, n=6 
Parkinson’s Disease, n=4 Kidney Disease or stones, n=20 
Asthma, n=60 Liver Disease, n=7 
Chronic Kidney Failure, n=4 Osteomalacia, n=0 
Hypo/Hyperthyroidism, n=30 Vitamin D abnormality, n=64 
Hypogonadism, n=0 Spinal surgery, n=16 
Hypercortisolism, n=0 Stroke/hemiplegia, n=5 
Heart disease, n=36 Diabetes type 1, n=5 
Cancer, n=45 Diabetes Type II, n=45 
Cushing’s Syndrome, n=1 Lactose intolerance, n=8 
Gastrectomy, n=11 Osteoarthritis, n=132 
Celiac Disease, n=3 Hypercholesterolemia, n=44 
Primary Hyperparathyroidism, n=3 Malabsorption syndrome, n=8 
Angina, n=24 Other conditions, n=60 
Heart Attack, n=23 Impaired Memory, n=10 
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Appendix F: Adverse Events questionnaire administered after the commencement of the intervention. 
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Appendix G: Frequency of missing data from the original cohort of 300 participants 
enrolled in the intervention trial, and from the 268 participants included in Study 1 
(Chapter 4). 
 Missing Data 
 Whole sample (n=300) 
Chapter 4 
(n=268) 
Demographics and health   
Weight 2 0 
Height 1 0 
BMI  2 0 
Body composition  13 10 
Medications  4 0 
Smoking status  4 0 
DASS-21-Depression  3 0 
Chronic health conditions  4 0 
Presence of Cardiometabolic Risk Factors 4 0 
Employment Status  4 0 
Race 4 0 
Education 4 0 
Physical activity 4 1 
Cognitive Function   
Groton Maze Learning Test* 11 6 
Detection Task 2 1 
Identification Task 2 1 
One Card Learning Task † 3 2 
One Back Task 2 1 
Global Cognitive Function 11 6 
Psychomotor function-Attention composite 2 1 
Working-Memory Learning composite 3 2 
CogState Brief Battery 3 2 
HR-QoL   
Physical Functioning 3 0 
Role Physical 3 0 
Bodily Pain 3 0 
General Health 4 1 
Vitality 3 0 
Social Functioning 3 0 
Role Emotional 3 0 
Mental Health 3 0 
Physical component summary 4 1 
Mental component summary 4 1 
Overall HR-QoL 3 0 
Satisfaction with life single-item score 4 1 
Personal Wellbeing Index Composite 3 0 
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Inflammatory and neurological markers   
Interleukin-6 31 0 
Tumor-necrosis factor-α 31 0 
Interleukin-1β 31 0 
Interleukin-10 31 0 
Interleukin-4 32 0 
Interleukin-8 31 0 
C-reactive protein 35 4 
Amyloid β (1-40) 31 0 
Amyloid β (1-42) 31 0 
Brain derived neurotrophic factor  31 0 
Insulin-like growth factor-1 35 4 
Vascular endothelial growth factor  31 0 
Inflammatory composite 31 0 
Pro-inflammatory composite 31 0 
Anti-inflammatory composite 31 0 
Apolipoprotein E (APOE) polymorphisms  18 0 
BDNF polymorphisms 18 0 
All missing data points for the original sample of 300 include n=1 participant who requested 
data be withdrawn. Body composition not collected due to pacemaker (n=11) and unavailable 
for testing (n=1). All missing data for CogState represents participants not wishing to attempt 
a task or physically unable to complete a task, except those failing task criteria, denoted by          
* (n=3) and † (n=1). BMI: body mass index; DASS: Depression, anxiety and stress scale; HR-
QoL: health-related quality of life. 
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Appendix H: Mean unweighted scores for domains of the SF-36 for the 268 
participants included in the analyses for Chapter 4.  
SF-36 domains Raw scores 
n 268 
Physical Functioning 63.4 ± 24.1 
Role Physical 71.9 ± 25.3 
Bodily Pain 64.7 ± 24.5 
General Health 1 65.9 ± 18.5 
Vitality 59.3 ± 20.0 
Social Functioning 84.6 ± 20.8 
Role Emotional 86.3 ± 20.4 
Mental Health 80.2 ± 15.4 
Baseline values are means ± SD. 1 n=267. 
 
Appendix I: Mean baseline inflammatory and neurological marker values for the 268 
participants included in the analysis for Chapter 4. 
Biomarker  
Pro-inflammatory  
IL-6, pg/mL 2.43 ± 2.83 
TNF-α, pg/mL 11.2 ± 7.42 
IL-1β, pg/mL 1.73 ± 3.83 
IL-8, pg/mL1 15.4 ± 12.6 
CRP, mg/L 2 3.05 ± 3.50 
Anti-inflammatory  
IL-10, pg/mL 6.86 ± 13.3 
IL-4, pg/mL1 25.7 ± 53.9 
Neurological markers  
Aβ (1-40) pg/mL 111.1 ± 42.9 
Aβ (1-42) pg/mL 5.01 ± 6.07 
BDNF, ng/mL 30.8 ± 9.65 
IGF-1, nmol/L 3 16.7 ± 5.10 
VEGF, pg/mL 376.7 ± 335.8 
Baseline values are means ± SD.  1 n=267, 2 n=263, 3 n=264.
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Appendix J: Associations between cognitive function and neurological markers.   
 
n 
Aβ (1-40) Aβ (1-42) BDNF IGF-1 VEGF 
β-value (95% CI) β-value (95% CI) β-value (95% CI) β-value (95% CI) β-value (95% CI) 
Model 1        
     GMT  262 -0.08 (-0.32, 0.16) 0.03 (-0.08, 0.13) 0.01 (-0.002, 0.02) 0.01 (-0.02, 0.03) -0.07 (-0.21, 0.07) 
     DET  267 -0.19 (-0.46, 0.07) -0.11 (-0.22, 0.001)  0.01 (0.0005, 0.02) §  -0.005 (-0.03, 0.02) -0.11 (-0.26, 0.04) 
     IDN  266 -0.23 (-0.47, 0.01) § -0.05 (-0.15, 0.06) 0.02 (0.004, 0.03) ** -0.01 (-0.03, 0.02) -0.07 ( -0.21, 0.07) 
     OCL  266 -0.03 (-0.29, 0.23) -0.08 (-0.20, 0.04) 0.003 (-0.01, 0.02) -0.03 (-0.06, -0.01) ** 0.05 (-0.11, 0.21) 
     ONB  267 -0.21 (-0.45, 0.02) -0.11 (-0.21, 0.001)  0.01 (-0.003, 0.02) -0.01 (-0.03, 0.02) -0.11 (-0.25, 0.04) 
 Model 2       
     GMT  262 -0.09 (-0.32, 0.15) 0.04 (-0.07, 0.14) 0.01 (-0.002, 0.02) 0.01 (-0.01, 0.03) -0.09 (-0.23, 0.05) 
     DET  267 -0.19 (-0.45, 0.08) -0.11 (-0.22, 0.002)  0.01 (0.0004, 0.03) § -0.003 (-0.03, 0.02) -0.13 (-0.28, 0.02) 
     IDN  266 -0.21 (-0.45, 0.02) § -0.05 (-0.16, 0.05) 0.02 (0.005, 0.03) **† -0.004 (-0.03, 0.02) -0.07 (-0.21, 0.07) 
     OCL  266 -0.04 (-0.29, 0.22) -0.06 (-0.18, 0.05) 0.002 (-0.01, 0.02) -0.03 (-0.06, -0.01) **† 0.04 (-0.12, 0.19) 
     ONB  267 -0.21 (-0.44, 0.02) -0.10 (-0.21, 0.002)  0.01 (-0.003, 0.02) -0.01 (-0.03, 0.02) -0.11 (-0.26, 0.03) 
All values represent β values and 95% confidence interval (CI). Data not available for IGF, n=4. Model 1: adjusted for age and sex, Model 2: adjusted for age, 
sex, education, DASS-21 depression subscale score, BMI, cardiometabolic status, and smoking status. Additionally adjusted for APOE and BDNF genotype. 
All models adjusted for clustering. ** P≤0.01, † significant after adjusting for genotype, § not significant after adjusting for multiple comparisons. Aβ: amyloid 
beta; BDNF: brain derived neurotrophic factor; DET: Detection task; GMT: Groton Maze Learning Test; IDN: Identification task; IGF-1: insulin-like growth 
factor-1; OCL: One Card Learning task; ONB: One Back task; VEGF: vascular endothelial growth factor. N.B: Aβ (1-40), Aβ (1-42), and VEGF were log-
transformed.     
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Appendix K: Associations between HR-QoL subdomains and inflammatory markers.  
 n 
IL-6 TNF-α IL-1β IL-10 IL-4 IL-8          CRP 
β-value (95% CI) β-value (95% CI) β-value (95% CI) β-value (95% CI) β-value (95% CI) β-value (95% CI) β-value (95% CI) 
Model 1         
PF 268 -1.26 (-2.68, 0.15)  0.42 (-1.54, 2.39) -0.05 (-0.95, 0.85) -0.48 (-1.28, 0.32) -0.17 (-0.99, 0.65) -1.96 (-4.16, 0.24)  -1.11 (-2.42, 0.20)  
RP 268 -0.69 (-1.99, 0.61) 0.82 (-0.98, 2.61) 0.09 (-0.73, 0.91) -0.45 (-1.18, 0.28) -0.05 (-0.80, 0.70) -1.18 (-3.20, 0.84) -0.99 (-2.19, 0.21)  
BP 268 -0.07 (-1.55, 1.41) 0.48 (-1.56, 2.52) 0.03 (-0.91, 0.96) 0.32 (-0.51, 1.15) -0.13 (-0.98, 0.72) -2.02 (-4.30, 0.25) -1.18 (-2.54, 0.17)  
GH 267 -1.11 (-2.12, 0.01) -0.78 (-2.32, 0.76) -0.55 (-1.26, 0.15) -0.003 (-0.63, 0.63) -0.46 (-1.10, 0.18) -1.90 (-3.63, -0.19) § -0.27 (-1.30, 0.76) 
VT 268 -1.50 (-2.76, -0.24) § -1.45 (-3.20, 0.30) 0.79 (-1.59, 0.001)  -0.82 (-1.53, -0.11) § -0.58 (-1.31, 0.15) -1.73 (-3.70, 0.23) -1.80 (-2.96, -0.64) † 
SF 268 -0.76 (-2.00, 0.48) 0.13 (-1.60, 1.85) -0.05 (-0.83, 0.74) -0.53 (-1.23, 0.17) -0.48 (-1.19, 0.24) -0.66 (-2.59, 1.27) -0.04 (-1.21, 1.11) 
RE 268 -0.80 (-2.33, 0.74) 1.23 (-0.90, 3.37) 0.09 (-0.89, 1.07) -0.27 (-1.14, 0.59) -0.18 (-1.07, 0.71) -0.10 (-2.49, 2.28) -0.46 (-1.90, 0.99) 
MH 268 -0.99 (-2.19, 0.20) -0.54 (-2.23, 1.16) -0.28 (-1.05, 0.48) -0.38 (-1.06, 0.30) -0.48 (-1.19, 0.23) -1.32 (-3.21, 0.56) 0.13 (-0.98, 1.25) 
Model 2         
PF 268 -0.65 (-1.92, 0.62) 0.72 (-1.01, 2.45) -0.07 (-0.87, 0.72) -0.20 (-0.92, 0.51) 0.09 (-0.64, 0.82) -1.53 (-3.46, 0.40) 0.21 (-1.46, 1.03) 
RP 268 -0.24 (-1.37, 0.89) 1.27 (-0.27, 2.80) -0.002 (-0.71, 0.70) -0.27 (-0.91, 0.36) 0.16 (-0.49, 0.80) -0.64 (-2.36, 1.08) -0.70 (-1.81, 0.40) 
BP 268 0.26 (-1.13, 1.64) 0.85 (-1.04, 2.73) -0.03 (-0.89, 0.83) 0.45 (-0.32, 1.22) 0.01 (-0.78, 0.81) -1.65 (-3.73, 0.43) -1.09 (-2.43, 0.25) 
GH 267 -0.69 (-1.70, 0.32) -0.42 (-1.79, 0.96) -0.52 (-1.15, 0.11) 0.17 (-0.40, 0.74) -0.23 (-0.81, 0.34) -1.49 (-3.01, 0.03) 0.11 (-0.87, 1.11) 
VT 268 -0.83 (-1.90, 0.24) -0.88 (-2.34, 0.58) -0.80 (-1.46, -0.13) § -0.53 (-1.13, 0.07) -0.27 (-0.89, 0.35) -1.25 (-2.88, 0.39) -1.49 (-2.53, -0.46) † 
SF 268 -0.27 (-1.33, 0.78) 0.91 (-0.55, 2.38) -0.17 (-0.83, 0.49) -0.28 (-0.87, 0.31) -0.30 (-0.90, 0.30) -0.07 (-1.68, 1.55) 0.10 (-0.94, 1.13) 
RE 268 0.13 (-1.16, 1.42) 2.19 (0.45, 3.93) § -0.12 (-0.93, 0.68) 0.10 (-0.63, 0.82) 0.06 (-0.68, 0.81) 0.62 (-1.34, 2.59) -0.47 (-1.75, 0.81) 
MH 268 -0.32 (-1.21, 0.57) 0.55 (-0.70, 1.79) -0.31 (-0.87, 0.25) 0.11 (-0.39, 0.60) -0.11 (-0.65, 0.42) -0.62 (-1.99, 0.76) 0.18 (-0.66, 1.02) 
All values represent β values and 95% confidence interval (CI). Data not available for CRP, n=4; and outliers removed for IL-8, IL-4 and CRP; n=1. Model 1: adjusted for age and sex, 
Model 2: adjusted for age, sex, education, DASS-21 depression subscale score, BMI, cardiometabolic status, and smoking status. Additionally adjusted for APOE and BDNF genotype. 
All models adjusted for clustering. † significant after adjusting for multiple comparisons and genotype, P≤0.006; § not significant after adjusting for multiple comparisons. BP: bodily 
pain; CRP: C-reactive protein; GH: general health; HR-QoL: health-related quality of life; IL-1β: interleukin-1 beta; IL-4: interleukin-4; IL-6: interleukin-6; IL-8: interleukin-8; IL-10: 
interleukin-10; MH: mental health; PF: physical functioning; RE: role emotional; RP: role physical; SF: social functioning; TNF-α: tumor-necrosis factor alpha; VT: vitality. N.B: All 
markers were log-transformed.
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Appendix L: Associations between HR-QoL and neurological markers. 
Characteristics n 
Aβ (1-40) Aβ (1-42) BDNF IGF-1 VEGF 
β-value (95% CI) β-value (95% CI) β-value (95% CI) β-value (95% CI) β-value (95% CI) 
Model 1        
PF 268 -0.78 (-3.47, 1.92)  0.20 (-1.03, 1.42) 0.01 (-0.12, 0.15)  0.10 (-0.15, 0.35) -0.61 (-2.25, 1.03) 
RP 268 -0.08 (-2.55, 2.39) -0.22 (-1.34, 0.90) 0.13 (0.01, 0.25) § 0.01 (-0.22, 0.24) -1.00 (-2.50, 0.50) 
BP 268 0.94 (-1.85, 3.74)  0.71 (-0.56, 1.98) 0.07 (-0.07, 0.21) 0.24 (-0.02, 0.50)   0.06 (-1.65, 1.77) 
GH 267  0.09 (-2.03, 2.21)  0.09 (-0.87, 1.06) 0.03 (-0.07, 0.14)  0.09 (-0.11, 0.29) -0.38 (-1.68, 0.91) 
VT 268 0.70 (-1.71, 3.10) -0.28 (-1.37, 0.81) 0.09 (-0.03, 0.21)  0.08 (-0.15, 0.30) -0.31 (-1.78, 1.16) 
SF 268 1.22 (-1.10, 3.55) 0.45 (-0.62, 1.51) 0.01 (-0.11, 0.12) -0.09 (-0.31, 0.13)  0.15 (-1.28, 1.59) 
RE 268 0.59 (-2.31, 3.50) -0.50 (-1.83, 0.83) 0.13 (-0.02, 0.27) -0.13 (-0.41, 0.14)  0.24 (-1.55, 2.04) 
MH 268 0.55 (-1.79, 2.88) -0.07 (-1.10, 0.97) 0.03 (-0.08, 0.14) 0.04 (-0.17, 0.25)  0.62 (-0.77, 2.02) 
Model 2       
PF 268 -0.54 (-2.90, 1.81)  0.14 (-0.93, 1.22) -0.04 (-0.16, 0.08) 0.08 (-0.14, 0.30) -0.59 (-2.05, 0.88) 
RP 268 0.28 (-1.82, 2.37) -0.31 (-1.27, 0.65)  0.09 (-0.02, 0.19)  0.02 (-0.18, 0.21) -1.07 (-2.37, 0.23)  
BP 268 1.33 (-1.23, 3.89) 0.67 (-0.50, 1.84)  0.03 (-0.10, 0.16) 0.25 (0.01, 0.49) § -0.11 (-1.70, 1.49) 
GH 267 0.23 (-1.64, 2.11) -0.02 (-0.88, 0.84)  0.01 (-0.09, 0.10) 0.08 (-0.10, 0.25) -0.52 (-1.69, 0.65) 
VT 268 0.96 (-1.03, 2.96) -0.20 (-1.11, 0.71)  0.05 (-0.05, 0.14) 0.07 (-0.11, 0.26) -0.63 (-1.87, 0.61) 
SF 268 1.61 (-0.34, 3.57) 0.56 (-0.34, 1.45) -0.04 (-0.14, 0.05) -0.08 (-0.26, 0.11) -0.24 (-1.46, 0.98) 
RE 268 1.69 (-0.69, 4.08) -0.23 (-1.33, 0.86)  0.06 (-0.06, 0.18) -0.13 (-0.36, 0.10) -0.11 (-1.60, 1.37) 
MH 268 0.39 (-1.37, 2.15) 0.16 (-0.57, 0.90) -0.02 (-0.10, 0.06)  0.05 (-0.10, 0.20) -0.30 (-1.30, 0.70) 
All values represent β values and 95% confidence interval (CI). Data not available for IGF, n=4. Model 1: adjusted for age and sex, Model 2: adjusted for age, sex, 
education, DASS-21 depression subscale score, BMI, cardiometabolic status, and smoking status. Additionally adjusted for APOE and BDNF genotype. All models 
adjusted for clustering. § not significant after adjusting for multiple comparisons. Aβ: amyloid beta; BDNF: brain derived neurotrophic factor; BP: bodily pain; GH: 
general health; HR-QoL: health-related quality of life; IGF-1: insulin-like growth factor-1; MH: mental health; PF: physical functioning; RE: role emotional; RP: role 
physical; SF: social functioning; VEGF: vascular endothelial growth factor; VT: vitality. N.B: Aβ (1-40), Aβ (1-42), and VEGF were log-transformed.  
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Appendix M: Associations between HR-QoL and well-being and neurological markers. 
Characteristics n 
Aβ (1-40) Aβ (1-42) BDNF IGF-1 VEGF 
β-value (95% CI) β-value (95% CI) β-value (95% CI) β-value (95% CI) β-value (95% CI) 
Model 1        
  PCS 267 -0.37 (-2.94, 2.19) 0.43 (-0.74, 1.61) 0.08 (-0.05, 0.20) 0.22 (-0.02, 0.46) -0.72 (-2.31, 0.86) 
  MCS 267 1.36 (-0.94, 3.66) -0.18 (-1.23, 0.88) 0.06 (-0.05, 0.18) -0.13 (-0.35, 0.09)  0.71 (-0.71, 2.13) 
  GQoL 268 0.47 (-1.44, 2.38) 0.04 (-0.83, 0.90) 0.06 (-0.03, 0.15) 0.03 (-0.14, 0.21) -0.17 (-1.33, 1.00) 
  SWL 267 1.00 (-3.33, 5.34) -0.13 (-2.14, 1.88) -0.07 (-0.28, 0.15) 0.02 (-0.39, 0.44)  0.16 (-2.53, 2.84) 
  PWI  268 0.89 (-2.43, 4.22) 0.21 (-1.32, 1.73) 0.01 (-0.16, 0.17) 0.03 (-0.29, 0.35) -1.01 (-3.07, 1.04) 
Model 2       
  PCS 267 -0.04 (-2.30, 2.23) 0.16 (-0.88, 1.20)  0.02 (-0.09, 0.14)  0.14 (-0.07, 0.35) -0.76 (-2.17, 0.65) 
  MCS 267 1.72 (-0.02, 3.46)  0.08 (-0.72, 0.89)  0.01 (-0.07, 0.10) -0.09 (-0.25, 0.08) -0.02 (-1.11, 1.07) 
  GQoL 268 0.79 (-0.61, 2.19) 0.09 (-0.55, 0.73)  0.02 (-0.05, 0.09)  0.05 (-0.09, 0.18) -0.43 (-1.30, 0.44) 
  SWL 267 0.78 (-3.17, 4.74) 0.08 (-1.75, 1.90) -0.12 (-0.32, 0.07)  0.06 (-0.32, 0.44) -0.62 (-3.08, 1.84) 
  PWI  268 0.89 (-2.09, 3.88) 0.19 (-1.18, 1.55) -0.02 (-0.17, 0.12)  0.03 (-0.25, 0.31) -1.34 (-3.20, 0.51) 
All values represent β values and 95% confidence interval (CI). Data not available for IGF, n=4. Model 1: adjusted for age and sex, Model 2: adjusted for age, sex, 
education, DASS-21 depression subscale score, BMI, cardiometabolic status, and smoking status. Additionally adjusted for APOE and BDNF genotype. All models 
adjusted for clustering. Aβ: amyloid beta; BDNF: brain derived neurotrophic factor; GQoL: overall HR-QoL composite; IGF-1: insulin-like growth factor-1; MCS: 
mental component summary; PCS: physical component summary; PWI: Personal Well-being Index composite; SWL: Satisfaction with Life single item score; VEGF: 
vascular endothelial growth factor. N.B: Aβ (1-40), Aβ (1-42), and VEGF were log-transformed.  
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Appendix N: Mean baseline outcome values (raw and standardised) for participants 
that provided data at both time points, and those not providing data at 26-week follow-
up testing.  
Characteristics 
Data provided at 
both baseline and 26 
weeks 1 
Data not provided 
 at 26 weeks2 
n 233 66 
Age, years 77.3 ± 6.8 78.0 ± 7.0 
Height, cm 162.0 ± 8.6 160.7 ± 9.2 
Cognition a   
  GMT  – Errors  84.2 ± 40.0 * 99.4 ± 40.8 
  GMT – Z-Score 0.08 ± 0.99 * -0.29 ± 1.00 
  DET– Speed  2.59 ± 0.09 * 2.62 ± 0.11 
  DET – Z-Score 0.07 ± 0.93 * -0.26 ± 1.19 
  IDN – Speed  2.76 ± 0.07 * 2.79 ± 0.10 
  IDN – Z-Score 0.09 ± 0.90 * -0.30 ± 1.26 
  OCL – Accuracy  0.93 ± 0.10 0.92 ± 0.10 
  OCL – Z-Score 0.03 ± 1.00 -0.09 ± 1.00 
  ONB – Speed  2.98 ± 0.10 * 3.02 ± 0.12 
  ONB – Z-Score 0.08 ± 0.94 * -0.29 ± 1.14 
  GCF Z-score  0.08 ± 0.60 * -0.21 ± 0.75 
  L-WM Z-Score  0.06 ± 0.77 * -0.19 ± 0.83 
  Psy-Att Z-Score 0.08 ± 0.79 * -0.28 ± 1.11 
  CBB Z-Score  0.07 ± 0.66 * -0.24 ± 0.84 
Muscle strength   
  Grip strength (D) 25.3 ± 8.6 23.4 ± 8.6 
  Grip strength (ND) 23.3 ± 8.3 21.9 ± 8.0 
Muscle function   
  TUG single-task (s) 9.0 ± 3.1 9.4 ± 2.8 
  TUG dual-task (s) 12.6 ± 6.5 14.2 ± 7.4 
  TUG DT-cost (%) 38.2 ± 41.4 * 51.6 ± 65.2 
  FSST (s) 10.5 ± 4.2 10.5 ± 3.9 
Muscle power   
  5-STS power (W/kg) 4.6 ± 0.83 * 4.4 ± 0.80 
Functional gait     
  Speed single-task (m/s) 1.2 ± 0.24 * 1.1 ± 0.21 
  Speed dual-task (m/s) 0.91 ± 0.27 0.83 ± 0.29 
  Speed DT-cost (%) 24.5 ± 15.6  26.9 ± 16.9 
CSRT   
  RT single-task (ms) 1138 ± 237 1194 ± 236 
  DT single-task (ms) 840 ± 187 867 ± 187 
  MT single-task (ms)           299 ± 83 * 323 ± 82 
  RT dual-task (ms) 1245 ± 226 * 1327 ± 289 
  DT dual-task (ms)   946 ± 170 * 1002 ± 216 
  MT dual-task (ms) 299 ± 101 325 ± 99 
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 RT DT-cost (%) 10.7 ± 14.5 11.9 ± 17.1 
 DT-cost (%) 14.6 ± 16.5 16.8 ± 17.4 
 MT DT-cost (%) 1.5 ± 26.3 0.6 ± 28.9 
Body composition   
  Weight (kg) 76.6 ± 15.5 74.0 ± 14.0 
  BMI (kg/m2) 29.2 ± 5.2 28.6 ± 4.6 
  Fat mass (kg) 29.7 ± 9.9 28.5 ± 9.4 
  Whole body fat (%) 38.0 ± 7.6 38.0 ± 7.7 
  Fat-free mass (kg) 47.4 ± 9.5 45.5 ± 8.4 
Baseline values are means ± SD. ‘Data not provided at 26 weeks’ is comprised of withdrawals 
(n=48) and those that did not attend testing due to illness/lost-to follow-up (n=18). N.B. Not 
included in ‘Data not provided at 26 weeks’ is n=1 for whom all data was withdrawn. a Means 
and standard deviations of raw scores are calculated on transformed data from CogState. 1 
n=232 for timed up and go (TUG) dual-task, TUG dual-task (DT)-cost, four square step test 
(FSST), gait speed dual-task, gait speed DT cost;  n=231 for One Card Learning task (OCL), 
Learning-Working memory composite (L-WM), CogState Brief Battery (CBB); n=226 for 
Groton Maze Learning Test (GMT), global cognitive function (GCF); n=225 for fat mass, 
whole body fat, and fat-free mass; 2 n=65 for weight, body mass index (BMI), height, grip 
strength, gait speed single-task, TUG single-task, choice stepping reaction time (CSRT) 
single-task decision (DT), response (RT), and movement times (MT); n=64 for TUG dual-
task, TUG DT-cost, gait speed dual-task condition, gait speed DT-cost, CSRT DT, RT, MT 
under dual-task conditions and dual-task cost; n=63 for 5-sit-to-stand (5-STS) power, FSST; 
n=62 for GMT, GCF, fat mass, whole body fat, fat-free mass, gait speed dual-task. * P<0.05 
for baseline differences. 
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Appendix O: Frequency of missing baseline data for participants randomised to the 
dual task functional power training group (DT-FPT) and the usual care control (CON) 
group. 
Characteristics DT-FPT CON 
Weight, kg  2 0 
BMI (kg/m2)  2 0 
Body composition  8 5 
Medication, n  2 2 
Smoking status, n  2 2 
DASS-21-Depression  2 1 
ApoE-ε4 carrier, n  11 7 
BDNF Met carrier, n  11 7 
Number of health conditions  2 2 
Presence of Cardiometabolic Risk Factors, n  2 2 
Employment Status, n  2 2 
Race 2 2 
Education, n 2 2 
Physical activity, n 2 2 
TUG-Single-Task, n 2 0 
TUG-Dual-Task, n 3 1 
Four square step test (FSST), n 3 2 
Gait, n 3 1 
Choice stepping reaction time test, n 2 1 
Grip Strength, n 2 1 
5-STS concentric power, n 2 2 
Groton Maze Learning Test, n * 5 6 
Detection Task, n 2 0 
Identification Task, n 2 0 
One Card Learning Task, n † 3 0 
One Back Task, n 2 0 
Includes n=1 participant who requested data be withdrawn for all categories in DT-
FPT group. N.B: Body composition not collected due to pacemaker; n=11. FSST not 
completed due to walker; n=3. All missing data represents participant not wishing/ 
physically unable to complete a task/provide data except those failing task criteria 
denoted by * (n=3) and † (n=1). BDNF: brain derived neurotrophic factor; BMI: body 
mass index; DASS: Depression, anxiety and stress scale; 5-STS: five sit-to-stand; 
TUG: Timed Up and Go.  
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Appendix P: Mean baseline cognitive function Z-scores by group, the within-group changes relative to baseline and net between-group differences for 
the change after 26 weeks in the dual-task functional power training (DT-FPT) and control (CON) groups according to per protocol analyses (≥50% 
compliance). 
 Baseline Values and Within Group Changes  
                    DT-FPT  CON Intervention Effects 
 n Mean ± SD or (95% CI) P-value n 
Mean ± SD or 
(95% CI) P-value 
Net Difference 
(95% CI) 
P- values 
Model 1 | Model 2 | Model 3  
GMT (Executive function)       
  Baseline  89 0.28 ± 0.87 ‡  138 -0.17 ± 1.03    
  ∆ 26 weeks 85 0.06 (-0.12, 0.24) 0.476 113 0.05 (-0.10, -0.20) 0.351 0.01 (-0.23, 0.24) 0.918 | 0.883 | 0.332 
DET (Psychomotor function)       
  Baseline  90 0.17 ± 0.89  144 -0.02 ± 0.98    
  ∆ 26 weeks 86 -0.25 (-0.44, -0.06)   0.006 117 -0.36 (-0.54, -0.19)   0.000 0.11 (-0.14, 0.37)  0.589 | 0.544 | 0.051 
IDN (Attention/Choice reaction time)       
  Baseline  90 0.07 ± 1.06  144 0.01 ± 1.00    
  ∆ 26 weeks 86 0.15 (-0.01, 0.31) 0.100 117 -0.12 (-0.25, 0.02) 0.228 0.27 (0.06, 0.48)  0.036 | 0.074 | 0.001 
OCL (Visual learning)        
  Baseline  90 0.18 ± 0.91 ‡  144 -0.09 ± 0.99    
  ∆ 26 weeks 86 -0.01 (-0.19, 0.18) 0.999 117 0.20 (0.01, 0.38) 0.067 -0.20 (-0.47, 0.07) 0.216 | 0.224 | 0.981 
ONB (Working memory)         
  Baseline  90 0.24 ± 1.06 ‡  144 -0.09 ± 0.94    
  ∆ 26 weeks 86 0.04 (-0.08, 0.16) 0.540 117 0.09 (-0.03, 0.22) 0.071 -0.05 (-0.22, 0.13) 0.423 | 0.268 | 0.760 
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Global cognitive function       
  Baseline  89 0.21 ± 0.61 ‡  138 -0.05 ± 0.62    
  ∆ 26 weeks 85 -0.01 (-0.09, 0.08) 0.878 113 -0.03 (-0.10, 0.04) 0.535 0.02 (-0.09, 0.13)  0.795 | 0.917 | 0.065 
Learning-Working Memory       
  Baseline  90 0.21 ± 0.78 ‡  144 -0.09 ± 0.73    
  ∆ 26 weeks 86 0.02 (-0.10, 0.13) 0.789 117 0.14 (0.04, 0.25)  0.004 -0.13 (-0.28, 0.03) 0.097 | 0.068 | 0.699 
Psychomotor function-Attention       
  Baseline  90 0.12 ± 0.87   144 -0.003 ± 0.88    
  ∆ 26 weeks 86 -0.05 (-0.19, 0.09) 0.382 117 -0.24 (-0.37, -0.11)  0.001 0.19 (0.001, 0.38)  0.107 | 0.147 | 0.006 
CogState Brief Battery       
  Baseline  90 0.17 ± 0.72 ‡  144 -0.05 ± 0.69    
  ∆ 26 weeks 86 -0.02 (-0.11, 0.07) 0.657 117  -0.05 (-0.13, 0.03) 0.379 0.03 (-0.09, 0.15)  0.755 | 0.928 | 0.065 
Baseline values are means ± SD; within and between-group (net) differences are unadjusted means with 95% CI. Net differences (95% CIs) were calculated by 
subtracting within-group changes from baseline for the CON group from within-group changes for the DT-FPT group after 26 weeks. Missing data points at 26-week 
testing compared to baseline for DT-FPT were due to unable to test at 26 weeks (n=2) and withdrawal (n=2). Missing data points at 26 weeks were due to unable to 
complete cognitive test (DT-FPT, n=1; CON, n=4). P-values for group, time, and group-by-time interaction terms were derived from linear mixed models with random 
effects after accounting for the following covariates: Model 1: Education level, sex and age, Model 2: Education level, age, sex, cardiometabolic status, baseline DASS-
21 depression subscale score at baseline, ApoE genotype and BDNF genotype and smoking history. P-values for Model 3 were derived from ANCOVA, adjusting for 
baseline differences and covariates in Model 1. ‡ P<0.05 baseline differences. GMT: Groton Maze Learning Test; DET: Detection task; IDN: Identification task; OCL: 
One Card Learning task; ONB: One Back task. 
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Appendix Q: Mean baseline body composition variables, the within-group changes relative to baseline and net between-group differences for the change 
after 26 weeks in the dual-task functional power training (DT-FPT) and control (CON) groups according to per protocol analyses (≥50% compliance). 
 Baseline Values and Within Group Changes  
 DT-FPT CON Intervention Effects 
 n Mean ± SD or (95% CI) P-value n 
Mean ± SD or 
(95% CI) P-value 
Net Difference 
(95% CI) 
P- values 
Model 1 | Model 2 
Weight         
  Baseline, kg  91 79.0 ± 17.7    144 74.3 ± 14.1    
  ∆ 26 weeks 87 -0.14 (-0.56, 0.28) 0.497 117 0.43 (0.05, 0.80)  0.024 -0.57 (-1.13, -0.01)   0.045 | 0.214 
BMI         
  Baseline, kg/m2 91 29.2 ± 5.6  144 29.0 ± 4.9    
  ∆ 26 weeks 87 -0.04 (-0.19, 0.10) 0.544 117 0.21 (0.05, 0.36) 0.009 -0.25 (-0.47, -0.03)  0.024 | 0.099 
Fat mass         
  Baseline, kg  86 29.5 ± 11.7  139 29.5 ± 8.9    
  ∆ 26 weeks 82 0.28 (-0.33, 0.89) 0.370 111 0.37 (-0.01, 0.74)  0.048 -0.09 (-0.77, 0.58) 0.773 | 0.836 
Total body fat         
  Baseline, % 86 36.2 ± 8.5  139 39.1 ± 6.7     
  % ∆ 26 weeks 82 0.38 (-0.25, 1.02) 0.228 111 0.21 (-0.22, 0.64) 0.332 0.18 (-0.56, 0.91) 0.647 | 0.552 
Fat-free mass           
  Baseline, kg 86 50.3 ± 10.5   139 45.0 ± 8.3    
  ∆ 26 weeks 82 -0.40 (-0.95, 0.14) 0.129 111 0.00 (-0.34, 0.34) 0.985 -0.40 (-1.01, 0.20) 0.165 | 0.375 
Baseline values are means ± SD; within and between-group (net) differences are unadjusted means of absolute and percentage change with 95% CI. Net differences (95% CIs) were calculated 
by subtracting within-group percentage changes from baseline for the CON group from within-group percentage changes for the DT-FPT group after 26 weeks. Missing data points at 26-
week testing compared to baseline for DT-FPT were due to unable to test at 26 weeks (n=2), and withdrawal (n=2). Missing data points at 26-week testing were due to injury (DT-FPT, n=1; 
CON, n=1), and the presence of a pacemaker (DT-FPT, n=4; CON, n=5). P-values for time and group-by-time interaction terms were derived from linear mixed models with random effects 
after accounting for sex (Model 1), and from ANCOVA after adjusting for sex and baseline differences (Model 2). ‡ P<0.05 baseline differences; BMI: body mass index. 
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Appendix R: Mean baseline muscle function variables, within-group changes relative to baseline and net between-group differences for the change after 
26 weeks in the dual-task functional power training (DT-FPT) and control (CON) groups.    
 Baseline Values and Within Group Changes  
     DT-FPT                          CON Intervention Effects 
 n Mean ± SD or (95% CI) P-value n 
Mean ± SD or 
(95% CI) P-value 
Net Difference 
(95% CI) 
P- values 
 Model 1  | Model 
TUG - Single-task         
  Baseline, sec  91 8.4 ± 2.4   144 9.5 ± 3.0    
   % ∆ 26 weeks 87 -1.6 (-5.0, 1.9) 0.388 117 1.3 (-1.7, 4.3) 0.480 -2.9 (-7.4, 1.7) 0.308 | 0.191 
TUG - Dual-task         
  Baseline, sec 91 11.8 ± 7.6  143 13.6 ± 6.6    
  % ∆ 26 weeks 87 -3.1 (-8.8, 2.7) 0.308 116 -0.7 (-6.0, 4.6) 0.587 -2.4 (-10.1, 5.4) 0.729 | 0.340 
TUG - DT cost         
  Baseline, % 91 37.2 ± 39.8  143 44.0 ± 55.3    
 %  ∆ 26 weeks 87 -1.2 (-8.3, 5.9) 0.606 116 -3.8 (-11.6, 3.9) 0.242 2.6 (-8.2, 13.4) 0.624 | 0.537 
FSST         
  Baseline, sec  91 10.2 ± 4.3  142    11.0 ± 4.4    
  %  ∆ 26 weeks 86 -6.3 (-10.3, -2.3)  0.002 117 -1.2 (-5.1, 2.8) 0.526    -5.1 (-10.8, 0.6)    0.087 | 0.017 
Baseline values are means ± SD; within and between-group (net) differences are unadjusted means of absolute and percentage change with 95% CI. Net differences (95% 
CIs) were calculated by subtracting within-group percentage changes from baseline for the CON group from within-group percentage changes for the DT-FPT group 
after 26 weeks. Missing data points at 26-week testing compared to baseline for DT-FPT were due to unable to test at 26 weeks (n=2), and withdrawal (n=2). Missing data points at 26-
week testing were due to unwillingness to undergo test (CON, n=1) and outliers (DT-FPT, n=1).  Log-transformed values of TUG DT-Cost were used in analysis but 
percentages are presented as absolute values. Percentages for TUG and FSST were calculated as log-transformed within-group and between-group changes x 100. P- 
values for time and group-by-time interaction terms were derived from linear mixed models with random effects after accounting for sex and change in gait aid (Model 
1), and from ANCOVA after adjusting for sex, change in gait aid, and baseline differences (Model 2). DT: dual-task; FSST: four square step test; sec: seconds; TUG: 
Timed Up and Go. 
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Appendix S: Mean baseline muscle power/strength variables, within-group changes relative to baseline and net between-group differences for 
the change after 26 weeks in the dual-task functional power training (DT-FPT) and control (CON) groups.    
 Baseline Values and Within Group Changes  
     DT-FPT                          CON Intervention Effects 
 n Mean ± SD or (95% CI) P-value n 
Mean ± SD or 
(95% CI) P-value 
Net Difference 
(95% CI) 
P- values 
 Model 1  | Model 2   
Grip strength (D)         
  Baseline, kg  91 28.0 ± 9.9   144 23.2 ± 7.7    
  % ∆ 26 weeks 86 0.0 (-2.6, 2.6) 0.933 116 -1.4 (-4.4, 1.6)  0.438 1.4 (-2.7, 5.5) 0.506 | 0.562 
Grip strength (ND)           
  Baseline, kg 91 25.9 ± 9.5   143 21.4 ± 7.2    
  %  ∆ 26 weeks 87 0.6 (-2.2, 3.4) 0.638 116 0.1 (-3.0, 3.2) 0.864 0.5 (-3.8, 4.8)  0.843 | 0.918 
5-STS power         
  Baseline, W/kg 91 4.8 ± 0.87  142   4.5 ± 0.83    
  %  ∆ 26 weeks 86 6.3 (3.8, 8.8)  0.000 115 -1.7 (-3.9, 0.6) 0.072    8.0 (4.6, 11.3)    0.000 | 0.000 
Baseline values are means ± SD; within and between-group (net) differences are unadjusted means of percentage change with 95% CI. Net differences (95% CIs) 
were calculated by subtracting within-group percentage changes from baseline for the CON group from within-group percentage changes for the DT-FPT group 
after 26 weeks. Missing data points at 26-week testing compared to baseline for DT-FPT were due to unable to test at 26 weeks (n=2), and withdrawal (n=2). 
Missing data points at 26-week testing due to injury (DT-FPT, n=1; CON, n=2). Percentages for grip strength are calculated as log-transformed within-group and 
between-group changes x 100. P-values for time and group-by-time interaction terms were derived from linear mixed models with random effects after accounting 
for sex (Model 1), and from ANCOVA after adjusting for sex and baseline differences (Model 2). 5-STS: five sit-to-stand test; D: dominant hand; ND: non-dominant 
hand; W/kg: power relative to body weight.
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Appendix T: Mean baseline functional gait performance while under single and dual-task conditions, within-group changes relative to baseline 
and net between-group differences for the change after 26 weeks in the dual-task functional power training (DT-FPT) and control (CON) groups.    
 Baseline Values and Within Group Changes  
     DT-FPT                          CON Intervention Effects 
 n Mean ± SD or (95% CI) P-value n 
Mean ± SD or 
(95% CI) P-value 
Net Difference 
(95% CI) 
P- values 
 Model 1  | Model 2   
Gait - Single-task         
  Baseline, m/s 91 1.24 ± 0.23   144 1.15 ± 0.23    
   ∆ 26 weeks 87 -0.001 (-0.05, 0.01) 0.884 117 -0.01 (-0.03, 0.02) 0.771 0.004 (-0.04, 0.05) 0.968 | 0.249  
Gait - Dual-task         
  Baseline, m/s 91 0.93 ± 0.26  143 0.87 ± 0.27    
  ∆ 26 weeks 87 0.04 (0.003, 0.1) 0.035 116 0.01 (-0.02, 0.03) 0.436 0.03 (-0.02, 0.08) 0.252 | 0.177 
Gait-DT cost         
  Baseline, % 91 25.2 ± 14.9  143 24.7 ± 15.4    
 ∆ 26 weeks 87 -3.0 (-5.8, -0.15) 0.032 116 -1.2 (-3.1, 0.7) 0.173 -1.8 (-5.0, 1.5) 0.302 | 0.713 
Baseline values are means ± SD; within and between-group (net) differences are unadjusted means of absolute and percentage change with 95% CI. Net differences 
(95% CIs) were calculated by subtracting within-group percentage changes from baseline for the CON group from within-group percentage changes for the DT-
FPT group after 26 weeks. Missing data points at 26-week testing compared to baseline for DT-FPT were due to unable to test at 26 weeks (n=2), and withdrawal 
(n=2). Missing data points at 26-week testing were due to unwillingness to undergo test (CON, n=1). P-values for time and group-by-time interaction terms were 
derived from linear mixed models with random effects after accounting for sex and change in gait aid (Model 1), and from ANCOVA after adjusting for sex, change 
in gait aid and baseline differences (Model 2). DT: dual-task, m/s: metres per second. 
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Appendix U: Mean baseline choice stepping reaction time (CSRT) test variables, within-group changes relative to baseline and net between-group 
differences for the change after 26 weeks in the dual-task functional power training (DT-FPT) and control (CON) groups.    
 Baseline Values and Within Group Changes  
     DT-FPT                          CON Intervention Effects 
 n Mean ± SD or (95% CI) P-value n 
Mean ± SD or 
(95% CI) P-value 
    Net Difference 
   (95% CI) 
P- values 
 Model 1  | Model 2   
CSRT - Single-task         
  Response time         
  Baseline, ms  91 1115 ± 222   144 1174 ± 251    
   ∆ 26 weeks 87 -22.4 (-65.2, 20.5) 0.327 117 23.2 (-13.8, 60.3) 0.359 -45.6 (-102.0, 10.8)     0.198 | 0.020 
  Decision time         
  Baseline, ms  91 824 ± 177  144 862 ± 174    
  ∆ 26 weeks 87 -29.5 (-67.1, 8.1) 0.094 117 11.4 (-21.8, 44.5) 0.694 -40.8 (-90.8, 9.1)  0.131 | 0.012  
  Movement time         
  Baseline, ms 91 290 ± 83  144 312 ± 87    
  ∆ 26 weeks 87 7.1 (-8.2, 22.4) 0.240 117 12.1 (-0.9, 25.0) 0.232 -4.9 (-24.8, 15.0) 0.806 | 0.593 
CSRT - Dual-task         
  Response time         
  Baseline, ms  91 1209 ± 206  143 1297 ± 271 ‡    
  ∆ 26 weeks 87 9.2 (-35.4, 53.9) 0.867 117 13.5 (-23.8, 50.9) 0.830 -4.3 (-61.9, 53.3) 0.968 | 0.602 
  Decision time         
  Baseline, ms   91 914 ± 162  143 987 ± 197 ‡     
  ∆ 26 weeks 87 3.5 (-34.1, 41.1) 0.992 117 2.6 (-28.3, 33.5) 0.572 0.9 (-47.1, 48.9) 0.699 | 0.689  
  Movement time         
  Baseline, ms  91 295 ± 87  143 311 ± 117    
 ∆ 26 weeks 87 5.5 (-13.1, 24.1) 0.637 117 11.0 (-8.6, 30.7) 0.203 -5.5 (-33.2, 22.2) 0.613 | 0.184 
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Dual-task Cost         
  Response-DT Cost         
  Baseline, % 91 10.0 ± 14.4   143 11.7 ± 16.7    
  ∆ 26 weeks 87 2.1 (-2.8, 6.9) 0.448 117 -1.49 (-5.0, 2.05) 0.776 3.6 (-2.3, 9.4)      0.482 | 0.864 
  Decision-DT Cost         
  Baseline, %  91 13.1 ± 16.9  143 16.3 ± 17.5    
  ∆ 26 weeks 87 3.8 (-1.5, 8.0) 0.552 117 -1.76 (-2.4, 9.7) 0.768 5.5 (-1.4, 12.5)      0.510 | 0.854 
  Movement-DT Cost         
  Baseline, %   91 3.3 ± 20.5  143 1.2 ± 33.1    
  ∆ 26 weeks 87 -1.7 (-8.5, 5.2) 0.562 117 -0.2 (-6.6, 6.2) 0.493 -1.5 (-10.9, 8.0) 0.964 | 0.286 
Baseline values are means ± SD; within and between-group (net) differences are unadjusted means of absolute and percentage change with 95% CI. Net differences 
(95% CIs) were calculated by subtracting within-group percentage changes from baseline for the CON group from within-group percentage changes for the DT-
FPT group after 26 weeks, however analyses were performed using log-transformed values. Missing data points at 26-week testing compared to baseline for DT-
FPT were due to unable to test at 26 weeks (n=2), and withdrawal (n=2). P-values for time and group-by-time interaction terms were derived from linear mixed 
models with random effects after accounting for sex and change in gait aid (Model 1), and from ANCOVA after adjusting for sex, change in gait aid and baseline 
differences (Model 2). ‡ P<0.05 baseline differences. DT: dual-task; ms: milliseconds.  
.
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Appendix V: Mean baseline HR-QoL and well-being norm-based values for 
participants that provided HR-QoL and well-being data at both time points, and those 
not providing data at 26-week follow-up testing.  
Variable 
Data provided at both 
baseline and 26 weeks 
Data not provided 
at 26 weeks 
n 236 61 
SF-36   
Physical Functioning 40.6 ± 11.4 * 37.2 ± 10.1 
Role Physical 45.1 ± 10.4 42.8 ± 9.8 
Bodily Pain 44.4 ± 11.4 43.6 ± 11.6 
General Health 2  47.3 ± 8.7 46.6 ± 8.1 
Vitality 49.0 ± 9.5 48.2 ± 10.0 
Social Functioning 49.7 ± 9.4 * 47.6 ± 9.3 
Role Emotional 47.3 ± 11.5 * 43.9 ± 12.8 
Mental Health 49.9 ± 8.8 49.3 ± 9.9 
PCS 2 42.7 ± 10.7 41.0 ± 8.7 
MCS 2 51.7 ± 9.1 50.6 ± 10.1 
Global HR-QoL 46.8 ±7.6 * 44.6 ± 8.0 
PWI   
Satisfaction with Life 1 79.2 ± 16.6 77.1 ± 19.8 
PWI average     80.7 ± 12.0 * 76.4 ± 16.5 
Baseline values are means ± SD, calculated on norm-based and composite data from SF-36. 1 
n=235 for ‘Data provided at both baseline and 26 weeks’, 2 n=60 for ‘Data not provided at 26 
weeks’. Data not provided at 26 weeks due to withdrawal (n=46) and did not attend testing 
due to illness/lost to follow-up (n=15). N.B: Three participants did not provide HR-QoL or 
well-being data at baseline. PCS: Physical component summary; MCS: Mental component 
summary. * P<0.05 for baseline differences. 
 
Appendix W: Mean baseline raw HR-QoL values for participants randomised to the 
dual-task functional power training group (DT-FPT) and control (CON) group.   
SF-36 domains DT-FPT CON 
    n 154 143 
Physical Functioning 63.4 ± 24.2 * 61.6 ± 24.8 
Role Physical 72.0 ± 25.5 69.8 ± 26.4 
Bodily Pain 65.8 ± 23.3 62.5 ± 25.4 
General Health 1  66.6 ± 17.6 64.8 ± 20.0 
Vitality 58.6 ± 20.1 58.9 ± 19.9 
Social Functioning 84.3 ± 21.3 84.7 ± 20.8 
Role Emotional 85.3 ± 21.2 * 86.2 ± 20.1 
Mental Health 79.9 ± 15.3 80.6 ± 15.4 
Baseline values are means ± SD and represent raw scores from SF-36 scales. 
1 n=142 for CON group. * P<0.05 for baseline differences. 
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Appendix X: Mean baseline HR-QoL norm-based and well-being scores, the within-group changes relative to baseline and net between-group 
differences for the change after 26 weeks in dual-task functional power training (DT-FPT) and control (CON) groups in per protocol analyses (≥50% 
compliance). 
 Baseline Values and Within Group Changes  
 DT-FPT CON Intervention Effects 
     n Mean  (95% CI) 
P-value n Mean  
(95% CI) 
P-value Net Difference  
(95% CI) 
P- values 
 Model 1 | Model 2 | Model 3 
Physical functioning         
  Baseline  91 41.7 ± 11.1  143 39.5 ± 11.4    
  ∆ 26 weeks 88 -0.10 (-1.40, 1.19) 0.868 118 -1.65 (-2.77, -0.53)  0.008 1.54 (0.16, 3.25)  0.136 | 0.131 | 0.060 
Role physical         
  Baseline  91 46.8 ± 9.63  143 44.2 ± 10.5    
  ∆ 26 weeks 88 0.71 (-1.06, 2.47) 0.439 118 -1.73 (-3.57, 0.11) 0.123 2.43 (-0.17, 5.04)  0.149 | 0.136 | 0.007 
Bodily pain         
  Baseline  91 45.6 ± 11.0  143 43.4 ± 11.9    
  ∆ 26 weeks 88 0.46 (-1.78, 2.70) 0.666 118 -0.70 (-2.43, 1.03) 0.603 1.16 (-1.61, 3.93) 0.564 | 0.562 | 0.278 
General health         
  Baseline  91 47.8 ± 8.27  142 46.8 ± 9.14    
  ∆ 26 weeks 88 0.77 (-0.57, 2.11) 0.266 118 0.74 (-0.42, 1.91) 0.164 0.03 (-1.74, 1.80) 0.911 | 0.944 | 0.405 
Vitality           
  Baseline  91 49.3 ± 9.36  143 48.9 ± 9.58    
  ∆ 26 weeks 88 0.21 (-1.22, 1.63) 0.839 118 0.13 (-1.28, 1.53) 0.720 0.08 (-1.95, 2.11) 0.970 | 0.991 | 0.949 
Social functioning         
  Baseline  91 50.3 ± 9.49  143 49.3 ± 9.31    
  ∆ 26 weeks 88 0.06 (-2.08, 2.21) 0.928 118 -2.28 (-4.22, -0.34)  0.039 2.34 (-0.55, 5.23)  0.202 | 0.169 | 0.039 
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Role emotional         
  Baseline  91 48.3 ± 12.1  143 46.9 ± 11.5    
  ∆ 26 weeks 88 0.81 (-1.44, 3.07) 0.507 118 -1.33 (-3.58, 0.92) 0.354 2.14 (-1.09, 5.38)  0.354 | 0.303 | 0.050 
Mental health         
  Baseline  91 49.7 ± 9.01  143 50.0 ± 9.05    
  ∆ 26 weeks 88 0.64 (-0.87, 2.14) 0.472 118 -0.17 (-1.51, 1.16) 0.988 0.81 (-1.19, 2.82) 0.483 | 0.462 | 0.921 
PCS         
  Baseline  91 44.1 ± 10.6  142 41.7 ± 10.4    
  ∆ 26 weeks 88 0.24 (-1.14, 1.62) 0.720 118 -1.01 (-2.15, 0.14) 0.131 1.25 (-0.53, 3.02)  | 0.257 | 0.254 | 0.032 
MCS         
  Baseline  91 51.7 ± 9.38  142 52.0 ± 9.29    
  ∆ 26 weeks 88 0.62 (-1.05, 2.29) 0.522 118 -0.62 (-2.10, 0.86) 0.441 1.24 (-0.99, 3.47) 0.340 | 0.286 | 0.193 
Global HR-QoL         
  Baseline  91 47.4 ± 7.56  143 46.1 ± 7.78    
  ∆ 26 weeks 88 0.44 (-0.50, 1.39) 0.367 118 -0.87 (-1.84, 0.09) 0.129 1.32 (-0.06, 2.69)  0.114 | 0.114 | 0.037 
Satisfaction with life         
  Baseline  90 79.2 ± 16.6  143 79.0 ± 18.0    
  ∆ 26 weeks 87 0.34 (-2.76, 3.45) 0.829 118 1.19 (-1.21, 3.58) 0.212 -0.84 (-4.68, 3.0) 0.604 | 0.664 | 0.146 
PWI          
  Baseline  91 81.5 ± 11.5  143 79.3 ± 14.1    
  ∆ 26 weeks 88 1.12 (-0.88, 3.13) 0.305 118 0.33 (-1.17, 1.83) 0.443 0.79 (-1.64, 3.23) 0.655 | 0.627 | 0.403 
Baseline values are means ± SD; within and between-group (net) differences are means with 95% CI. Net differences (95% CIs) were calculated by subtracting within-group changes from baseline for 
the DT-FPT group from within-group changes for the CON group after 26 weeks. Missing data points at 26-week testing compared to baseline for DT-FPT were due to unable to test at 26 weeks (n=1), 
and withdrawal (n=2). Missing data points at 26-week testing were due to unwillingness to complete test (DT-FPT, n=1). P-values for time, and group-by-time interaction terms were derived from linear 
mixed models with random effects after accounting for the following covariates: Model 1: adjusted for age and sex, Model 2: adjusted for age, sex, DASS-21 depression subscale score at baseline and 
cardiometabolic disease risk. P-values for Model 3 were derived from ANCOVA, adjusting for baseline differences and covariates in Model 1. HR-QoL: health-related quality of life; MCS: mental 
component summary; PCS: physical component summary; PWI: Personal Well-being Index composite.  
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Appendix Y: Mean baseline inflammatory and neurological biomarker untransformed 
concentrations in the subset of participants who provided blood samples at both time 
points and those not attending 26-week follow-up testing.    
Characteristics Serum at baseline  
and 26 weeks 
No serum at 26 weeks 
n 211 57 
Age, years 77.4 ± 6.8 77.2 ± 7.6 
Height, cm 162.3 ± 8.5 160.4 ± 8.8 
Weight (kg) 76.7 ± 14.9 75.3 ± 14.9 
BMI (kg/m2) 29.0 ± 5.1 29.2 ± 4.8 
Biomarkers   
IL-6, pg/mL 2.46 ± 2.07 2.30 ± 2.07 
TNF-α, pg/mL 11.5 ± 7.95 10.4 ± 5.00 
IL-1β, pg/mL 1.83 ± 4.20 1.39 ± 1.89 
IL-10, pg/mL 7.45 ± 14.5 4.67 ± 6.86 
IL-4, pg/mL1 27.2 ± 59.6  20.2 ± 22.0 
IL-8, pg/mL1 15.9 ± 13.6 13.7 ± 7.47 
CRP, mg/L2 2.59 ± 2.69     4.77 ± 5.23 * 
Aβ (1-40), pg/mL 110.6 ± 46.0 112.9 ± 28.9 
Aβ (1-42), pg/mL 5.13 ± 6.20 4.56 ± 6.20 
BDNF, ng/mL 30.5 ± 9.93 32.1 ± 8.53 
IGF-1, nmol/L 3 16.8 ± 4.96 16.1 ± 5.61 
VEGF, pg/mL 368.7 ± 344.2 406.7 ± 303.9 
 Total Z score -0.04 ± 0.76 0.15 ± 0.56 
Baseline values are means ± SD. 1 n=210, 2 n=207, 3 n=208 for ‘serum at baseline and 26 
weeks’; 2,3 n=56 for ‘no serum at 26 weeks’; * P<0.05 for baseline differences. 
 
Appendix Z: Reasons why total sample of participants randomised to the dual task 
functional power training group (DT-FPT) and the usual care control (CON) group 
(n=300), did not provide blood samples at baseline and 26-week time points.  
 
 
 Baseline 26 weeks 
 DT-FPT CON DT-FPT CON 
Illness/could not attend collection, n 8 9 9 11 
Withdrawal/loss to follow-up, n 4 4 32 19 
Unable to collect blood sample, n 3 3 2 1 
Total 15 16 43 31 
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Appendix AA: Mean baseline inflammatory profile by group, within-group changes relative to baseline and net between-group differences for the 
change after 26 weeks in the dual-task functional power training (DT-FPT) and control (CON) groups according to per protocol analyses (≥50% 
compliance). 
 Baseline Values and Within Group Changes  
 DT-FPT CON Intervention Effects 
 n Mean ± SD or (95% CI) 
P-value n Mean ± SD or 
(95% CI) 
P-value Net Difference 
(95% CI) 
P- values 
Model 1 | Model 2 | Model 3 
IL-6         
  Baseline  87 1.69 ± 1.39  128 3.06 ± 3.61 ‡    
  % ∆ 26 weeks 82 5.3 (-7.7, 18.3) 0.320 103 -5.3 (-21.7, 11.1) 0.325 8.6 (-14.0, 32.0) 0.178 | 0.147 | 0.814 
TNF-α         
  Baseline  87 9.53 ± 4.95  128 12.4 ± 8.68 ‡    
  % ∆ 26 weeks 82 -7.3 (-14.8, 0.2)  0.098 103 1.0 (-8.0, 10.1) 0.855 8.3 (-20.4, 3.8) 0.370 | 0.363 | 0.192 
IL-1β         
  Baseline  87 1.72 ± 5.25  128 1.95 ± 3.31    
  % ∆ 26 weeks 82 -4.7 (-20.1, 10.7) 0.654 103 -1.2 (-13.9, 11.5) 0.869 -3.5 (-23.2, 16.1) 0.831 | 0.840 | 0.586 
IL-8         
  Baseline  87 13.6 ± 9.86  127 17.1 ± 15.5     
  % ∆ 26 weeks 82 -4.4 (-11.3, 2.6) 0.332 102 -8.8 (-14.6, -2.9)  0.003 4.4 (-4.6, 13.4) 0.268 | 0.290 | 0.843 
CRP           
  Baseline  86 2.23 ± 1.95  126 3.37 ± 3.57 ‡     
  % ∆ 26 weeks 81 19.1 (-3.2, 41.4) 0.148 99 4.2 (-8.4, 16.9) 0.694 14.9 (-9.5, 39.3) 0.204 | 0.154 | 0.496 
IL-10         
  Baseline  87 4.64 ± 8.86  128 9.28 ± 16.8 ‡    
    % ∆ 26 weeks 82 -9.5 (-25.4, 6.4) 0.258 103 -16.4 (-28.1, -4.8)  0.004 6.9 (-12.2, 26.0) 0.439 | 0.407 | 0.778 
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IL-4         
  Baseline  87 17.0 ± 36.2  127 32.9 ± 66.3     
  % ∆ 26 weeks 82 24.1 (-0.8, 49.1)  0.060 102 -7.3 (-25.8, 11.1) 0.400 31.4 (1.2, 61.7) 0.039 | 0.035 | 0.488 
Single composite inflammatory Z-score        
  Baseline  87 -0.01 ± 0.42  128 -0.02 ± 0.91    
  ∆ 26 weeks 82 0.05 (-0.06, 0.16) 0.702 103 -0.08 (-0.18, 0.02) 0.651 0.13 (-0.02, 0.28) 0.967 | 0.980 | 0.540 
Pro-inflammatory Z-Score       
  Baseline  87 -0.17 ± 0.49  128 0.14 ± 0.71 ‡    
  ∆ 26 weeks 82 0.07 (-0.05, 0.19) 0.945 103 -0.10 (-0.19, -0.01)  0.142 0.17 (0.02, 0.31)  0.338 | 0.301 | 0.844 
Anti-inflammatory Z-Score       
  Baseline  87 -0.16 ± 0.55  128 0.16 ± 1.16 ‡    
  ∆ 26 weeks 82 0.02 (-0.02, 0.06)  0.734 103 -0.02 (-0.09, 0.06) 0.036 0.04 (-0.05, 0.13) 0.306 | 0.288 | 0.444 
Baseline values are means ± SD; within and between-group (net) differences are means with 95% confidence intervals (CI), and calculated by subtracting within-
group changes from baseline for the DT-FPT group from within-group changes for the CON group after 26 weeks. Missing data points at 26-week testing compared 
to baseline for DT-FPT were due to unable to test/have blood collected at 26 weeks (n=3), and withdrawal (n=2). Missing data points at 26-week testing were due to 
insufficient sample (DT-FPT, n=1; CON, n=4) and outliers (CON, n=2). Percentages are calculated as log-transformed within-group and between-group changes x 
100. Inflammatory Z-score was constructed from log-transformed concentrations where applicable and expressed as change. P-values were derived from linear mixed 
models with random effects after accounting for the following covariates: Model 1: age and sex, Model 2: adjusted for age, sex, BMI, cardiometabolic disease risk. 
P-values for Model 3 were derived from ANCOVA, adjusting for baseline differences and covariates in Model 1. ‡ P<0.05 baseline differences. Cytokine 
concentrations at baseline are presented in pg/mL, except for CRP which is measured in mg/L. CRP: C-reactive protein; IL-1β: interleukin-1 beta; IL-4: interleukin-
4; IL-6: interleukin-6; IL-8: interleukin-8; IL-10: interleukin-10; TNF-α: tumor-necrosis factor alpha.
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Appendix BB: Mean baseline neurological marker concentrations by group, within-group changes relative to baseline and net between-group 
differences for the change after 26 weeks in the dual-task functional power training (DT-FPT) and control (CON) groups according to per protocol 
analyses (≥50% compliance). 
 Baseline Values and Within Group Changes  
 DT-FPT CON Intervention Effects 
 n Mean ± SD or (95% CI) 
P-value n Mean ± SD or 
(95% CI) 
P-value Net Difference 
(95% CI) 
P- values 
Model 1 | Model 2 | Model 3 
Aβ (1-40)         
  Baseline  87 108.6 ± 50.4  128 109.2 ± 32.8    
  % ∆ 26 weeks 82 -2.8 (-9.4, 3.7) 0.369 102 7.80 (2.3, 13.3)  0.004 -10.6 (-19.0, -2.3)   0.010 | 0.010 | 0.100 
Aβ (1-42)         
  Baseline  87 5.45 ± 7.09  128 4.27 ± 4.92    
  % ∆ 26 weeks 82 20.7 (1.3, 40.1)  0.025 102 13.6 (-6.9, 34.0) 0.143 7.1 (-21.4, 35.7) 0.578 | 0.575 | 0.412 
BDNF         
  Baseline  87 31.9 ± 9.06 ‡  128 28.9 ± 9.80    
  % ∆ 26 weeks 82 0.97 (-5.5, 7.4) 0.662 103 12.4 (-0.04, 24.8) 0.762 -11.4 (-26.3, 3.5) 0.626 | 0.615 | 0.649 
IGF-1         
  Baseline  87 17.4 ± 5.37  127 16.5 ± 5.08    
  % ∆ 26 weeks 81 0.3 (-4.1, 4.8) 0.689 100 -0.21 (-3.2, 2.8) 0.616 0.5 (-4.6, 5.7) 0.984 | 0.911 | 0.907 
VEGF         
  Baseline  14 327.7 ± 225.1  128 415.6 ± 401.5 ‡    
  % ∆ 26 weeks 82 -9.7 (-19.9, 0.5) 0.053 103 -9.77 (-21.4, 1.8) 0.090 0.1 (-15.7, 15.8) 0.984 | 0.985 | 0.908 
Baseline values are means ± SD; within and between-group (net) differences are means with 95% confidence intervals (CI), and calculated by subtracting within-group changes from baseline for the 
DT-FPT group from within-group changes for the CON group after 26 weeks. Missing data points at 26-week testing compared to baseline for DT-FPT were due to unable to test/have blood collected 
at 26 weeks (n=3), and withdrawal (n=2). Missing data points at 26-week testing were due to insufficient sample (DT-FPT, n=1; CON, n=4). Percentages are calculated as log-transformed within-
group and between-group changes x 100 except for BDNF and IGF-1 which were not transformed. P-values were derived from linear mixed models with random effects after accounting for the 
following covariates: Model 1: age and sex, Model 2: adjusted for age, sex, BMI, cardiometabolic disease risk. P-values for Model 3 were derived from ANCOVA, adjusting for baseline differences 
and covariates in Model 1. ‡ P<0.05 baseline differences. Concentrations for Aβ and VEGF at baseline are presented as pg/mL, BDNF as ng/mL and IGF as nmol/L. Aβ: amyloid beta, BDNF: brain 
derived neurotrophic factor, IGF-1: insulin-like growth factor-1, VEGF: vascular endothelial growth factor. 
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Appendix CC: Review article of dual-task training published in Frontiers in Aging 
Neuroscience November 2017 (Tait et al. 2017). 
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